data_2kxr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.1 p -122.52 143.25 49.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 111.078 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.81 112.4 7.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.901 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 11.3 ttm-85 -121.54 129.43 52.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 156.89 27.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.685 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.68 154.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 110.989 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.438 ' CD1' HG13 ' A' ' 28' ' ' ILE . 18.7 m-85 -127.5 175.25 8.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.135 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -151.31 171.79 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -61.7 -23.13 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.942 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -56.4 -45.44 80.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.29 152.36 8.75 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.827 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.69 -173.32 45.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.087 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.8 t -145.64 150.61 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.392 0.615 . . . . 0.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 25' ' ' SER . 22.3 tp -123.34 100.18 6.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.233 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 143.82 50.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.99 0.424 . . . . 0.0 111.811 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.29 97.09 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.247 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -54.06 -26.82 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.419 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.47 -22.73 66.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.314 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -126.16 -52.97 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.79 -40.27 1.65 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.694 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -53.55 137.98 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.741 0.305 . . . . 0.0 111.129 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.5 p -141.82 169.75 17.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.0 mt -141.59 113.65 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.209 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.426 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.0 mp -93.14 131.42 40.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.438 HG13 ' CD1' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -103.41 95.15 6.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.608 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.54 138.41 75.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.353 2.036 . . . . 0.0 112.084 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -51.09 101.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.009 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.3 -3.98 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.013 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.05 -30.28 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.892 0.346 . . . . 0.0 111.225 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.491 HG23 HD11 ' A' ' 33' ' ' ILE . 28.3 mt -119.93 143.48 35.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.53 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HD3' HD22 ' A' ' 78' ' ' LEU . 21.5 Cg_exo -64.9 150.8 87.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.375 2.05 . . . . 0.0 112.114 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.57 151.68 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.46 65.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.57 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.81 160.56 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -128.68 113.83 15.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.05 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.443 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.05 109.05 20.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.04 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.45 114.69 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.808 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -124.91 139.02 52.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.138 0.494 . . . . 0.0 111.048 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.442 ' CB ' ' HA ' ' A' ' 7' ' ' ARG . 21.3 p90 -153.45 171.51 18.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.7 OUTLIER -175.5 156.81 2.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.181 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 122.12 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.077 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.441 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 39.6 t -110.32 136.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.537 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.27 96.43 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.554 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -69.14 143.16 54.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.25 -57.73 1.38 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -96.42 -173.89 0.36 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.258 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.37 -40.31 3.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.281 1.987 . . . . 0.0 111.877 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.2 tm? -161.19 78.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.6 t -137.61 117.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.566 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.42 106.17 16.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.707 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -163.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.114 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -74.59 -144.54 0.97 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.442 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 45.2 Cg_endo -68.12 128.33 17.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.133 . . . . 0.0 112.148 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -57.58 110.83 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.8 77.48 0.86 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.743 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 22.6 tp -141.41 86.64 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 110.061 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -56.18 166.27 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.134 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 19.2 m-85 -148.72 143.54 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.683 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -96.53 17.9 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -167.48 136.37 2.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.209 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.54 96.88 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.408 2.072 . . . . 0.0 112.6 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.1 140.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.536 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.03 125.12 32.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.798 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 20.5 tp -124.19 128.1 48.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.944 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -119.76 130.71 55.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.862 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.418 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -143.68 154.96 60.06 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.531 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 131.57 23.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.352 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -51.84 8.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.73 44.9 10.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.59 105.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.78 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.81 39.39 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.666 2.244 . . . . 0.0 112.828 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -108.71 13.26 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.132 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -120.99 16.19 11.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.493 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 8.8 p-90 -118.72 -45.01 2.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.781 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.493 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.9 OUTLIER -88.07 91.36 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -162.04 71.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tptp 60.29 34.93 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.64 -173.59 4.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.0 mt -83.87 126.03 71.55 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -71.29 -24.44 23.02 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.584 2.189 . . . . 0.0 112.602 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.31 14.12 20.97 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 6.3 t70 -114.0 130.53 23.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.893 0.346 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.423 ' O ' HG13 ' A' ' 106' ' ' VAL . 29.3 Cg_endo -62.94 -30.83 77.27 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.57 2.18 . . . . 0.0 112.222 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -55.57 -20.17 12.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 110.888 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.52 -12.21 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.06 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -165.26 -13.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -177.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 102' ' ' PRO . 15.9 m -65.12 36.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -153.15 25.26 0.79 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.15 -33.91 14.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.133 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -58.63 -31.62 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -150.43 139.14 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.415 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 13.8 p -91.31 112.0 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 105.04 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.27 123.6 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.061 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -93.5 139.16 31.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.953 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.2 mm -121.33 122.22 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.41 25.94 6.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.092 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.503 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.63 102.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.078 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 p -137.41 143.39 41.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.995 0.426 . . . . 0.0 111.274 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.37 137.21 38.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.8 mpp_? -134.73 137.72 43.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 160.86 33.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.822 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.43 154.88 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.598 0.237 . . . . 0.0 110.655 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.45 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 51.1 m-85 -135.17 146.01 48.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.28 171.87 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.631 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p -48.84 -26.92 2.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.172 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -56.8 -31.91 65.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.62 -174.57 32.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.546 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.26 -161.66 29.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.121 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.427 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.8 t -143.75 151.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 111.731 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 25' ' ' SER . 39.2 tp -123.02 99.96 6.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.041 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.39 154.8 33.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 111.961 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.405 ' OG ' ' CZ ' ' A' ' 43' ' ' PHE . 19.4 m -120.94 97.22 5.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.147 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -51.56 -26.53 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.697 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.41 -46.29 77.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.464 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.92 -52.94 3.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 111.371 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.02 -36.25 2.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -53.93 145.8 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.738 0.304 . . . . 0.0 110.853 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.69 167.34 26.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 0.0 111.513 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 mt -134.1 113.84 18.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.717 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.427 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.5 mp -91.69 119.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.797 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 5.3 mt -106.77 97.35 17.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.95 156.86 64.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.435 2.09 . . . . 0.0 112.139 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -57.75 112.97 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.71 5.93 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.198 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.68 -25.88 24.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.022 0.411 . . . . 0.0 111.21 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 32.4 mt -122.53 141.92 36.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.45 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.75 155.47 53.92 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.315 2.01 . . . . 0.0 112.11 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -67.89 154.99 40.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.41 26.6 56.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -133.3 159.93 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.64 113.81 12.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.852 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.74 112.05 25.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.14 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -72.59 124.23 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.72 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.6 135.24 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.17 0.509 . . . . 0.0 111.423 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.429 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.9 p90 -148.36 169.33 20.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.9 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -165.63 157.7 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.443 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.66 115.95 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -109.44 135.44 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.523 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.443 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.9 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.388 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.49 109.45 20.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.26 142.57 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.5 -57.75 1.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 111.254 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -98.58 -175.22 0.42 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.308 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.5 Cg_exo -40.53 -44.35 4.4 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.242 1.961 . . . . 0.0 111.684 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 46' ' ' CYS . 3.0 tm? -153.18 86.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.495 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.3 t -147.63 117.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.429 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -108.52 105.86 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.83 -172.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.19 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 42' ' ' TYR . . . -62.87 -147.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.42 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 36.6 Cg_endo -65.51 126.68 16.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.137 . . . . 0.0 111.932 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -52.97 110.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.27 80.86 1.37 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.9 tp -143.05 86.81 1.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.17 0.51 . . . . 0.0 110.26 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 8.5 tmtt? -67.39 145.72 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.092 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 52.3 m-85 -122.77 151.41 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.715 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.16 14.62 21.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.28 0.562 . . . . 0.0 111.145 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -161.15 136.51 5.72 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.288 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.47 98.47 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.376 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 4.5 m -70.58 142.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.82 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.75 125.94 36.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.309 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 tp -124.08 129.01 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.5 mtm105 -125.76 124.78 41.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.182 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.422 ' HG ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -137.0 134.36 19.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.631 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.94 143.37 49.56 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.352 2.035 . . . . 0.0 112.152 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 25.6 p-80 -49.78 -47.32 51.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 9.2 m 49.22 76.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.213 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.32 92.83 0.28 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.71 41.13 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.94 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.08 -11.3 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.1 t -120.69 16.07 11.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.458 ' CZ2' ' HG3' ' A' ' 94' ' ' GLN . 2.4 p-90 -113.65 -35.75 5.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.458 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -101.45 -23.25 14.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.254 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -98.81 -27.09 14.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -67.3 0.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.134 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.92 177.0 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.53 129.45 42.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.98 -22.31 68.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.662 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.48 -39.92 6.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.946 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 2.5 m-20 -55.3 124.96 56.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.48 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 49.3 Cg_exo -55.24 -31.58 76.99 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.377 2.051 . . . . 0.0 112.2 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.8 -14.94 57.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.481 ' C ' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -17.49 6.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.912 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.481 ' HG ' ' C ' ' A' ' 104' ' ' TYR . 10.3 mt -158.08 -32.11 0.07 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.1 m -69.11 36.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -144.04 -42.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.746 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.42 -60.29 3.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 111.346 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 62.91 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 22.4 m -151.2 171.55 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 0.0 111.009 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.422 HG12 ' HG ' ' A' ' 85' ' ' LEU . 11.1 p -109.24 120.11 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.34 105.1 7.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -127.24 121.71 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.056 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 mt -89.46 140.33 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.414 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 29.8 mm -127.22 121.93 58.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.73 24.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.251 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.481 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 179.2 111.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.004 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.751 0.31 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -127.46 143.69 51.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 0.0 111.15 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.7 107.07 8.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.901 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 17.6 mtt180 -107.08 129.39 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.4 142.03 6.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.006 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.436 HG23 HD13 ' A' ' 9' ' ' ILE . 25.9 mt -87.51 159.82 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.633 0.254 . . . . 0.0 110.433 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 28' ' ' ILE . 92.5 m-85 -140.73 152.28 45.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -131.17 172.3 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.6 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -44.82 -28.89 0.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.49 -33.79 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -174.86 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.754 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.07 163.28 11.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.144 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.92 150.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.369 0.604 . . . . 0.0 111.702 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -123.5 100.34 6.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.457 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.18 149.53 50.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 111.958 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.54 97.1 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.927 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.77 -26.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.742 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 9.5 tt0 -62.24 -41.42 98.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 p -106.34 -52.91 2.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.67 -35.18 2.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 t -49.08 139.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.14 155.64 42.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 111.382 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 26' ' ' ILE . 49.5 mt -136.98 113.54 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.568 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.64 136.01 26.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.002 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.455 HD13 ' CD2' ' A' ' 10' ' ' PHE . 2.7 mt -124.65 89.22 52.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.8 160.87 46.38 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.495 2.13 . . . . 0.0 112.218 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -57.12 113.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.65 -2.7 4.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.033 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.33 -29.43 21.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.997 0.399 . . . . 0.0 111.043 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 20.9 mt -122.78 137.16 27.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.62 155.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.214 1.943 . . . . 0.0 112.149 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.59 140.43 58.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.39 21.71 78.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.429 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 43.3 t -123.34 160.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 111.211 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 2.7 mt-10 -139.28 113.6 8.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.74 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 7.5 mm-40 -105.04 108.95 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.056 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -72.96 121.1 19.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 mt -128.18 130.16 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.437 ' CE1' ' HD3' ' A' ' 72' ' ' PRO . 31.8 p90 -144.75 142.2 29.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.904 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 2.3 p90 -145.08 164.36 31.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.088 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 150.25 50.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.22 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.6 t -144.07 140.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.748 0.309 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 118.77 30.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -95.66 137.97 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.39 -57.59 1.38 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.482 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -89.68 -177.56 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.679 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.3 -49.02 4.01 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.53 2.154 . . . . 0.0 111.771 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -151.15 84.82 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 46.2 t -146.78 118.21 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.563 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.66 107.08 16.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.692 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.94 -168.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.151 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.55 -155.98 0.17 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.615 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.437 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 51.1 Cg_exo -53.78 130.63 40.02 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.519 2.146 . . . . 0.0 112.201 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 111.05 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.816 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.21 84.04 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.719 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 33.0 tp -142.16 86.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 110.146 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.449 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 0.5 OUTLIER -57.53 164.51 1.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.117 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -148.13 146.98 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.67 15.32 22.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.07 136.53 6.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.52 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.64 99.32 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.446 2.098 . . . . 0.0 112.457 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.67 143.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.864 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.85 128.2 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.192 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -124.35 127.06 47.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.499 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -114.93 133.78 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.7 107.6 17.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.08 131.23 43.62 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.388 2.059 . . . . 0.0 112.14 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -27.13 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.085 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 12.9 m 65.37 -166.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.25 94.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.38 49.57 3.25 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.668 2.245 . . . . 0.0 112.666 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 5.04 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.412 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.51 16.12 10.41 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.922 0.392 . . . . 0.0 111.845 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.654 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -115.0 -36.11 4.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.654 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 3.1 mt-30 -105.04 55.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.098 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -157.63 105.16 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.16 33.3 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.4 m -133.95 176.17 8.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.991 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.5 mt -91.31 131.67 35.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -77.23 -2.35 12.56 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.26 -18.44 6.72 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.806 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.409 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -66.26 116.57 34.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.59 0.233 . . . . 0.0 110.86 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 71.6 Cg_exo -50.82 -30.61 30.33 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.472 2.115 . . . . 0.0 112.296 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -60.59 -19.49 57.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.4 -18.71 19.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.735 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 20.2 mt -157.01 -29.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.85 36.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 118.62 47.41 0.41 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.566 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.5 -34.49 12.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.46 82.47 2.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.04 139.24 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.706 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 111' ' ' VAL . 14.9 p -99.57 108.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.466 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.09 104.91 11.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.68 131.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.241 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mt -103.35 134.81 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 38.0 mm -122.13 122.9 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.559 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -124.01 26.47 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.956 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.449 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -173.11 101.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.16 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 2.3 m-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -119.89 143.99 47.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.74 115.71 16.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.852 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -120.48 131.95 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.35 28.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.084 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -105.72 131.84 54.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.709 0.29 . . . . 0.0 110.453 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CG ' HD13 ' A' ' 28' ' ' ILE . 71.6 m-85 -112.48 153.26 27.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.047 0.451 . . . . 0.0 111.429 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.7 171.99 9.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -48.26 -27.48 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.33 -37.26 69.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.258 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 179.01 23.62 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.577 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.01 167.45 15.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.084 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.87 148.22 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.73 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.4 tp -123.3 100.2 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.203 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.91 145.51 50.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 111.854 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -110.84 97.19 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.249 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -50.48 -26.5 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.644 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -30.5 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.36 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -115.52 -53.0 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.726 0.298 . . . . 0.0 111.291 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.65 -38.04 1.97 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.788 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -48.56 144.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.0 p -149.73 152.06 34.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.465 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.6 mt -129.84 113.37 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.442 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 mt -97.3 123.24 49.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.058 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.42 HD13 ' CG ' ' A' ' 10' ' ' PHE . 1.5 mt -113.53 92.91 25.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.63 157.37 58.93 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.94 106.54 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 137.68 -7.23 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.106 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' CB ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.72 -24.28 36.22 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.934 0.367 . . . . 0.0 111.234 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 35.4 mt -125.68 141.1 38.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.472 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 39.2 Cg_exo -59.92 155.45 44.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.85 148.68 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.63 22.89 68.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.547 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.5 t -130.31 160.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.027 0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -131.55 113.96 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.996 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -101.12 109.05 20.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.993 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.1 123.23 21.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.595 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.34 132.71 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.5 p90 -146.81 170.07 17.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.333 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -175.93 157.31 1.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.378 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -128.35 133.04 48.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.079 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.9 t -119.86 130.63 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.569 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 67' ' ' LEU . 1.1 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.179 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 pm0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -123.01 99.15 6.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.236 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.34 138.32 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.39 -57.62 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.996 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.522 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -91.49 -172.56 0.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.195 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 63.7 Cg_exo -40.19 -48.53 3.97 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.203 1.936 . . . . 0.0 111.815 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 46' ' ' CYS . 1.9 tm? -155.67 78.72 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.781 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 42.5 t -137.56 117.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.746 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.3 106.91 17.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.662 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.86 -171.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.065 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -63.87 -144.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.542 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 51.4 Cg_endo -68.97 130.59 20.61 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.475 2.116 . . . . 0.0 111.989 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -57.67 110.76 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.5 75.59 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.765 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 5.1 tp -138.76 84.62 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 1.5 tmtm? -63.23 151.88 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.236 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 31.4 m-85 -129.69 151.17 50.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.551 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -93.73 15.23 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 111.221 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.04 136.42 3.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.269 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.06 99.2 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 6.6 m -69.76 152.8 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.0 126.81 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 111.343 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.413 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 36.5 tp -124.21 116.94 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -106.92 131.01 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.159 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.417 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.1 OUTLIER -130.54 123.29 20.26 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.765 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.08 120.1 5.9 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.34 2.027 . . . . 0.0 112.095 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.06 -30.19 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.1 m 60.54 65.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -114.32 110.83 47.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.815 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.98 39.04 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.653 2.235 . . . . 0.0 112.929 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 -9.13 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.597 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.6 t -122.7 16.07 10.25 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.451 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.8 p-90 -107.03 -38.4 6.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.071 0.462 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.451 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -95.61 56.4 1.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.811 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.16 -45.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.1 -46.58 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 62.3 m -54.9 176.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.122 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.8 mt -99.86 124.26 44.47 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.23 -26.97 72.22 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.469 2.112 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.55 -16.11 44.06 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.967 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.62 137.95 51.13 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.808 0.304 . . . . 0.0 111.008 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 53.2 Cg_endo -68.71 -24.39 35.0 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.4 ' HA ' HG23 ' A' ' 106' ' ' VAL . 96.9 m-20 -64.07 -17.01 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -20.21 15.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.85 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 16.6 mt -155.08 -26.82 0.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.9 m -66.78 36.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 123.06 36.4 0.66 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.531 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.44 -33.32 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -134.03 51.48 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.87 141.05 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 13.8 p -85.38 107.61 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.391 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.71 104.92 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.99 125.0 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.4 mt -90.07 145.13 25.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 35.3 mm -129.32 117.66 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.53 27.42 8.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.492 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.98 106.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.815 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 p -136.59 145.38 44.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 17' ' ' LEU . . . -133.84 133.06 41.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 4.6 ttt180 -135.7 129.33 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.526 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.99 169.96 42.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.64 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 28.2 mt -104.49 137.88 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 87.9 m-85 -120.35 153.2 36.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -124.21 171.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 p -55.91 -22.38 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.266 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.61 -36.31 71.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 110.963 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.68 158.68 11.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.72 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.01 164.46 25.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.255 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.26 152.38 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 25' ' ' SER . 28.5 tp -123.34 100.2 6.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.365 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.47 154.35 42.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 0.0 112.039 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 p -119.92 97.2 5.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.967 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.0 mm -49.4 -26.57 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.914 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -65.35 -55.69 16.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.343 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 p -90.45 -52.88 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.296 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.43 -36.54 2.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.781 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.66 143.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.655 0.264 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -148.8 161.63 41.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.474 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.511 HG23 HD12 ' A' ' 26' ' ' ILE . 32.2 mt -137.38 113.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.774 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 82' ' ' GLU . 2.4 mp -92.39 128.24 44.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.851 0.358 . . . . 0.0 110.926 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.444 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 2.2 mt -112.75 94.49 28.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.435 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.21 157.68 48.46 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.661 2.241 . . . . 0.0 112.452 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -60.89 95.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.617 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 145.14 -11.3 1.82 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.877 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -72.94 -23.57 60.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.823 0.311 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 33' ' ' ILE . 39.1 mt -124.5 141.85 38.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.449 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.68 152.37 56.71 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.378 2.052 . . . . 0.0 112.371 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.93 152.55 45.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.96 23.34 56.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.1 160.75 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 111.075 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -132.62 113.94 13.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.121 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.01 113.37 25.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.037 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -74.4 115.66 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.4 mt -123.23 139.71 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.174 0.511 . . . . 0.0 111.255 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.436 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 21.0 p90 -153.06 162.61 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -166.36 158.89 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.923 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.92 149.33 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.509 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.429 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 37.1 t -145.29 135.36 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 18.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.944 -179.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.839 0.352 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.78 104.98 10.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.71 139.06 37.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.46 -57.6 1.37 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.284 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.475 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -94.37 -175.37 0.47 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.29 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.25 -46.97 5.49 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.169 1.912 . . . . 0.0 111.538 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.6 tm? -151.53 80.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.528 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.9 t -141.85 118.24 6.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.511 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -106.53 106.16 16.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.613 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.87 -178.67 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.08 -156.71 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.637 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 48.7 Cg_exo -55.4 129.26 34.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.534 2.156 . . . . 0.0 112.12 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -58.45 111.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.06 72.42 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 20.6 tp -137.96 83.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.262 0.553 . . . . 0.0 110.002 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 10.3 mttt -73.0 117.16 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.046 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -90.76 154.24 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -96.36 17.17 16.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.43 136.68 4.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.69 94.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.537 2.158 . . . . 0.0 112.769 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 m -70.1 133.4 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.553 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 28.9 mt-10 -82.64 128.18 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 111.563 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 14.7 tp -124.19 128.72 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.164 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -115.73 127.41 55.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 0.0 111.561 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -143.64 162.25 42.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.18 120.07 6.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.391 2.061 . . . . 0.0 112.313 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.54 -54.52 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 65.0 m 56.14 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.85 74.87 0.72 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.265 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 93' ' ' TRP . 96.3 Cg_endo -86.46 35.48 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.753 2.302 . . . . 0.0 112.929 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -13.75 14.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.658 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -122.62 16.15 10.32 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.476 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.3 p-90 -106.83 -35.87 6.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.476 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 7.7 pt20 -102.02 35.02 2.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -156.81 28.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -177.2 -62.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.4 m -70.75 178.93 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.1 mt -98.68 121.61 55.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.8 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.71 -35.54 97.75 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.457 2.105 . . . . 0.0 112.36 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.56 -17.42 66.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.889 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -81.56 138.57 47.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.976 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 50.0 Cg_endo -68.4 -24.52 36.74 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.516 2.144 . . . . 0.0 112.327 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -63.73 -16.77 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 110.568 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.68 -18.89 23.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.98 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 16.4 mt -156.75 -24.19 0.1 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 8.0 m -67.99 36.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.5 -44.18 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.238 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.83 -68.28 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.402 . . . . 0.0 110.994 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.68 -67.91 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 66.1 m -121.34 167.85 12.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.095 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -108.0 139.22 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.86 105.05 16.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.371 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.1 m -129.8 123.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.073 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mt -97.04 142.12 29.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 39.5 mm -123.84 123.26 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.0 25.83 7.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.915 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.473 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -174.2 103.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.401 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.2 p -118.35 143.25 46.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.0 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.56 109.35 8.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.664 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -117.68 129.85 55.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.07 154.26 22.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.709 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.28 144.14 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.935 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD2' ' CD1' ' A' ' 28' ' ' ILE . 29.4 m-85 -117.64 151.87 36.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.218 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -125.52 171.89 10.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.753 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -53.85 -23.65 13.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -42.48 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.186 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.04 130.47 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.771 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -151.93 -139.78 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.983 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 27' ' ' ILE . 2.1 t -151.52 148.3 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 111.684 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 43' ' ' PHE . 15.3 tp -123.29 100.06 6.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.718 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.22 139.91 52.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.198 0.523 . . . . 0.0 112.391 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 t -111.54 96.54 6.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.905 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 tp -58.85 -26.61 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.81 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -28.8 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.313 . . . . 0.0 110.722 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -115.73 -52.81 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.777 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.56 -32.03 3.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.953 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.6 147.07 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.826 0.346 . . . . 0.0 111.201 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.78 160.81 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.4 HG12 ' CD1' ' A' ' 83' ' ' LEU . 13.5 mt -135.58 113.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.75 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HA ' HG12 ' A' ' 16' ' ' VAL . 2.6 mt -96.38 114.72 33.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.451 ' CD1' ' CD2' ' A' ' 10' ' ' PHE . 4.3 mt -103.41 91.67 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.26 161.67 33.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.472 2.115 . . . . 0.0 112.506 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -59.49 111.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.36 -4.46 5.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.086 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -82.51 -22.51 35.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.782 0.291 . . . . 0.0 111.377 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.471 HG23 HD13 ' A' ' 33' ' ' ILE . 32.9 mt -131.58 139.17 34.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.768 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.03 155.47 28.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.46 2.106 . . . . 0.0 112.221 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -68.82 148.96 49.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.81 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.51 24.86 69.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -130.02 160.69 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -134.7 113.82 12.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.018 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -100.64 109.59 21.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.035 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -69.71 118.43 12.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.65 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.4 mt -127.1 139.95 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.429 ' HB3' ' CG ' ' A' ' 7' ' ' ARG . 39.9 p90 -155.62 159.17 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.347 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CD1' HD23 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -164.18 163.5 22.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.955 0.407 . . . . 0.0 111.592 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -131.06 142.31 50.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.743 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.54 138.8 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.401 ' O ' HD13 ' A' ' 67' ' ' LEU . 40.9 t . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.49 98.35 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.73 142.14 35.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.993 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -90.56 -173.19 0.37 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.187 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.3 Cg_exo -40.63 -43.71 4.39 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.209 1.94 . . . . 0.0 111.716 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.2 tm? -160.6 79.73 0.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.2 t -138.27 118.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.701 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.06 106.27 17.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.632 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -170.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -62.94 -154.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.431 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -62.56 123.4 12.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.462 2.108 . . . . 0.0 112.058 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -50.77 110.86 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.54 0.67 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 11.9 tp -139.15 85.17 2.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.0 110.242 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 16.2 tttm -65.96 138.49 57.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.866 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 37.6 m-85 -115.89 151.94 34.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.572 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.27 14.04 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 111.032 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -160.77 136.42 5.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.131 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.86 98.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.391 2.061 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.92 156.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.884 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.35 106.62 17.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.354 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 26' ' ' ILE . 22.9 tp -104.26 129.72 52.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.82 134.04 54.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.67 136.46 13.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.3 135.16 18.18 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.488 2.125 . . . . 0.0 112.206 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -59.2 -26.41 64.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.56 31.2 18.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.783 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -153.32 100.6 2.63 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.07 50.65 3.56 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.651 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 -6.64 15.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.514 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -111.07 16.15 21.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.402 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.6 p-90 -113.26 -37.24 4.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.402 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.8 OUTLIER -107.79 162.68 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.993 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.88 -65.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -69.01 -61.35 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 m -84.04 -178.27 6.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.95 123.32 66.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.24 -46.35 25.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.533 2.155 . . . . 0.0 112.467 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.54 -21.12 79.21 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.992 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -69.15 121.74 82.92 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.584 0.231 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.446 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 51.8 Cg_exo -53.3 -29.87 49.45 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.414 2.076 . . . . 0.0 112.223 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.51 -19.72 57.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.35 -19.81 16.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.627 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 17.9 mt -155.79 -29.2 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.98 36.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 174.59 -32.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.71 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.05 18.46 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.587 0.232 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -70.46 -31.76 69.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 13.0 m -139.88 166.05 25.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.412 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 14.8 p -101.34 120.22 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 105.15 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 m -126.18 121.88 60.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.88 145.99 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.046 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 33.9 mm -129.72 120.24 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -123.61 25.76 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.234 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.432 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.46 109.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.496 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.627 0.251 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.9 p -133.52 143.57 48.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.13 124.05 14.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.899 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.403 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 15.0 mtm180 -127.09 129.52 48.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.574 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 148.03 11.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.042 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.5 mt -87.68 155.39 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.519 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CE2' HD12 ' A' ' 28' ' ' ILE . 56.5 m-85 -132.02 148.23 52.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.26 172.21 12.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.449 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -46.56 -27.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.438 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.23 -41.23 49.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.76 129.06 3.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.44 -158.86 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.016 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.7 t -140.02 151.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.793 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.5 tp -123.22 100.18 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.232 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -122.47 154.03 38.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.469 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 p -126.09 97.15 4.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.101 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -53.33 -26.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.783 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.8 -24.86 64.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.44 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -129.03 -52.79 1.21 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 111.306 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.96 -35.88 2.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.713 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.5 t -49.31 141.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.706 0.289 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 p -148.24 162.28 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.497 HG22 HD12 ' A' ' 26' ' ' ILE . 26.8 mt -135.52 113.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.889 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.1 mp -94.05 123.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.432 HD12 ' CE2' ' A' ' 10' ' ' PHE . 3.3 mt -112.62 91.37 17.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 157.54 57.55 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.136 . . . . 0.0 112.25 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 107.9 0.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.57 -9.39 3.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.051 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.85 -29.05 50.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.969 0.384 . . . . 0.0 111.202 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 20.4 mt -118.83 141.52 30.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 21.1 Cg_exo -64.79 155.32 68.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.454 2.102 . . . . 0.0 112.101 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.78 141.04 58.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.25 23.37 78.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.624 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 43.4 t -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.274 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 1.8 mt-10 -137.46 113.73 10.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.706 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.403 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 4.6 mm-40 -105.74 108.95 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -70.54 122.57 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -130.74 129.9 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.544 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 39.4 p90 -145.72 158.41 43.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.935 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -163.09 160.81 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.733 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 123.67 28.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.96 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.15 129.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . 1.9 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.942 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.841 0.353 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.74 101.4 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.288 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.4 142.95 40.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.46 -57.61 1.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.482 ' CB ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.93 -174.12 0.37 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 65' ' ' SER . 87.6 Cg_exo -43.28 -32.97 3.54 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.024 1.816 . . . . 0.0 111.52 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -165.49 84.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.851 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.8 t -145.91 117.64 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.099 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -104.31 106.15 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.532 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.93 -172.01 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.12 -158.25 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.5 Cg_endo -63.23 121.74 9.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.526 2.151 . . . . 0.0 111.994 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.69 110.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.72 72.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.471 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 31.4 tp -142.52 85.86 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 110.321 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 40.4 tttt -57.69 159.64 5.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.045 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.97 143.16 34.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.55 16.71 16.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.142 0.496 . . . . 0.0 111.228 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.53 136.45 5.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.333 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.31 100.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.473 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.3 m -72.94 139.42 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.759 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -85.57 124.57 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.269 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.435 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 21.1 tp -124.21 128.26 48.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.439 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.0 mtm-85 -119.06 127.17 53.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.435 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -141.99 131.47 12.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.31 143.94 73.88 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.398 2.066 . . . . 0.0 112.092 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -59.13 -46.35 88.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.3 m 57.76 176.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.6 t70 58.28 100.58 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.08 41.02 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.672 2.248 . . . . 0.0 112.87 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -108.94 -3.75 17.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.564 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -122.62 16.07 10.32 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.469 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.7 p-90 -110.26 -36.68 5.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 6.3 pt20 -106.85 51.43 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.974 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -21.97 13.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -171.58 -38.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 m -47.89 171.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.66 123.5 69.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -63.93 -33.81 62.11 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.542 2.162 . . . . 0.0 112.223 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.05 76.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.898 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -70.9 121.52 84.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.688 0.244 . . . . 0.0 110.776 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 27.9 Cg_endo -62.35 -27.5 77.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.348 2.032 . . . . 0.0 112.107 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.35 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.38 -18.35 10.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.958 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 13.4 mt -156.7 -28.92 0.09 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.7 m -67.44 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.64 -38.42 0.04 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.61 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.0 18.46 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.702 0.287 . . . . 0.0 111.512 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -63.11 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.5 p -93.49 149.32 21.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.435 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 11.8 p -109.83 119.09 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.87 105.05 12.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.281 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.6 m -121.02 129.22 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.042 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mt -96.8 132.06 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.066 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.9 mm -118.77 118.79 59.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -119.93 25.65 9.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.39 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.428 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -178.79 115.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.26 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.2 m-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.901 0.382 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 p -123.59 143.76 50.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.93 131.02 42.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.407 ' CG ' ' CB ' ' A' ' 42' ' ' TYR . 1.1 mtt-85 -128.51 138.69 52.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.33 143.83 8.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.662 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -89.11 138.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.644 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 17' ' ' LEU . 76.1 m-85 -129.35 148.97 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.334 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 172.08 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.748 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -45.18 -28.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -57.32 -31.14 65.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.89 168.84 16.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.823 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.62 148.09 5.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.085 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 27' ' ' ILE . 4.0 t -110.66 152.76 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.4 0.619 . . . . 0.0 111.85 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 32.4 tp -123.53 100.23 6.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.21 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 153.65 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.15 0.5 . . . . 0.0 111.889 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.08 96.92 4.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.971 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -55.42 -26.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.573 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.94 -26.11 68.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.436 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -121.32 -52.95 2.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.685 0.279 . . . . 0.0 111.413 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.09 -41.39 1.51 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.775 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.0 t -50.16 144.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.676 0.274 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.5 t -149.89 167.74 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.423 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.2 mt -142.54 113.45 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HA ' HG13 ' A' ' 16' ' ' VAL . 4.4 mp -93.23 120.49 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.827 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 HD11 ' CD2' ' A' ' 10' ' ' PHE . 5.2 mt -105.98 91.84 5.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.48 159.92 38.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.512 2.141 . . . . 0.0 112.475 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.38 104.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.07 -9.81 3.59 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.215 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.66 -28.31 58.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.942 0.371 . . . . 0.0 111.308 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 33' ' ' ILE . 33.7 mt -119.69 142.75 33.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.373 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.2 Cg_exo -60.07 152.9 62.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.24 1.96 . . . . 0.0 112.178 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.63 150.1 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 24.97 68.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.462 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -130.58 160.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 111.242 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -133.09 113.9 13.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.998 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.404 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -102.76 109.24 20.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -74.53 122.36 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 41' ' ' ILE . 37.6 mt -130.08 141.51 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.149 0.5 . . . . 0.0 111.584 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.418 ' CZ ' ' HD3' ' A' ' 72' ' ' PRO . 14.0 p90 -153.5 146.87 24.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.781 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CE1' ' HG ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -147.98 159.0 44.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.063 0.458 . . . . 0.0 112.031 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -116.0 147.83 40.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.468 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.404 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 25.1 t -145.23 140.81 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.045 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.7 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.798 0.333 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -105.54 100.37 9.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.681 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.23 136.1 36.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -57.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.455 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -85.16 -177.95 1.06 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 75.8 Cg_exo -41.32 -47.07 5.6 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -153.58 84.49 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.427 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.4 t -146.04 118.1 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.597 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.68 106.21 16.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.564 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.07 -168.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.17 -137.86 0.93 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 32.8 Cg_endo -64.17 125.95 16.18 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.441 2.094 . . . . 0.0 112.073 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -56.33 110.85 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.14 83.35 1.58 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 16.6 tp -142.2 86.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.189 0.519 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 17.3 tttp -57.98 159.9 5.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.124 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 24.4 m-85 -141.49 147.91 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -98.92 17.62 19.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.26 0.552 . . . . 0.0 111.19 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -164.81 136.55 3.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.577 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.0 97.96 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 0.0 112.472 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.413 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 5.1 m -70.5 137.69 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -81.3 119.25 23.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.258 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.415 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 13.6 tp -124.32 119.18 28.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -113.99 133.31 55.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -137.33 112.68 9.37 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.927 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.29 120.25 8.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.293 1.995 . . . . 0.0 111.918 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.68 -54.67 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.148 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.86 -177.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.99 167.56 12.75 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.94 41.73 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.843 2.362 . . . . 0.0 112.944 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.52 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.698 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -99.36 3.54 46.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.565 0.698 . . . . 0.0 111.081 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.62 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 1.8 p-90 -56.0 -31.79 63.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.845 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.62 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 4.5 mt-30 -95.44 138.35 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.612 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.71 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.484 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -163.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.3 m 71.17 -167.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 8.9 mt -99.91 117.99 62.47 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.673 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 3.6 Cg_exo -74.96 -6.63 18.32 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.64 2.227 . . . . 0.0 111.913 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.84 -43.17 35.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.981 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 m-20 -85.38 111.48 37.04 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.837 0.319 . . . . 0.0 110.807 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.4 Cg_exo -60.25 -27.21 84.42 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.276 1.984 . . . . 0.0 111.946 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 11.1 p30 -78.79 4.64 13.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -50.54 -100.42 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.594 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -80.15 -12.5 59.65 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 27.8 m -62.65 27.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.13 -3.86 2.42 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.164 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.55 17.66 12.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.593 0.235 . . . . 0.0 111.386 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.44 -75.43 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.724 0.297 . . . . 0.0 111.04 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.3 m -101.13 133.69 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 111' ' ' VAL . 14.3 p -105.39 106.95 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.469 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.64 104.87 11.46 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.1 m -122.01 131.65 72.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.2 mt -95.84 146.85 24.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.661 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.413 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 43.5 mm -128.49 121.64 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.23 25.44 7.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.081 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.22 109.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.3 p -136.12 143.91 44.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 111.107 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.36 132.72 24.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.984 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.5 mtt180 -128.23 135.25 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.32 156.95 27.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.9 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.441 HD13 HG23 ' A' ' 9' ' ' ILE . 29.7 mt -91.39 156.26 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CG ' HG13 ' A' ' 28' ' ' ILE . 25.8 m-85 -131.46 170.59 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.36 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -152.14 171.94 17.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.915 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.7 p -58.69 -21.09 53.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -54.87 -51.25 66.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.46 128.64 3.76 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.733 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.16 -172.73 25.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.02 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.5 t -141.78 150.29 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 111.745 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 tp -123.24 100.1 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.324 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -125.24 154.52 41.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 111.786 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -127.11 97.14 4.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.1 mm -52.62 -26.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.647 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -63.39 -21.22 66.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.305 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.93 -52.93 1.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.788 0.327 . . . . 0.0 111.264 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.6 -33.82 2.9 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.696 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.67 145.4 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.8 t -148.7 164.41 34.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.0 mt -139.25 113.81 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.933 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.454 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.0 mp -94.72 135.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.638 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.443 HG13 ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -107.67 97.08 18.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.712 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.49 145.19 95.52 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.288 1.992 . . . . 0.0 112.115 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.1 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.202 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.18 4.27 5.52 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.367 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.7 -26.41 34.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.108 0.454 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 HD13 ' A' ' 33' ' ' ILE . 26.2 mt -121.81 141.49 34.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.69 143.87 88.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.333 2.022 . . . . 0.0 112.218 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.79 151.35 34.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.08 25.54 62.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.47 160.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.268 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.02 113.93 15.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.797 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.35 109.23 21.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 14.2 tt0 -72.29 118.96 15.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 41' ' ' ILE . 39.6 mt -127.35 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.014 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.425 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 34.3 p90 -152.83 173.46 15.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.416 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -175.05 163.51 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.885 0.374 . . . . 0.0 111.535 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.62 117.63 15.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.045 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.416 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 33.1 t -106.87 141.82 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.841 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 m -85.71 105.26 16.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.59 139.64 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 -57.69 1.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.508 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -95.18 -174.53 0.4 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.332 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.8 Cg_exo -40.46 -46.99 4.45 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.228 1.952 . . . . 0.0 111.843 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.7 tm? -153.89 82.23 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.748 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.8 t -143.15 118.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.476 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -105.87 106.25 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.614 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -165.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.028 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.53 -146.71 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 41.6 Cg_endo -67.38 134.15 32.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.451 2.101 . . . . 0.0 112.191 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.99 111.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.86 84.0 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.1 tp -144.44 87.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 77.4 tttt -62.7 159.78 15.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.956 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 29.0 m-85 -138.6 155.79 48.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.66 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.22 14.33 29.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.367 0.603 . . . . 0.0 110.96 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.62 136.51 2.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.263 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -61.58 95.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.413 2.075 . . . . 0.0 112.414 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 m -61.38 166.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.516 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 126.12 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 111.493 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 34.4 tp -124.24 128.01 48.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.098 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -120.45 126.1 49.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.788 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.433 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -143.58 163.31 37.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.477 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.52 120.07 7.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.447 2.098 . . . . 0.0 112.202 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -82.32 -48.55 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.19 48.09 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -112.89 81.91 4.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.45 47.24 2.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.73 2.287 . . . . 0.0 112.611 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -108.93 13.09 24.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 t -119.58 15.96 12.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.46 . . . . 0.0 111.812 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.1 p-90 -121.01 -37.87 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.586 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.1 mt-30 -103.53 68.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -156.22 -45.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -46.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.25 -178.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.8 mt -98.64 131.46 25.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.35 -23.59 70.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.421 2.081 . . . . 0.0 112.316 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.87 -25.21 32.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.832 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 8.3 m-20 -61.3 113.56 8.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.562 0.181 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.454 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 72.7 Cg_exo -50.09 -30.72 25.87 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.378 2.052 . . . . 0.0 112.273 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.11 -19.89 62.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.361 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.97 -20.45 16.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.824 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 19.0 mt -155.51 -26.57 0.11 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.5 m -68.18 36.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -155.17 -42.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.584 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.47 18.69 10.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.655 0.264 . . . . 0.0 111.455 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -65.84 -44.57 85.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.63 149.03 21.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.94 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 14.3 p -106.32 109.83 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.68 105.03 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.07 122.05 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.4 mt -87.5 137.67 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 35.1 mm -122.43 116.85 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.348 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 27.03 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.195 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.429 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.87 114.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.3 p -122.34 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 0.0 111.037 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -127.57 121.77 31.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.6 mtt180 -120.97 131.52 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.22 147.82 11.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.797 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 9' ' ' ILE . 26.2 mt -90.53 159.64 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.685 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CD2' HD13 ' A' ' 28' ' ' ILE . 79.9 m-85 -141.49 154.87 45.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.421 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -128.4 172.15 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -51.69 -24.5 5.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -55.19 -38.9 68.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.215 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 137.84 9.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.67 171.83 40.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.198 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.402 HG13 ' HA ' ' A' ' 27' ' ' ILE . 2.2 t -117.49 150.29 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.156 0.503 . . . . 0.0 111.548 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 25' ' ' SER . 32.9 tp -123.21 100.16 6.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.12 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.44 151.0 45.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.108 0.48 . . . . 0.0 111.835 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.6 p -121.23 97.05 5.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.023 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mm -52.53 -26.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.536 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -61.86 -29.6 70.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.083 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.66 -52.93 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.054 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.5 -38.02 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.694 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.2 t -49.48 144.47 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.73 0.3 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.74 158.37 44.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.434 HD13 HG22 ' A' ' 26' ' ' ILE . 38.1 mt -132.39 113.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.446 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.402 ' HA ' HG13 ' A' ' 16' ' ' VAL . 3.6 mt -94.64 118.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 0.0 111.276 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.42 HD13 ' CD2' ' A' ' 10' ' ' PHE . 3.9 mt -105.97 92.98 7.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 148.39 92.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.393 2.062 . . . . 0.0 112.167 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -53.34 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.7 -19.54 0.78 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.946 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.8 83.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.841 0.321 . . . . 0.0 111.363 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.449 HG21 HD12 ' A' ' 33' ' ' ILE . 32.1 mt -110.97 143.94 29.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.589 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.42 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -62.85 155.18 61.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.439 2.093 . . . . 0.0 112.295 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -69.41 153.81 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.17 24.46 58.73 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 44.8 t -130.08 160.87 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 32.7 mt-10 -132.87 113.64 13.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.854 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -106.08 109.06 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.02 128.56 36.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 41' ' ' ILE . 44.4 mt -134.87 140.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.275 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.433 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 28.0 p90 -154.22 149.66 27.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.427 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -151.53 167.01 29.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.056 0.455 . . . . 0.0 111.662 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -127.52 146.12 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.542 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.427 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 45.3 t -138.78 136.91 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.845 -179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.93 97.5 8.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.515 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.76 140.24 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 -57.58 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.931 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 66' ' ' PRO . 1.1 p -91.28 -173.85 0.4 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.249 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 65' ' ' SER . 72.8 Cg_exo -41.63 -51.27 4.41 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.19 1.926 . . . . 0.0 111.861 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -151.08 85.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 92.7 t -147.09 118.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.216 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.22 109.33 21.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.785 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.26 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.186 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 42' ' ' TYR . . . -78.26 -144.33 2.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.76 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.433 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 59.8 Cg_exo -51.84 123.14 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.596 2.197 . . . . 0.0 112.186 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -55.38 110.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.63 83.76 1.75 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 15.1 tp -138.43 85.01 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.199 0.524 . . . . 0.0 110.084 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 85.5 tttt -58.03 161.98 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.167 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 17.2 m-85 -143.38 148.43 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.576 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.42 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -97.06 18.26 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.263 0.554 . . . . 0.0 110.941 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.86 136.39 3.96 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.409 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.61 101.09 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.496 2.131 . . . . 0.0 112.467 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 m -68.53 153.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.698 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 108.66 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.406 HD11 HG12 ' A' ' 26' ' ' ILE . 5.0 tp -105.02 121.32 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -123.87 139.83 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.19 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.42 144.77 54.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.613 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.15 134.74 17.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.478 2.119 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 109' ' ' ASN . 2.7 p80 -49.49 -47.05 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.46 -81.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.878 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.48 162.51 46.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.74 32.84 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.966 2.444 . . . . 0.0 112.848 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.01 1.17 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.402 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -122.67 16.07 10.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.822 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 10.8 p-90 -117.69 -47.86 2.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.545 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 5.1 pt20 -77.28 64.79 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.33 -46.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -32.73 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.0 m -85.14 172.12 11.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.9 mt -99.9 125.17 41.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.051 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.09 -15.48 50.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.541 2.161 . . . . 0.0 112.297 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.77 -22.22 31.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.8 t0 -62.19 136.45 95.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.649 0.262 . . . . 0.0 110.723 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.84 -20.73 34.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.42 2.08 . . . . 0.0 112.274 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.521 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 87.9 m-20 -91.61 17.31 8.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.921 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -64.68 -113.44 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.993 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -48.98 -23.14 1.02 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 11.8 m -71.29 36.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 0.0 111.33 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 145.49 40.54 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.77 -74.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.796 0.332 . . . . 0.0 111.362 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 2.9 t-20 -148.78 32.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.3 p -80.97 150.06 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.734 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 p -84.81 114.45 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.265 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.68 105.08 12.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.195 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.91 124.85 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.57 143.26 26.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.6 mm -129.71 120.1 49.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.24 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -123.27 25.74 8.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.21 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.43 108.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.936 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.063 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.707 0.289 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.3 p -123.11 143.76 49.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 111.081 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.78 130.55 40.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -129.34 132.18 47.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.29 149.71 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.91 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -88.26 158.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.599 0.237 . . . . 0.0 110.636 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 28' ' ' ILE . 49.8 m-85 -138.64 164.03 30.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.971 0.415 . . . . 0.0 111.438 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.73 172.13 14.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -53.05 -22.7 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.122 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -51.28 -35.23 36.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 28' ' ' ILE . . . 100.29 112.8 3.47 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.698 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.36 144.2 10.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.054 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 17' ' ' LEU . 2.2 p -102.89 157.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.0 111.814 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 15.2 tp -119.98 99.9 6.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.462 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.41 ' HA ' ' CB ' ' A' ' 25' ' ' SER . 4.6 m -115.51 145.6 42.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.7 m -121.82 96.68 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.258 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 tp -60.3 -26.6 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.41 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 2.4 mt-10 -62.68 -26.38 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.71 -52.9 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.69 6.56 9.35 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.216 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.02 141.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.856 0.328 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 92.5 p -149.75 162.52 40.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.917 0.389 . . . . 0.0 111.529 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.2 mt -130.79 113.46 24.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.188 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 16' ' ' VAL . 2.5 mp -91.6 116.29 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.435 HD11 ' CD2' ' A' ' 10' ' ' PHE . 1.2 mt -102.94 87.0 1.11 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.682 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 158.73 40.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.546 2.164 . . . . 0.0 112.328 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.14 108.57 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.23 -9.94 3.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.904 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.09 -33.13 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.874 0.337 . . . . 0.0 110.939 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 39' ' ' GLN . 36.7 mt -119.91 143.75 35.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.344 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.09 154.3 72.85 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.364 2.043 . . . . 0.0 112.247 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.17 154.22 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.78 62.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.567 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -128.1 160.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.059 0.456 . . . . 0.0 111.187 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -134.35 113.9 12.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.967 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.418 ' HB3' HD12 ' A' ' 33' ' ' ILE . 6.4 tp60 -101.71 109.01 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.061 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.91 116.7 12.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.0 mt -127.21 139.39 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 111.263 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' GLY . 29.9 p90 -153.06 162.82 40.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.203 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' HD22 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -167.28 168.43 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.873 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.06 132.69 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.721 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 68' ' ' VAL . 21.7 t -126.1 148.29 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.95 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 17.2 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.014 179.887 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.934 0.397 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.22 100.77 11.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.67 139.18 37.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.492 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -57.63 1.38 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.639 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.547 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -91.58 -171.32 0.27 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.974 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 47.5 Cg_exo -38.4 -48.42 2.46 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.324 2.016 . . . . 0.0 112.116 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.458 ' O ' HD11 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -158.66 66.72 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 111.054 178.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 99.0 t -121.58 118.35 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.575 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.5 106.24 17.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.575 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -167.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.998 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -68.38 -152.35 0.41 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.655 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 71.4 Cg_exo -50.71 160.57 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.563 2.175 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -84.51 111.0 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.66 78.98 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.899 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 8.3 tp -135.9 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.28 0.562 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.0 ttpt -73.0 149.69 43.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.909 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 73.5 m-85 -122.59 166.97 13.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.98 16.39 19.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.448 0.642 . . . . 0.0 110.824 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -168.75 136.54 1.66 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.185 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.55 107.24 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.438 2.092 . . . . 0.0 112.579 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 10.8 m -70.71 140.64 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -87.51 108.35 19.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.564 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -105.77 129.71 53.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -123.32 132.23 53.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 111.613 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.404 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.63 156.07 59.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.481 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.44 123.9 11.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 49.9 p-80 -71.66 -46.92 57.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 85.8 m 57.61 178.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.993 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.38 87.94 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.53 46.86 2.18 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.814 2.342 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -109.06 5.09 23.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.665 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -122.56 16.17 10.37 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.922 0.391 . . . . 0.0 111.931 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.457 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.6 p-90 -110.6 -37.26 5.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.457 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 5.5 pt20 -101.13 61.0 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.097 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -106.48 -37.05 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -86.47 -179.05 6.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 mt -100.05 120.54 56.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.76 -21.32 72.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.605 2.203 . . . . 0.0 112.669 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.46 -5.42 54.2 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.116 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.63 123.93 58.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.896 0.348 . . . . 0.0 111.004 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.459 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.58 -28.71 56.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.387 2.058 . . . . 0.0 112.335 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -61.72 -18.38 59.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.63 -19.3 15.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.62 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.482 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 15.6 mt -156.22 -30.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.0 m -68.05 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 177.41 -30.49 0.07 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.851 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 18.58 6.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -57.93 -30.27 65.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.95 170.74 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.74 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 11.7 p -103.7 105.88 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.287 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 105.09 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.82 121.53 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.255 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.99 143.8 26.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.408 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 28.5 mm -129.89 116.72 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.0 0.429 . . . . 0.0 111.544 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.84 27.48 8.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.974 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.79 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.784 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.9 p -125.28 143.01 51.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.945 0.402 . . . . 0.0 111.39 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.14 106.97 6.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.402 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.3 mtt180 -113.52 131.88 55.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 140.67 6.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.786 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.4 mt -87.09 135.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.608 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 17' ' ' LEU . 83.1 m-85 -116.71 160.98 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.286 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -146.48 172.31 13.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.592 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -44.44 -27.43 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -33.93 56.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 111.185 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 154.27 29.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.9 175.06 39.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.459 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 27' ' ' ILE . 2.2 t -126.96 150.86 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.471 . . . . 0.0 111.415 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 49.4 tp -123.22 100.16 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.472 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -126.37 152.19 46.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.044 0.45 . . . . 0.0 111.745 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.76 97.05 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -51.1 -26.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.479 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.19 -26.69 67.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.235 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -123.91 -52.92 1.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.174 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.42 -36.63 2.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.896 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.6 t -48.56 144.4 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 111.26 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 p -149.83 150.75 32.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.515 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mt -128.75 113.69 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.414 ' HA ' HG13 ' A' ' 16' ' ' VAL . 3.8 mt -93.21 134.41 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 10' ' ' PHE . 4.2 mt -123.93 94.26 45.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.161 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 155.82 66.97 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.423 2.082 . . . . 0.0 112.085 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.68 98.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.34 -21.75 0.74 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.945 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.21 -28.38 67.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 111.419 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.412 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 38.9 mt -123.84 137.88 29.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.548 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD3' ' CD2' ' A' ' 78' ' ' LEU . 17.8 Cg_endo -60.35 155.5 46.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.385 2.056 . . . . 0.0 112.544 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -66.64 151.86 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.766 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.05 19.52 59.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.635 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 40.8 t -125.62 160.77 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 5.3 mt-10 -137.06 113.71 10.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.053 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.16 110.75 22.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.814 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.65 119.4 13.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.136 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 41' ' ' ILE . 43.8 mt -126.92 139.82 50.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 110.867 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' GLY . 29.7 p90 -155.55 162.96 40.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -166.98 159.49 13.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.945 0.402 . . . . 0.0 111.526 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 133.5 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.297 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.87 135.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.586 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.417 ' O ' HD11 ' A' ' 67' ' ' LEU . 52.2 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.033 0.444 . . . . 0.0 111.272 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.886 0.374 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 m -89.67 110.8 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.5 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.87 138.18 34.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.303 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.51 -57.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -92.19 -175.59 0.51 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.379 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 69.5 Cg_exo -40.93 -46.79 4.97 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.326 2.017 . . . . 0.0 111.529 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 46' ' ' CYS . 2.8 tm? -153.57 83.93 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.658 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.6 t -145.15 117.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.405 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -106.13 106.2 16.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.07 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -64.06 -153.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 20.6 Cg_endo -60.97 129.73 29.97 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.457 2.104 . . . . 0.0 111.909 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -54.98 110.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.48 79.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.716 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 14.8 tp -138.94 85.28 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 110.2 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 59.7 tttp -63.71 151.09 42.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.873 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 75.0 m-85 -127.92 154.11 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.771 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.482 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -98.51 13.92 30.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.436 0.636 . . . . 0.0 110.765 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.02 136.39 4.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.188 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.15 99.01 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.359 2.039 . . . . 0.0 112.379 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 m -67.86 154.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.637 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 119.0 38.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.413 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 tp -115.81 114.96 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.286 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.0 136.46 52.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.43 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.63 133.02 24.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 119.71 6.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.189 1.926 . . . . 0.0 112.383 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.64 -33.68 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.53 163.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.78 69.95 0.46 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.27 42.4 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.247 2.631 . . . . 0.0 112.558 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 13.17 25.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 t -114.02 15.98 18.3 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 0.0 111.914 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.607 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -117.53 -36.67 3.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.607 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 10.4 mt-30 -106.38 76.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.34 -49.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -138.89 29.82 2.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.4 m -138.48 -175.38 4.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.751 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.91 127.6 38.5 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.12 -5.01 15.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.495 2.13 . . . . 0.0 112.558 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.46 -7.42 26.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.945 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.449 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -68.75 134.28 90.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.812 0.306 . . . . 0.0 110.621 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.419 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 58.3 Cg_endo -71.51 -8.17 22.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.341 2.027 . . . . 0.0 112.612 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.409 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 77.2 m-20 -99.8 17.29 21.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 110.843 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.35 -113.9 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.282 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -47.87 -15.85 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 5.1 m -67.62 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 111.782 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -175.91 -34.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.39 25.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 110.835 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.59 -57.16 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.079 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.9 p -141.84 159.77 41.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -95.67 113.41 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.219 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.49 105.1 10.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.143 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 m -128.79 122.67 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 mt -91.87 148.53 22.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 33.8 mm -129.82 123.49 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.317 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.15 24.5 6.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.181 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.433 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.49 104.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.872 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.4 ' CB ' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -142.24 143.74 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.48 116.93 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.8 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.17 144.63 8.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.673 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.66 134.44 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CG ' HD13 ' A' ' 28' ' ' ILE . 77.2 m-85 -119.73 157.79 27.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.35 172.16 13.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.754 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 t -48.19 -27.26 2.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.379 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -32.46 62.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 111.341 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.96 173.05 21.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.589 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.33 155.26 7.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.22 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 27' ' ' ILE . 3.4 t -112.08 151.98 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.366 0.603 . . . . 0.0 111.734 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' SER . 40.9 tp -123.57 100.23 6.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.149 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -121.62 149.46 43.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 112.017 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.04 97.13 5.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.166 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.41 -26.53 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.725 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -50.54 -50.53 53.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.679 -179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.34 -52.8 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.529 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.64 -28.42 2.04 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.132 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.3 t -52.8 135.9 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 66.3 p -146.06 170.96 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.27 113.86 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.408 ' HA ' HG11 ' A' ' 16' ' ' VAL . 3.4 mp -92.4 120.28 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 HD13 ' CG ' ' A' ' 10' ' ' PHE . 3.2 mt -108.46 90.4 7.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.34 151.86 82.81 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.088 . . . . 0.0 112.142 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -53.9 107.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.06 -6.7 3.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.092 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.92 -29.63 44.28 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.985 0.392 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.5 mt -119.4 141.76 31.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.601 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -64.9 154.21 74.22 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.279 1.986 . . . . 0.0 112.054 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.93 154.45 39.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.43 60.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.8 t -129.46 160.77 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.258 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -134.31 113.8 12.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.957 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.32 109.13 20.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.075 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.97 110.43 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.673 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.71 136.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -154.96 151.29 28.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.266 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.7 OUTLIER -154.24 159.76 41.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 0.0 111.314 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -128.15 124.76 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.029 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.449 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 46.1 t -113.81 128.79 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.718 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 0.0 111.25 -179.612 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 108.41 19.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -87.67 138.84 31.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.266 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.493 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -88.86 -175.22 0.53 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.421 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 70.2 Cg_exo -41.01 -50.58 4.11 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.267 1.978 . . . . 0.0 111.676 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.8 tm? -151.94 83.35 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.703 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 44.4 t -144.46 118.23 3.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.529 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.53 106.11 16.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.658 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.15 -166.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.41 -148.25 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.73 127.77 20.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.431 2.087 . . . . 0.0 112.103 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -56.29 110.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.92 78.3 1.0 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.715 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.0 tp -142.45 87.52 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.255 0.55 . . . . 0.0 110.016 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 7.6 ttpp -64.13 149.24 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 42.2 m-85 -126.61 151.32 48.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.38 16.14 24.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.353 0.597 . . . . 0.0 111.007 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.38 136.5 4.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.394 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.49 103.6 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.532 2.154 . . . . 0.0 112.695 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 m -76.44 143.78 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.736 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.95 117.36 29.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.8 tp -111.73 117.59 33.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -108.34 139.45 43.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.404 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 1.3 mt -134.47 140.76 36.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.4 125.89 9.35 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.391 2.061 . . . . 0.0 112.388 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -77.69 -44.16 28.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.5 m 60.2 86.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -179.35 75.62 0.2 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.17 42.92 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.973 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -108.61 -47.52 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.025 0.44 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 t -111.57 3.99 18.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.598 0.713 . . . . 0.0 111.055 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 105' ' ' LEU . 1.5 p-90 -55.36 -31.67 61.94 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.96 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.455 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 1.8 pt20 -92.68 144.73 25.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.47 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -170.56 -42.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.749 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 -164.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m 64.23 159.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.054 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.2 mt -59.89 137.13 90.52 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.059 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -17.79 16.56 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.674 2.249 . . . . 0.0 112.691 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.97 -43.93 7.94 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.794 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.48 113.23 17.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.538 0.209 . . . . 0.0 111.061 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.9 -26.61 68.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.439 2.093 . . . . 0.0 111.995 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.69 -11.21 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.396 . . . . 0.0 110.806 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.528 ' C ' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -52.58 -23.28 6.13 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.151 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.528 ' HG ' ' C ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -156.73 -20.17 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.74 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -146.23 -42.61 0.04 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.375 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.45 62.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.583 0.23 . . . . 0.0 111.569 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.92 80.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 175.42 131.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 12.5 p -84.9 110.71 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.45 104.88 11.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.11 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.33 122.02 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.35 135.57 33.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.3 mm -126.45 115.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -116.7 14.07 15.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 116' ' ' ASP . 4.3 m80 -162.8 127.95 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.1 p -121.86 143.54 49.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.82 108.02 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.987 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.467 ' HG3' ' CB ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -111.36 136.09 50.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.054 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.26 149.28 12.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.231 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.2 mt -104.86 138.82 27.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.711 0.291 . . . . 0.0 110.52 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.439 ' CG ' HD11 ' A' ' 28' ' ' ILE . 90.3 m-85 -127.64 174.04 9.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 111.422 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -147.87 172.17 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.636 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -45.19 -28.79 0.82 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -56.39 -31.41 63.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 177.98 22.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.645 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.52 162.78 10.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.17 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.404 ' CG1' HG13 ' A' ' 27' ' ' ILE . 3.9 t -118.46 153.74 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.269 0.557 . . . . 0.0 111.762 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 25' ' ' SER . 40.5 tp -123.14 100.09 6.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.107 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 149.32 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.45 . . . . 0.0 111.735 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.46 97.22 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.224 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -51.74 -26.45 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.512 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -60.81 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.352 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.25 -53.03 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.238 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.66 -34.58 2.46 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.679 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 25' ' ' SER . 39.4 t -54.64 139.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.684 0.278 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -143.11 167.65 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.43 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.6 mt -134.42 113.75 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.656 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.468 ' HB ' ' HG2' ' A' ' 82' ' ' GLU . 4.7 mp -90.71 122.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.439 HD11 ' CG ' ' A' ' 10' ' ' PHE . 7.1 mt -110.03 94.7 18.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 150.97 87.38 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.34 2.027 . . . . 0.0 112.05 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.79 108.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -2.79 4.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.141 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.43 -26.06 33.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.383 . . . . 0.0 111.24 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 33' ' ' ILE . 48.6 mt -122.97 142.3 37.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.553 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.15 155.48 39.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.398 2.065 . . . . 0.0 112.442 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.19 152.74 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 23.76 56.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.63 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.0 t -131.22 160.9 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.179 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -131.39 113.78 14.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.944 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.13 110.93 23.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.93 126.54 29.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.78 132.77 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.997 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.467 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 52.6 p90 -149.23 174.5 12.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.276 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 45' ' ' VAL . 1.2 p90 -175.34 176.15 2.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.022 0.439 . . . . 0.0 111.783 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.28 148.58 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.995 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG21 ' CE2' ' A' ' 43' ' ' PHE . 59.4 t -142.37 139.31 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.685 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.093 -179.785 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.85 95.44 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.73 142.29 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.088 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.42 -57.58 1.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.929 0.395 . . . . 0.0 111.171 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.494 ' CB ' ' CD ' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -97.1 -174.28 0.37 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 65' ' ' SER . 71.5 Cg_exo -41.35 -45.4 5.8 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.263 1.975 . . . . 0.0 111.699 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.445 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.9 tm? -153.13 83.92 1.2 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 178.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 61.7 t -145.06 118.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.423 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.64 109.07 20.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.695 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.3 -173.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -78.24 -126.84 0.42 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.595 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 37.3 Cg_endo -65.98 134.08 35.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.18 110.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.89 83.61 1.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 3.5 tp -131.4 84.43 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.478 ' CD ' ' CD2' ' A' ' 117' ' ' HIS . 10.5 tptt -53.3 153.83 3.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.404 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 35.2 m-85 -136.35 144.27 44.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.68 17.59 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.285 0.564 . . . . 0.0 111.226 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -162.71 136.5 4.71 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.173 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.68 97.27 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.337 2.025 . . . . 0.0 112.488 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 2.8 m -72.91 154.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.53 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HG2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 pm0 -110.91 116.46 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.399 . . . . 0.0 111.275 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 9.3 tp -104.75 129.72 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -112.88 126.2 55.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.944 0.402 . . . . 0.0 111.406 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.418 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -138.63 155.08 73.66 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.658 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.25 144.21 13.36 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.687 2.258 . . . . 0.0 112.665 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -79.31 -26.28 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 m 68.3 -173.05 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.13 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -85.21 35.75 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.122 2.548 . . . . 0.0 112.866 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.24 -13.53 14.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.424 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t -122.65 15.78 10.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 111.786 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.633 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.5 p-90 -95.19 -36.12 11.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.941 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.633 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.0 mt-30 -104.67 114.38 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -161.02 -44.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 34.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.37 175.93 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 29.1 mt -87.65 128.6 53.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.26 -13.6 16.87 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.473 2.116 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.09 -21.21 8.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.857 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.419 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -74.46 137.17 74.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.617 0.246 . . . . 0.0 110.903 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.427 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 56.4 Cg_endo -70.21 -26.63 25.24 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.162 . . . . 0.0 112.101 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -65.23 -15.68 62.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.34 -18.47 10.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.948 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 12.7 mt -156.93 -27.89 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.55 36.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 172.61 -33.41 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.604 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.83 44.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -88.58 96.59 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.65 143.13 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.418 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 7.9 p -112.05 133.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.257 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.24 104.99 17.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -119.57 123.78 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.029 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.0 137.16 33.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.404 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 25.9 mm -129.82 123.28 56.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.256 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.86 25.66 5.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.941 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.478 ' CD2' ' CD ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 178.82 104.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.655 0.264 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.6 p -136.01 143.22 44.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.36 121.95 13.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.813 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 1.1 ttp180 -127.05 130.22 49.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.14 144.12 8.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.66 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.6 mt -79.6 152.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.65 0.262 . . . . 0.0 110.8 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.434 ' CZ ' HD11 ' A' ' 28' ' ' ILE . 42.3 m-85 -129.6 154.04 47.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 0.0 111.303 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.51 172.62 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.592 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.1 m -44.18 -30.43 0.78 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.188 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.13 -42.02 99.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.454 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.06 142.32 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.096 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -120.23 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.787 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 2.0 t -151.29 145.98 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.238 0.542 . . . . 0.0 111.53 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 25' ' ' SER . 26.5 tp -123.51 100.38 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.65 138.31 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 112.077 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.8 m -100.57 96.84 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.391 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.06 -26.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.014 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -21.53 63.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -126.04 -52.99 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.659 0.266 . . . . 0.0 111.494 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.84 2.34 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.537 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -52.54 145.55 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.731 0.301 . . . . 0.0 110.931 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.4 p -148.06 165.31 31.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 48.1 mt -138.12 113.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 82' ' ' GLU . 2.8 mt -96.07 112.86 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 111.123 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.434 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 6.3 mt -98.31 99.85 8.0 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.773 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 156.66 63.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.268 1.979 . . . . 0.0 112.343 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -60.35 111.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.06 0.6 6.96 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.043 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.07 -30.05 49.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.929 0.365 . . . . 0.0 111.057 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 33' ' ' ILE . 32.8 mt -115.37 142.52 28.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.448 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.39 155.52 46.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.284 1.989 . . . . 0.0 112.351 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.57 153.36 43.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.2 25.5 57.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.85 160.24 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.303 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -137.84 113.83 9.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.739 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 1.9 mm-40 -101.6 125.63 48.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.055 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -82.45 121.64 27.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 41' ' ' ILE . 38.3 mt -124.97 136.39 60.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.221 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.424 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 26.6 p90 -155.51 159.92 40.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.414 ' CD1' HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -165.65 165.45 18.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 111.654 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.57 119.32 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.055 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -105.33 137.24 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.61 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.413 HG23 ' CD2' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -114.41 97.27 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.446 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.59 139.22 37.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.338 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -57.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.989 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.486 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -89.53 -175.77 0.58 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.217 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.04 -35.39 1.78 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.268 1.979 . . . . 0.0 111.785 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.2 tm? -168.09 78.24 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.955 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.8 t -137.46 117.87 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.48 105.99 17.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.717 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -165.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -71.47 -154.36 1.7 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.576 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 51.9 Cg_exo -53.9 130.1 37.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.5 2.134 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.413 ' CD2' HG23 ' A' ' 62' ' ' THR . 1.8 t-80 -56.68 110.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.742 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.05 83.95 1.77 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 3.4 tp -138.68 86.52 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.293 0.568 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -50.54 164.47 0.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -149.48 136.82 19.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.436 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.93 16.95 16.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.319 0.581 . . . . 0.0 111.06 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -159.8 136.45 6.57 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.258 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.7 95.82 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.505 2.137 . . . . 0.0 112.51 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.413 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 3.8 m -70.72 142.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.607 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 7.0 mp0 -90.93 129.19 36.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 111.563 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 26.9 tp -124.32 114.99 20.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -112.32 131.18 55.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.876 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.433 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -143.85 141.43 18.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.521 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.03 127.66 10.83 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.492 2.128 . . . . 0.0 112.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.55 -43.78 30.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t 62.09 59.75 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.92 122.74 1.13 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.714 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -86.62 39.87 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.643 2.229 . . . . 0.0 112.871 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 -4.29 16.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.612 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -122.67 16.16 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 6.8 p-90 -117.7 -43.49 2.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -91.74 133.04 35.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.291 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.31 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.66 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 32.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.734 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.36 -166.88 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 13.4 mt -95.72 121.43 61.34 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 5.7 Cg_exo -77.84 4.03 6.44 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.753 2.302 . . . . 0.0 112.686 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.55 2.24 8.14 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.822 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.499 ' OD1' ' HB3' ' A' ' 104' ' ' TYR . 37.1 p-10 -81.31 133.23 53.94 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 117.62 0.71 . . . . 0.0 110.317 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.432 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.65 -9.43 24.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.504 2.136 . . . . 0.0 113.085 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.436 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 7.2 m120 -96.89 17.62 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 111.109 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.499 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -75.03 -110.02 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.5 OUTLIER -55.89 -13.81 2.06 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 11.2 m -69.14 36.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.84 -37.88 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.134 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -24.79 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.651 0.262 . . . . 0.0 111.243 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.37 65.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 173.21 127.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.721 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.423 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 11.6 p -102.52 105.93 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.37 105.05 5.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.307 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.51 120.74 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.87 132.31 37.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.413 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 26.7 mm -113.74 124.79 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.58 26.52 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.637 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.466 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -178.32 98.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.89 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.738 0.304 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.7 p -123.15 143.64 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.374 . . . . 0.0 111.195 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.36 124.77 20.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.831 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.447 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.8 mtt180 -130.42 129.84 43.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.42 145.89 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.039 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.2 mt -90.45 159.67 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.514 0.197 . . . . 0.0 110.539 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 92.9 m-85 -137.57 152.29 49.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 111.411 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.76 172.11 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.764 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.02 -28.47 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -60.14 -37.28 79.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.62 -160.81 12.99 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.752 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.63 170.74 13.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.204 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.414 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.2 t -124.51 149.09 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.646 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 tp -123.35 100.38 6.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.58 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -129.47 153.95 47.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.142 0.496 . . . . 0.0 111.925 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -126.28 97.09 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.074 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -51.81 -26.68 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.639 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.21 -26.95 68.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.88 -52.91 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.137 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.55 -28.91 3.92 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.728 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.09 145.87 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.671 0.272 . . . . 0.0 110.795 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 p -149.66 156.35 41.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.43 . . . . 0.0 111.381 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 83' ' ' LEU . 23.9 mt -135.03 113.59 16.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.656 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.414 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.7 mp -93.26 126.79 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.894 0.378 . . . . 0.0 110.98 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.454 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 2.9 mt -110.77 99.36 41.72 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.39 153.45 76.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.586 2.191 . . . . 0.0 112.28 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -60.67 100.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.68 -6.3 3.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -73.28 -24.14 60.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.878 0.339 . . . . 0.0 111.202 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 18.5 mt -121.64 140.91 32.56 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.18 152.9 49.43 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.316 2.011 . . . . 0.0 112.243 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.59 143.42 57.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.75 25.58 72.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 48.0 t -127.99 161.14 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -139.96 113.67 8.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.847 179.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 27.9 mm100 -103.56 113.77 27.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.093 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.43 122.33 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.18 137.31 57.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.018 0.437 . . . . 0.0 111.213 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.447 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 13.2 p90 -154.41 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.28 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -166.95 153.88 8.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.058 0.456 . . . . 0.0 111.539 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 117.48 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.827 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 59.6 t -102.87 126.86 57.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.582 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 111.08 -179.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.786 0.327 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.72 95.44 4.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -77.97 139.31 39.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.025 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.44 -57.71 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -88.03 -174.49 0.48 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.246 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 53.4 Cg_exo -38.68 -45.06 2.4 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.287 1.991 . . . . 0.0 112.125 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -161.66 65.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 90.0 t -121.63 118.61 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.573 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.58 106.71 17.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.871 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -63.74 -167.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -78.12 -150.75 4.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.439 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 52.0 Cg_exo -54.47 121.59 10.03 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 112.006 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -55.53 110.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.938 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.33 78.55 0.9 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.738 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 65.8 tp -136.65 84.68 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.184 0.516 . . . . 0.0 110.477 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.1 tttt -58.85 162.11 4.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.184 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.418 ' CE1' ' HG ' ' A' ' 75' ' ' LEU . 42.1 m-85 -144.42 150.01 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -96.75 12.61 31.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.302 0.573 . . . . 0.0 111.259 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mmpp? -157.24 136.73 8.37 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.965 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.87 93.49 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.293 1.995 . . . . 0.0 112.28 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.6 m -64.26 166.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 126.84 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.045 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 12.1 tp -124.22 107.04 10.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.22 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.34 129.69 53.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.362 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.418 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -136.34 154.18 76.89 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.652 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.96 120.21 7.4 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.502 2.135 . . . . 0.0 112.069 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.55 -54.4 7.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.27 158.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' CB ' ' CD ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -57.92 177.84 0.2 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.693 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 89' ' ' ASP . 92.4 Cg_endo -84.78 35.62 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.558 2.172 . . . . 0.0 112.93 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -109.33 -0.19 19.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.361 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -122.54 15.86 10.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 112.038 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.428 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 5.1 p-90 -105.48 -35.67 7.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 1.1 pt20 -94.18 29.83 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.369 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -101.7 -30.95 11.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -172.2 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.23 -165.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.788 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.67 124.64 63.5 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.78 -23.68 35.35 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.563 2.175 . . . . 0.0 112.25 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.88 4.43 39.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.136 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -60.96 138.97 94.1 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.916 0.358 . . . . 0.0 110.474 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 101' ' ' ASP . 3.0 Cg_exo -74.38 -3.08 13.27 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.483 2.122 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.421 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 10.3 p30 -109.22 17.41 21.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 0.0 111.053 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -80.15 -113.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.978 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.5 OUTLIER -47.76 -19.55 0.23 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 8.4 m -68.4 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -174.39 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.849 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.58 67.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.86 -66.56 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.45 142.74 51.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 111' ' ' VAL . 12.0 p -98.09 103.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.98 104.78 6.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -116.11 126.82 73.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.837 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.6 mt -81.62 136.55 35.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 34.9 mm -129.79 121.71 53.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.39 25.46 6.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.206 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 176.71 111.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.3 m-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.027 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.814 0.34 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.1 p -140.6 144.37 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.965 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.98 113.7 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 129.88 50.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.16 145.26 9.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.05 138.89 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.425 ' CD2' HD11 ' A' ' 28' ' ' ILE . 79.0 m-85 -117.41 161.24 19.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -134.55 172.07 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 t -49.91 -27.04 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -56.35 -33.11 65.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.64 173.2 22.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.647 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.63 158.35 8.74 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.067 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.9 152.05 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.359 0.6 . . . . 0.0 111.824 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' SER . 54.2 tp -123.66 100.21 6.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.38 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.12 142.02 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.076 0.465 . . . . 0.0 111.767 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.74 97.11 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.338 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.48 -26.4 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.617 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.66 -26.63 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.365 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 p -132.32 -52.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.287 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.59 -36.65 1.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.755 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.5 t -48.56 142.1 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 51.0 p -149.73 172.05 15.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 111.525 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mt -145.02 113.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.606 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.05 118.83 39.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 10' ' ' PHE . 2.6 mt -106.48 90.96 5.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.43 159.52 43.74 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.517 2.145 . . . . 0.0 112.334 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.31 106.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.08 -8.88 3.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.056 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.01 -23.91 55.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.97 0.385 . . . . 0.0 111.451 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 36.3 mt -131.0 141.09 40.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 38.3 Cg_exo -60.34 155.48 46.26 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.392 2.061 . . . . 0.0 112.264 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 152.63 45.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.74 23.34 63.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -128.51 160.75 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.146 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.8 113.84 11.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.008 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -101.05 110.73 22.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.6 114.16 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -124.99 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.56 152.92 29.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -157.1 162.92 39.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.401 . . . . 0.0 111.384 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.33 126.67 37.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.774 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 39.2 t -114.3 134.71 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.944 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 11.2 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.816 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -100.76 98.47 8.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.588 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -76.45 133.92 39.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.44 -57.66 1.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.206 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.546 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -87.13 174.31 5.55 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.576 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 7.5 Cg_exo -34.5 -44.85 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 0.0 111.735 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.1 tm? -156.45 84.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.699 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 51.6 t -146.89 118.07 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.289 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.85 106.19 16.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.786 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.25 -168.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.85 -148.07 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.53 127.56 21.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.505 2.137 . . . . 0.0 112.009 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -57.2 110.87 0.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.88 76.33 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.74 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 18.9 tp -140.56 86.06 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 110.006 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 11.2 mtpp -75.99 123.89 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.173 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 40.8 m-85 -98.68 168.59 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.557 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.63 16.16 25.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.609 . . . . 0.0 111.032 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.42 136.51 5.54 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.46 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.41 107.06 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.491 2.128 . . . . 0.0 112.499 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 m -79.41 144.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -88.4 116.04 26.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 111.05 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 9.2 tp -113.39 129.83 56.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -121.66 132.65 54.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.358 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.414 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -139.51 113.82 8.0 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.64 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.68 120.69 8.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.095 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.77 -21.32 55.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 68.66 -168.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 62.62 79.53 0.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.47 46.57 2.12 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.826 2.351 . . . . 0.0 112.776 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.06 4.94 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.468 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.53 16.0 10.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.881 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -114.17 -36.86 4.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.67 43.63 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.934 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 -47.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.12 -38.19 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.36 174.51 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.47 139.27 21.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.27 -17.82 27.21 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.597 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.47 -29.47 19.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.705 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 140.29 83.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.792 0.33 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HB2' HG21 ' A' ' 106' ' ' VAL . 43.0 Cg_endo -67.2 -25.73 42.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.592 2.195 . . . . 0.0 112.259 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -16.85 62.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.607 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.31 -19.01 19.65 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.936 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 18.0 mt -155.96 -26.87 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.428 HG21 ' HB2' ' A' ' 102' ' ' PRO . 4.5 m -67.35 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 156.82 -27.92 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.411 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.03 -32.39 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -127.66 42.1 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.45 122.21 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.41 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 13.5 p -106.15 111.54 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.388 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.9 104.98 13.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -122.78 126.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mt -99.12 121.0 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.88 119.53 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.356 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.504 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 2.7 t0 -119.57 15.39 12.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 116' ' ' ASP . 4.3 m80 -162.35 125.42 2.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.723 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.593 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.17 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.8 p -132.55 143.8 49.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.58 120.97 21.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 1.4 mtt180 -122.0 132.12 54.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.39 157.29 28.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.954 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.1 mt -94.98 151.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 41.1 m-85 -128.26 144.86 51.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 111.402 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -128.58 171.91 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -47.38 -28.64 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.203 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -54.3 -38.48 65.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.04 173.73 40.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.717 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.28 -155.17 26.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 t -146.97 150.23 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 0.0 111.628 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.4 tp -123.34 100.27 6.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.352 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.79 148.48 50.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 112.016 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 p -116.16 96.99 5.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.001 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -50.15 -26.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.741 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -38.49 91.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.193 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.01 -52.87 2.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.193 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.73 -30.92 3.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.12 142.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 110.845 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.01 154.0 41.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 111.453 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.7 mt -132.13 113.62 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.59 136.11 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.992 0.425 . . . . 0.0 111.174 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.443 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 2.3 mt -128.69 87.02 56.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.744 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.42 162.19 37.61 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.494 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.72 107.4 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.992 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.89 -10.75 3.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.114 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' CB ' ' CG2' ' A' ' 28' ' ' ILE . . . -86.14 -33.69 20.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 mm -101.51 132.74 21.42 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.08 144.97 77.77 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.154 1.903 . . . . 0.0 111.949 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -57.76 141.57 48.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.25 28.04 71.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.0 t -131.98 159.87 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -129.96 113.95 15.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.755 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -101.22 109.0 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.374 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -75.8 116.06 16.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.4 mt -124.63 134.29 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.151 0.501 . . . . 0.0 111.6 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.41 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 30.6 p90 -150.79 155.06 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.972 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -157.86 160.36 37.61 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.653 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -120.07 151.65 38.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.846 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.81 143.38 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.448 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 111.348 -179.796 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.886 0.374 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 m -102.05 111.77 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -77.2 142.04 39.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.198 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.44 -57.56 1.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -103.2 -173.1 0.27 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.192 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 55.7 Cg_exo -39.87 -58.49 0.88 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.075 1.85 . . . . 0.0 111.747 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -138.13 85.24 2.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.1 t -147.17 118.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.731 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.14 106.11 14.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.9 -143.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.55 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 31.7 Cg_endo -64.07 131.53 30.96 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.494 2.129 . . . . 0.0 112.04 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -56.59 110.82 0.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.37 79.8 1.27 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.638 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 28.9 tp -142.3 85.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.467 ' CB ' ' CD2' ' A' ' 117' ' ' HIS . 4.9 ptmt -85.23 122.01 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.078 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 33.2 m-85 -93.2 170.9 9.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.6 18.41 16.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.569 . . . . 0.0 111.077 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 136.6 3.02 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.512 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.52 104.08 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.504 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.73 139.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.887 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -84.5 127.98 34.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.919 0.39 . . . . 0.0 111.347 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -124.21 118.24 26.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.47 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.1 mmm-85 -105.46 134.33 48.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.933 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.44 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.4 OUTLIER -131.83 122.26 18.46 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.27 120.24 5.9 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.429 2.086 . . . . 0.0 112.168 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -73.52 -27.12 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.2 m 63.41 55.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.011 0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -130.92 92.0 35.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.774 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.0 41.03 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.191 2.594 . . . . 0.0 112.783 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -1.46 19.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.525 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -122.75 16.14 10.21 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.441 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.9 p-90 -110.73 -38.77 5.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.441 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 5.0 pt20 -95.51 152.73 18.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.059 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 64.04 31.22 13.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.761 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.22 -47.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.6 m -129.3 -172.3 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.2 mt -85.75 141.01 35.66 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.57 -1.71 11.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.67 2.247 . . . . 0.0 112.847 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.41 -34.22 4.55 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.707 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.414 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 77.3 m-20 -61.08 123.12 74.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.538 0.209 . . . . 0.0 110.978 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.456 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.24 -30.84 63.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.345 2.03 . . . . 0.0 112.158 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -61.91 -17.22 55.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.38 -17.69 13.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.665 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.0 mt -157.94 -30.58 0.08 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.93 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 178.84 -47.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.688 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.75 67.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.388 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -97.63 53.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -162.6 135.9 5.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 13.2 p -99.86 116.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.28 105.03 13.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.916 0.389 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.18 123.09 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mt -93.17 131.95 37.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 39.8 mm -114.15 117.26 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.305 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.81 27.23 8.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.13 179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.467 ' CD2' ' CB ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 177.3 104.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.4 m-85 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.14 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.2 p -119.07 143.7 46.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.413 . . . . 0.0 110.782 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.53 112.29 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.4 mtp85 -110.53 137.61 48.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.05 153.93 22.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.928 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 mt -95.97 154.43 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.486 ' CE2' ' CD1' ' A' ' 28' ' ' ILE . 22.4 m-85 -122.79 172.18 8.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -155.1 171.87 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 p -58.62 -25.63 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.58 -57.4 12.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.48 133.11 4.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.45 -169.83 21.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.126 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.89 148.76 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.669 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 43' ' ' PHE . 10.1 tp -123.14 100.11 6.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.22 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.45 140.87 52.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.733 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.47 97.17 6.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.225 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.37 -26.53 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.671 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.02 -40.82 98.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.291 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -105.84 -52.95 2.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.73 -30.94 3.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.609 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.3 t -57.15 144.01 10.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.715 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 p -144.95 161.58 39.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.47 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 mt -137.88 114.07 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.843 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.0 mt -96.31 136.38 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -108.85 93.94 13.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.98 145.07 96.93 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.335 2.023 . . . . 0.0 112.236 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.75 104.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.276 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.09 5.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.203 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' O ' HD23 ' A' ' 78' ' ' LEU . . . -76.34 -28.07 56.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.013 0.406 . . . . 0.0 111.258 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 27.4 mt -126.42 141.84 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD3' HD23 ' A' ' 78' ' ' LEU . 39.4 Cg_exo -60.34 155.37 46.9 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.395 2.063 . . . . 0.0 112.234 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.48 141.91 57.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.03 79.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.683 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 46.9 t -121.84 160.69 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.311 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -140.11 113.8 8.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.868 179.211 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.455 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.21 120.03 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.23 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -81.31 108.85 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.651 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.467 ' HB ' ' CE2' ' A' ' 10' ' ' PHE . 2.5 mt -117.17 137.54 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.417 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.422 ' CE1' ' HD3' ' A' ' 72' ' ' PRO . 52.5 p90 -149.06 157.14 43.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.052 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.417 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -159.37 159.71 34.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.075 0.464 . . . . 0.0 111.64 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.45 124.08 39.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.809 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.6 t -112.75 130.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.2 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.903 0.383 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 m -106.02 106.36 16.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -75.69 135.11 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.38 -57.7 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.297 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.478 ' CB ' ' CD ' ' A' ' 66' ' ' PRO . 1.1 p -86.78 -175.16 0.56 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.511 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 65' ' ' SER . 79.6 Cg_exo -42.06 -47.86 6.56 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.214 1.943 . . . . 0.0 111.705 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.7 tm? -154.86 81.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.805 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 69.0 t -142.27 118.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.296 178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.72 106.16 16.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.507 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -166.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.211 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -79.35 -144.2 2.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 75.4 Cg_exo -49.77 121.69 7.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.144 . . . . 0.0 112.197 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -58.17 111.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.09 83.93 1.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.625 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 11.9 tp -137.64 85.1 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HD3' ' CD2' ' A' ' 117' ' ' HIS . 1.7 tptp -61.7 132.82 54.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 43.3 m-85 -112.7 144.11 42.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -88.8 17.22 5.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 111.369 179.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -164.68 136.33 3.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.21 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.28 102.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.522 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 4.4 m -74.06 161.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.504 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.81 129.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 111.317 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 tp -124.16 118.07 26.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.387 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -105.94 130.93 53.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 1.3 mt -128.13 116.18 20.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.48 136.73 70.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.385 2.057 . . . . 0.0 112.251 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.29 -20.12 57.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 68.31 31.45 5.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -143.63 77.88 14.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.697 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.48 54.42 2.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.923 2.415 . . . . 0.0 112.628 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.31 -13.05 14.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.617 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 t -122.6 16.1 10.33 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.463 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.4 p-90 -106.78 -36.05 6.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.463 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -104.32 71.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -119.37 -39.51 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -43.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 35.4 m -54.56 179.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.13 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -99.0 135.87 20.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.93 -5.72 16.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 112.58 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.4 -41.04 7.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.648 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 61.2 m-20 -61.53 138.51 95.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.52 0.2 . . . . 0.0 110.745 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.05 -27.29 50.04 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.175 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -65.28 -15.06 62.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.986 0.422 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.97 -19.45 18.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.839 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.7 mt -155.58 -28.2 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.11 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -177.88 -36.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.649 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.98 -58.95 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.256 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -96.18 88.39 4.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.47 141.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.43 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 14.2 p -97.32 115.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.18 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.77 104.99 10.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.133 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -128.07 120.97 54.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.994 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.06 146.12 26.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.42 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 30.8 mm -129.8 120.39 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.2 25.87 8.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.078 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.459 ' CD2' ' HD3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 179.36 103.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.823 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.8 0.333 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.2 p -118.57 143.27 46.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.45 122.96 17.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.967 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -127.85 129.36 46.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.36 142.88 7.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -89.89 135.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.44 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 92.7 m-85 -115.89 151.6 35.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 111.374 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.0 172.31 11.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.654 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.42 -28.97 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -54.76 -29.7 54.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 167.43 32.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.679 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.97 158.48 9.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.347 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -114.58 151.03 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 111.512 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 25' ' ' SER . 44.0 tp -123.47 100.24 6.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.29 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.47 152.9 42.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.022 0.439 . . . . 0.0 111.89 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.2 m -120.75 97.25 5.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -52.73 -26.54 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.7 -36.3 82.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.304 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 p -109.22 -52.89 2.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.736 0.303 . . . . 0.0 111.356 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.92 -43.11 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.812 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.83 143.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 111.181 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.4 p -149.47 167.14 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.516 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.417 HG12 HD13 ' A' ' 83' ' ' LEU . 14.0 mt -139.67 113.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.038 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.81 122.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.44 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 2.2 mt -112.08 89.48 11.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.85 156.67 65.03 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.499 2.133 . . . . 0.0 112.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -57.29 104.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.17 -13.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.13 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -78.13 -36.01 48.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.382 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 16.3 mt -108.32 141.37 23.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.596 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 19.7 Cg_exo -65.37 155.17 70.12 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.336 2.024 . . . . 0.0 112.131 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 142.46 57.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.53 23.37 75.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 48.2 t -126.88 161.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 111.251 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.415 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 3.2 mt-10 -137.04 113.74 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.813 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 1.4 mm-40 -105.71 117.41 33.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -69.72 119.58 14.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -120.66 109.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 12.3 p90 -138.18 161.27 37.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.309 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -170.84 165.22 7.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 111.86 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -132.37 132.63 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.603 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.437 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 56.4 t -119.2 138.52 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.228 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.773 -179.924 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.22 111.31 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.472 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.87 144.04 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.296 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 -57.68 1.38 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.013 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.521 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -98.97 -173.37 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.297 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.2 Cg_exo -40.49 -42.4 3.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.223 1.949 . . . . 0.0 111.864 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.6 tm? -157.6 81.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.744 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 43.2 t -141.55 118.01 7.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.63 106.19 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.553 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.8 -169.6 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.041 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.431 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -61.3 -152.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.541 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.433 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 37.1 Cg_endo -65.94 134.37 36.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.544 2.163 . . . . 0.0 112.065 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -60.57 110.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.37 75.98 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.718 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 24.4 tp -142.27 86.41 1.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.144 0.497 . . . . 0.0 110.2 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -53.78 164.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.433 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.443 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 4.5 m-85 -146.34 141.37 27.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.625 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.68 16.66 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.317 0.58 . . . . 0.0 110.827 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -166.51 136.78 2.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.021 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.77 100.65 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.525 2.15 . . . . 0.0 112.641 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 13.5 m -68.13 139.48 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -82.86 123.39 29.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 0.0 111.409 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.417 HD13 HG12 ' A' ' 26' ' ' ILE . 7.7 tp -124.2 121.05 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.182 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -115.78 132.88 56.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.42 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 119.49 6.37 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.527 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.63 130.75 38.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.274 1.983 . . . . 0.0 112.236 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.6 -54.8 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.27 168.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 56.04 85.25 0.19 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.187 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.14 38.21 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.855 2.37 . . . . 0.0 112.681 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -108.98 13.17 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.54 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 t -105.47 15.92 26.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 111.819 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.452 ' CE2' ' CG ' ' A' ' 94' ' ' GLN . 4.6 p-90 -121.16 -39.94 2.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.452 ' CG ' ' CE2' ' A' ' 93' ' ' TRP . 4.6 mm100 -99.51 59.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.97 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -127.12 89.2 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tptt 60.74 29.62 19.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -120.5 -171.13 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.81 128.75 57.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.27 -7.97 17.26 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.497 2.132 . . . . 0.0 112.539 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.92 10.95 8.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.053 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -71.48 126.62 91.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.937 0.369 . . . . 0.0 110.375 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.423 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 58.2 Cg_endo -71.48 -7.03 20.41 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.165 1.91 . . . . 0.0 112.671 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.471 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -104.82 17.36 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.504 ' CG ' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -75.43 -113.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.034 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 HD12 ' CG ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -48.04 -21.09 0.4 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 15.6 m -68.71 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 155.2 34.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.645 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.72 -51.59 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.04 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.3 29.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.859 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 151.17 36.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.769 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.42 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 11.8 p -93.63 103.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.204 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.34 104.98 7.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 m -120.85 123.22 69.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.45 135.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.408 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 35.7 mm -119.54 117.83 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.244 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.34 26.29 9.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.292 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.482 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.7 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.575 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p 44.36 30.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.677 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.24 142.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.994 0.426 . . . . 0.0 111.153 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -119.65 117.76 29.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.1 p -122.52 143.25 49.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 111.078 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.81 112.4 7.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.901 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 11.3 ttm-85 -121.54 129.43 52.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 156.89 27.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.685 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.68 154.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 110.989 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.438 ' CD1' HG13 ' A' ' 28' ' ' ILE . 18.7 m-85 -127.5 175.25 8.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.135 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -151.31 171.79 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -61.7 -23.13 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.942 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -56.4 -45.44 80.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.29 152.36 8.75 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.827 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.69 -173.32 45.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.087 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.8 t -145.64 150.61 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.392 0.615 . . . . 0.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 25' ' ' SER . 22.3 tp -123.34 100.18 6.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.233 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 143.82 50.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.99 0.424 . . . . 0.0 111.811 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.29 97.09 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.247 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -54.06 -26.82 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.419 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.47 -22.73 66.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.314 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -126.16 -52.97 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.79 -40.27 1.65 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.694 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -53.55 137.98 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.741 0.305 . . . . 0.0 111.129 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.5 p -141.82 169.75 17.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.0 mt -141.59 113.65 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.209 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.426 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.0 mp -93.14 131.42 40.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.438 HG13 ' CD1' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -103.41 95.15 6.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.608 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.54 138.41 75.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.353 2.036 . . . . 0.0 112.084 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -51.09 101.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.009 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.3 -3.98 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.013 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.05 -30.28 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.892 0.346 . . . . 0.0 111.225 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.491 HG23 HD11 ' A' ' 33' ' ' ILE . 28.3 mt -119.93 143.48 35.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.53 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HD3' HD22 ' A' ' 78' ' ' LEU . 21.5 Cg_exo -64.9 150.8 87.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.375 2.05 . . . . 0.0 112.114 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.57 151.68 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.46 65.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.57 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.81 160.56 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -128.68 113.83 15.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.05 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.443 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.05 109.05 20.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.04 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.45 114.69 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.808 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -124.91 139.02 52.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.138 0.494 . . . . 0.0 111.048 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.442 ' CB ' ' HA ' ' A' ' 7' ' ' ARG . 21.3 p90 -153.45 171.51 18.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.7 OUTLIER -175.5 156.81 2.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.181 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 122.12 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.077 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.441 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 39.6 t -110.32 136.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.537 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -168.3 149.02 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -30.77 62.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.2 133.77 33.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -90.68 -31.31 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 p -84.49 -28.46 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.158 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.3 mm -76.78 -2.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.517 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -52.92 124.6 37.1 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.157 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.37 138.32 13.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.414 2.076 . . . . 0.0 112.236 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.42 122.36 11.58 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.413 2.075 . . . . 0.0 112.346 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.77 -62.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -175.4 76.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.703 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.02 18.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.005 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.32 -29.69 66.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -64.31 -31.06 72.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.69 113.19 2.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.401 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.45 129.77 53.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.27 96.43 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.554 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -69.14 143.16 54.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.25 -57.73 1.38 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -96.42 -173.89 0.36 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.258 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.37 -40.31 3.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.281 1.987 . . . . 0.0 111.877 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.2 tm? -161.19 78.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.6 t -137.61 117.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.566 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.42 106.17 16.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.707 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -163.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.114 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -74.59 -144.54 0.97 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.442 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 45.2 Cg_endo -68.12 128.33 17.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.133 . . . . 0.0 112.148 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -57.58 110.83 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.8 77.48 0.86 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.743 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 22.6 tp -141.41 86.64 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 110.061 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -56.18 166.27 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.134 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 19.2 m-85 -148.72 143.54 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.683 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -96.53 17.9 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -167.48 136.37 2.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.209 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.54 96.88 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.408 2.072 . . . . 0.0 112.6 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.1 140.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.536 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.03 125.12 32.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.798 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 20.5 tp -124.19 128.1 48.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.944 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -119.76 130.71 55.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.862 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.418 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -143.68 154.96 60.06 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.531 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 131.57 23.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.352 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -51.84 8.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.73 44.9 10.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.59 105.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.78 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.81 39.39 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.666 2.244 . . . . 0.0 112.828 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -108.71 13.26 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.132 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -120.99 16.19 11.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.493 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 8.8 p-90 -118.72 -45.01 2.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.781 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.493 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.9 OUTLIER -88.07 91.36 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -162.04 71.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tptp 60.29 34.93 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.64 -173.59 4.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.0 mt -83.87 126.03 71.55 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -71.29 -24.44 23.02 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.584 2.189 . . . . 0.0 112.602 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.31 14.12 20.97 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 6.3 t70 -114.0 130.53 23.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.893 0.346 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' O ' HG13 ' A' ' 106' ' ' VAL . 29.3 Cg_endo -62.94 -30.83 77.27 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.57 2.18 . . . . 0.0 112.222 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -55.57 -20.17 12.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 110.888 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.52 -12.21 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.06 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.0 OUTLIER -165.26 -13.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -177.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 102' ' ' PRO . 15.9 m -65.12 36.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -153.15 25.26 0.79 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.15 -33.91 14.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.133 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -58.63 -31.62 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -150.43 139.14 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.415 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 13.8 p -91.31 112.0 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 105.04 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.27 123.6 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.061 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -93.5 139.16 31.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.953 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.2 mm -121.33 122.22 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.41 25.94 6.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.092 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.503 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.63 102.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.078 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.41 140.7 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG2' ' CD1' ' A' ' 52' ' ' LEU . 20.5 t -147.54 139.28 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.15 117.57 31.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.712 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 p -137.41 143.39 41.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.995 0.426 . . . . 0.0 111.274 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.37 137.21 38.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.8 mpp_? -134.73 137.72 43.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 160.86 33.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.822 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.43 154.88 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.598 0.237 . . . . 0.0 110.655 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.45 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 51.1 m-85 -135.17 146.01 48.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.28 171.87 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.631 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p -48.84 -26.92 2.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.172 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -56.8 -31.91 65.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.62 -174.57 32.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.546 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.26 -161.66 29.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.121 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.8 t -143.75 151.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 111.731 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 25' ' ' SER . 39.2 tp -123.02 99.96 6.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.041 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.39 154.8 33.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 111.961 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.405 ' OG ' ' CZ ' ' A' ' 43' ' ' PHE . 19.4 m -120.94 97.22 5.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.147 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -51.56 -26.53 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.697 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.41 -46.29 77.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.464 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.92 -52.94 3.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 111.371 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.02 -36.25 2.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -53.93 145.8 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.738 0.304 . . . . 0.0 110.853 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.69 167.34 26.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 0.0 111.513 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 mt -134.1 113.84 18.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.717 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.427 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.5 mp -91.69 119.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.797 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 5.3 mt -106.77 97.35 17.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.95 156.86 64.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.435 2.09 . . . . 0.0 112.139 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -57.75 112.97 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.71 5.93 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.198 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.68 -25.88 24.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.022 0.411 . . . . 0.0 111.21 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 32.4 mt -122.53 141.92 36.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.45 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.75 155.47 53.92 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.315 2.01 . . . . 0.0 112.11 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -67.89 154.99 40.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.41 26.6 56.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -133.3 159.93 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.64 113.81 12.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.852 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.74 112.05 25.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.14 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -72.59 124.23 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.72 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.6 135.24 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.17 0.509 . . . . 0.0 111.423 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.429 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.9 p90 -148.36 169.33 20.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.9 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -165.63 157.7 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.443 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.66 115.95 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -109.44 135.44 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.523 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.443 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.9 t -175.36 149.59 1.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.388 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.25 5.12 18.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -119.99 110.81 17.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' HA ' ' HG ' ' A' ' 67' ' ' LEU . 45.5 t-20 -90.86 -59.68 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.591 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.49 -28.01 46.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.2 mp -72.85 -6.26 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -151.65 136.38 10.29 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.248 . . . . 0.0 111.1 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -78.33 160.5 29.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.483 2.122 . . . . 0.0 112.382 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.5 172.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.674 2.249 . . . . 0.0 112.414 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.25 -66.45 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -138.59 103.19 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -32.13 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -72.37 -37.21 68.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -73.36 -29.0 62.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.78 113.24 2.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.282 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.03 106.45 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.49 109.45 20.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.26 142.57 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.5 -57.75 1.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 111.254 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -98.58 -175.22 0.42 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.308 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.5 Cg_exo -40.53 -44.35 4.4 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.242 1.961 . . . . 0.0 111.684 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.475 ' HG ' ' HA ' ' A' ' 49' ' ' ASN . 3.0 tm? -153.18 86.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.495 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.3 t -147.63 117.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.429 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -108.52 105.86 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.83 -172.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.19 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 42' ' ' TYR . . . -62.87 -147.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.42 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 36.6 Cg_endo -65.51 126.68 16.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.137 . . . . 0.0 111.932 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -52.97 110.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.27 80.86 1.37 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.9 tp -143.05 86.81 1.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.17 0.51 . . . . 0.0 110.26 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 8.5 tmtt? -67.39 145.72 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.092 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 52.3 m-85 -122.77 151.41 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.715 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.16 14.62 21.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.28 0.562 . . . . 0.0 111.145 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -161.15 136.51 5.72 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.288 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.47 98.47 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.376 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 4.5 m -70.58 142.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.82 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.75 125.94 36.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.309 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.1 tp -124.08 129.01 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.5 mtm105 -125.76 124.78 41.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.182 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.422 ' HG ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -137.0 134.36 19.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.631 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.94 143.37 49.56 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.352 2.035 . . . . 0.0 112.152 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 25.6 p-80 -49.78 -47.32 51.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 9.2 m 49.22 76.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.213 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.32 92.83 0.28 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.71 41.13 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.94 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.08 -11.3 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.1 t -120.69 16.07 11.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.458 ' CZ2' ' HG3' ' A' ' 94' ' ' GLN . 2.4 p-90 -113.65 -35.75 5.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.458 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -101.45 -23.25 14.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.254 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -98.81 -27.09 14.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -67.3 0.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.134 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.92 177.0 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.53 129.45 42.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.98 -22.31 68.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.662 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.48 -39.92 6.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.946 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 2.5 m-20 -55.3 124.96 56.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.48 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 49.3 Cg_exo -55.24 -31.58 76.99 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.377 2.051 . . . . 0.0 112.2 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.8 -14.94 57.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.481 ' C ' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -17.49 6.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.912 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.481 ' HG ' ' C ' ' A' ' 104' ' ' TYR . 10.3 mt -158.08 -32.11 0.07 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.1 m -69.11 36.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -144.04 -42.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.746 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.42 -60.29 3.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 111.346 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 62.91 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 22.4 m -151.2 171.55 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 0.0 111.009 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.422 HG12 ' HG ' ' A' ' 85' ' ' LEU . 11.1 p -109.24 120.11 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.34 105.1 7.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -127.24 121.71 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.056 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 mt -89.46 140.33 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.414 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 29.8 mm -127.22 121.93 58.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.73 24.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.251 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.481 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 179.2 111.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.004 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.767 0.317 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -149.66 36.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.047 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.36 148.41 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 21' ' ' GLU . . . -101.99 117.58 35.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.479 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -127.46 143.69 51.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 0.0 111.15 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.7 107.07 8.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.901 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 17.6 mtt180 -107.08 129.39 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.4 142.03 6.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.006 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.436 HG23 HD13 ' A' ' 9' ' ' ILE . 25.9 mt -87.51 159.82 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.633 0.254 . . . . 0.0 110.433 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 28' ' ' ILE . 92.5 m-85 -140.73 152.28 45.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -131.17 172.3 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.6 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -44.82 -28.89 0.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.49 -33.79 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -174.86 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.754 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.07 163.28 11.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.144 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.92 150.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.369 0.604 . . . . 0.0 111.702 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -123.5 100.34 6.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.457 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.18 149.53 50.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 111.958 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.54 97.1 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.927 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.77 -26.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.742 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 9.5 tt0 -62.24 -41.42 98.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 p -106.34 -52.91 2.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.67 -35.18 2.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.6 t -49.08 139.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.14 155.64 42.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 111.382 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 26' ' ' ILE . 49.5 mt -136.98 113.54 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.568 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.64 136.01 26.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.002 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.455 HD13 ' CD2' ' A' ' 10' ' ' PHE . 2.7 mt -124.65 89.22 52.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.8 160.87 46.38 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.495 2.13 . . . . 0.0 112.218 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -57.12 113.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.65 -2.7 4.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.033 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.33 -29.43 21.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.997 0.399 . . . . 0.0 111.043 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 20.9 mt -122.78 137.16 27.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.62 155.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.214 1.943 . . . . 0.0 112.149 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.59 140.43 58.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.39 21.71 78.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.429 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 43.3 t -123.34 160.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 111.211 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 2.7 mt-10 -139.28 113.6 8.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.74 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 7.5 mm-40 -105.04 108.95 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.056 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -72.96 121.1 19.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 mt -128.18 130.16 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.437 ' CE1' ' HD3' ' A' ' 72' ' ' PRO . 31.8 p90 -144.75 142.2 29.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.904 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 2.3 p90 -145.08 164.36 31.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.088 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 150.25 50.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.22 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.6 t -144.07 140.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.01 148.89 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -36.49 82.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.77 116.34 29.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.991 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.409 ' HA ' ' HG ' ' A' ' 67' ' ' LEU . 4.5 p30 -90.75 -50.61 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.472 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.6 t -74.18 -29.31 61.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.363 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 23.4 mt -78.51 -2.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.311 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.93 121.82 6.24 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.848 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.5 144.46 73.16 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.36 2.04 . . . . 0.0 112.216 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.66 172.14 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.493 2.129 . . . . 0.0 112.457 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 tp -82.33 -41.8 19.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.813 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -149.56 82.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.725 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -56.05 5.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.034 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.02 -35.52 73.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -33.46 71.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.62 111.8 3.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.468 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -123.79 138.59 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.309 . . . . 0.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 118.77 30.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -95.66 137.97 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.39 -57.59 1.38 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.482 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -89.68 -177.56 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.679 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.3 -49.02 4.01 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.53 2.154 . . . . 0.0 111.771 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -151.15 84.82 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 46.2 t -146.78 118.21 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.563 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.66 107.08 16.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.692 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.94 -168.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.151 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.55 -155.98 0.17 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.615 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.437 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 51.1 Cg_exo -53.78 130.63 40.02 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.519 2.146 . . . . 0.0 112.201 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 111.05 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.816 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.21 84.04 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.719 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 33.0 tp -142.16 86.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 110.146 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.449 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 0.5 OUTLIER -57.53 164.51 1.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.117 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -148.13 146.98 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.67 15.32 22.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.07 136.53 6.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.52 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.64 99.32 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.446 2.098 . . . . 0.0 112.457 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.67 143.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.864 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.85 128.2 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.192 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -124.35 127.06 47.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.499 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -114.93 133.78 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.7 107.6 17.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.08 131.23 43.62 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.388 2.059 . . . . 0.0 112.14 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -27.13 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.085 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 12.9 m 65.37 -166.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.25 94.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.38 49.57 3.25 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.668 2.245 . . . . 0.0 112.666 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 5.04 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.412 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.51 16.12 10.41 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.922 0.392 . . . . 0.0 111.845 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.654 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -115.0 -36.11 4.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.654 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 3.1 mt-30 -105.04 55.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.098 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -157.63 105.16 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.16 33.3 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.4 m -133.95 176.17 8.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.991 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.5 mt -91.31 131.67 35.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -77.23 -2.35 12.56 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.26 -18.44 6.72 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.806 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.409 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -66.26 116.57 34.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.59 0.233 . . . . 0.0 110.86 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 71.6 Cg_exo -50.82 -30.61 30.33 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.472 2.115 . . . . 0.0 112.296 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -60.59 -19.49 57.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.4 -18.71 19.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.735 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 20.2 mt -157.01 -29.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.85 36.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 118.62 47.41 0.41 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.566 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.5 -34.49 12.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.46 82.47 2.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.04 139.24 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.706 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 111' ' ' VAL . 14.9 p -99.57 108.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.466 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.09 104.91 11.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.68 131.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.241 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mt -103.35 134.81 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 38.0 mm -122.13 122.9 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.559 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -124.01 26.47 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.956 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.449 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -173.11 101.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.16 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 2.3 m-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.473 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.573 0.225 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 1' ' ' THR . 7.0 p 50.93 162.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.988 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.0 133.72 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.67 117.81 34.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -119.89 143.99 47.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.74 115.71 16.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.852 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -120.48 131.95 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.35 28.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.084 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -105.72 131.84 54.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.709 0.29 . . . . 0.0 110.453 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CG ' HD13 ' A' ' 28' ' ' ILE . 71.6 m-85 -112.48 153.26 27.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.047 0.451 . . . . 0.0 111.429 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.7 171.99 9.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -48.26 -27.48 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.33 -37.26 69.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.258 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 179.01 23.62 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.577 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.01 167.45 15.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.084 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.87 148.22 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.73 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.4 tp -123.3 100.2 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.203 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.91 145.51 50.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 111.854 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -110.84 97.19 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.249 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -50.48 -26.5 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.644 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -30.5 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.36 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -115.52 -53.0 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.726 0.298 . . . . 0.0 111.291 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.65 -38.04 1.97 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.788 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -48.56 144.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.0 p -149.73 152.06 34.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.465 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.6 mt -129.84 113.37 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.442 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.8 mt -97.3 123.24 49.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.058 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 HD13 ' CG ' ' A' ' 10' ' ' PHE . 1.5 mt -113.53 92.91 25.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.63 157.37 58.93 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.94 106.54 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 137.68 -7.23 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.106 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' CB ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.72 -24.28 36.22 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.934 0.367 . . . . 0.0 111.234 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 35.4 mt -125.68 141.1 38.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.472 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 39.2 Cg_exo -59.92 155.45 44.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.85 148.68 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.63 22.89 68.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.547 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.5 t -130.31 160.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.027 0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -131.55 113.96 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.996 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -101.12 109.05 20.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.993 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.1 123.23 21.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.595 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.34 132.71 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.5 p90 -146.81 170.07 17.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.333 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -175.93 157.31 1.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.378 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -128.35 133.04 48.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.079 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.9 t -119.86 130.63 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.569 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 67' ' ' LEU . 1.1 p -162.99 149.41 12.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.179 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -78.25 0.45 25.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.858 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.62 122.13 16.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.847 0.356 . . . . 0.0 111.128 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 11.2 t-20 -90.71 -59.92 2.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.486 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -66.62 -26.06 66.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.6 mm -74.68 -4.54 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.631 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mt -143.37 147.42 40.02 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.64 139.18 30.61 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.499 2.133 . . . . 0.0 112.297 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.02 164.87 2.29 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.424 2.083 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.88 -37.29 12.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.93 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -169.45 75.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.799 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -72.86 -31.84 65.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -69.31 -33.31 72.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -30.17 57.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.16 113.19 2.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.341 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 pm0 -101.06 141.39 34.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -123.01 99.15 6.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.236 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.34 138.32 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.39 -57.62 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.996 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.522 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -91.49 -172.56 0.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.195 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 63.7 Cg_exo -40.19 -48.53 3.97 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.203 1.936 . . . . 0.0 111.815 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 46' ' ' CYS . 1.9 tm? -155.67 78.72 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.781 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 42.5 t -137.56 117.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.746 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.3 106.91 17.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.662 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.86 -171.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.065 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -63.87 -144.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.542 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 51.4 Cg_endo -68.97 130.59 20.61 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.475 2.116 . . . . 0.0 111.989 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -57.67 110.76 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.5 75.59 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.765 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 5.1 tp -138.76 84.62 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 1.5 tmtm? -63.23 151.88 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.236 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 31.4 m-85 -129.69 151.17 50.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.551 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -93.73 15.23 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 111.221 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.04 136.42 3.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.269 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.06 99.2 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 6.6 m -69.76 152.8 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.0 126.81 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 111.343 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.413 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 36.5 tp -124.21 116.94 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -106.92 131.01 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.159 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.417 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.1 OUTLIER -130.54 123.29 20.26 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.765 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.08 120.1 5.9 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.34 2.027 . . . . 0.0 112.095 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.06 -30.19 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.1 m 60.54 65.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -114.32 110.83 47.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.815 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.98 39.04 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.653 2.235 . . . . 0.0 112.929 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 -9.13 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.597 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.6 t -122.7 16.07 10.25 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.451 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.8 p-90 -107.03 -38.4 6.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.071 0.462 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.451 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -95.61 56.4 1.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.811 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.16 -45.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.1 -46.58 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 62.3 m -54.9 176.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.122 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.8 mt -99.86 124.26 44.47 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.23 -26.97 72.22 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.469 2.112 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.55 -16.11 44.06 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.967 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.62 137.95 51.13 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.808 0.304 . . . . 0.0 111.008 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 53.2 Cg_endo -68.71 -24.39 35.0 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.4 ' HA ' HG23 ' A' ' 106' ' ' VAL . 96.9 m-20 -64.07 -17.01 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -20.21 15.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.85 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 16.6 mt -155.08 -26.82 0.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.9 m -66.78 36.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 123.06 36.4 0.66 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.531 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.44 -33.32 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -134.03 51.48 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.87 141.05 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 13.8 p -85.38 107.61 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.391 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.71 104.92 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.99 125.0 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.4 mt -90.07 145.13 25.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 35.3 mm -129.32 117.66 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.53 27.42 8.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.492 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.98 106.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.815 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.796 0.332 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.75 30.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 t -105.56 133.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.232 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 21' ' ' GLU . . . -94.15 117.43 30.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 p -136.59 145.38 44.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 17' ' ' LEU . . . -133.84 133.06 41.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 4.6 ttt180 -135.7 129.33 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.526 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.99 169.96 42.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.64 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 28.2 mt -104.49 137.88 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 87.9 m-85 -120.35 153.2 36.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -124.21 171.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 p -55.91 -22.38 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.266 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.61 -36.31 71.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 110.963 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.68 158.68 11.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.72 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.01 164.46 25.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.255 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.26 152.38 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 25' ' ' SER . 28.5 tp -123.34 100.2 6.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.365 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.47 154.35 42.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 0.0 112.039 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 p -119.92 97.2 5.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.967 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.0 mm -49.4 -26.57 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.914 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -65.35 -55.69 16.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.343 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.9 p -90.45 -52.88 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.296 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.43 -36.54 2.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.781 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.66 143.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.655 0.264 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -148.8 161.63 41.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.474 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.511 HG23 HD12 ' A' ' 26' ' ' ILE . 32.2 mt -137.38 113.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.774 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 82' ' ' GLU . 2.4 mp -92.39 128.24 44.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.851 0.358 . . . . 0.0 110.926 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 2.2 mt -112.75 94.49 28.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.435 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.21 157.68 48.46 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.661 2.241 . . . . 0.0 112.452 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -60.89 95.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.617 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 145.14 -11.3 1.82 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.877 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -72.94 -23.57 60.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.823 0.311 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 33' ' ' ILE . 39.1 mt -124.5 141.85 38.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.449 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.68 152.37 56.71 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.378 2.052 . . . . 0.0 112.371 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.93 152.55 45.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.96 23.34 56.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.1 160.75 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 111.075 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -132.62 113.94 13.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.121 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.01 113.37 25.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.037 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -74.4 115.66 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.4 mt -123.23 139.71 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.174 0.511 . . . . 0.0 111.255 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.436 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 21.0 p90 -153.06 162.61 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -166.36 158.89 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.923 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.92 149.33 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.509 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.429 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 37.1 t -145.29 135.36 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 18.1 t -173.44 148.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -24.38 67.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.978 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -90.7 -59.52 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.65 -25.28 6.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.07 -8.34 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.651 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.1 tp -173.68 106.4 0.3 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.84 172.02 3.23 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.597 2.198 . . . . 0.0 111.91 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.32 170.93 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.56 2.173 . . . . 0.0 112.226 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 mp -59.89 -37.41 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.066 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -162.94 121.08 2.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -72.97 -37.13 67.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -73.14 -32.98 65.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -33.69 74.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 112.18 3.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.542 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.28 141.97 40.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.78 104.98 10.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.71 139.06 37.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.46 -57.6 1.37 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.284 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.475 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -94.37 -175.37 0.47 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.29 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.25 -46.97 5.49 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.169 1.912 . . . . 0.0 111.538 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.6 tm? -151.53 80.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.528 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.9 t -141.85 118.24 6.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.511 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -106.53 106.16 16.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.613 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.87 -178.67 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.08 -156.71 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.637 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 48.7 Cg_exo -55.4 129.26 34.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.534 2.156 . . . . 0.0 112.12 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -58.45 111.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.06 72.42 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 20.6 tp -137.96 83.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.262 0.553 . . . . 0.0 110.002 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 10.3 mttt -73.0 117.16 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.046 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -90.76 154.24 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -96.36 17.17 16.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.43 136.68 4.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.69 94.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.537 2.158 . . . . 0.0 112.769 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 m -70.1 133.4 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.553 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 28.9 mt-10 -82.64 128.18 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 111.563 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.43 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 14.7 tp -124.19 128.72 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.164 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -115.73 127.41 55.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 0.0 111.561 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -143.64 162.25 42.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.18 120.07 6.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.391 2.061 . . . . 0.0 112.313 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.54 -54.52 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 65.0 m 56.14 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.85 74.87 0.72 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.265 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 93' ' ' TRP . 96.3 Cg_endo -86.46 35.48 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.753 2.302 . . . . 0.0 112.929 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -13.75 14.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.658 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -122.62 16.15 10.32 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.476 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.3 p-90 -106.83 -35.87 6.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.476 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 7.7 pt20 -102.02 35.02 2.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -156.81 28.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -177.2 -62.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.4 m -70.75 178.93 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.1 mt -98.68 121.61 55.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.8 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.71 -35.54 97.75 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.457 2.105 . . . . 0.0 112.36 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.56 -17.42 66.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.889 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -81.56 138.57 47.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.976 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 50.0 Cg_endo -68.4 -24.52 36.74 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.516 2.144 . . . . 0.0 112.327 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -63.73 -16.77 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 110.568 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.68 -18.89 23.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.98 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 16.4 mt -156.75 -24.19 0.1 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 8.0 m -67.99 36.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.5 -44.18 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.238 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.83 -68.28 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.402 . . . . 0.0 110.994 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.68 -67.91 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 66.1 m -121.34 167.85 12.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.095 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -108.0 139.22 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.86 105.05 16.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.371 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.1 m -129.8 123.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.073 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mt -97.04 142.12 29.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 39.5 mm -123.84 123.26 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.0 25.83 7.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.915 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.473 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -174.2 103.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.401 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 p -156.15 26.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.38 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -114.63 134.86 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.159 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -107.08 117.78 34.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.642 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.2 p -118.35 143.25 46.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.0 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.56 109.35 8.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.664 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -117.68 129.85 55.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.07 154.26 22.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.709 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.28 144.14 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.935 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD2' ' CD1' ' A' ' 28' ' ' ILE . 29.4 m-85 -117.64 151.87 36.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.218 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -125.52 171.89 10.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.753 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -53.85 -23.65 13.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -42.48 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.186 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.04 130.47 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.771 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -151.93 -139.78 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.983 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 27' ' ' ILE . 2.1 t -151.52 148.3 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 111.684 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 43' ' ' PHE . 15.3 tp -123.29 100.06 6.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.718 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.22 139.91 52.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.198 0.523 . . . . 0.0 112.391 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 t -111.54 96.54 6.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.905 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 tp -58.85 -26.61 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.81 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -28.8 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.313 . . . . 0.0 110.722 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -115.73 -52.81 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.777 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.56 -32.03 3.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.953 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.6 147.07 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.826 0.346 . . . . 0.0 111.201 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.78 160.81 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.4 HG12 ' CD1' ' A' ' 83' ' ' LEU . 13.5 mt -135.58 113.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.75 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HA ' HG12 ' A' ' 16' ' ' VAL . 2.6 mt -96.38 114.72 33.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.451 ' CD1' ' CD2' ' A' ' 10' ' ' PHE . 4.3 mt -103.41 91.67 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.26 161.67 33.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.472 2.115 . . . . 0.0 112.506 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -59.49 111.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.36 -4.46 5.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.086 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -82.51 -22.51 35.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.782 0.291 . . . . 0.0 111.377 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.471 HG23 HD13 ' A' ' 33' ' ' ILE . 32.9 mt -131.58 139.17 34.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.768 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.03 155.47 28.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.46 2.106 . . . . 0.0 112.221 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -68.82 148.96 49.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.81 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.51 24.86 69.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -130.02 160.69 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -134.7 113.82 12.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.018 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -100.64 109.59 21.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.035 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -69.71 118.43 12.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.65 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.4 mt -127.1 139.95 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.429 ' HB3' ' CG ' ' A' ' 7' ' ' ARG . 39.9 p90 -155.62 159.17 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.347 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CD1' HD23 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -164.18 163.5 22.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.955 0.407 . . . . 0.0 111.592 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -131.06 142.31 50.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.743 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.54 138.8 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.425 ' HB2' HG11 ' A' ' 3' ' ' VAL . 40.9 t -176.03 149.09 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 119.26 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.567 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 63.15 141.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -90.5 -30.19 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.32 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 p -54.78 -25.97 31.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.373 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.1 mt -71.56 -9.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.385 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.17 128.75 0.22 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.576 0.227 . . . . 0.0 110.981 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 164.36 9.29 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.464 2.11 . . . . 0.0 112.279 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.7 172.26 14.78 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.623 2.215 . . . . 0.0 112.513 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.33 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.836 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.32 108.19 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -72.92 -42.58 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.19 -31.27 65.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -75.41 -28.89 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.03 113.02 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.291 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.68 105.04 16.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.351 . . . . 0.0 111.176 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.49 98.35 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.73 142.14 35.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.993 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -90.56 -173.19 0.37 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.187 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.3 Cg_exo -40.63 -43.71 4.39 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.209 1.94 . . . . 0.0 111.716 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.2 tm? -160.6 79.73 0.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.2 t -138.27 118.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.701 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.06 106.27 17.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.632 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -170.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -62.94 -154.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.431 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -62.56 123.4 12.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.462 2.108 . . . . 0.0 112.058 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -50.77 110.86 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.54 0.67 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 11.9 tp -139.15 85.17 2.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.0 110.242 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 16.2 tttm -65.96 138.49 57.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.866 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 37.6 m-85 -115.89 151.94 34.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.572 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.27 14.04 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 111.032 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -160.77 136.42 5.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.131 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.86 98.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.391 2.061 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.92 156.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.884 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.35 106.62 17.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.354 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 26' ' ' ILE . 22.9 tp -104.26 129.72 52.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.82 134.04 54.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.67 136.46 13.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.3 135.16 18.18 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.488 2.125 . . . . 0.0 112.206 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -59.2 -26.41 64.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.56 31.2 18.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.783 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -153.32 100.6 2.63 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.07 50.65 3.56 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.651 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 -6.64 15.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.514 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -111.07 16.15 21.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.402 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.6 p-90 -113.26 -37.24 4.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.402 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.8 OUTLIER -107.79 162.68 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.993 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.88 -65.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -69.01 -61.35 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 m -84.04 -178.27 6.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.95 123.32 66.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.24 -46.35 25.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.533 2.155 . . . . 0.0 112.467 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.54 -21.12 79.21 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.992 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -69.15 121.74 82.92 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.584 0.231 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.446 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 51.8 Cg_exo -53.3 -29.87 49.45 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.414 2.076 . . . . 0.0 112.223 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.51 -19.72 57.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.35 -19.81 16.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.627 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 17.9 mt -155.79 -29.2 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.98 36.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 174.59 -32.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.71 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.05 18.46 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.587 0.232 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -70.46 -31.76 69.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 13.0 m -139.88 166.05 25.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.412 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 14.8 p -101.34 120.22 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 105.15 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 m -126.18 121.88 60.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.88 145.99 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.046 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 33.9 mm -129.72 120.24 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -123.61 25.76 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.234 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.432 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.46 109.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.496 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.12 51.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.024 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.77 131.07 54.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.21 123.12 37.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.391 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.9 p -133.52 143.57 48.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.13 124.05 14.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.899 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.403 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 15.0 mtm180 -127.09 129.52 48.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.574 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 148.03 11.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.042 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.5 mt -87.68 155.39 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.519 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.432 ' CE2' HD12 ' A' ' 28' ' ' ILE . 56.5 m-85 -132.02 148.23 52.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.26 172.21 12.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.449 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -46.56 -27.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.438 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.23 -41.23 49.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.76 129.06 3.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.44 -158.86 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.016 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.7 t -140.02 151.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.793 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.5 tp -123.22 100.18 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.232 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -122.47 154.03 38.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.469 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 p -126.09 97.15 4.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.101 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -53.33 -26.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.783 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.8 -24.86 64.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.44 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -129.03 -52.79 1.21 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 111.306 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.96 -35.88 2.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.713 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.5 t -49.31 141.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.706 0.289 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 p -148.24 162.28 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.497 HG22 HD12 ' A' ' 26' ' ' ILE . 26.8 mt -135.52 113.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.889 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.1 mp -94.05 123.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.432 HD12 ' CE2' ' A' ' 10' ' ' PHE . 3.3 mt -112.62 91.37 17.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 157.54 57.55 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.136 . . . . 0.0 112.25 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 107.9 0.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.57 -9.39 3.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.051 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.85 -29.05 50.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.969 0.384 . . . . 0.0 111.202 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 20.4 mt -118.83 141.52 30.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 21.1 Cg_exo -64.79 155.32 68.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.454 2.102 . . . . 0.0 112.101 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.78 141.04 58.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.25 23.37 78.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.624 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 43.4 t -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.274 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 1.8 mt-10 -137.46 113.73 10.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.706 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.403 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 4.6 mm-40 -105.74 108.95 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -70.54 122.57 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -130.74 129.9 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.544 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 39.4 p90 -145.72 158.41 43.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.935 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -163.09 160.81 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.733 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 123.67 28.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.96 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.15 129.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . 1.9 m -143.12 149.0 37.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.942 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -29.4 58.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -113.37 134.94 54.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.451 ' HA ' ' HG ' ' A' ' 67' ' ' LEU . 8.4 p-10 -90.98 -53.11 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.709 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -35.01 59.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.69 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -74.34 -2.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.352 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -132.65 138.35 31.84 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.717 0.294 . . . . 0.0 110.998 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.29 151.93 15.81 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.627 2.218 . . . . 0.0 112.616 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.29 172.24 3.46 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.672 2.248 . . . . 0.0 112.342 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 tp -97.57 -67.04 0.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 0.0 110.869 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -145.71 65.91 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -37.04 85.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.23 -31.31 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -86.38 -23.76 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.94 113.34 1.55 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.271 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -112.69 122.74 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 111.316 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.74 101.4 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.288 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.4 142.95 40.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.46 -57.61 1.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.482 ' CB ' ' CD ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -96.93 -174.12 0.37 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 65' ' ' SER . 87.6 Cg_exo -43.28 -32.97 3.54 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.024 1.816 . . . . 0.0 111.52 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -165.49 84.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.851 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.8 t -145.91 117.64 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.099 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -104.31 106.15 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.532 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.93 -172.01 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.12 -158.25 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.5 Cg_endo -63.23 121.74 9.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.526 2.151 . . . . 0.0 111.994 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.69 110.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.72 72.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.471 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 31.4 tp -142.52 85.86 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 110.321 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 40.4 tttt -57.69 159.64 5.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.045 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.97 143.16 34.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.55 16.71 16.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.142 0.496 . . . . 0.0 111.228 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.53 136.45 5.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.333 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.31 100.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.473 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.3 m -72.94 139.42 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.759 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -85.57 124.57 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.269 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.435 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 21.1 tp -124.21 128.26 48.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.439 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.0 mtm-85 -119.06 127.17 53.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.435 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -141.99 131.47 12.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.31 143.94 73.88 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.398 2.066 . . . . 0.0 112.092 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -59.13 -46.35 88.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.3 m 57.76 176.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.6 t70 58.28 100.58 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.08 41.02 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.672 2.248 . . . . 0.0 112.87 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -108.94 -3.75 17.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.564 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -122.62 16.07 10.32 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.469 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.7 p-90 -110.26 -36.68 5.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 6.3 pt20 -106.85 51.43 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.974 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -21.97 13.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -171.58 -38.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 m -47.89 171.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.66 123.5 69.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -63.93 -33.81 62.11 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.542 2.162 . . . . 0.0 112.223 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.05 76.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.898 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -70.9 121.52 84.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.688 0.244 . . . . 0.0 110.776 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 27.9 Cg_endo -62.35 -27.5 77.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.348 2.032 . . . . 0.0 112.107 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.35 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.38 -18.35 10.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.958 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 13.4 mt -156.7 -28.92 0.09 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.7 m -67.44 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.64 -38.42 0.04 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.61 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.0 18.46 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.702 0.287 . . . . 0.0 111.512 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -63.11 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.5 p -93.49 149.32 21.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.435 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 11.8 p -109.83 119.09 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.87 105.05 12.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.281 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.6 m -121.02 129.22 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.042 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mt -96.8 132.06 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.066 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.9 mm -118.77 118.79 59.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -119.93 25.65 9.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.39 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.428 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -178.79 115.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.26 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.2 m-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.498 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.628 0.252 . . . . 0.0 111.129 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 1' ' ' THR . 7.3 p 52.14 160.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.983 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.9 147.75 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -107.37 117.82 35.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.4 p -123.59 143.76 50.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.93 131.02 42.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' CG ' ' CB ' ' A' ' 42' ' ' TYR . 1.1 mtt-85 -128.51 138.69 52.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.33 143.83 8.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.662 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -89.11 138.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.644 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 17' ' ' LEU . 76.1 m-85 -129.35 148.97 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.334 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 172.08 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.748 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -45.18 -28.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -57.32 -31.14 65.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.89 168.84 16.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.823 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.62 148.09 5.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.085 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 27' ' ' ILE . 4.0 t -110.66 152.76 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.4 0.619 . . . . 0.0 111.85 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 32.4 tp -123.53 100.23 6.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.21 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 153.65 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.15 0.5 . . . . 0.0 111.889 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.08 96.92 4.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.971 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -55.42 -26.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.573 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.94 -26.11 68.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.436 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -121.32 -52.95 2.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.685 0.279 . . . . 0.0 111.413 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.09 -41.39 1.51 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.775 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.0 t -50.16 144.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.676 0.274 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.5 t -149.89 167.74 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.423 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.2 mt -142.54 113.45 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HA ' HG13 ' A' ' 16' ' ' VAL . 4.4 mp -93.23 120.49 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.827 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 HD11 ' CD2' ' A' ' 10' ' ' PHE . 5.2 mt -105.98 91.84 5.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.48 159.92 38.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.512 2.141 . . . . 0.0 112.475 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.38 104.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.07 -9.81 3.59 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.215 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.66 -28.31 58.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.942 0.371 . . . . 0.0 111.308 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 33' ' ' ILE . 33.7 mt -119.69 142.75 33.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.373 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.2 Cg_exo -60.07 152.9 62.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.24 1.96 . . . . 0.0 112.178 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.63 150.1 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 24.97 68.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.462 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -130.58 160.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 111.242 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -133.09 113.9 13.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.998 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.404 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -102.76 109.24 20.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -74.53 122.36 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 41' ' ' ILE . 37.6 mt -130.08 141.51 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.149 0.5 . . . . 0.0 111.584 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.418 ' CZ ' ' HD3' ' A' ' 72' ' ' PRO . 14.0 p90 -153.5 146.87 24.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.781 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CE1' ' HG ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -147.98 159.0 44.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.063 0.458 . . . . 0.0 112.031 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -116.0 147.83 40.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.468 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.404 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 25.1 t -145.23 140.81 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.045 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.7 t -176.64 149.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.46 2.4 25.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.723 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.55 115.78 7.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -90.62 -42.92 10.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -52.82 -24.4 8.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.605 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.5 mm -65.99 -13.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.539 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 178.21 142.43 0.28 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.026 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.68 172.72 6.48 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.491 2.127 . . . . 0.0 112.274 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.99 172.14 3.24 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.57 2.18 . . . . 0.0 112.348 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.71 -74.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.029 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.67 107.56 8.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.026 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -72.95 -35.72 67.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -64.9 -36.81 85.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -72.74 -27.85 62.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.89 111.36 3.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 124.2 51.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -105.54 100.37 9.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.681 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.23 136.1 36.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -57.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.455 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -85.16 -177.95 1.06 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 75.8 Cg_exo -41.32 -47.07 5.6 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -153.58 84.49 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.427 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.4 t -146.04 118.1 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.597 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.68 106.21 16.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.564 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.07 -168.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.17 -137.86 0.93 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 32.8 Cg_endo -64.17 125.95 16.18 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.441 2.094 . . . . 0.0 112.073 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -56.33 110.85 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.14 83.35 1.58 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 16.6 tp -142.2 86.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.189 0.519 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 17.3 tttp -57.98 159.9 5.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.124 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 24.4 m-85 -141.49 147.91 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -98.92 17.62 19.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.26 0.552 . . . . 0.0 111.19 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -164.81 136.55 3.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.577 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.0 97.96 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 0.0 112.472 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 5.1 m -70.5 137.69 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -81.3 119.25 23.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.258 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.415 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 13.6 tp -124.32 119.18 28.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -113.99 133.31 55.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -137.33 112.68 9.37 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.927 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.29 120.25 8.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.293 1.995 . . . . 0.0 111.918 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.68 -54.67 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.148 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.86 -177.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.99 167.56 12.75 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.94 41.73 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.843 2.362 . . . . 0.0 112.944 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.52 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.698 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -99.36 3.54 46.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.565 0.698 . . . . 0.0 111.081 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.62 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 1.8 p-90 -56.0 -31.79 63.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.845 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.62 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 4.5 mt-30 -95.44 138.35 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.612 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.71 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.484 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -163.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.3 m 71.17 -167.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 8.9 mt -99.91 117.99 62.47 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.673 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 3.6 Cg_exo -74.96 -6.63 18.32 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.64 2.227 . . . . 0.0 111.913 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.84 -43.17 35.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.981 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 m-20 -85.38 111.48 37.04 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.837 0.319 . . . . 0.0 110.807 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.4 Cg_exo -60.25 -27.21 84.42 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.276 1.984 . . . . 0.0 111.946 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 11.1 p30 -78.79 4.64 13.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -50.54 -100.42 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.594 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -80.15 -12.5 59.65 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 27.8 m -62.65 27.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.13 -3.86 2.42 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.164 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.55 17.66 12.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.593 0.235 . . . . 0.0 111.386 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.44 -75.43 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.724 0.297 . . . . 0.0 111.04 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.3 m -101.13 133.69 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 111' ' ' VAL . 14.3 p -105.39 106.95 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.469 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.64 104.87 11.46 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.1 m -122.01 131.65 72.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.2 mt -95.84 146.85 24.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.661 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.413 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 43.5 mm -128.49 121.64 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.23 25.44 7.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.081 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.22 109.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.845 0.355 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -129.26 132.08 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t -142.65 141.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.142 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.71 117.64 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.176 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.3 p -136.12 143.91 44.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 111.107 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.36 132.72 24.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.984 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.5 mtt180 -128.23 135.25 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.32 156.95 27.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.9 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.441 HD13 HG23 ' A' ' 9' ' ' ILE . 29.7 mt -91.39 156.26 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CG ' HG13 ' A' ' 28' ' ' ILE . 25.8 m-85 -131.46 170.59 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.36 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -152.14 171.94 17.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.915 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.7 p -58.69 -21.09 53.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -54.87 -51.25 66.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.46 128.64 3.76 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.733 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.16 -172.73 25.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.02 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.5 t -141.78 150.29 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 111.745 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 tp -123.24 100.1 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.324 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -125.24 154.52 41.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 111.786 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -127.11 97.14 4.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.1 mm -52.62 -26.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.647 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -63.39 -21.22 66.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.305 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.93 -52.93 1.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.788 0.327 . . . . 0.0 111.264 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.6 -33.82 2.9 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.696 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.67 145.4 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.8 t -148.7 164.41 34.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.0 mt -139.25 113.81 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.933 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.454 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.0 mp -94.72 135.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.638 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.443 HG13 ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -107.67 97.08 18.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.712 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.49 145.19 95.52 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.288 1.992 . . . . 0.0 112.115 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.1 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.202 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.18 4.27 5.52 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.367 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.7 -26.41 34.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.108 0.454 . . . . 0.0 111.201 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 HD13 ' A' ' 33' ' ' ILE . 26.2 mt -121.81 141.49 34.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.69 143.87 88.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.333 2.022 . . . . 0.0 112.218 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.79 151.35 34.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.08 25.54 62.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.5 t -129.47 160.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.268 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.02 113.93 15.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.797 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.35 109.23 21.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 14.2 tt0 -72.29 118.96 15.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 41' ' ' ILE . 39.6 mt -127.35 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.014 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.425 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 34.3 p90 -152.83 173.46 15.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.416 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -175.05 163.51 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.885 0.374 . . . . 0.0 111.535 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.62 117.63 15.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.045 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.416 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 33.1 t -106.87 141.82 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.9 t -178.1 149.09 0.53 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 49.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 11.9 m-20 -167.85 107.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.673 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -90.6 -55.06 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.637 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.7 p -64.31 -34.41 78.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 48' ' ' ASP . 4.3 mp -75.39 -2.49 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.498 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.36 116.49 0.54 Allowed Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.617 0.246 . . . . 0.0 111.066 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.96 169.05 21.17 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.472 2.115 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.62 172.32 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.588 2.192 . . . . 0.0 112.265 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -65.62 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.85 121.12 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -33.32 65.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -62.44 -31.39 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -81.39 -30.97 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 110.91 3.14 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.434 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.83 111.38 24.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 m -85.71 105.26 16.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.59 139.64 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 -57.69 1.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.508 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -95.18 -174.53 0.4 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.332 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.8 Cg_exo -40.46 -46.99 4.45 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.228 1.952 . . . . 0.0 111.843 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.7 tm? -153.89 82.23 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.748 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.8 t -143.15 118.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.476 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -105.87 106.25 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.614 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -165.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.028 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.53 -146.71 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 41.6 Cg_endo -67.38 134.15 32.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.451 2.101 . . . . 0.0 112.191 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.99 111.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.86 84.0 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.1 tp -144.44 87.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 77.4 tttt -62.7 159.78 15.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.956 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 29.0 m-85 -138.6 155.79 48.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.66 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.22 14.33 29.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.367 0.603 . . . . 0.0 110.96 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.62 136.51 2.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.263 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -61.58 95.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.413 2.075 . . . . 0.0 112.414 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.2 m -61.38 166.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.516 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 126.12 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 111.493 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 34.4 tp -124.24 128.01 48.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.098 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -120.45 126.1 49.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.788 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.433 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -143.58 163.31 37.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.477 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.52 120.07 7.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.447 2.098 . . . . 0.0 112.202 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -82.32 -48.55 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.19 48.09 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -112.89 81.91 4.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.45 47.24 2.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.73 2.287 . . . . 0.0 112.611 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -108.93 13.09 24.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 t -119.58 15.96 12.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.46 . . . . 0.0 111.812 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.1 p-90 -121.01 -37.87 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.586 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.1 mt-30 -103.53 68.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -156.22 -45.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -46.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.25 -178.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.8 mt -98.64 131.46 25.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.35 -23.59 70.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.421 2.081 . . . . 0.0 112.316 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.87 -25.21 32.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.832 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 8.3 m-20 -61.3 113.56 8.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.562 0.181 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.454 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 72.7 Cg_exo -50.09 -30.72 25.87 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.378 2.052 . . . . 0.0 112.273 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.11 -19.89 62.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.361 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.97 -20.45 16.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.824 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 19.0 mt -155.51 -26.57 0.11 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.5 m -68.18 36.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -155.17 -42.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.584 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.47 18.69 10.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.655 0.264 . . . . 0.0 111.455 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -65.84 -44.57 85.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.63 149.03 21.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.94 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 14.3 p -106.32 109.83 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.68 105.03 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.07 122.05 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.4 mt -87.5 137.67 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 35.1 mm -122.43 116.85 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.348 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 27.03 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.195 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.429 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.87 114.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.859 0.361 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.2 p -105.45 159.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.71 142.41 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.144 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.76 117.73 34.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.73 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.3 p -122.34 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 0.0 111.037 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -127.57 121.77 31.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.124 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.6 mtt180 -120.97 131.52 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.22 147.82 11.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.797 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 9' ' ' ILE . 26.2 mt -90.53 159.64 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.685 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CD2' HD13 ' A' ' 28' ' ' ILE . 79.9 m-85 -141.49 154.87 45.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.421 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -128.4 172.15 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -51.69 -24.5 5.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -55.19 -38.9 68.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.215 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 137.84 9.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.67 171.83 40.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.198 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.402 HG13 ' HA ' ' A' ' 27' ' ' ILE . 2.2 t -117.49 150.29 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.156 0.503 . . . . 0.0 111.548 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 25' ' ' SER . 32.9 tp -123.21 100.16 6.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.12 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.44 151.0 45.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.108 0.48 . . . . 0.0 111.835 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.6 p -121.23 97.05 5.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.023 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mm -52.53 -26.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.536 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -61.86 -29.6 70.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.083 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.66 -52.93 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.054 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.5 -38.02 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.694 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.2 t -49.48 144.47 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.73 0.3 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.74 158.37 44.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.434 HD13 HG22 ' A' ' 26' ' ' ILE . 38.1 mt -132.39 113.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.446 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.402 ' HA ' HG13 ' A' ' 16' ' ' VAL . 3.6 mt -94.64 118.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 0.0 111.276 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 HD13 ' CD2' ' A' ' 10' ' ' PHE . 3.9 mt -105.97 92.98 7.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 148.39 92.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.393 2.062 . . . . 0.0 112.167 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -53.34 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.7 -19.54 0.78 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.946 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.8 83.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.841 0.321 . . . . 0.0 111.363 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.449 HG21 HD12 ' A' ' 33' ' ' ILE . 32.1 mt -110.97 143.94 29.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.589 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.42 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -62.85 155.18 61.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.439 2.093 . . . . 0.0 112.295 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -69.41 153.81 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.17 24.46 58.73 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 44.8 t -130.08 160.87 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 32.7 mt-10 -132.87 113.64 13.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.854 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -106.08 109.06 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.02 128.56 36.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 41' ' ' ILE . 44.4 mt -134.87 140.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.275 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.433 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 28.0 p90 -154.22 149.66 27.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.427 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -151.53 167.01 29.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.056 0.455 . . . . 0.0 111.662 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -127.52 146.12 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.542 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.427 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 45.3 t -138.78 136.91 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.1 t -162.02 148.75 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.845 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -34.54 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -122.56 144.36 49.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -90.65 -26.41 19.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -70.52 -23.01 62.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.22 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 51' ' ' ILE . 36.6 mm -60.93 -20.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 tp 176.81 135.47 0.2 Allowed Pre-proline 0 C--O 1.232 0.15 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.64 173.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.425 2.083 . . . . 0.0 112.297 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.86 172.29 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.58 -29.25 12.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.921 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.85 85.21 2.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -37.61 66.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.32 -56.75 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -64.06 -76.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.074 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . 169.62 -97.7 0.13 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.133 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 165.4 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.864 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.93 97.5 8.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.515 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.76 140.24 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 -57.58 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.931 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.492 ' CB ' ' CD ' ' A' ' 66' ' ' PRO . 1.1 p -91.28 -173.85 0.4 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.249 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 65' ' ' SER . 72.8 Cg_exo -41.63 -51.27 4.41 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.19 1.926 . . . . 0.0 111.861 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -151.08 85.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 92.7 t -147.09 118.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.216 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.22 109.33 21.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.785 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.26 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.186 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 42' ' ' TYR . . . -78.26 -144.33 2.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.76 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.433 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 59.8 Cg_exo -51.84 123.14 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.596 2.197 . . . . 0.0 112.186 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -55.38 110.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.63 83.76 1.75 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 15.1 tp -138.43 85.01 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.199 0.524 . . . . 0.0 110.084 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 85.5 tttt -58.03 161.98 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.167 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 17.2 m-85 -143.38 148.43 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.576 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -97.06 18.26 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.263 0.554 . . . . 0.0 110.941 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.86 136.39 3.96 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.409 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.61 101.09 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.496 2.131 . . . . 0.0 112.467 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 m -68.53 153.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.698 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 108.66 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD11 HG12 ' A' ' 26' ' ' ILE . 5.0 tp -105.02 121.32 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -123.87 139.83 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.19 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.42 144.77 54.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.613 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.15 134.74 17.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.478 2.119 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 109' ' ' ASN . 2.7 p80 -49.49 -47.05 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.46 -81.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.878 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.48 162.51 46.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.74 32.84 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.966 2.444 . . . . 0.0 112.848 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.01 1.17 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.402 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -122.67 16.07 10.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.822 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 10.8 p-90 -117.69 -47.86 2.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.545 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 5.1 pt20 -77.28 64.79 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.33 -46.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -32.73 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.0 m -85.14 172.12 11.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.9 mt -99.9 125.17 41.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.051 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.09 -15.48 50.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.541 2.161 . . . . 0.0 112.297 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.77 -22.22 31.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.8 t0 -62.19 136.45 95.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.649 0.262 . . . . 0.0 110.723 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.84 -20.73 34.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.42 2.08 . . . . 0.0 112.274 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.521 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 87.9 m-20 -91.61 17.31 8.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.921 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -64.68 -113.44 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.993 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -48.98 -23.14 1.02 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 11.8 m -71.29 36.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 0.0 111.33 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 145.49 40.54 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.77 -74.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.796 0.332 . . . . 0.0 111.362 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 2.9 t-20 -148.78 32.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.3 p -80.97 150.06 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.734 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 p -84.81 114.45 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.265 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.68 105.08 12.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.195 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.91 124.85 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.57 143.26 26.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.6 mm -129.71 120.1 49.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.24 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -123.27 25.74 8.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.21 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.43 108.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.936 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.063 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.27 143.16 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.052 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.73 156.54 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 21' ' ' GLU . . . -117.41 117.53 29.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.477 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.3 p -123.11 143.76 49.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 111.081 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.78 130.55 40.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -129.34 132.18 47.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.29 149.71 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.91 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -88.26 158.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.599 0.237 . . . . 0.0 110.636 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 28' ' ' ILE . 49.8 m-85 -138.64 164.03 30.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.971 0.415 . . . . 0.0 111.438 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.73 172.13 14.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -53.05 -22.7 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.122 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -51.28 -35.23 36.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 28' ' ' ILE . . . 100.29 112.8 3.47 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.698 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.36 144.2 10.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.054 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 17' ' ' LEU . 2.2 p -102.89 157.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.0 111.814 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.474 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 15.2 tp -119.98 99.9 6.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.462 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.41 ' HA ' ' CB ' ' A' ' 25' ' ' SER . 4.6 m -115.51 145.6 42.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.7 m -121.82 96.68 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.258 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 tp -60.3 -26.6 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.41 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 2.4 mt-10 -62.68 -26.38 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.71 -52.9 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.69 6.56 9.35 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.216 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.02 141.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.856 0.328 . . . . 0.0 110.822 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 92.5 p -149.75 162.52 40.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.917 0.389 . . . . 0.0 111.529 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.2 mt -130.79 113.46 24.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.188 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 16' ' ' VAL . 2.5 mp -91.6 116.29 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.435 HD11 ' CD2' ' A' ' 10' ' ' PHE . 1.2 mt -102.94 87.0 1.11 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.682 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 158.73 40.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.546 2.164 . . . . 0.0 112.328 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.14 108.57 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.23 -9.94 3.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.904 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.09 -33.13 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.874 0.337 . . . . 0.0 110.939 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 39' ' ' GLN . 36.7 mt -119.91 143.75 35.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.344 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.09 154.3 72.85 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.364 2.043 . . . . 0.0 112.247 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.17 154.22 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.78 62.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.567 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -128.1 160.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.059 0.456 . . . . 0.0 111.187 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -134.35 113.9 12.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.967 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.418 ' HB3' HD12 ' A' ' 33' ' ' ILE . 6.4 tp60 -101.71 109.01 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.061 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.91 116.7 12.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.0 mt -127.21 139.39 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 111.263 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' GLY . 29.9 p90 -153.06 162.82 40.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.203 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' HD22 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -167.28 168.43 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.873 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.06 132.69 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.721 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 68' ' ' VAL . 21.7 t -126.1 148.29 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.95 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 17.2 p -143.71 148.96 36.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.014 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -76.75 -31.02 56.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.26 134.2 54.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.743 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -66.01 -9.29 29.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.766 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.7 m -50.44 -23.07 2.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.739 0.304 . . . . 0.0 111.392 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 53' ' ' PRO . 18.7 mm -75.91 -1.41 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.696 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.553 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 12.84 -74.86 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 52' ' ' LEU . 1.2 Cg_endo -44.56 125.99 6.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.631 2.221 . . . . 0.0 112.573 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.42 172.38 14.31 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.831 2.354 . . . . 0.0 112.475 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.89 -30.45 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.46 92.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -41.67 63.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.225 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -62.82 -24.41 67.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.48 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -93.96 19.92 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.519 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 107.97 0.43 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.46 105.07 13.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.934 0.397 . . . . 0.0 111.209 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.22 100.77 11.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.67 139.18 37.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.492 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -57.63 1.38 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.639 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.547 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -91.58 -171.32 0.27 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.974 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 47.5 Cg_exo -38.4 -48.42 2.46 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.324 2.016 . . . . 0.0 112.116 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.458 ' O ' HD11 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -158.66 66.72 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 111.054 178.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 99.0 t -121.58 118.35 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.575 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.5 106.24 17.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.575 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -167.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.998 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -68.38 -152.35 0.41 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.655 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 71.4 Cg_exo -50.71 160.57 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.563 2.175 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -84.51 111.0 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.66 78.98 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.899 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 8.3 tp -135.9 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.28 0.562 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.0 ttpt -73.0 149.69 43.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.909 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 73.5 m-85 -122.59 166.97 13.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.98 16.39 19.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.448 0.642 . . . . 0.0 110.824 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -168.75 136.54 1.66 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.185 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.55 107.24 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.438 2.092 . . . . 0.0 112.579 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 10.8 m -70.71 140.64 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -87.51 108.35 19.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.564 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -105.77 129.71 53.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -123.32 132.23 53.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 111.613 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.404 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.63 156.07 59.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.481 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.44 123.9 11.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 49.9 p-80 -71.66 -46.92 57.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 85.8 m 57.61 178.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.993 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.38 87.94 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.53 46.86 2.18 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.814 2.342 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -109.06 5.09 23.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.665 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -122.56 16.17 10.37 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.922 0.391 . . . . 0.0 111.931 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.457 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.6 p-90 -110.6 -37.26 5.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.457 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 5.5 pt20 -101.13 61.0 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.097 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -106.48 -37.05 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -86.47 -179.05 6.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 mt -100.05 120.54 56.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.76 -21.32 72.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.605 2.203 . . . . 0.0 112.669 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.46 -5.42 54.2 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.116 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.63 123.93 58.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.896 0.348 . . . . 0.0 111.004 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.459 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.58 -28.71 56.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.387 2.058 . . . . 0.0 112.335 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -61.72 -18.38 59.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.63 -19.3 15.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.62 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.482 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 15.6 mt -156.22 -30.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.0 m -68.05 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 177.41 -30.49 0.07 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.851 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 18.58 6.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -57.93 -30.27 65.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.95 170.74 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.74 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 11.7 p -103.7 105.88 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.287 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 105.09 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.82 121.53 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.255 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.99 143.8 26.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.408 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 28.5 mm -129.89 116.72 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.0 0.429 . . . . 0.0 111.544 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.84 27.48 8.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.974 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.79 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.784 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.93 124.16 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -152.2 145.24 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.014 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.13 117.54 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.047 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.9 p -125.28 143.01 51.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.945 0.402 . . . . 0.0 111.39 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.14 106.97 6.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.3 mtt180 -113.52 131.88 55.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 140.67 6.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.786 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.4 mt -87.09 135.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.608 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 17' ' ' LEU . 83.1 m-85 -116.71 160.98 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.286 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -146.48 172.31 13.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.592 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -44.44 -27.43 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -33.93 56.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 111.185 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 154.27 29.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.9 175.06 39.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.459 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 27' ' ' ILE . 2.2 t -126.96 150.86 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.471 . . . . 0.0 111.415 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 49.4 tp -123.22 100.16 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.472 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -126.37 152.19 46.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.044 0.45 . . . . 0.0 111.745 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.76 97.05 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -51.1 -26.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.479 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.19 -26.69 67.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.235 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -123.91 -52.92 1.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.174 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.42 -36.63 2.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.896 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.6 t -48.56 144.4 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 111.26 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 p -149.83 150.75 32.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.515 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mt -128.75 113.69 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.414 ' HA ' HG13 ' A' ' 16' ' ' VAL . 3.8 mt -93.21 134.41 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 10' ' ' PHE . 4.2 mt -123.93 94.26 45.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.161 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 155.82 66.97 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.423 2.082 . . . . 0.0 112.085 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.68 98.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.34 -21.75 0.74 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.945 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.21 -28.38 67.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 111.419 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.412 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 38.9 mt -123.84 137.88 29.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.548 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD3' ' CD2' ' A' ' 78' ' ' LEU . 17.8 Cg_endo -60.35 155.5 46.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.385 2.056 . . . . 0.0 112.544 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -66.64 151.86 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.766 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.05 19.52 59.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.635 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 40.8 t -125.62 160.77 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 5.3 mt-10 -137.06 113.71 10.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.053 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.16 110.75 22.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.814 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.65 119.4 13.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.136 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 41' ' ' ILE . 43.8 mt -126.92 139.82 50.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 110.867 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' GLY . 29.7 p90 -155.55 162.96 40.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -166.98 159.49 13.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.945 0.402 . . . . 0.0 111.526 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 133.5 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.297 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.87 135.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.586 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.417 ' O ' HD11 ' A' ' 67' ' ' LEU . 52.2 t -173.18 149.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.033 0.444 . . . . 0.0 111.272 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -71.29 108.28 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.85 107.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -90.59 -21.52 21.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.301 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -50.7 -25.13 3.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.518 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.9 mm -72.49 -7.45 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.726 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.24 164.37 20.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.861 0.362 . . . . 0.0 111.252 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.79 150.8 56.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.711 2.274 . . . . 0.0 112.14 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.31 172.15 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 tp -83.67 -34.56 24.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.92 89.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -73.05 -44.23 60.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.84 -31.95 65.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -79.55 -27.82 41.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.048 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.99 111.37 3.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.357 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -111.5 113.9 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.252 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 m -89.67 110.8 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.5 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.87 138.18 34.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.303 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.51 -57.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -92.19 -175.59 0.51 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.379 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 69.5 Cg_exo -40.93 -46.79 4.97 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.326 2.017 . . . . 0.0 111.529 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 46' ' ' CYS . 2.8 tm? -153.57 83.93 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.658 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.6 t -145.15 117.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.405 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -106.13 106.2 16.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.07 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -64.06 -153.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 20.6 Cg_endo -60.97 129.73 29.97 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.457 2.104 . . . . 0.0 111.909 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -54.98 110.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.48 79.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.716 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 14.8 tp -138.94 85.28 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 110.2 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 59.7 tttp -63.71 151.09 42.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.873 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.415 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 75.0 m-85 -127.92 154.11 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.771 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.482 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -98.51 13.92 30.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.436 0.636 . . . . 0.0 110.765 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.02 136.39 4.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.188 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.15 99.01 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.359 2.039 . . . . 0.0 112.379 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 m -67.86 154.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.637 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 119.0 38.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.413 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 tp -115.81 114.96 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.286 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.0 136.46 52.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.43 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.63 133.02 24.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 119.71 6.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.189 1.926 . . . . 0.0 112.383 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.64 -33.68 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.53 163.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.78 69.95 0.46 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.27 42.4 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.247 2.631 . . . . 0.0 112.558 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 13.17 25.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 t -114.02 15.98 18.3 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 0.0 111.914 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.607 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -117.53 -36.67 3.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.607 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 10.4 mt-30 -106.38 76.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.34 -49.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -138.89 29.82 2.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.4 m -138.48 -175.38 4.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.751 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.91 127.6 38.5 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.12 -5.01 15.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.495 2.13 . . . . 0.0 112.558 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.46 -7.42 26.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.945 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.449 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -68.75 134.28 90.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.812 0.306 . . . . 0.0 110.621 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.419 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 58.3 Cg_endo -71.51 -8.17 22.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.341 2.027 . . . . 0.0 112.612 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.409 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 77.2 m-20 -99.8 17.29 21.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 110.843 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.35 -113.9 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.282 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -47.87 -15.85 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 5.1 m -67.62 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 111.782 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -175.91 -34.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.39 25.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 110.835 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.59 -57.16 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.079 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.9 p -141.84 159.77 41.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -95.67 113.41 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.219 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.49 105.1 10.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.143 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 m -128.79 122.67 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 mt -91.87 148.53 22.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 33.8 mm -129.82 123.49 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.317 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.15 24.5 6.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.181 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.433 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.49 104.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.872 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.67 38.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.66 137.54 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.238 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.4 ' CB ' ' HB3' ' A' ' 21' ' ' GLU . . . -95.49 127.29 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -142.24 143.74 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.48 116.93 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.8 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.17 144.63 8.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.673 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.66 134.44 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.43 ' CG ' HD13 ' A' ' 28' ' ' ILE . 77.2 m-85 -119.73 157.79 27.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.35 172.16 13.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.754 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 t -48.19 -27.26 2.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.379 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -32.46 62.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 111.341 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.96 173.05 21.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.589 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.33 155.26 7.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.22 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 27' ' ' ILE . 3.4 t -112.08 151.98 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.366 0.603 . . . . 0.0 111.734 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' SER . 40.9 tp -123.57 100.23 6.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.149 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -121.62 149.46 43.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 112.017 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.04 97.13 5.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.166 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.41 -26.53 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.725 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -50.54 -50.53 53.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.679 -179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.34 -52.8 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.529 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.64 -28.42 2.04 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.132 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.3 t -52.8 135.9 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 66.3 p -146.06 170.96 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.3 mt -141.27 113.86 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.408 ' HA ' HG11 ' A' ' 16' ' ' VAL . 3.4 mp -92.4 120.28 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 HD13 ' CG ' ' A' ' 10' ' ' PHE . 3.2 mt -108.46 90.4 7.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.34 151.86 82.81 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.088 . . . . 0.0 112.142 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -53.9 107.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.06 -6.7 3.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.092 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.92 -29.63 44.28 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.985 0.392 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.5 mt -119.4 141.76 31.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.601 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -64.9 154.21 74.22 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.279 1.986 . . . . 0.0 112.054 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.93 154.45 39.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.43 60.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.8 t -129.46 160.77 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.258 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -134.31 113.8 12.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.957 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.32 109.13 20.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.075 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.97 110.43 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.673 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.71 136.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -154.96 151.29 28.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.266 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.7 OUTLIER -154.24 159.76 41.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 0.0 111.314 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -128.15 124.76 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.029 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.449 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 46.1 t -113.81 128.79 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.718 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 8.8 t -153.72 148.92 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 0.0 111.25 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -74.32 -23.64 59.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.55 102.69 3.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.614 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.73 -30.36 61.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -58.23 -22.89 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.247 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.497 HD11 HG21 ' A' ' 51' ' ' ILE . 38.7 mt -70.53 -10.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.611 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -179.06 134.07 0.28 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.64 0.257 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.78 158.17 48.1 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.521 2.148 . . . . 0.0 112.473 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.22 172.32 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.684 2.256 . . . . 0.0 112.415 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.32 -51.42 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 110.827 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -149.47 85.57 1.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.84 -33.48 66.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.022 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.51 -35.72 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -72.29 -28.2 62.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.09 112.7 2.27 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -110.18 108.66 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 108.41 19.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -87.67 138.84 31.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.266 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.493 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -88.86 -175.22 0.53 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.421 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 70.2 Cg_exo -41.01 -50.58 4.11 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.267 1.978 . . . . 0.0 111.676 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.8 tm? -151.94 83.35 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.703 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 44.4 t -144.46 118.23 3.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.529 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.53 106.11 16.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.658 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.15 -166.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.41 -148.25 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.73 127.77 20.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.431 2.087 . . . . 0.0 112.103 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -56.29 110.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.92 78.3 1.0 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.715 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.0 tp -142.45 87.52 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.255 0.55 . . . . 0.0 110.016 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 7.6 ttpp -64.13 149.24 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 42.2 m-85 -126.61 151.32 48.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.38 16.14 24.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.353 0.597 . . . . 0.0 111.007 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.38 136.5 4.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.394 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.49 103.6 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.532 2.154 . . . . 0.0 112.695 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 m -76.44 143.78 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.736 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.95 117.36 29.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.8 tp -111.73 117.59 33.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -108.34 139.45 43.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.404 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 1.3 mt -134.47 140.76 36.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.4 125.89 9.35 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.391 2.061 . . . . 0.0 112.388 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -77.69 -44.16 28.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.5 m 60.2 86.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -179.35 75.62 0.2 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.17 42.92 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.973 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -108.61 -47.52 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.025 0.44 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 t -111.57 3.99 18.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.598 0.713 . . . . 0.0 111.055 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 105' ' ' LEU . 1.5 p-90 -55.36 -31.67 61.94 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.96 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.455 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 1.8 pt20 -92.68 144.73 25.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.47 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -170.56 -42.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.749 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 -164.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m 64.23 159.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.054 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.2 mt -59.89 137.13 90.52 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.059 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -17.79 16.56 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.674 2.249 . . . . 0.0 112.691 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.97 -43.93 7.94 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.794 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.48 113.23 17.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.538 0.209 . . . . 0.0 111.061 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.9 -26.61 68.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.439 2.093 . . . . 0.0 111.995 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.69 -11.21 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.396 . . . . 0.0 110.806 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.528 ' C ' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -52.58 -23.28 6.13 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.151 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.528 ' HG ' ' C ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -156.73 -20.17 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 m -67.74 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -146.23 -42.61 0.04 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.375 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.45 62.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.583 0.23 . . . . 0.0 111.569 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.92 80.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 175.42 131.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 12.5 p -84.9 110.71 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.45 104.88 11.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.11 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.33 122.02 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.35 135.57 33.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.3 mm -126.45 115.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -116.7 14.07 15.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 116' ' ' ASP . 4.3 m80 -162.8 127.95 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.903 0.382 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.18 133.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.1 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.58 148.15 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.997 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.96 117.64 30.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.464 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.1 p -121.86 143.54 49.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.82 108.02 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.987 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' HG3' ' CB ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -111.36 136.09 50.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.054 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.26 149.28 12.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.231 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.2 mt -104.86 138.82 27.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.711 0.291 . . . . 0.0 110.52 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.439 ' CG ' HD11 ' A' ' 28' ' ' ILE . 90.3 m-85 -127.64 174.04 9.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 111.422 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -147.87 172.17 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.636 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -45.19 -28.79 0.82 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -56.39 -31.41 63.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 177.98 22.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.645 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.52 162.78 10.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.17 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.404 ' CG1' HG13 ' A' ' 27' ' ' ILE . 3.9 t -118.46 153.74 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.269 0.557 . . . . 0.0 111.762 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 25' ' ' SER . 40.5 tp -123.14 100.09 6.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.107 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 149.32 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.45 . . . . 0.0 111.735 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.46 97.22 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.224 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -51.74 -26.45 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.512 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -60.81 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.352 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.25 -53.03 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.238 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.66 -34.58 2.46 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.679 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 25' ' ' SER . 39.4 t -54.64 139.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.684 0.278 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -143.11 167.65 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.43 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.6 mt -134.42 113.75 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.656 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.468 ' HB ' ' HG2' ' A' ' 82' ' ' GLU . 4.7 mp -90.71 122.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.439 HD11 ' CG ' ' A' ' 10' ' ' PHE . 7.1 mt -110.03 94.7 18.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 150.97 87.38 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.34 2.027 . . . . 0.0 112.05 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.79 108.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -2.79 4.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.141 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.43 -26.06 33.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.383 . . . . 0.0 111.24 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG21 HD11 ' A' ' 33' ' ' ILE . 48.6 mt -122.97 142.3 37.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.553 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.15 155.48 39.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.398 2.065 . . . . 0.0 112.442 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.19 152.74 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 23.76 56.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.63 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.0 t -131.22 160.9 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.179 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -131.39 113.78 14.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.944 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.13 110.93 23.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.93 126.54 29.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.78 132.77 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.997 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.467 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 52.6 p90 -149.23 174.5 12.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.276 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 45' ' ' VAL . 1.2 p90 -175.34 176.15 2.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.022 0.439 . . . . 0.0 111.783 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.28 148.58 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.995 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG21 ' CE2' ' A' ' 43' ' ' PHE . 59.4 t -142.37 139.31 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.685 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.7 t -173.16 148.93 1.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.093 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 145.38 54.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.836 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.16 125.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.017 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.64 -34.69 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.236 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 t -76.61 -27.82 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.6 mt -77.16 -2.93 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.482 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.47 128.26 1.55 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.039 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.25 171.35 17.07 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.451 2.101 . . . . 0.0 112.272 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.15 171.79 3.68 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.4 tp -67.25 -66.43 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.015 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -145.76 115.81 7.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.02 -54.08 9.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.209 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.7 -55.41 35.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -26.55 60.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.299 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.43 110.76 0.58 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.674 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.44 104.93 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.85 95.44 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.73 142.29 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.088 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.42 -57.58 1.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.929 0.395 . . . . 0.0 111.171 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.494 ' CB ' ' CD ' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -97.1 -174.28 0.37 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 65' ' ' SER . 71.5 Cg_exo -41.35 -45.4 5.8 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.263 1.975 . . . . 0.0 111.699 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.445 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.9 tm? -153.13 83.92 1.2 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 178.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 61.7 t -145.06 118.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.423 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.64 109.07 20.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.695 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.3 -173.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -78.24 -126.84 0.42 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.595 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 37.3 Cg_endo -65.98 134.08 35.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.18 110.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.89 83.61 1.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 3.5 tp -131.4 84.43 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.478 ' CD ' ' CD2' ' A' ' 117' ' ' HIS . 10.5 tptt -53.3 153.83 3.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.404 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 35.2 m-85 -136.35 144.27 44.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.68 17.59 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.285 0.564 . . . . 0.0 111.226 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -162.71 136.5 4.71 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.173 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.68 97.27 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.337 2.025 . . . . 0.0 112.488 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 2.8 m -72.91 154.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.53 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HG2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 pm0 -110.91 116.46 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.399 . . . . 0.0 111.275 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 9.3 tp -104.75 129.72 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -112.88 126.2 55.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.944 0.402 . . . . 0.0 111.406 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.418 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -138.63 155.08 73.66 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.658 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.25 144.21 13.36 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.687 2.258 . . . . 0.0 112.665 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -79.31 -26.28 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 m 68.3 -173.05 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.13 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -85.21 35.75 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.122 2.548 . . . . 0.0 112.866 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.24 -13.53 14.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.424 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t -122.65 15.78 10.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 111.786 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.633 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.5 p-90 -95.19 -36.12 11.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.941 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.633 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.0 mt-30 -104.67 114.38 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -161.02 -44.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 34.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.37 175.93 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 29.1 mt -87.65 128.6 53.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.26 -13.6 16.87 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.473 2.116 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.09 -21.21 8.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.857 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.419 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -74.46 137.17 74.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.617 0.246 . . . . 0.0 110.903 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.427 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 56.4 Cg_endo -70.21 -26.63 25.24 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.162 . . . . 0.0 112.101 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -65.23 -15.68 62.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.34 -18.47 10.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.948 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 12.7 mt -156.93 -27.89 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.55 36.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 172.61 -33.41 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.604 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.83 44.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -88.58 96.59 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.65 143.13 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.418 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 7.9 p -112.05 133.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.257 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.24 104.99 17.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -119.57 123.78 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.029 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.0 137.16 33.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.404 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 25.9 mm -129.82 123.28 56.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.256 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.86 25.66 5.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.941 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.478 ' CD2' ' CD ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 178.82 104.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.815 0.341 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -150.55 151.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 t -140.93 155.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.6 117.83 35.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.355 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.6 p -136.01 143.22 44.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.36 121.95 13.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.813 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 1.1 ttp180 -127.05 130.22 49.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.14 144.12 8.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.66 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.6 mt -79.6 152.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.65 0.262 . . . . 0.0 110.8 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.434 ' CZ ' HD11 ' A' ' 28' ' ' ILE . 42.3 m-85 -129.6 154.04 47.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 0.0 111.303 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.51 172.62 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.592 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.1 m -44.18 -30.43 0.78 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.188 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.13 -42.02 99.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.454 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.06 142.32 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.096 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -120.23 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.787 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 2.0 t -151.29 145.98 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.238 0.542 . . . . 0.0 111.53 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 25' ' ' SER . 26.5 tp -123.51 100.38 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.65 138.31 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 112.077 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.8 m -100.57 96.84 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.391 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.06 -26.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.014 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -21.53 63.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 p -126.04 -52.99 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.659 0.266 . . . . 0.0 111.494 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.84 2.34 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.537 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -52.54 145.55 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.731 0.301 . . . . 0.0 110.931 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.4 p -148.06 165.31 31.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 48.1 mt -138.12 113.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 82' ' ' GLU . 2.8 mt -96.07 112.86 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 111.123 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.434 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 6.3 mt -98.31 99.85 8.0 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.773 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 156.66 63.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.268 1.979 . . . . 0.0 112.343 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -60.35 111.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.06 0.6 6.96 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.043 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.07 -30.05 49.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.929 0.365 . . . . 0.0 111.057 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 33' ' ' ILE . 32.8 mt -115.37 142.52 28.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.448 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.39 155.52 46.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.284 1.989 . . . . 0.0 112.351 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.57 153.36 43.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.2 25.5 57.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.85 160.24 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.303 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -137.84 113.83 9.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.739 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 1.9 mm-40 -101.6 125.63 48.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.055 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -82.45 121.64 27.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 41' ' ' ILE . 38.3 mt -124.97 136.39 60.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.221 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.424 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 26.6 p90 -155.51 159.92 40.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.414 ' CD1' HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -165.65 165.45 18.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 111.654 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.57 119.32 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.055 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -105.33 137.24 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.61 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -162.22 149.06 13.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.32 -31.62 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -135.12 156.06 49.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -90.64 -36.29 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.31 -25.67 62.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.29 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 mt -61.73 -17.26 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.281 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.66 140.23 0.3 Allowed Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 120.657 0.265 . . . . 0.0 111.045 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.72 171.52 17.28 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.541 2.16 . . . . 0.0 112.217 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.55 161.81 7.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.689 2.26 . . . . 0.0 112.252 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mp -59.07 -79.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.06 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.84 119.24 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.937 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -72.71 -19.25 61.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -51.06 -32.77 23.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.388 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -95.02 -76.46 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . 170.01 -99.53 0.15 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.241 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 160.57 124.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.55 0.34 . . . . 0.0 110.912 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.413 HG23 ' CD2' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -114.41 97.27 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.446 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.59 139.22 37.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.338 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -57.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.989 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.486 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -89.53 -175.77 0.58 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.217 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.04 -35.39 1.78 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.268 1.979 . . . . 0.0 111.785 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.2 tm? -168.09 78.24 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.955 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.8 t -137.46 117.87 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.48 105.99 17.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.717 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -165.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -71.47 -154.36 1.7 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.576 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 51.9 Cg_exo -53.9 130.1 37.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.5 2.134 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.413 ' CD2' HG23 ' A' ' 62' ' ' THR . 1.8 t-80 -56.68 110.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.742 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.05 83.95 1.77 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 3.4 tp -138.68 86.52 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.293 0.568 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -50.54 164.47 0.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -149.48 136.82 19.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.436 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.93 16.95 16.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.319 0.581 . . . . 0.0 111.06 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -159.8 136.45 6.57 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.258 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.7 95.82 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.505 2.137 . . . . 0.0 112.51 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 3.8 m -70.72 142.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.607 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 7.0 mp0 -90.93 129.19 36.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 111.563 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 26.9 tp -124.32 114.99 20.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -112.32 131.18 55.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.876 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.433 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -143.85 141.43 18.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.521 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.03 127.66 10.83 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.492 2.128 . . . . 0.0 112.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.55 -43.78 30.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t 62.09 59.75 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.92 122.74 1.13 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.714 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -86.62 39.87 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.643 2.229 . . . . 0.0 112.871 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 -4.29 16.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.612 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -122.67 16.16 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 6.8 p-90 -117.7 -43.49 2.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -91.74 133.04 35.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.291 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.31 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.66 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 32.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.734 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.36 -166.88 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 13.4 mt -95.72 121.43 61.34 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 5.7 Cg_exo -77.84 4.03 6.44 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.753 2.302 . . . . 0.0 112.686 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.55 2.24 8.14 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.822 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.499 ' OD1' ' HB3' ' A' ' 104' ' ' TYR . 37.1 p-10 -81.31 133.23 53.94 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 117.62 0.71 . . . . 0.0 110.317 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.432 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.65 -9.43 24.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.504 2.136 . . . . 0.0 113.085 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.436 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 7.2 m120 -96.89 17.62 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 111.109 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.499 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -75.03 -110.02 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.5 OUTLIER -55.89 -13.81 2.06 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 11.2 m -69.14 36.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.84 -37.88 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.134 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -24.79 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.651 0.262 . . . . 0.0 111.243 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.37 65.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 173.21 127.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.721 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.423 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 11.6 p -102.52 105.93 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.37 105.05 5.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.307 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.51 120.74 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.87 132.31 37.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.413 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 26.7 mm -113.74 124.79 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.58 26.52 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.637 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.466 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -178.32 98.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.89 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.475 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.46 158.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.985 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.21 134.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.227 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.66 117.71 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.3 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.7 p -123.15 143.64 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.374 . . . . 0.0 111.195 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.36 124.77 20.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.831 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.447 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.8 mtt180 -130.42 129.84 43.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.42 145.89 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.039 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.2 mt -90.45 159.67 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.514 0.197 . . . . 0.0 110.539 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 92.9 m-85 -137.57 152.29 49.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 111.411 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.76 172.11 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.764 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.02 -28.47 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -60.14 -37.28 79.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.62 -160.81 12.99 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.752 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.63 170.74 13.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.204 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.414 ' CG1' HG13 ' A' ' 27' ' ' ILE . 2.2 t -124.51 149.09 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.646 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 tp -123.35 100.38 6.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.58 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -129.47 153.95 47.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.142 0.496 . . . . 0.0 111.925 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -126.28 97.09 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.074 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -51.81 -26.68 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.639 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.21 -26.95 68.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.88 -52.91 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.137 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.55 -28.91 3.92 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.728 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.7 t -57.09 145.87 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.671 0.272 . . . . 0.0 110.795 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 p -149.66 156.35 41.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.43 . . . . 0.0 111.381 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 83' ' ' LEU . 23.9 mt -135.03 113.59 16.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.656 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.414 HG13 ' CG1' ' A' ' 16' ' ' VAL . 3.7 mp -93.26 126.79 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.894 0.378 . . . . 0.0 110.98 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.454 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 2.9 mt -110.77 99.36 41.72 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.39 153.45 76.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.586 2.191 . . . . 0.0 112.28 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -60.67 100.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.68 -6.3 3.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -73.28 -24.14 60.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.878 0.339 . . . . 0.0 111.202 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 18.5 mt -121.64 140.91 32.56 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.18 152.9 49.43 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.316 2.011 . . . . 0.0 112.243 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.59 143.42 57.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.75 25.58 72.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 48.0 t -127.99 161.14 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -139.96 113.67 8.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.847 179.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 27.9 mm100 -103.56 113.77 27.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.093 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.43 122.33 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.18 137.31 57.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.018 0.437 . . . . 0.0 111.213 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.447 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 13.2 p90 -154.41 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.28 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -166.95 153.88 8.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.058 0.456 . . . . 0.0 111.539 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 117.48 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.827 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 59.6 t -102.87 126.86 57.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.582 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m -137.97 132.76 32.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 111.08 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -28.41 61.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.34 134.87 51.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.021 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.07 -8.85 57.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.317 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -50.58 -22.65 2.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 53' ' ' PRO . 22.8 mm -69.51 -2.0 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.852 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 2.8 mt 7.06 -71.98 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 52' ' ' LEU . 80.0 Cg_exo -44.2 125.81 5.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.009 1.806 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.84 172.33 14.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.582 2.188 . . . . 0.0 112.686 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tp -83.84 -30.71 26.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.548 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -171.35 83.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -62.98 -40.66 98.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -28.69 60.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.74 -29.3 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.55 112.76 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.372 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -91.64 121.64 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.72 95.44 4.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -77.97 139.31 39.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.025 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.44 -57.71 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -88.03 -174.49 0.48 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.246 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 53.4 Cg_exo -38.68 -45.06 2.4 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.287 1.991 . . . . 0.0 112.125 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -161.66 65.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 90.0 t -121.63 118.61 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.573 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.58 106.71 17.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.871 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -63.74 -167.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -78.12 -150.75 4.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 52.0 Cg_exo -54.47 121.59 10.03 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 112.006 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -55.53 110.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.938 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.33 78.55 0.9 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.738 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 65.8 tp -136.65 84.68 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.184 0.516 . . . . 0.0 110.477 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.1 tttt -58.85 162.11 4.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.184 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.418 ' CE1' ' HG ' ' A' ' 75' ' ' LEU . 42.1 m-85 -144.42 150.01 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -96.75 12.61 31.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.302 0.573 . . . . 0.0 111.259 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mmpp? -157.24 136.73 8.37 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.965 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.87 93.49 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.293 1.995 . . . . 0.0 112.28 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.6 m -64.26 166.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 126.84 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.045 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 12.1 tp -124.22 107.04 10.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.22 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.34 129.69 53.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.362 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.418 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -136.34 154.18 76.89 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.652 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.96 120.21 7.4 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.502 2.135 . . . . 0.0 112.069 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.55 -54.4 7.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.27 158.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' CB ' ' CD ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -57.92 177.84 0.2 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.693 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 89' ' ' ASP . 92.4 Cg_endo -84.78 35.62 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.558 2.172 . . . . 0.0 112.93 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -109.33 -0.19 19.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.361 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -122.54 15.86 10.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 112.038 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.428 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 5.1 p-90 -105.48 -35.67 7.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 1.1 pt20 -94.18 29.83 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.369 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -101.7 -30.95 11.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -172.2 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.23 -165.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.788 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.67 124.64 63.5 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.78 -23.68 35.35 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.563 2.175 . . . . 0.0 112.25 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.88 4.43 39.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.136 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -60.96 138.97 94.1 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.916 0.358 . . . . 0.0 110.474 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 101' ' ' ASP . 3.0 Cg_exo -74.38 -3.08 13.27 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.483 2.122 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.421 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 10.3 p30 -109.22 17.41 21.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 0.0 111.053 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -80.15 -113.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.978 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.5 OUTLIER -47.76 -19.55 0.23 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 8.4 m -68.4 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -174.39 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.849 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.58 67.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.86 -66.56 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.45 142.74 51.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 111' ' ' VAL . 12.0 p -98.09 103.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.98 104.78 6.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 m -116.11 126.82 73.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.837 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.6 mt -81.62 136.55 35.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 34.9 mm -129.79 121.71 53.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.39 25.46 6.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.206 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 176.71 111.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.3 m-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.027 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -171.79 150.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.92 142.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.33 125.03 38.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.1 p -140.6 144.37 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.965 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.98 113.7 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 129.88 50.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.16 145.26 9.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mt -84.05 138.89 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.425 ' CD2' HD11 ' A' ' 28' ' ' ILE . 79.0 m-85 -117.41 161.24 19.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -134.55 172.07 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 t -49.91 -27.04 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -56.35 -33.11 65.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.64 173.2 22.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.647 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.63 158.35 8.74 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.067 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.9 152.05 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.359 0.6 . . . . 0.0 111.824 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' SER . 54.2 tp -123.66 100.21 6.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.38 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.12 142.02 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.076 0.465 . . . . 0.0 111.767 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.74 97.11 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.338 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.48 -26.4 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.617 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.66 -26.63 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.365 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 p -132.32 -52.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.287 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.59 -36.65 1.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.755 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.5 t -48.56 142.1 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 51.0 p -149.73 172.05 15.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 111.525 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mt -145.02 113.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.606 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.05 118.83 39.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 10' ' ' PHE . 2.6 mt -106.48 90.96 5.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.43 159.52 43.74 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.517 2.145 . . . . 0.0 112.334 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.31 106.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.08 -8.88 3.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.056 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.01 -23.91 55.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.97 0.385 . . . . 0.0 111.451 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 36.3 mt -131.0 141.09 40.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 38.3 Cg_exo -60.34 155.48 46.26 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.392 2.061 . . . . 0.0 112.264 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 152.63 45.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.74 23.34 63.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -128.51 160.75 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.146 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.8 113.84 11.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.008 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -101.05 110.73 22.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.6 114.16 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -124.99 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.56 152.92 29.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -157.1 162.92 39.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.401 . . . . 0.0 111.384 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.33 126.67 37.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.774 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 39.2 t -114.3 134.71 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.944 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 11.2 t -159.66 148.81 17.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -70.95 -24.18 62.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.701 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -132.74 139.96 47.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -90.59 -30.79 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.274 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 m -71.26 -26.49 62.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.56 -14.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.418 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 177.57 116.89 0.17 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.035 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.36 173.22 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.483 2.122 . . . . 0.0 112.115 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 171.99 15.22 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.506 2.137 . . . . 0.0 112.354 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.21 -73.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -130.82 89.73 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.92 75.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.61 -35.82 77.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.945 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -66.87 -28.51 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.8 111.7 3.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -113.36 136.88 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -100.76 98.47 8.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.588 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -76.45 133.92 39.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.44 -57.66 1.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.206 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.546 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -87.13 174.31 5.55 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.576 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 7.5 Cg_exo -34.5 -44.85 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 0.0 111.735 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.1 tm? -156.45 84.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.699 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 51.6 t -146.89 118.07 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.289 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.85 106.19 16.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.786 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.25 -168.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.85 -148.07 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.53 127.56 21.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.505 2.137 . . . . 0.0 112.009 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -57.2 110.87 0.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.88 76.33 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.74 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 18.9 tp -140.56 86.06 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 110.006 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 11.2 mtpp -75.99 123.89 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.173 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 40.8 m-85 -98.68 168.59 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.557 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.63 16.16 25.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.609 . . . . 0.0 111.032 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.42 136.51 5.54 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.46 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.41 107.06 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.491 2.128 . . . . 0.0 112.499 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 m -79.41 144.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -88.4 116.04 26.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 111.05 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 9.2 tp -113.39 129.83 56.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -121.66 132.65 54.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.358 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -139.51 113.82 8.0 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.64 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.68 120.69 8.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.095 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.77 -21.32 55.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 68.66 -168.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 62.62 79.53 0.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.47 46.57 2.12 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.826 2.351 . . . . 0.0 112.776 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.06 4.94 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.468 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.53 16.0 10.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.881 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -114.17 -36.86 4.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.67 43.63 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.934 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 -47.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.12 -38.19 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.36 174.51 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.47 139.27 21.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.27 -17.82 27.21 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.597 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.47 -29.47 19.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.705 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 140.29 83.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.792 0.33 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HB2' HG21 ' A' ' 106' ' ' VAL . 43.0 Cg_endo -67.2 -25.73 42.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.592 2.195 . . . . 0.0 112.259 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -16.85 62.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.607 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.31 -19.01 19.65 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.936 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 18.0 mt -155.96 -26.87 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.428 HG21 ' HB2' ' A' ' 102' ' ' PRO . 4.5 m -67.35 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 156.82 -27.92 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.411 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.03 -32.39 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -127.66 42.1 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.45 122.21 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.41 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 13.5 p -106.15 111.54 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.388 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.9 104.98 13.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -122.78 126.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mt -99.12 121.0 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.88 119.53 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.356 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.504 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 2.7 t0 -119.57 15.39 12.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.504 ' CD2' ' O ' ' A' ' 116' ' ' ASP . 4.3 m80 -162.35 125.42 2.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.723 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.593 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.17 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.507 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 6.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.487 0.184 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 1' ' ' THR . 8.0 p 52.34 162.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.927 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.0 t -121.64 139.07 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.302 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.31 117.3 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.156 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.8 p -132.55 143.8 49.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.58 120.97 21.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 1.4 mtt180 -122.0 132.12 54.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.39 157.29 28.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.954 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.1 mt -94.98 151.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.443 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 41.1 m-85 -128.26 144.86 51.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 111.402 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -128.58 171.91 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -47.38 -28.64 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.203 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -54.3 -38.48 65.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.04 173.73 40.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.717 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.28 -155.17 26.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 t -146.97 150.23 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 0.0 111.628 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.4 tp -123.34 100.27 6.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.352 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.79 148.48 50.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 112.016 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 p -116.16 96.99 5.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.001 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -50.15 -26.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.741 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -38.49 91.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.193 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.01 -52.87 2.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.193 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.73 -30.92 3.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.12 142.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 110.845 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.01 154.0 41.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 111.453 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.7 mt -132.13 113.62 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.59 136.11 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.992 0.425 . . . . 0.0 111.174 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.443 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 2.3 mt -128.69 87.02 56.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.744 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.42 162.19 37.61 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.494 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.72 107.4 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.992 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.89 -10.75 3.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.114 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' CB ' ' CG2' ' A' ' 28' ' ' ILE . . . -86.14 -33.69 20.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 mm -101.51 132.74 21.42 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.08 144.97 77.77 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.154 1.903 . . . . 0.0 111.949 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -57.76 141.57 48.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.25 28.04 71.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.0 t -131.98 159.87 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -129.96 113.95 15.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.755 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -101.22 109.0 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.374 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -75.8 116.06 16.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.4 mt -124.63 134.29 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.151 0.501 . . . . 0.0 111.6 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.41 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 30.6 p90 -150.79 155.06 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.972 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -157.86 160.36 37.61 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.653 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -120.07 151.65 38.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.846 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.81 143.38 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.448 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.5 p -173.76 149.1 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 111.348 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -38.28 76.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 111.0 23.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.91 -9.49 58.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.668 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -72.47 -43.92 63.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.3 mt -77.45 0.12 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.402 ' CD1' HD11 ' A' ' 67' ' ' LEU . 11.5 tp -47.53 104.12 0.4 Allowed Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -84.87 147.52 10.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.703 2.269 . . . . 0.0 112.203 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.64 122.79 12.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.402 2.068 . . . . 0.0 112.259 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.88 -50.74 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -178.38 68.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.99 -49.89 26.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.064 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.13 -34.58 68.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.112 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -25.54 66.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 112.2 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.254 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -115.18 124.55 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 111.239 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 m -102.05 111.77 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -77.2 142.04 39.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.198 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.44 -57.56 1.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -103.2 -173.1 0.27 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.192 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 55.7 Cg_exo -39.87 -58.49 0.88 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.075 1.85 . . . . 0.0 111.747 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 3.0 tm? -138.13 85.24 2.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.1 t -147.17 118.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.731 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.14 106.11 14.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.9 -143.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.55 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 31.7 Cg_endo -64.07 131.53 30.96 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.494 2.129 . . . . 0.0 112.04 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -56.59 110.82 0.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.37 79.8 1.27 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.638 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 28.9 tp -142.3 85.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.467 ' CB ' ' CD2' ' A' ' 117' ' ' HIS . 4.9 ptmt -85.23 122.01 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.078 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 33.2 m-85 -93.2 170.9 9.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.6 18.41 16.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.569 . . . . 0.0 111.077 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 136.6 3.02 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.512 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.52 104.08 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.504 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.73 139.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.887 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -84.5 127.98 34.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.919 0.39 . . . . 0.0 111.347 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.3 tp -124.21 118.24 26.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.47 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.1 mmm-85 -105.46 134.33 48.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.933 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.44 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.4 OUTLIER -131.83 122.26 18.46 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.27 120.24 5.9 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.429 2.086 . . . . 0.0 112.168 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -73.52 -27.12 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.2 m 63.41 55.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.011 0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -130.92 92.0 35.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.774 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.0 41.03 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.191 2.594 . . . . 0.0 112.783 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -1.46 19.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.525 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -122.75 16.14 10.21 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.441 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.9 p-90 -110.73 -38.77 5.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.441 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 5.0 pt20 -95.51 152.73 18.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.059 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 64.04 31.22 13.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.761 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.22 -47.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.6 m -129.3 -172.3 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.2 mt -85.75 141.01 35.66 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.57 -1.71 11.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.67 2.247 . . . . 0.0 112.847 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.41 -34.22 4.55 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.707 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.414 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 77.3 m-20 -61.08 123.12 74.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.538 0.209 . . . . 0.0 110.978 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.456 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.24 -30.84 63.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.345 2.03 . . . . 0.0 112.158 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -61.91 -17.22 55.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.38 -17.69 13.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.665 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.0 mt -157.94 -30.58 0.08 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.93 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 178.84 -47.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.688 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.75 67.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.388 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -97.63 53.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -162.6 135.9 5.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 13.2 p -99.86 116.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.28 105.03 13.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.916 0.389 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.18 123.09 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mt -93.17 131.95 37.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 39.8 mm -114.15 117.26 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.305 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.81 27.23 8.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.13 179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.467 ' CD2' ' CB ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 177.3 104.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.4 m-85 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.14 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.737 0.303 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.19 164.31 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.47 125.13 63.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.15 117.63 30.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.554 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.2 p -119.07 143.7 46.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.413 . . . . 0.0 110.782 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.53 112.29 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.4 mtp85 -110.53 137.61 48.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.05 153.93 22.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.928 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 mt -95.97 154.43 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.486 ' CE2' ' CD1' ' A' ' 28' ' ' ILE . 22.4 m-85 -122.79 172.18 8.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -155.1 171.87 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 p -58.62 -25.63 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.58 -57.4 12.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.48 133.11 4.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.45 -169.83 21.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.126 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.89 148.76 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.669 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 43' ' ' PHE . 10.1 tp -123.14 100.11 6.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.22 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.45 140.87 52.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.733 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.47 97.17 6.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.225 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.37 -26.53 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.671 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.02 -40.82 98.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.291 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -105.84 -52.95 2.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.73 -30.94 3.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.609 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.3 t -57.15 144.01 10.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.715 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 p -144.95 161.58 39.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.47 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 mt -137.88 114.07 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.843 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.0 mt -96.31 136.38 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -108.85 93.94 13.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.98 145.07 96.93 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.335 2.023 . . . . 0.0 112.236 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.75 104.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.276 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.09 5.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.203 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' O ' HD23 ' A' ' 78' ' ' LEU . . . -76.34 -28.07 56.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.013 0.406 . . . . 0.0 111.258 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 27.4 mt -126.42 141.84 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD3' HD23 ' A' ' 78' ' ' LEU . 39.4 Cg_exo -60.34 155.37 46.9 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.395 2.063 . . . . 0.0 112.234 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.48 141.91 57.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.03 79.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.683 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 46.9 t -121.84 160.69 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.311 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -140.11 113.8 8.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.868 179.211 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.455 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.21 120.03 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.23 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -81.31 108.85 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.651 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.467 ' HB ' ' CE2' ' A' ' 10' ' ' PHE . 2.5 mt -117.17 137.54 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.417 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.422 ' CE1' ' HD3' ' A' ' 72' ' ' PRO . 52.5 p90 -149.06 157.14 43.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.052 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.417 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -159.37 159.71 34.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.075 0.464 . . . . 0.0 111.64 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.45 124.08 39.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.809 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.6 t -112.75 130.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.2 t -151.65 148.86 28.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -74.75 -41.78 59.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.96 131.03 47.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.738 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -90.65 -40.63 11.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.11 -31.49 27.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.89 -3.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.385 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.32 114.73 4.19 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.96 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.16 157.89 28.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.403 2.068 . . . . 0.0 112.261 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.49 172.2 14.72 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.634 2.223 . . . . 0.0 112.444 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 tp -77.2 -53.57 7.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 107.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -73.0 -35.71 66.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.8 -35.6 73.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.018 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -71.49 -29.92 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.37 111.55 3.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.392 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -128.37 132.46 48.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.933 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 m -106.02 106.36 16.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -75.69 135.11 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.38 -57.7 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.297 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.478 ' CB ' ' CD ' ' A' ' 66' ' ' PRO . 1.1 p -86.78 -175.16 0.56 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.511 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 65' ' ' SER . 79.6 Cg_exo -42.06 -47.86 6.56 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.214 1.943 . . . . 0.0 111.705 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.7 tm? -154.86 81.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.805 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 69.0 t -142.27 118.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.296 178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.72 106.16 16.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.507 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -166.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.211 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -79.35 -144.2 2.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 75.4 Cg_exo -49.77 121.69 7.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.144 . . . . 0.0 112.197 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -58.17 111.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.09 83.93 1.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.625 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 11.9 tp -137.64 85.1 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HD3' ' CD2' ' A' ' 117' ' ' HIS . 1.7 tptp -61.7 132.82 54.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 43.3 m-85 -112.7 144.11 42.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -88.8 17.22 5.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 111.369 179.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -164.68 136.33 3.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.21 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.28 102.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.522 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 4.4 m -74.06 161.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.504 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.81 129.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 111.317 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 tp -124.16 118.07 26.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.387 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -105.94 130.93 53.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 1.3 mt -128.13 116.18 20.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.48 136.73 70.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.385 2.057 . . . . 0.0 112.251 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.29 -20.12 57.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 68.31 31.45 5.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -143.63 77.88 14.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.697 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.48 54.42 2.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.923 2.415 . . . . 0.0 112.628 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.31 -13.05 14.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.617 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 t -122.6 16.1 10.33 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.463 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.4 p-90 -106.78 -36.05 6.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.463 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -104.32 71.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -119.37 -39.51 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -43.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 35.4 m -54.56 179.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.13 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -99.0 135.87 20.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.93 -5.72 16.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 112.58 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.4 -41.04 7.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.648 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 61.2 m-20 -61.53 138.51 95.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.52 0.2 . . . . 0.0 110.745 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.05 -27.29 50.04 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.175 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -65.28 -15.06 62.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.986 0.422 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.97 -19.45 18.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.839 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.7 mt -155.58 -28.2 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.11 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -177.88 -36.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.649 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.98 -58.95 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.256 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -96.18 88.39 4.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.47 141.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.43 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 14.2 p -97.32 115.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.18 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.77 104.99 10.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.133 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -128.07 120.97 54.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.994 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.06 146.12 26.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.42 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 30.8 mm -129.8 120.39 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.2 25.87 8.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.078 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.459 ' CD2' ' HD3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 179.36 103.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.823 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.2 -19.16 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.21 126.25 68.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.363 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.84 117.61 34.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.2 p -118.57 143.27 46.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.45 122.96 17.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.967 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -127.85 129.36 46.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.36 142.88 7.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -89.89 135.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.44 ' CG ' ' CD1' ' A' ' 28' ' ' ILE . 92.7 m-85 -115.89 151.6 35.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 111.374 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.0 172.31 11.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.654 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.42 -28.97 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -54.76 -29.7 54.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 167.43 32.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.679 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.97 158.48 9.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.347 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -114.58 151.03 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 111.512 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 25' ' ' SER . 44.0 tp -123.47 100.24 6.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.29 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.47 152.9 42.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.022 0.439 . . . . 0.0 111.89 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.2 m -120.75 97.25 5.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -52.73 -26.54 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.7 -36.3 82.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.304 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 p -109.22 -52.89 2.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.736 0.303 . . . . 0.0 111.356 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.92 -43.11 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.812 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.83 143.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 111.181 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.4 p -149.47 167.14 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.516 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.417 HG12 HD13 ' A' ' 83' ' ' LEU . 14.0 mt -139.67 113.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.038 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.81 122.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.44 ' CD1' ' CG ' ' A' ' 10' ' ' PHE . 2.2 mt -112.08 89.48 11.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.85 156.67 65.03 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.499 2.133 . . . . 0.0 112.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -57.29 104.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.17 -13.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.13 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -78.13 -36.01 48.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.382 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 16.3 mt -108.32 141.37 23.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.596 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 19.7 Cg_exo -65.37 155.17 70.12 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.336 2.024 . . . . 0.0 112.131 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 142.46 57.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.53 23.37 75.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 38' ' ' GLU . 48.2 t -126.88 161.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 111.251 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 3.2 mt-10 -137.04 113.74 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.813 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 1.4 mm-40 -105.71 117.41 33.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -69.72 119.58 14.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 mm -120.66 109.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 12.3 p90 -138.18 161.27 37.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.309 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -170.84 165.22 7.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 111.86 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -132.37 132.63 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.603 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.437 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 56.4 t -119.2 138.52 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.228 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.3 t -165.53 148.99 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.773 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.7 -38.97 70.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 110.829 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -132.73 157.99 43.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.595 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -90.43 -40.77 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.553 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -53.54 -23.64 11.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.642 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.8 mm -66.76 -12.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.647 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.0 tp -169.35 137.07 1.53 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.663 0.268 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.56 163.69 36.84 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.449 2.1 . . . . 0.0 112.333 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.43 169.17 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.575 2.183 . . . . 0.0 112.231 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 mp -86.63 -35.47 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.81 96.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -33.87 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.023 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.73 -29.58 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -80.33 -32.9 37.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.05 111.85 3.6 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.33 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -96.3 115.11 26.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.22 111.31 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.472 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.87 144.04 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.296 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 -57.68 1.38 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.013 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.521 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -98.97 -173.37 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.297 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.2 Cg_exo -40.49 -42.4 3.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.223 1.949 . . . . 0.0 111.864 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 67' ' ' LEU . 2.6 tm? -157.6 81.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.744 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 43.2 t -141.55 118.01 7.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.63 106.19 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.553 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.8 -169.6 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.041 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.431 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -61.3 -152.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.541 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.433 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 37.1 Cg_endo -65.94 134.37 36.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.544 2.163 . . . . 0.0 112.065 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -60.57 110.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.37 75.98 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.718 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 24.4 tp -142.27 86.41 1.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.144 0.497 . . . . 0.0 110.2 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -53.78 164.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.433 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.443 ' CZ ' HD22 ' A' ' 75' ' ' LEU . 4.5 m-85 -146.34 141.37 27.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.625 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.68 16.66 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.317 0.58 . . . . 0.0 110.827 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -166.51 136.78 2.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.021 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.77 100.65 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.525 2.15 . . . . 0.0 112.641 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 115' ' ' ILE . 13.5 m -68.13 139.48 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -82.86 123.39 29.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 0.0 111.409 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.417 HD13 HG12 ' A' ' 26' ' ' ILE . 7.7 tp -124.2 121.05 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.182 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -115.78 132.88 56.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.42 ' CD1' ' CG1' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 119.49 6.37 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.527 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.63 130.75 38.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.274 1.983 . . . . 0.0 112.236 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.6 -54.8 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.27 168.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 56.04 85.25 0.19 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.187 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.14 38.21 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.855 2.37 . . . . 0.0 112.681 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -108.98 13.17 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.54 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 t -105.47 15.92 26.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 111.819 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.452 ' CE2' ' CG ' ' A' ' 94' ' ' GLN . 4.6 p-90 -121.16 -39.94 2.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.452 ' CG ' ' CE2' ' A' ' 93' ' ' TRP . 4.6 mm100 -99.51 59.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.97 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -127.12 89.2 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tptt 60.74 29.62 19.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -120.5 -171.13 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.81 128.75 57.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.27 -7.97 17.26 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.497 2.132 . . . . 0.0 112.539 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.92 10.95 8.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.053 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -71.48 126.62 91.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.937 0.369 . . . . 0.0 110.375 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 58.2 Cg_endo -71.48 -7.03 20.41 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.165 1.91 . . . . 0.0 112.671 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.471 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -104.82 17.36 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.504 ' CG ' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -75.43 -113.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.034 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 HD12 ' CG ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -48.04 -21.09 0.4 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 15.6 m -68.71 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 155.2 34.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.645 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.72 -51.59 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.04 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.3 29.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.859 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 151.17 36.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.769 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.42 ' CG1' ' CD1' ' A' ' 85' ' ' LEU . 11.8 p -93.63 103.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.204 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.34 104.98 7.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 m -120.85 123.22 69.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.45 135.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.408 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 35.7 mm -119.54 117.83 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.244 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.34 26.29 9.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.292 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.482 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.7 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.575 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.759 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 44' ' ' LYS . 81.1 p -122.52 143.25 49.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -141.81 112.4 7.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 11.3 ttm-85 -121.54 129.43 52.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 156.89 27.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.685 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 38.1 mt -89.68 154.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.608 ' CE2' HD11 ' A' ' 28' ' ' ILE . 18.7 m-85 -127.5 175.25 8.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.135 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 37' ' ' VAL . 2.3 m120 -151.31 171.79 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -61.7 -23.13 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.942 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -56.4 -45.44 80.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.29 152.36 8.75 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.827 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.69 -173.32 45.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.087 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.498 HG13 HG13 ' A' ' 27' ' ' ILE . 2.8 t -145.64 150.61 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.392 0.615 . . . . 0.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.652 HD11 ' CB ' ' A' ' 6' ' ' ALA . 22.3 tp -123.34 100.18 6.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.233 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 143.82 50.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.99 0.424 . . . . 0.0 111.811 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.29 97.09 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.247 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -54.06 -26.82 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.419 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.759 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 1.4 mm-40 -62.47 -22.73 66.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.314 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' CB ' ' A' ' 4' ' ' ALA . 1.1 p -126.16 -52.97 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.79 -40.27 1.65 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.694 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 84' ' ' ARG . 33.9 t -53.55 137.98 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.741 0.305 . . . . 0.0 111.129 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.5 p -141.82 169.75 17.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.632 HG12 HD13 ' A' ' 83' ' ' LEU . 24.0 mt -141.59 113.65 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.209 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.0 mp -93.14 131.42 40.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.608 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -103.41 95.15 6.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.608 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.54 138.41 75.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.353 2.036 . . . . 0.0 112.084 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -51.09 101.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.009 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.3 -3.98 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.013 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.05 -30.28 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.892 0.346 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 39' ' ' GLN . 28.3 mt -119.93 143.48 35.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.53 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.5 Cg_exo -64.9 150.8 87.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.375 2.05 . . . . 0.0 112.114 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.6 mt-10 -66.57 151.68 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.46 65.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.57 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 38' ' ' GLU . 44.2 t -127.81 160.56 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG12 ' A' ' 37' ' ' VAL . 17.8 mt-10 -128.68 113.83 15.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.05 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.937 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.05 109.05 20.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.04 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.3 tt0 -74.45 114.69 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.808 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -124.91 139.02 52.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.138 0.494 . . . . 0.0 111.048 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 7' ' ' ARG . 21.3 p90 -153.45 171.51 18.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -175.5 156.81 2.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.181 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.659 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -129.41 122.12 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.077 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.753 HG22 HG13 ' A' ' 68' ' ' VAL . 39.6 t -110.32 136.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.537 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.27 96.43 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.554 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -69.14 143.16 54.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -126.25 -57.73 1.38 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.539 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -96.42 -173.89 0.36 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.258 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.37 -40.31 3.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.281 1.987 . . . . 0.0 111.877 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.74 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -161.19 78.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.753 HG13 HG22 ' A' ' 45' ' ' VAL . 48.6 t -137.61 117.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.566 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.42 106.17 16.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.707 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -60.28 -163.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.114 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -74.59 -144.54 0.97 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.442 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 45.2 Cg_endo -68.12 128.33 17.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.133 . . . . 0.0 112.148 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -57.58 110.83 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.8 77.48 0.86 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.743 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.729 HD11 ' HG2' ' A' ' 39' ' ' GLN . 22.6 tp -141.41 86.64 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 110.061 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.505 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -56.18 166.27 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.134 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 19.2 m-85 -148.72 143.54 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.683 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -96.53 17.9 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.3 ttmt -167.48 136.37 2.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.209 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 39.3 Cg_exo -60.54 96.88 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.408 2.072 . . . . 0.0 112.6 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 115' ' ' ILE . 3.5 m -68.1 140.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.536 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.03 125.12 32.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.798 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 26' ' ' ILE . 20.5 tp -124.19 128.1 48.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.944 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.763 ' O ' HG13 ' A' ' 24' ' ' VAL . 36.1 mtt-85 -119.76 130.71 55.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.862 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.543 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 154.96 60.06 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.531 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 131.57 23.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.352 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -51.84 8.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.73 44.9 10.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.59 105.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.78 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.81 39.39 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.666 2.244 . . . . 0.0 112.828 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -108.71 13.26 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.132 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -120.99 16.19 11.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.493 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 8.8 p-90 -118.72 -45.01 2.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.781 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.493 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.9 OUTLIER -88.07 91.36 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -162.04 71.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tptp 60.29 34.93 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.64 -173.59 4.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 23.0 mt -83.87 126.03 71.55 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 9.4 Cg_exo -71.29 -24.44 23.02 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.584 2.189 . . . . 0.0 112.602 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.31 14.12 20.97 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 6.3 t70 -114.0 130.53 23.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.893 0.346 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.823 ' O ' HG22 ' A' ' 106' ' ' VAL . 29.3 Cg_endo -62.94 -30.83 77.27 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.57 2.18 . . . . 0.0 112.222 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -55.57 -20.17 12.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 110.888 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CE1' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.52 -12.21 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.06 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.849 HD22 ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -165.26 -13.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -177.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 102' ' ' PRO . 15.9 m -65.12 36.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -153.15 25.26 0.79 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.15 -33.91 14.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.133 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -58.63 -31.62 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -150.43 139.14 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 111' ' ' VAL . 13.8 p -91.31 112.0 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 105.04 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 83' ' ' LEU . 11.5 m -123.27 123.6 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.061 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -93.5 139.16 31.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.953 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.502 ' HB ' HG22 ' A' ' 81' ' ' VAL . 37.2 mm -121.33 122.22 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.41 25.94 6.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.092 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.505 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.63 102.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.078 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.556 HG22 ' CG ' ' A' ' 44' ' ' LYS . 55.7 p -137.41 143.39 41.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.995 0.426 . . . . 0.0 111.274 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.706 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -137.37 137.21 38.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.8 mpp_? -134.73 137.72 43.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 160.86 33.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.822 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.424 HD13 ' HG3' ' A' ' 40' ' ' GLU . 10.4 mm -94.43 154.88 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.598 0.237 . . . . 0.0 110.655 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.931 ' CD1' HD12 ' A' ' 28' ' ' ILE . 51.1 m-85 -135.17 146.01 48.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.28 171.87 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.631 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p -48.84 -26.92 2.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.172 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -56.8 -31.91 65.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.62 -174.57 32.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.546 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.26 -161.66 29.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.121 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 27' ' ' ILE . 2.8 t -143.75 151.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 111.731 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 25' ' ' SER . 39.2 tp -123.02 99.96 6.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.041 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.39 154.8 33.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 111.961 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 m -120.94 97.22 5.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.147 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.56 -26.53 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.697 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.2 mt-10 -66.41 -46.29 77.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.464 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.632 HG21 HG12 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -100.92 -52.94 3.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 111.371 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.02 -36.25 2.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.646 HG22 ' HD2' ' A' ' 86' ' ' PRO . 43.6 t -53.93 145.8 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.738 0.304 . . . . 0.0 110.853 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.69 167.34 26.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 0.0 111.513 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.818 HG12 HD13 ' A' ' 83' ' ' LEU . 27.8 mt -134.1 113.84 18.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.717 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.5 mp -91.69 119.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.797 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.931 HD12 ' CD1' ' A' ' 10' ' ' PHE . 5.3 mt -106.77 97.35 17.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.95 156.86 64.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.435 2.09 . . . . 0.0 112.139 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -57.75 112.97 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.71 5.93 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.198 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -86.68 -25.88 24.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.022 0.411 . . . . 0.0 111.21 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.868 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.4 mt -122.53 141.92 36.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.45 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -61.75 155.47 53.92 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.315 2.01 . . . . 0.0 112.11 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 37' ' ' VAL . 34.1 mt-10 -67.89 154.99 40.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.41 26.6 56.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 35' ' ' GLU . 38.6 t -133.3 159.93 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -133.64 113.81 12.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.852 179.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.868 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -104.74 112.05 25.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.14 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG3' HD13 ' A' ' 9' ' ' ILE . 44.2 tt0 -72.59 124.23 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.72 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.6 135.24 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.17 0.509 . . . . 0.0 111.423 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.485 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.9 p90 -148.36 169.33 20.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.9 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.706 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -165.63 157.7 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.443 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.556 ' CG ' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER -124.66 115.95 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 22' ' ' THR . 25.0 t -109.44 135.44 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.523 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.9 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.388 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.49 109.45 20.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.26 142.57 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.5 -57.75 1.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 111.254 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.519 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.58 -175.22 0.42 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.308 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.5 Cg_exo -40.53 -44.35 4.4 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.242 1.961 . . . . 0.0 111.684 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.688 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -153.18 86.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.495 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.3 t -147.63 117.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.429 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -108.52 105.86 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.83 -172.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.19 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 42' ' ' TYR . . . -62.87 -147.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.42 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 36.6 Cg_endo -65.51 126.68 16.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.137 . . . . 0.0 111.932 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -52.97 110.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.27 80.86 1.37 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.9 tp -143.05 86.81 1.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.17 0.51 . . . . 0.0 110.26 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 8.5 tmtt? -67.39 145.72 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.092 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 52.3 m-85 -122.77 151.41 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.715 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.552 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.16 14.62 21.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.28 0.562 . . . . 0.0 111.145 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -161.15 136.51 5.72 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.288 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.47 98.47 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.376 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.5 m -70.58 142.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.82 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.75 125.94 36.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.309 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.818 HD13 HG12 ' A' ' 26' ' ' ILE . 9.1 tp -124.08 129.01 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.593 ' N ' HD12 ' A' ' 83' ' ' LEU . 10.5 mtm105 -125.76 124.78 41.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.182 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.519 HD13 ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -137.0 134.36 19.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.631 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.646 ' HD2' HG22 ' A' ' 24' ' ' VAL . 52.0 Cg_exo -52.94 143.37 49.56 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.352 2.035 . . . . 0.0 112.152 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 25.6 p-80 -49.78 -47.32 51.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 9.2 m 49.22 76.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.213 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.32 92.83 0.28 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.71 41.13 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.94 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.08 -11.3 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.1 t -120.69 16.07 11.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.483 ' CZ2' ' HG3' ' A' ' 94' ' ' GLN . 2.4 p-90 -113.65 -35.75 5.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 0.7 OUTLIER -101.45 -23.25 14.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.254 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -98.81 -27.09 14.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -67.3 0.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.134 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.92 177.0 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 23.4 mt -91.53 129.45 42.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 36.7 Cg_exo -59.98 -22.31 68.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.662 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.48 -39.92 6.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.946 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 2.5 m-20 -55.3 124.96 56.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.899 ' O ' HG22 ' A' ' 106' ' ' VAL . 49.3 Cg_exo -55.24 -31.58 76.99 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.377 2.051 . . . . 0.0 112.2 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.8 -14.94 57.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.76 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -17.49 6.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.912 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.76 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 10.3 mt -158.08 -32.11 0.07 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.1 m -69.11 36.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -144.04 -42.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.746 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.42 -60.29 3.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 111.346 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 62.91 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 22.4 m -151.2 171.55 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 0.0 111.009 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 111' ' ' VAL . 11.1 p -109.24 120.11 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.34 105.1 7.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 83' ' ' LEU . 10.6 m -127.24 121.71 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.056 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 mt -89.46 140.33 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 81' ' ' VAL . 29.8 mm -127.22 121.93 58.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.73 24.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.251 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER 179.2 111.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.004 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.751 0.31 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -127.46 143.69 51.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 0.0 111.15 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -130.7 107.07 8.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.452 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 17.6 mtt180 -107.08 129.39 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.4 142.03 6.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.006 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 10' ' ' PHE . 25.9 mt -87.51 159.82 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.633 0.254 . . . . 0.0 110.433 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.5 m-85 -140.73 152.28 45.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -131.17 172.3 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.6 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -44.82 -28.89 0.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.49 -33.79 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -174.86 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.754 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.07 163.28 11.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.144 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 27' ' ' ILE . 2.9 t -119.92 150.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.369 0.604 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.535 HD11 ' HB1' ' A' ' 6' ' ' ALA . 22.3 tp -123.5 100.34 6.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.457 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.18 149.53 50.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 111.958 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.54 97.1 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.927 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.77 -26.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.742 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 9.5 tt0 -62.24 -41.42 98.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.599 HG23 ' CB ' ' A' ' 4' ' ' ALA . 2.8 p -106.34 -52.91 2.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.67 -35.18 2.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 45' ' ' VAL . 22.6 t -49.08 139.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.14 155.64 42.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 111.382 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.736 HG12 HD13 ' A' ' 83' ' ' LEU . 49.5 mt -136.98 113.54 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.568 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 16' ' ' VAL . 2.0 mp -92.64 136.01 26.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.002 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.736 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.7 mt -124.65 89.22 52.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.8 160.87 46.38 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.495 2.13 . . . . 0.0 112.218 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -57.12 113.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.65 -2.7 4.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.033 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -87.33 -29.43 21.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.997 0.399 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 39' ' ' GLN . 20.9 mt -122.78 137.16 27.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.609 ' HD3' HD21 ' A' ' 78' ' ' LEU . 34.3 Cg_exo -60.62 155.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.214 1.943 . . . . 0.0 112.149 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.59 140.43 58.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.39 21.71 78.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.429 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 38' ' ' GLU . 43.3 t -123.34 160.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 111.211 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.553 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.7 mt-10 -139.28 113.6 8.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.74 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' CG ' HD13 ' A' ' 33' ' ' ILE . 7.5 mm-40 -105.04 108.95 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.056 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -72.96 121.1 19.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 mt -128.18 130.16 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.452 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 31.8 p90 -144.75 142.2 29.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.904 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.488 ' CE1' HG23 ' A' ' 45' ' ' VAL . 2.3 p90 -145.08 164.36 31.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.088 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 150.25 50.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.22 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 68' ' ' VAL . 78.6 t -144.07 140.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.799 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.8 pp20? . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.748 0.309 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 118.77 30.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -95.66 137.97 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.722 HD13 HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.39 -57.59 1.38 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.612 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -89.68 -177.56 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.679 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.3 -49.02 4.01 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.53 2.154 . . . . 0.0 111.771 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.711 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -151.15 84.82 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 45' ' ' VAL . 46.2 t -146.78 118.21 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.563 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.799 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -110.66 107.08 16.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.692 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -65.94 -168.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.151 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 42' ' ' TYR . . . -64.55 -155.98 0.17 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.615 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 51.1 Cg_exo -53.78 130.63 40.02 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.519 2.146 . . . . 0.0 112.201 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 111.05 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.816 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.21 84.04 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.719 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 33.0 tp -142.16 86.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 110.146 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.5 OUTLIER -57.53 164.51 1.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.117 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -148.13 146.98 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.609 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.67 15.32 22.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -160.07 136.53 6.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.52 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 26.5 Cg_exo -62.64 99.32 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.446 2.098 . . . . 0.0 112.457 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 115' ' ' ILE . 11.3 m -69.67 143.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.864 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.85 128.2 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.192 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 26' ' ' ILE . 7.1 tp -124.35 127.06 47.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.499 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.628 ' N ' HD12 ' A' ' 83' ' ' LEU . 25.1 mtt180 -114.93 133.78 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.956 HD12 HG11 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -129.7 107.6 17.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.894 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.08 131.23 43.62 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.388 2.059 . . . . 0.0 112.14 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -27.13 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.085 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 12.9 m 65.37 -166.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.25 94.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.38 49.57 3.25 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.668 2.245 . . . . 0.0 112.666 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 5.04 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.412 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.51 16.12 10.41 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.922 0.392 . . . . 0.0 111.845 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.664 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -115.0 -36.11 4.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.664 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 3.1 mt-30 -105.04 55.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.098 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -157.63 105.16 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.16 33.3 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.4 m -133.95 176.17 8.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.991 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.5 mt -91.31 131.67 35.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -77.23 -2.35 12.56 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.26 -18.44 6.72 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.806 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.409 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -66.26 116.57 34.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.59 0.233 . . . . 0.0 110.86 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.792 ' O ' HG22 ' A' ' 106' ' ' VAL . 71.6 Cg_exo -50.82 -30.61 30.33 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.472 2.115 . . . . 0.0 112.296 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.803 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 32.9 m-80 -60.59 -19.49 57.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.4 -18.71 19.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.735 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 20.2 mt -157.01 -29.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.85 36.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 118.62 47.41 0.41 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.566 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 103' ' ' ASN . . . -94.5 -34.49 12.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.46 82.47 2.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.04 139.24 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.706 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.956 HG11 HD12 ' A' ' 85' ' ' LEU . 14.9 p -99.57 108.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.466 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.09 104.91 11.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.1 m -122.68 131.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.241 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mt -103.35 134.81 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.899 ' O ' HG22 ' A' ' 81' ' ' VAL . 38.0 mm -122.13 122.9 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.559 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -124.01 26.47 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.956 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.453 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -173.11 101.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.16 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.718 ' CE1' HG21 ' A' ' 115' ' ' ILE . 2.3 m-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -119.89 143.99 47.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -131.74 115.71 16.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.852 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -120.48 131.95 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.35 28.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.084 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -105.72 131.84 54.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.709 0.29 . . . . 0.0 110.453 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CG ' HD13 ' A' ' 28' ' ' ILE . 71.6 m-85 -112.48 153.26 27.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.047 0.451 . . . . 0.0 111.429 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.7 171.99 9.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -48.26 -27.48 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.33 -37.26 69.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.258 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 179.01 23.62 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.577 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.01 167.45 15.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.084 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG13 HG13 ' A' ' 27' ' ' ILE . 1.9 t -117.87 148.22 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.73 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.737 HD11 ' HB1' ' A' ' 6' ' ' ALA . 30.4 tp -123.3 100.2 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.203 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.91 145.51 50.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 111.854 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -110.84 97.19 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.249 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -50.48 -26.5 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.644 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -65.86 -30.5 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.36 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 4' ' ' ALA . 1.3 p -115.52 -53.0 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.726 0.298 . . . . 0.0 111.291 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.65 -38.04 1.97 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.788 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG22 ' HD2' ' A' ' 86' ' ' PRO . 60.6 t -48.56 144.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.0 p -149.73 152.06 34.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.465 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.664 HG12 HD13 ' A' ' 83' ' ' LEU . 41.6 mt -129.84 113.37 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.442 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.645 HG13 HG13 ' A' ' 16' ' ' VAL . 2.8 mt -97.3 123.24 49.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.058 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.68 ' CG2' ' HB3' ' A' ' 32' ' ' ALA . 1.5 mt -113.53 92.91 25.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.63 157.37 58.93 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.94 106.54 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 137.68 -7.23 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.106 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -81.72 -24.28 36.22 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.934 0.367 . . . . 0.0 111.234 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.642 HD13 ' CB ' ' A' ' 39' ' ' GLN . 35.4 mt -125.68 141.1 38.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.472 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' HD21 ' A' ' 78' ' ' LEU . 39.2 Cg_exo -59.92 155.45 44.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 37' ' ' VAL . 20.6 mt-10 -70.85 148.68 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.63 22.89 68.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.547 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 38' ' ' GLU . 38.5 t -130.31 160.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.027 0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' N ' HG12 ' A' ' 37' ' ' VAL . 20.1 mt-10 -131.55 113.96 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.996 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.693 ' HG2' HD11 ' A' ' 75' ' ' LEU . 23.6 tp60 -101.12 109.05 20.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.993 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.1 123.23 21.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.595 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.34 132.71 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.521 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.5 p90 -146.81 170.07 17.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.333 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.681 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.3 p90 -175.93 157.31 1.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.378 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -128.35 133.04 48.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.079 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.811 HG22 HG13 ' A' ' 68' ' ' VAL . 88.9 t -119.86 130.63 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.569 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.551 ' O ' HD12 ' A' ' 67' ' ' LEU . 1.1 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.179 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 pm0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 3.0 m -123.01 99.15 6.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.236 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.34 138.32 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.444 HD13 HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.39 -57.62 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.996 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.544 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -91.49 -172.56 0.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.195 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 63.7 Cg_exo -40.19 -48.53 3.97 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.203 1.936 . . . . 0.0 111.815 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.68 ' O ' HD13 ' A' ' 67' ' ' LEU . 1.9 tm? -155.67 78.72 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.781 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.811 HG13 HG22 ' A' ' 45' ' ' VAL . 42.5 t -137.56 117.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.746 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.3 106.91 17.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.662 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -61.86 -171.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -63.87 -144.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.542 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 51.4 Cg_endo -68.97 130.59 20.61 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.475 2.116 . . . . 0.0 111.989 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -57.67 110.76 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.5 75.59 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.765 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.693 HD11 ' HG2' ' A' ' 39' ' ' GLN . 5.1 tp -138.76 84.62 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.578 ' HG3' ' CE1' ' A' ' 117' ' ' HIS . 1.5 tmtm? -63.23 151.88 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.236 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 31.4 m-85 -129.69 151.17 50.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.551 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.706 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -93.73 15.23 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 111.221 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -165.04 136.42 3.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.269 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.06 99.2 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 115' ' ' ILE . 6.6 m -69.76 152.8 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HB3' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -95.0 126.81 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 111.343 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.666 ' HG ' HD21 ' A' ' 85' ' ' LEU . 36.5 tp -124.21 116.94 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -106.92 131.01 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.159 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.94 HD12 HG11 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -130.54 123.29 20.26 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.765 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 24' ' ' VAL . 73.9 Cg_endo -75.08 120.1 5.9 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.34 2.027 . . . . 0.0 112.095 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.06 -30.19 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.1 m 60.54 65.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -114.32 110.83 47.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.815 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.98 39.04 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.653 2.235 . . . . 0.0 112.929 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 -9.13 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.597 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.6 t -122.7 16.07 10.25 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.456 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.8 p-90 -107.03 -38.4 6.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.071 0.462 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.456 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -95.61 56.4 1.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.811 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.16 -45.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.1 -46.58 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 62.3 m -54.9 176.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.122 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 11.8 mt -99.86 124.26 44.47 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.23 -26.97 72.22 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.469 2.112 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.55 -16.11 44.06 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.967 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 98' ' ' LEU . 5.8 t70 -80.62 137.95 51.13 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.808 0.304 . . . . 0.0 111.008 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.76 ' O ' HG22 ' A' ' 106' ' ' VAL . 53.2 Cg_endo -68.71 -24.39 35.0 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.751 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 96.9 m-20 -64.07 -17.01 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.79 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -20.21 15.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.85 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.79 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 16.6 mt -155.08 -26.82 0.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.9 m -66.78 36.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 123.06 36.4 0.66 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.531 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 103' ' ' ASN . . . -94.44 -33.32 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.113 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -134.03 51.48 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.87 141.05 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.94 HG11 HD12 ' A' ' 85' ' ' LEU . 13.8 p -85.38 107.61 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.391 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.71 104.92 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 111' ' ' VAL . 7.7 m -123.99 125.0 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.4 mt -90.07 145.13 25.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.3 mm -129.32 117.66 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.53 27.42 8.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.578 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 177.98 106.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.815 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.616 HG22 ' HG2' ' A' ' 44' ' ' LYS . 21.5 p -136.59 145.38 44.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.757 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -133.84 133.06 41.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 4.6 ttt180 -135.7 129.33 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.526 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.99 169.96 42.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.64 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 28.2 mt -104.49 137.88 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.719 ' CG ' HD12 ' A' ' 28' ' ' ILE . 87.9 m-85 -120.35 153.2 36.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -124.21 171.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 p -55.91 -22.38 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.266 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.61 -36.31 71.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 110.963 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.68 158.68 11.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.72 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.01 164.46 25.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.255 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 27' ' ' ILE . 3.1 t -122.26 152.38 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.757 HD11 ' CB ' ' A' ' 6' ' ' ALA . 28.5 tp -123.34 100.2 6.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.365 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.47 154.35 42.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 0.0 112.039 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.468 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 2.7 p -119.92 97.2 5.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.967 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.0 mm -49.4 -26.57 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.914 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.817 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -65.35 -55.69 16.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.343 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 4' ' ' ALA . 6.9 p -90.45 -52.88 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.296 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.43 -36.54 2.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.781 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 84' ' ' ARG . 21.5 t -48.66 143.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.655 0.264 . . . . 0.0 111.072 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -148.8 161.63 41.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.474 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.793 HG12 HD13 ' A' ' 83' ' ' LEU . 32.2 mt -137.38 113.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.774 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 16' ' ' VAL . 2.4 mp -92.39 128.24 44.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.851 0.358 . . . . 0.0 110.926 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.761 HG22 ' HB3' ' A' ' 32' ' ' ALA . 2.2 mt -112.75 94.49 28.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.435 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.21 157.68 48.46 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.661 2.241 . . . . 0.0 112.452 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -60.89 95.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.617 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 145.14 -11.3 1.82 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.877 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.761 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -72.94 -23.57 60.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.823 0.311 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.823 HD13 ' HB2' ' A' ' 39' ' ' GLN . 39.1 mt -124.5 141.85 38.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.449 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.728 ' HD3' HD21 ' A' ' 78' ' ' LEU . 32.0 Cg_exo -58.68 152.37 56.71 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.378 2.052 . . . . 0.0 112.371 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -67.93 152.55 45.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.96 23.34 56.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 35' ' ' GLU . 39.1 t -131.1 160.75 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 111.075 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.545 ' N ' HG12 ' A' ' 37' ' ' VAL . 14.9 mt-10 -132.62 113.94 13.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.121 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.823 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -99.01 113.37 25.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.037 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -74.4 115.66 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.577 HD11 ' HE1' ' A' ' 77' ' ' PHE . 29.4 mt -123.23 139.71 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.174 0.511 . . . . 0.0 111.255 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.425 ' CB ' ' HA ' ' A' ' 7' ' ' ARG . 21.0 p90 -153.06 162.61 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -166.36 158.89 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.923 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.664 ' HE2' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.92 149.33 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.509 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 68' ' ' VAL . 37.1 t -145.29 135.36 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.42 ' O ' HD12 ' A' ' 67' ' ' LEU . 18.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.839 0.352 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.78 104.98 10.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.71 139.06 37.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.46 -57.6 1.37 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.284 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.704 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -94.37 -175.37 0.47 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.29 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.25 -46.97 5.49 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.169 1.912 . . . . 0.0 111.538 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.74 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.6 tm? -151.53 80.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.528 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.9 t -141.85 118.24 6.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.511 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -106.53 106.16 16.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.613 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB1' ' CE2' ' A' ' 118' ' ' PHE . . . -64.87 -178.67 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.08 -156.71 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.637 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 48.7 Cg_exo -55.4 129.26 34.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.534 2.156 . . . . 0.0 112.12 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -58.45 111.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.06 72.42 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.727 HD11 ' HG2' ' A' ' 39' ' ' GLN . 20.6 tp -137.96 83.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.262 0.553 . . . . 0.0 110.002 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 10.3 mttt -73.0 117.16 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.046 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' HE1' HD11 ' A' ' 41' ' ' ILE . 84.6 m-85 -90.76 154.24 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.728 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.36 17.17 16.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.43 136.68 4.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.69 94.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.537 2.158 . . . . 0.0 112.769 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.5 m -70.1 133.4 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.553 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 28.9 mt-10 -82.64 128.18 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 111.563 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.793 HD13 HG12 ' A' ' 26' ' ' ILE . 14.7 tp -124.19 128.72 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.164 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.609 ' O ' HG13 ' A' ' 24' ' ' VAL . 25.5 mtt180 -115.73 127.41 55.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 0.0 111.561 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.704 HD13 ' OG ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -143.64 162.25 42.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.18 120.07 6.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.391 2.061 . . . . 0.0 112.313 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.54 -54.52 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 65.0 m 56.14 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.85 74.87 0.72 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.265 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HA ' ' CD1' ' A' ' 93' ' ' TRP . 96.3 Cg_endo -86.46 35.48 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.753 2.302 . . . . 0.0 112.929 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -13.75 14.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.658 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -122.62 16.15 10.32 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.502 ' CD1' ' HA ' ' A' ' 90' ' ' PRO . 3.3 p-90 -106.83 -35.87 6.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.476 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 7.7 pt20 -102.02 35.02 2.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -156.81 28.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -177.2 -62.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.4 m -70.75 178.93 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 98' ' ' LEU . 11.1 mt -98.68 121.61 55.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.8 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.71 -35.54 97.75 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.457 2.105 . . . . 0.0 112.36 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.56 -17.42 66.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.889 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -81.56 138.57 47.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.976 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.753 ' O ' HG22 ' A' ' 106' ' ' VAL . 50.0 Cg_endo -68.4 -24.52 36.74 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.516 2.144 . . . . 0.0 112.327 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.411 ' HA ' HG22 ' A' ' 106' ' ' VAL . 66.6 m-20 -63.73 -16.77 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 110.568 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.773 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.68 -18.89 23.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.98 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.773 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 16.4 mt -156.75 -24.19 0.1 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 102' ' ' PRO . 8.0 m -67.99 36.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.5 -44.18 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.238 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.83 -68.28 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.402 . . . . 0.0 110.994 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.68 -67.91 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 66.1 m -121.34 167.85 12.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.095 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 85' ' ' LEU . 13.4 p -108.0 139.22 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.86 105.05 16.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.371 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 m -129.8 123.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.073 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mt -97.04 142.12 29.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.74 ' O ' HG22 ' A' ' 81' ' ' VAL . 39.5 mm -123.84 123.26 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.0 25.83 7.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.915 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.473 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -174.2 103.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.401 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.686 ' CE1' HG21 ' A' ' 115' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.765 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 44' ' ' LYS . 71.2 p -118.35 143.25 46.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.0 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.69 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -135.56 109.35 8.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.664 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.445 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -117.68 129.85 55.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.07 154.26 22.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.709 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.28 144.14 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.935 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.971 ' CD2' HD12 ' A' ' 28' ' ' ILE . 29.4 m-85 -117.64 151.87 36.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.218 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -125.52 171.89 10.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.753 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -53.85 -23.65 13.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -42.48 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.186 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.04 130.47 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.771 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -151.93 -139.78 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.983 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 27' ' ' ILE . 2.1 t -151.52 148.3 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 111.684 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.69 HD11 ' HB1' ' A' ' 6' ' ' ALA . 15.3 tp -123.29 100.06 6.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.718 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.22 139.91 52.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.198 0.523 . . . . 0.0 112.391 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.745 ' OG ' ' HB1' ' A' ' 4' ' ' ALA . 32.1 t -111.54 96.54 6.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.905 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 20' ' ' ILE . 4.6 tp -58.85 -26.61 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.81 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.765 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -60.27 -28.8 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.313 . . . . 0.0 110.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.692 HG23 ' HB3' ' A' ' 4' ' ' ALA . 1.9 p -115.73 -52.81 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.777 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.56 -32.03 3.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.953 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 84' ' ' ARG . 21.7 t -59.6 147.07 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.826 0.346 . . . . 0.0 111.201 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.78 160.81 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.726 HG12 HD13 ' A' ' 83' ' ' LEU . 13.5 mt -135.58 113.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.75 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 16' ' ' VAL . 2.6 mt -96.38 114.72 33.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.971 HD12 ' CD2' ' A' ' 10' ' ' PHE . 4.3 mt -103.41 91.67 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.26 161.67 33.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.472 2.115 . . . . 0.0 112.506 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -59.49 111.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.36 -4.46 5.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.086 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.633 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -82.51 -22.51 35.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.782 0.291 . . . . 0.0 111.377 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.803 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.9 mt -131.58 139.17 34.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.768 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.79 ' HD3' HD21 ' A' ' 78' ' ' LEU . 35.1 Cg_exo -57.03 155.47 28.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.46 2.106 . . . . 0.0 112.221 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -68.82 148.96 49.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.81 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.51 24.86 69.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.3 t -130.02 160.69 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.7 mp0 -134.7 113.82 12.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.018 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.803 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.8 tp60 -100.64 109.59 21.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -69.71 118.43 12.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.65 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.4 mt -127.1 139.95 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB3' ' CG ' ' A' ' 7' ' ' ARG . 39.9 p90 -155.62 159.17 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.347 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -164.18 163.5 22.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.955 0.407 . . . . 0.0 111.592 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.553 ' HB3' HG22 ' A' ' 5' ' ' THR . 2.3 pttp -131.06 142.31 50.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.743 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 HG13 ' A' ' 68' ' ' VAL . 57.7 t -132.54 138.8 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.445 ' O ' HD12 ' A' ' 67' ' ' LEU . 40.9 t . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 111.176 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.49 98.35 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.73 142.14 35.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.993 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.605 ' CB ' HD13 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -90.56 -173.19 0.37 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.187 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.3 Cg_exo -40.63 -43.71 4.39 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.209 1.94 . . . . 0.0 111.716 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -160.6 79.73 0.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.834 HG13 HG22 ' A' ' 45' ' ' VAL . 47.2 t -138.27 118.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.701 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' HB1' ' HG2' ' A' ' 61' ' ' GLU . . . -102.06 106.27 17.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.632 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -170.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -62.94 -154.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.431 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -62.56 123.4 12.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.462 2.108 . . . . 0.0 112.058 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -50.77 110.86 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.54 0.67 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 39' ' ' GLN . 11.9 tp -139.15 85.17 2.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.0 110.242 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 16.2 tttm -65.96 138.49 57.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.866 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 37.6 m-85 -115.89 151.94 34.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.572 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.79 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.27 14.04 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 111.032 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -160.77 136.42 5.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.131 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.86 98.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.391 2.061 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.1 m -66.92 156.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.884 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.35 106.62 17.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.354 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.726 HD13 HG12 ' A' ' 26' ' ' ILE . 22.9 tp -104.26 129.72 52.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.424 ' O ' HG13 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -121.82 134.04 54.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.605 HD13 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -143.67 136.46 13.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.3 135.16 18.18 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.488 2.125 . . . . 0.0 112.206 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -59.2 -26.41 64.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.56 31.2 18.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.783 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -153.32 100.6 2.63 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.07 50.65 3.56 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.651 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 -6.64 15.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.514 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -111.07 16.15 21.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.422 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.6 p-90 -113.26 -37.24 4.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.422 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.8 OUTLIER -107.79 162.68 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.993 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.88 -65.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -69.01 -61.35 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 m -84.04 -178.27 6.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.95 123.32 66.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.24 -46.35 25.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.533 2.155 . . . . 0.0 112.467 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.54 -21.12 79.21 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.992 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -69.15 121.74 82.92 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.584 0.231 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.796 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.8 Cg_exo -53.3 -29.87 49.45 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.414 2.076 . . . . 0.0 112.223 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.51 -19.72 57.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.761 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.35 -19.81 16.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.627 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.761 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 17.9 mt -155.79 -29.2 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.98 36.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 174.59 -32.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.71 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.05 18.46 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.587 0.232 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -70.46 -31.76 69.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 13.0 m -139.88 166.05 25.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 111' ' ' VAL . 14.8 p -101.34 120.22 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 105.15 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 113' ' ' VAL . 11.4 m -126.18 121.88 60.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.88 145.99 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.046 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.506 ' O ' HG22 ' A' ' 81' ' ' VAL . 33.9 mm -129.72 120.24 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -123.61 25.76 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.234 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.424 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.46 109.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.627 0.251 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 44' ' ' LYS . 30.9 p -133.52 143.57 48.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 0.0 111.199 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -143.13 124.05 14.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.899 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 15.0 mtm180 -127.09 129.52 48.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.574 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 148.03 11.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.042 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 10' ' ' PHE . 25.5 mt -87.68 155.39 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.519 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.801 ' CG ' HD12 ' A' ' 28' ' ' ILE . 56.5 m-85 -132.02 148.23 52.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.26 172.21 12.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.449 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -46.56 -27.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.438 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -50.23 -41.23 49.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.76 129.06 3.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.44 -158.86 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.016 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 27' ' ' ILE . 2.7 t -140.02 151.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.793 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.578 HD11 ' HB1' ' A' ' 6' ' ' ALA . 35.5 tp -123.22 100.18 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -122.47 154.03 38.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.469 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 p -126.09 97.15 4.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.101 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -53.33 -26.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.783 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -59.8 -24.86 64.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.44 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 4' ' ' ALA . 6.6 p -129.03 -52.79 1.21 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 111.306 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.96 -35.88 2.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.713 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.669 ' HB ' HG21 ' A' ' 45' ' ' VAL . 20.5 t -49.31 141.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.706 0.289 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.6 p -148.24 162.28 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.826 HG12 HD13 ' A' ' 83' ' ' LEU . 26.8 mt -135.52 113.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.889 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.1 mp -94.05 123.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.801 HD12 ' CG ' ' A' ' 10' ' ' PHE . 3.3 mt -112.62 91.37 17.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 157.54 57.55 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.136 . . . . 0.0 112.25 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 107.9 0.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 139.57 -9.39 3.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.051 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -77.85 -29.05 50.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.969 0.384 . . . . 0.0 111.202 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.49 HD13 ' CG ' ' A' ' 39' ' ' GLN . 20.4 mt -118.83 141.52 30.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.534 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.1 Cg_exo -64.79 155.32 68.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.454 2.102 . . . . 0.0 112.101 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.78 141.04 58.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.25 23.37 78.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.624 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 38' ' ' GLU . 43.4 t -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.274 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.552 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.8 mt-10 -137.46 113.73 10.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.706 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.49 ' CG ' HD13 ' A' ' 33' ' ' ILE . 4.6 mm-40 -105.74 108.95 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -70.54 122.57 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -130.74 129.9 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.544 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 39.4 p90 -145.72 158.41 43.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.935 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -163.09 160.81 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.733 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -131.7 123.67 28.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.96 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.669 HG21 ' HB ' ' A' ' 24' ' ' VAL . 38.7 t -107.15 129.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.667 ' HB2' HD12 ' A' ' 67' ' ' LEU . 1.9 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.942 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.474 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 5.8 tt0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.841 0.353 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.74 101.4 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.288 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.4 142.95 40.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -126.46 -57.61 1.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.116 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.616 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -96.93 -174.12 0.37 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 87.6 Cg_exo -43.28 -32.97 3.54 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.024 1.816 . . . . 0.0 111.52 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -165.49 84.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.851 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.65 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -145.91 117.64 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.099 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB1' ' CG ' ' A' ' 61' ' ' GLU . . . -104.31 106.15 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.532 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -66.93 -172.01 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.12 -158.25 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.5 Cg_endo -63.23 121.74 9.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.526 2.151 . . . . 0.0 111.994 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.69 110.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.72 72.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.471 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 31.4 tp -142.52 85.86 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 110.321 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 40.4 tttt -57.69 159.64 5.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.045 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.97 143.16 34.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.534 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.55 16.71 16.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.142 0.496 . . . . 0.0 111.228 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -161.53 136.45 5.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.333 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 27.3 Cg_exo -62.31 100.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.473 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 115' ' ' ILE . 16.3 m -72.94 139.42 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.759 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -85.57 124.57 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.269 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 26' ' ' ILE . 21.1 tp -124.21 128.26 48.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.439 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.666 ' O ' HG13 ' A' ' 24' ' ' VAL . 13.0 mtm-85 -119.06 127.17 53.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.821 ' O ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -141.99 131.47 12.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.31 143.94 73.88 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.398 2.066 . . . . 0.0 112.092 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -59.13 -46.35 88.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.3 m 57.76 176.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.6 t70 58.28 100.58 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.08 41.02 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.672 2.248 . . . . 0.0 112.87 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -108.94 -3.75 17.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.564 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -122.62 16.07 10.32 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.459 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.7 p-90 -110.26 -36.68 5.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 6.3 pt20 -106.85 51.43 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.974 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -21.97 13.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -171.58 -38.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 m -47.89 171.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 9.9 mt -87.66 123.5 69.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 23.2 Cg_exo -63.93 -33.81 62.11 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.542 2.162 . . . . 0.0 112.223 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.05 76.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.898 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -70.9 121.52 84.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.688 0.244 . . . . 0.0 110.776 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.766 ' O ' HG22 ' A' ' 106' ' ' VAL . 27.9 Cg_endo -62.35 -27.5 77.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.348 2.032 . . . . 0.0 112.107 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.35 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.774 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.38 -18.35 10.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.958 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.774 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 13.4 mt -156.7 -28.92 0.09 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.7 m -67.44 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.64 -38.42 0.04 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.61 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.0 18.46 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.702 0.287 . . . . 0.0 111.512 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.48 -63.11 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.5 p -93.49 149.32 21.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 85' ' ' LEU . 11.8 p -109.83 119.09 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.87 105.05 12.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.281 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 83' ' ' LEU . 4.6 m -121.02 129.22 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.042 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mt -96.8 132.06 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.066 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.86 ' O ' HG22 ' A' ' 81' ' ' VAL . 42.9 mm -118.77 118.79 59.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -119.93 25.65 9.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.39 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -178.79 115.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.26 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.616 ' CE1' HG21 ' A' ' 115' ' ' ILE . 1.2 m-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.567 ' HB3' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.901 0.382 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.481 HG22 ' CB ' ' A' ' 44' ' ' LYS . 65.4 p -123.59 143.76 50.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -131.93 131.02 42.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.1 mtt-85 -128.51 138.69 52.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.33 143.83 8.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.662 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -89.11 138.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.644 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.64 ' CG ' HD12 ' A' ' 28' ' ' ILE . 76.1 m-85 -129.35 148.97 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.334 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.01 172.08 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.748 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -45.18 -28.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -57.32 -31.14 65.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.89 168.84 16.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.823 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.62 148.09 5.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.085 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 27' ' ' ILE . 4.0 t -110.66 152.76 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.4 0.619 . . . . 0.0 111.85 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 32.4 tp -123.53 100.23 6.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.21 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 153.65 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.15 0.5 . . . . 0.0 111.889 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.08 96.92 4.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.971 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -55.42 -26.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.573 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 26.8 mt-10 -64.94 -26.11 68.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 4' ' ' ALA . 2.3 p -121.32 -52.95 2.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.685 0.279 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.09 -41.39 1.51 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.775 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 84' ' ' ARG . 42.0 t -50.16 144.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.676 0.274 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.5 t -149.89 167.74 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.423 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.7 HG12 HD13 ' A' ' 83' ' ' LEU . 44.2 mt -142.54 113.45 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 ' HE ' ' A' ' 84' ' ' ARG . 4.4 mp -93.23 120.49 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.827 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.64 HD12 ' CG ' ' A' ' 10' ' ' PHE . 5.2 mt -105.98 91.84 5.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.48 159.92 38.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.512 2.141 . . . . 0.0 112.475 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.38 104.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.07 -9.81 3.59 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.215 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -75.66 -28.31 58.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.942 0.371 . . . . 0.0 111.308 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.859 HD13 ' HB2' ' A' ' 39' ' ' GLN . 33.7 mt -119.69 142.75 33.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.373 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.2 Cg_exo -60.07 152.9 62.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.24 1.96 . . . . 0.0 112.178 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.0 mt-10 -68.63 150.1 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 24.97 68.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.462 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.1 t -130.58 160.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 111.242 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 37' ' ' VAL . 55.1 mt-10 -133.09 113.9 13.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.998 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.859 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -102.76 109.24 20.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -74.53 122.36 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.08 141.51 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.149 0.5 . . . . 0.0 111.584 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' A' ' 72' ' ' PRO . 14.0 p90 -153.5 146.87 24.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.781 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CE1' ' HG ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -147.98 159.0 44.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.063 0.458 . . . . 0.0 112.031 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.481 ' CB ' HG22 ' A' ' 5' ' ' THR . 2.1 tmmm? -116.0 147.83 40.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.468 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.522 HG22 HG13 ' A' ' 68' ' ' VAL . 25.1 t -145.23 140.81 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.045 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.431 ' O ' HD12 ' A' ' 67' ' ' LEU . 26.7 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.798 0.333 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -105.54 100.37 9.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.681 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.23 136.1 36.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.506 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.35 -57.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.455 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.746 ' CB ' HD13 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -85.16 -177.95 1.06 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 75.8 Cg_exo -41.32 -47.07 5.6 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -153.58 84.49 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.427 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.4 t -146.04 118.1 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.597 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.68 106.21 16.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.564 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.07 -168.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.17 -137.86 0.93 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 32.8 Cg_endo -64.17 125.95 16.18 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.441 2.094 . . . . 0.0 112.073 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -56.33 110.85 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.14 83.35 1.58 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.813 HD11 ' HG2' ' A' ' 39' ' ' GLN . 16.6 tp -142.2 86.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.189 0.519 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 17.3 tttp -57.98 159.9 5.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.124 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 24.4 m-85 -141.49 147.91 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.655 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -98.92 17.62 19.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.26 0.552 . . . . 0.0 111.19 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 2.5 tttm -164.81 136.55 3.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.577 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 27.4 Cg_exo -62.0 97.96 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 0.0 112.472 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.1 m -70.5 137.69 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE1' HD13 ' A' ' 27' ' ' ILE . 8.2 tm-20 -81.3 119.25 23.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.258 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.7 HD13 HG12 ' A' ' 26' ' ' ILE . 13.6 tp -124.32 119.18 28.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HE ' HD11 ' A' ' 27' ' ' ILE . 6.2 ptt85 -113.99 133.31 55.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.746 HD13 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -137.33 112.68 9.37 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.927 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.29 120.25 8.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.293 1.995 . . . . 0.0 111.918 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.68 -54.67 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.148 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.86 -177.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.99 167.56 12.75 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.94 41.73 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.843 2.362 . . . . 0.0 112.944 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.52 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.698 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -99.36 3.54 46.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.565 0.698 . . . . 0.0 111.081 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.627 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 1.8 p-90 -56.0 -31.79 63.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.845 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.627 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 4.5 mt-30 -95.44 138.35 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.612 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -177.71 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.484 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -163.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.3 m 71.17 -167.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 8.9 mt -99.91 117.99 62.47 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.673 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 3.6 Cg_exo -74.96 -6.63 18.32 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.64 2.227 . . . . 0.0 111.913 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.84 -43.17 35.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.981 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 m-20 -85.38 111.48 37.04 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.837 0.319 . . . . 0.0 110.807 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.4 Cg_exo -60.25 -27.21 84.42 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.276 1.984 . . . . 0.0 111.946 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.506 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 11.1 p30 -78.79 4.64 13.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -50.54 -100.42 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -80.15 -12.5 59.65 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 27.8 m -62.65 27.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.13 -3.86 2.42 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.164 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.55 17.66 12.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.593 0.235 . . . . 0.0 111.386 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.44 -75.43 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.724 0.297 . . . . 0.0 111.04 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.3 m -101.13 133.69 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 85' ' ' LEU . 14.3 p -105.39 106.95 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.469 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.64 104.87 11.46 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 111' ' ' VAL . 10.1 m -122.01 131.65 72.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.2 mt -95.84 146.85 24.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.661 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 81' ' ' VAL . 43.5 mm -128.49 121.64 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.23 25.44 7.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.081 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.22 109.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.789 HG22 ' CB ' ' A' ' 44' ' ' LYS . 30.3 p -136.12 143.91 44.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 111.107 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.36 132.72 24.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.984 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.445 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.5 mtt180 -128.23 135.25 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.32 156.95 27.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.9 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.502 HG21 ' HG2' ' A' ' 38' ' ' GLU . 29.7 mt -91.39 156.26 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD1' HG13 ' A' ' 28' ' ' ILE . 25.8 m-85 -131.46 170.59 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.36 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -152.14 171.94 17.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.915 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.7 p -58.69 -21.09 53.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -54.87 -51.25 66.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.46 128.64 3.76 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.733 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.16 -172.73 25.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.02 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 27' ' ' ILE . 2.5 t -141.78 150.29 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 111.745 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 43' ' ' PHE . 23.5 tp -123.24 100.1 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.324 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -125.24 154.52 41.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 111.786 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -127.11 97.14 4.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.1 mm -52.62 -26.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.647 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 14.9 mt-10 -63.39 -21.22 66.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.305 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -126.93 -52.93 1.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.788 0.327 . . . . 0.0 111.264 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.6 -33.82 2.9 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.696 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.751 ' HB ' HG21 ' A' ' 45' ' ' VAL . 58.1 t -55.67 145.4 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 10.8 t -148.7 164.41 34.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.604 HG12 HD13 ' A' ' 83' ' ' LEU . 21.0 mt -139.25 113.81 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.933 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.0 mp -94.72 135.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.638 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -107.67 97.08 18.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.712 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 81' ' ' VAL . 27.5 Cg_endo -62.49 145.19 95.52 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.288 1.992 . . . . 0.0 112.115 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.1 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.202 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.18 4.27 5.52 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.367 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.61 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -81.7 -26.41 34.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.108 0.454 . . . . 0.0 111.201 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.965 HD13 ' HB2' ' A' ' 39' ' ' GLN . 26.2 mt -121.81 141.49 34.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' HD21 ' A' ' 78' ' ' LEU . 42.1 Cg_exo -56.69 143.87 88.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.333 2.022 . . . . 0.0 112.218 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.1 mt-10 -61.79 151.35 34.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.08 25.54 62.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 34' ' ' PRO . 40.5 t -129.47 160.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.268 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -129.02 113.93 15.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.797 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.965 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.35 109.23 21.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 14.2 tt0 -72.29 118.96 15.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.6 mt -127.35 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.014 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 34.3 p90 -152.83 173.46 15.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.43 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -175.05 163.51 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.885 0.374 . . . . 0.0 111.535 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.789 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER -135.62 117.63 15.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.045 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.751 HG21 ' HB ' ' A' ' 24' ' ' VAL . 33.1 t -106.87 141.82 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.841 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.797 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 m -85.71 105.26 16.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.59 139.64 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.43 -57.69 1.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -95.18 -174.53 0.4 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.332 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.8 Cg_exo -40.46 -46.99 4.45 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.228 1.952 . . . . 0.0 111.843 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.719 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.7 tm? -153.89 82.23 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.748 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -143.15 118.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.476 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.797 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -105.87 106.25 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.614 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -165.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.028 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.53 -146.71 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 41.6 Cg_endo -67.38 134.15 32.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.451 2.101 . . . . 0.0 112.191 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.99 111.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.86 84.0 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.1 tp -144.44 87.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 77.4 tttt -62.7 159.78 15.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.956 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 29.0 m-85 -138.6 155.79 48.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.66 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.706 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -99.22 14.33 29.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.367 0.603 . . . . 0.0 110.96 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -166.62 136.51 2.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.263 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 32.7 Cg_exo -61.58 95.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.413 2.075 . . . . 0.0 112.414 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 115' ' ' ILE . 9.2 m -61.38 166.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.516 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 126.12 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 111.493 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 26' ' ' ILE . 34.4 tp -124.24 128.01 48.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.098 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 24' ' ' VAL . 50.4 mtp180 -120.45 126.1 49.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.788 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.647 ' O ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.58 163.31 37.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.477 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.52 120.07 7.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.447 2.098 . . . . 0.0 112.202 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -82.32 -48.55 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.19 48.09 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -112.89 81.91 4.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.45 47.24 2.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.73 2.287 . . . . 0.0 112.611 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -108.93 13.09 24.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 t -119.58 15.96 12.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.46 . . . . 0.0 111.812 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.579 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.1 p-90 -121.01 -37.87 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.579 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 49.2 mt-30 -103.53 68.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -156.22 -45.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -46.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.25 -178.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 28.8 mt -98.64 131.46 25.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 33.0 Cg_exo -59.35 -23.59 70.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.421 2.081 . . . . 0.0 112.316 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.87 -25.21 32.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.832 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 8.3 m-20 -61.3 113.56 8.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.562 0.181 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.795 ' O ' HG22 ' A' ' 106' ' ' VAL . 72.7 Cg_exo -50.09 -30.72 25.87 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.378 2.052 . . . . 0.0 112.273 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.11 -19.89 62.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.361 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.778 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.97 -20.45 16.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.824 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.778 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 19.0 mt -155.51 -26.57 0.11 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.5 m -68.18 36.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -155.17 -42.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.584 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.47 18.69 10.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.655 0.264 . . . . 0.0 111.455 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -65.84 -44.57 85.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.63 149.03 21.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.94 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 85' ' ' LEU . 14.3 p -106.32 109.83 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.68 105.03 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 83' ' ' LEU . 12.1 m -122.07 122.05 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.4 mt -87.5 137.67 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.1 mm -122.43 116.85 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.348 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 27.03 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.195 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.87 114.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.613 HG22 ' CB ' ' A' ' 44' ' ' LYS . 65.3 p -122.34 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.685 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -127.57 121.77 31.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.6 mtt180 -120.97 131.52 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.22 147.82 11.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.797 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 10' ' ' PHE . 26.2 mt -90.53 159.64 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.685 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.721 ' CG ' HD12 ' A' ' 28' ' ' ILE . 79.9 m-85 -141.49 154.87 45.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.421 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -128.4 172.15 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -51.69 -24.5 5.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -55.19 -38.9 68.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.215 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 137.84 9.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.67 171.83 40.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.198 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -117.49 150.29 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.156 0.503 . . . . 0.0 111.548 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' SER . 32.9 tp -123.21 100.16 6.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.12 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.44 151.0 45.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.108 0.48 . . . . 0.0 111.835 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 12.6 p -121.23 97.05 5.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.023 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mm -52.53 -26.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.536 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.5 mm-40 -61.86 -29.6 70.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.083 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -119.66 -52.93 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.054 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.5 -38.02 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.694 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.603 ' CG2' HG11 ' A' ' 45' ' ' VAL . 24.2 t -49.48 144.47 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.73 0.3 . . . . 0.0 111.144 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.74 158.37 44.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.627 HG12 HD13 ' A' ' 83' ' ' LEU . 38.1 mt -132.39 113.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.446 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.508 HG13 HG13 ' A' ' 16' ' ' VAL . 3.6 mt -94.64 118.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 0.0 111.276 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.721 HD12 ' CG ' ' A' ' 10' ' ' PHE . 3.9 mt -105.97 92.98 7.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 148.39 92.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.393 2.062 . . . . 0.0 112.167 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -53.34 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.7 -19.54 0.78 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.946 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -66.29 -36.8 83.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.841 0.321 . . . . 0.0 111.363 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.917 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.1 mt -110.97 143.94 29.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.589 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -62.85 155.18 61.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.439 2.093 . . . . 0.0 112.295 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.5 mp0 -69.41 153.81 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.17 24.46 58.73 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 35' ' ' GLU . 44.8 t -130.08 160.87 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' N ' HG12 ' A' ' 37' ' ' VAL . 32.7 mt-10 -132.87 113.64 13.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.854 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.917 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -106.08 109.06 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.02 128.56 36.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -134.87 140.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.275 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 28.0 p90 -154.22 149.66 27.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -151.53 167.01 29.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.056 0.455 . . . . 0.0 111.662 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.613 ' CB ' HG22 ' A' ' 5' ' ' THR . 2.9 ptmt -127.52 146.12 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.542 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.603 HG11 ' CG2' ' A' ' 24' ' ' VAL . 45.3 t -138.78 136.91 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.845 -179.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -99.93 97.5 8.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.515 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.76 140.24 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.43 -57.58 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.931 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.1 p -91.28 -173.85 0.4 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.249 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.8 Cg_exo -41.63 -51.27 4.41 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.19 1.926 . . . . 0.0 111.861 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.705 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -151.08 85.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 92.7 t -147.09 118.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.216 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -107.22 109.33 21.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.785 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -62.26 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 42' ' ' TYR . . . -78.26 -144.33 2.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.76 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 59.8 Cg_exo -51.84 123.14 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.596 2.197 . . . . 0.0 112.186 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -55.38 110.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.63 83.76 1.75 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 15.1 tp -138.43 85.01 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.199 0.524 . . . . 0.0 110.084 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 85.5 tttt -58.03 161.98 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.167 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 17.2 m-85 -143.38 148.43 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.576 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.485 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -97.06 18.26 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.263 0.554 . . . . 0.0 110.941 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -163.86 136.39 3.96 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.409 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 20.8 Cg_exo -65.61 101.09 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.496 2.131 . . . . 0.0 112.467 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 115' ' ' ILE . 7.7 m -68.53 153.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.698 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 108.66 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.627 HD13 HG12 ' A' ' 26' ' ' ILE . 5.0 tp -105.02 121.32 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.577 ' N ' HD12 ' A' ' 83' ' ' LEU . 23.8 mtm180 -123.87 139.83 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.19 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -129.42 144.77 54.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.613 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.15 134.74 17.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.478 2.119 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -49.49 -47.05 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.46 -81.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.878 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.48 162.51 46.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.74 32.84 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.966 2.444 . . . . 0.0 112.848 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.01 1.17 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.402 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -122.67 16.07 10.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.822 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 10.8 p-90 -117.69 -47.86 2.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.545 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 5.1 pt20 -77.28 64.79 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.33 -46.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -32.73 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.0 m -85.14 172.12 11.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 20.9 mt -99.9 125.17 41.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 21.6 Cg_exo -65.09 -15.48 50.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.541 2.161 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.77 -22.22 31.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.8 t0 -62.19 136.45 95.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.649 0.262 . . . . 0.0 110.723 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.462 ' O ' HG21 ' A' ' 106' ' ' VAL . 55.6 Cg_endo -69.84 -20.73 34.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.42 2.08 . . . . 0.0 112.274 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 87.9 m-20 -91.61 17.31 8.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.921 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.606 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.68 -113.44 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.993 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.606 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -48.98 -23.14 1.02 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 11.8 m -71.29 36.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 0.0 111.33 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 145.49 40.54 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.77 -74.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.796 0.332 . . . . 0.0 111.362 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -148.78 32.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.06 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.3 p -80.97 150.06 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.734 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 111' ' ' VAL . 14.0 p -84.81 114.45 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.265 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.68 105.08 12.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.195 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.4 m -123.91 124.85 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.57 143.26 26.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 81' ' ' VAL . 37.6 mm -129.71 120.1 49.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.24 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -123.27 25.74 8.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.21 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.418 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.43 108.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.936 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.573 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.063 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.707 0.289 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.638 HG22 ' CB ' ' A' ' 44' ' ' LYS . 45.3 p -123.11 143.76 49.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 111.081 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.554 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -132.78 130.55 40.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.412 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.5 mtp85 -129.34 132.18 47.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.29 149.71 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.91 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.579 HG21 ' HB3' ' A' ' 38' ' ' GLU . 20.1 mt -88.26 158.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.599 0.237 . . . . 0.0 110.636 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.566 ' CG ' HD13 ' A' ' 28' ' ' ILE . 49.8 m-85 -138.64 164.03 30.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.971 0.415 . . . . 0.0 111.438 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.73 172.13 14.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -53.05 -22.7 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.122 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -51.28 -35.23 36.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 28' ' ' ILE . . . 100.29 112.8 3.47 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.698 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.852 ' O ' HD12 ' A' ' 28' ' ' ILE . . . -157.36 144.2 10.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.054 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 17' ' ' LEU . 2.2 p -102.89 157.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.0 111.814 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 43' ' ' PHE . 15.2 tp -119.98 99.9 6.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.462 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -115.51 145.6 42.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.7 m -121.82 96.68 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.258 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 20' ' ' ILE . 3.4 tp -60.3 -26.6 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.4 mt-10 -62.68 -26.38 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.674 HG21 ' HB ' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -115.71 -52.9 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.13 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.69 6.56 9.35 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.216 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 45' ' ' VAL . 38.4 t -106.02 141.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.856 0.328 . . . . 0.0 110.822 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 92.5 p -149.75 162.52 40.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.917 0.389 . . . . 0.0 111.529 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.758 HG12 HD13 ' A' ' 83' ' ' LEU . 26.2 mt -130.79 113.46 24.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.188 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.5 mp -91.6 116.29 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 15' ' ' GLY . 1.2 mt -102.94 87.0 1.11 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.682 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 158.73 40.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.546 2.164 . . . . 0.0 112.328 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.14 108.57 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.23 -9.94 3.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.904 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.639 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -84.09 -33.13 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.874 0.337 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 39' ' ' GLN . 36.7 mt -119.91 143.75 35.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.344 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD3' HD21 ' A' ' 78' ' ' LEU . 15.1 Cg_exo -68.09 154.3 72.85 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.364 2.043 . . . . 0.0 112.247 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.1 tt0 -66.17 154.22 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.78 62.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.567 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 38' ' ' GLU . 41.2 t -128.1 160.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.059 0.456 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 9' ' ' ILE . 43.1 mt-10 -134.35 113.9 12.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.967 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.816 ' HB2' HD13 ' A' ' 33' ' ' ILE . 6.4 tp60 -101.71 109.01 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.061 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.91 116.7 12.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.0 mt -127.21 139.39 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 111.263 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' GLY . 29.9 p90 -153.06 162.82 40.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.203 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -167.28 168.43 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.873 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.638 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -133.06 132.69 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.721 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.68 HG22 HG13 ' A' ' 68' ' ' VAL . 21.7 t -126.1 148.29 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.95 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 67' ' ' LEU . 17.2 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.014 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.934 0.397 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.22 100.77 11.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.67 139.18 37.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.492 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.35 -57.63 1.38 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.639 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.57 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -91.58 -171.32 0.27 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.974 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 47.5 Cg_exo -38.4 -48.42 2.46 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.324 2.016 . . . . 0.0 112.116 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.717 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -158.66 66.72 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 111.054 178.246 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG13 HG22 ' A' ' 45' ' ' VAL . 99.0 t -121.58 118.35 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.575 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.5 106.24 17.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.575 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -167.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.998 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -68.38 -152.35 0.41 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.655 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 71.4 Cg_exo -50.71 160.57 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.563 2.175 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -84.51 111.0 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.66 78.98 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.899 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 8.3 tp -135.9 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.28 0.562 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.0 ttpt -73.0 149.69 43.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.909 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 73.5 m-85 -122.59 166.97 13.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.446 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.98 16.39 19.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.448 0.642 . . . . 0.0 110.824 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' A' ' 80' ' ' PRO . 1.8 tttm -168.75 136.54 1.66 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.185 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.426 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 31.5 Cg_exo -59.55 107.24 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.438 2.092 . . . . 0.0 112.579 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.427 HG22 ' HB ' ' A' ' 115' ' ' ILE . 10.8 m -70.71 140.64 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -87.51 108.35 19.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.564 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.758 HD13 HG12 ' A' ' 26' ' ' ILE . 7.1 tp -105.77 129.71 53.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.658 ' N ' HD12 ' A' ' 83' ' ' LEU . 4.9 mmt180 -123.32 132.23 53.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 111.613 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.819 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.63 156.07 59.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.481 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 24' ' ' VAL . 41.5 Cg_endo -67.44 123.9 11.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 49.9 p-80 -71.66 -46.92 57.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 85.8 m 57.61 178.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.993 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.38 87.94 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.53 46.86 2.18 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.814 2.342 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -109.06 5.09 23.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.665 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -122.56 16.17 10.37 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.922 0.391 . . . . 0.0 111.931 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.492 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 4.6 p-90 -110.6 -37.26 5.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 5.5 pt20 -101.13 61.0 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.097 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -106.48 -37.05 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -86.47 -179.05 6.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 9.6 mt -100.05 120.54 56.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 25.4 Cg_exo -62.76 -21.32 72.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.605 2.203 . . . . 0.0 112.669 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.46 -5.42 54.2 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.116 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.63 123.93 58.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.896 0.348 . . . . 0.0 111.004 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.818 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.58 -28.71 56.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.387 2.058 . . . . 0.0 112.335 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -61.72 -18.38 59.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.751 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.63 -19.3 15.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.62 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.751 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 15.6 mt -156.22 -30.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.0 m -68.05 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 177.41 -30.49 0.07 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.851 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 18.58 6.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -57.93 -30.27 65.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.95 170.74 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.74 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.819 HG11 HD12 ' A' ' 85' ' ' LEU . 11.7 p -103.7 105.88 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.287 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 105.09 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.2 m -122.82 121.53 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.255 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.99 143.8 26.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.427 ' HB ' HG22 ' A' ' 81' ' ' VAL . 28.5 mm -129.89 116.72 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.0 0.429 . . . . 0.0 111.544 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.84 27.48 8.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.974 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.79 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.784 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.461 ' CB ' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.9 p -125.28 143.01 51.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.945 0.402 . . . . 0.0 111.39 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -136.14 106.97 6.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.3 mtt180 -113.52 131.88 55.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 140.67 6.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.786 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 38' ' ' GLU . 13.4 mt -87.09 135.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.608 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.808 ' CG ' HD12 ' A' ' 28' ' ' ILE . 83.1 m-85 -116.71 160.98 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.286 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -146.48 172.31 13.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.592 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -44.44 -27.43 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -33.93 56.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 111.185 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 154.27 29.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.9 175.06 39.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.459 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -126.96 150.86 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.471 . . . . 0.0 111.415 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD11 ' HB1' ' A' ' 6' ' ' ALA . 49.4 tp -123.22 100.16 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.472 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -126.37 152.19 46.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.044 0.45 . . . . 0.0 111.745 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.76 97.05 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.1 -26.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.19 -26.69 67.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.235 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' CB ' ' A' ' 4' ' ' ALA . 4.5 p -123.91 -52.92 1.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.42 -36.63 2.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.896 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.622 HG13 HD23 ' A' ' 85' ' ' LEU . 38.6 t -48.56 144.4 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 111.26 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 p -149.83 150.75 32.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.515 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 83' ' ' LEU . 32.2 mt -128.75 113.69 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.492 HG13 HG13 ' A' ' 16' ' ' VAL . 3.8 mt -93.21 134.41 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.808 HD12 ' CG ' ' A' ' 10' ' ' PHE . 4.2 mt -123.93 94.26 45.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.161 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 155.82 66.97 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.423 2.082 . . . . 0.0 112.085 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.68 98.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.34 -21.75 0.74 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.945 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -68.21 -28.38 67.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 39' ' ' GLN . 38.9 mt -123.84 137.88 29.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.548 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.786 ' HD3' HD21 ' A' ' 78' ' ' LEU . 17.8 Cg_endo -60.35 155.5 46.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.385 2.056 . . . . 0.0 112.544 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.0 mt-10 -66.64 151.86 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.766 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.05 19.52 59.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.635 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.8 t -125.62 160.77 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.551 ' N ' HG12 ' A' ' 37' ' ' VAL . 5.3 mt-10 -137.06 113.71 10.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.053 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.821 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -102.16 110.75 22.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.814 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.65 119.4 13.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.136 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mt -126.92 139.82 50.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 110.867 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.425 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 29.7 p90 -155.55 162.96 40.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -166.98 159.49 13.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.945 0.402 . . . . 0.0 111.526 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 133.5 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.297 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 68' ' ' VAL . 40.3 t -124.87 135.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.586 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.637 ' O ' HD12 ' A' ' 67' ' ' LEU . 52.2 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.033 0.444 . . . . 0.0 111.272 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.821 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 19.8 mt-10 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.886 0.374 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 m -89.67 110.8 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.5 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.87 138.18 34.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.303 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.51 -57.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -92.19 -175.59 0.51 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.379 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 69.5 Cg_exo -40.93 -46.79 4.97 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.326 2.017 . . . . 0.0 111.529 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.8 tm? -153.57 83.93 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.658 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 45' ' ' VAL . 47.6 t -145.15 117.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.405 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.821 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -106.13 106.2 16.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.07 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -64.06 -153.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 20.6 Cg_endo -60.97 129.73 29.97 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.457 2.104 . . . . 0.0 111.909 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -54.98 110.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.48 79.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.716 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.75 HD11 ' HG2' ' A' ' 39' ' ' GLN . 14.8 tp -138.94 85.28 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 110.2 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 59.7 tttp -63.71 151.09 42.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.873 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 75.0 m-85 -127.92 154.11 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.771 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.786 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -98.51 13.92 30.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.436 0.636 . . . . 0.0 110.765 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.02 136.39 4.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.188 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.15 99.01 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.359 2.039 . . . . 0.0 112.379 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.0 m -67.86 154.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 119.0 38.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.413 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.862 HD13 HG12 ' A' ' 26' ' ' ILE . 15.6 tp -115.81 114.96 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.286 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.0 136.46 52.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.43 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.795 HD12 HG11 ' A' ' 111' ' ' VAL . 1.2 mt -125.63 133.02 24.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 119.71 6.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.189 1.926 . . . . 0.0 112.383 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.64 -33.68 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.53 163.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.78 69.95 0.46 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.27 42.4 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.247 2.631 . . . . 0.0 112.558 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 13.17 25.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 t -114.02 15.98 18.3 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 0.0 111.914 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.597 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -117.53 -36.67 3.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.597 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 41.1 mt-30 -106.38 76.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.34 -49.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -138.89 29.82 2.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.4 m -138.48 -175.38 4.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.751 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.91 127.6 38.5 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.12 -5.01 15.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.495 2.13 . . . . 0.0 112.558 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.46 -7.42 26.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.945 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.449 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -68.75 134.28 90.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.812 0.306 . . . . 0.0 110.621 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 106' ' ' VAL . 58.3 Cg_endo -71.51 -8.17 22.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.341 2.027 . . . . 0.0 112.612 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 77.2 m-20 -99.8 17.29 21.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 110.843 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.559 ' CE1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.35 -113.9 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.282 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -47.87 -15.85 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 102' ' ' PRO . 5.1 m -67.62 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 111.782 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -175.91 -34.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.39 25.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 110.835 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.59 -57.16 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.079 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.9 p -141.84 159.77 41.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.795 HG11 HD12 ' A' ' 85' ' ' LEU . 13.4 p -95.67 113.41 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.219 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.49 105.1 10.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.143 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 111' ' ' VAL . 8.5 m -128.79 122.67 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 mt -91.87 148.53 22.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 81' ' ' VAL . 33.8 mm -129.82 123.49 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.317 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.15 24.5 6.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.181 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.49 104.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.872 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.824 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 44' ' ' LYS . 21.7 p -142.24 143.74 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.135 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.631 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -149.48 116.93 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.8 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.17 144.63 8.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.673 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.66 134.44 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.458 ' CG ' HD12 ' A' ' 28' ' ' ILE . 77.2 m-85 -119.73 157.79 27.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.35 172.16 13.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.754 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 t -48.19 -27.26 2.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.379 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -55.17 -32.46 62.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 111.341 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.96 173.05 21.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.589 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.33 155.26 7.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.22 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 27' ' ' ILE . 3.4 t -112.08 151.98 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.366 0.603 . . . . 0.0 111.734 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.631 HD11 ' HB1' ' A' ' 6' ' ' ALA . 40.9 tp -123.57 100.23 6.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.149 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -121.62 149.46 43.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 112.017 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.04 97.13 5.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.166 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.41 -26.53 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.725 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.824 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -50.54 -50.53 53.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.679 -179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.808 HG21 ' CG1' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -114.34 -52.8 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.529 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.64 -28.42 2.04 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.132 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.659 HG13 HD23 ' A' ' 85' ' ' LEU . 84.3 t -52.8 135.9 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 66.3 p -146.06 170.96 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.655 HG12 HD13 ' A' ' 83' ' ' LEU . 20.3 mt -141.27 113.86 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.4 mp -92.4 120.28 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.603 HG22 ' HB3' ' A' ' 32' ' ' ALA . 3.2 mt -108.46 90.4 7.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.34 151.86 82.81 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.088 . . . . 0.0 112.142 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -53.9 107.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 138.06 -6.7 3.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.092 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.603 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -78.92 -29.63 44.28 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.985 0.392 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.715 HD13 ' HB2' ' A' ' 39' ' ' GLN . 35.5 mt -119.4 141.76 31.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.601 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.0 Cg_exo -64.9 154.21 74.22 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.279 1.986 . . . . 0.0 112.054 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.1 mt-10 -65.93 154.45 39.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.43 60.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 35' ' ' GLU . 42.8 t -129.46 160.77 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.258 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.545 ' N ' HG12 ' A' ' 37' ' ' VAL . 4.9 mt-10 -134.31 113.8 12.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.957 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.715 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -103.32 109.13 20.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.075 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.97 110.43 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.673 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.71 136.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.413 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 54.3 p90 -154.96 151.29 28.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.7 OUTLIER -154.24 159.76 41.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 0.0 111.314 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG22 ' A' ' 5' ' ' THR . 1.7 pttp -128.15 124.76 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.029 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.808 ' CG1' HG21 ' A' ' 22' ' ' THR . 46.1 t -113.81 128.79 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.718 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 0.0 111.25 -179.612 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 108.41 19.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -87.67 138.84 31.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.266 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.515 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -88.86 -175.22 0.53 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.421 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 70.2 Cg_exo -41.01 -50.58 4.11 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.267 1.978 . . . . 0.0 111.676 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.8 tm? -151.94 83.35 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.703 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.722 HG13 HG22 ' A' ' 45' ' ' VAL . 44.4 t -144.46 118.23 3.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.529 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.53 106.11 16.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.658 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.15 -166.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.41 -148.25 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.73 127.77 20.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.431 2.087 . . . . 0.0 112.103 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -56.29 110.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.92 78.3 1.0 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.715 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.57 HD11 ' HG3' ' A' ' 39' ' ' GLN . 6.0 tp -142.45 87.52 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.255 0.55 . . . . 0.0 110.016 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 7.6 ttpp -64.13 149.24 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 42.2 m-85 -126.61 151.32 48.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.49 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -99.38 16.14 24.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.353 0.597 . . . . 0.0 111.007 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.38 136.5 4.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.394 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.4 Cg_exo -63.49 103.6 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.532 2.154 . . . . 0.0 112.695 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.5 m -76.44 143.78 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.736 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.95 117.36 29.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.655 HD13 HG12 ' A' ' 26' ' ' ILE . 31.8 tp -111.73 117.59 33.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -108.34 139.45 43.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.944 HD12 HG11 ' A' ' 111' ' ' VAL . 1.3 mt -134.47 140.76 36.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.527 ' HD2' HG22 ' A' ' 24' ' ' VAL . 72.0 Cg_endo -75.4 125.89 9.35 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.391 2.061 . . . . 0.0 112.388 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -77.69 -44.16 28.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.5 m 60.2 86.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -179.35 75.62 0.2 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.17 42.92 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.973 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -108.61 -47.52 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.025 0.44 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 t -111.57 3.99 18.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.598 0.713 . . . . 0.0 111.055 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.517 ' CE3' ' HB2' ' A' ' 105' ' ' LEU . 1.5 p-90 -55.36 -31.67 61.94 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.96 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.457 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 1.8 pt20 -92.68 144.73 25.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.47 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -170.56 -42.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.749 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 -164.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m 64.23 159.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.054 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.2 mt -59.89 137.13 90.52 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.059 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -17.79 16.56 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.674 2.249 . . . . 0.0 112.691 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.97 -43.93 7.94 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.794 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.48 113.23 17.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.538 0.209 . . . . 0.0 111.061 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.65 ' O ' HG13 ' A' ' 106' ' ' VAL . 39.3 Cg_exo -56.9 -26.61 68.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.439 2.093 . . . . 0.0 111.995 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.506 ' HA ' HG22 ' A' ' 106' ' ' VAL . 4.5 t-20 -70.69 -11.21 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.396 . . . . 0.0 110.806 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -52.58 -23.28 6.13 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.151 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.635 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -156.73 -20.17 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.337 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 102' ' ' PRO . 6.1 m -67.74 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -146.23 -42.61 0.04 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.375 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.45 62.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.583 0.23 . . . . 0.0 111.569 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.92 80.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 175.42 131.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.944 HG11 HD12 ' A' ' 85' ' ' LEU . 12.5 p -84.9 110.71 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.45 104.88 11.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.11 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.1 m -125.33 122.02 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.35 135.57 33.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.909 ' O ' HG22 ' A' ' 81' ' ' VAL . 15.3 mm -126.45 115.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.463 ' C ' ' CG ' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -116.7 14.07 15.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.463 ' CG ' ' C ' ' A' ' 116' ' ' ASP . 7.5 m-70 -162.8 127.95 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.607 ' CB ' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.1 p -121.86 143.54 49.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.733 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.82 108.02 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.987 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.464 ' HG3' ' CB ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -111.36 136.09 50.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.054 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.26 149.28 12.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.231 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.2 mt -104.86 138.82 27.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.711 0.291 . . . . 0.0 110.52 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CG ' HD12 ' A' ' 28' ' ' ILE . 90.3 m-85 -127.64 174.04 9.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 111.422 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -147.87 172.17 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.636 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -45.19 -28.79 0.82 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -56.39 -31.41 63.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 177.98 22.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.645 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.52 162.78 10.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.17 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG13 HG13 ' A' ' 27' ' ' ILE . 3.9 t -118.46 153.74 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.269 0.557 . . . . 0.0 111.762 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' SER . 40.5 tp -123.14 100.09 6.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.107 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 149.32 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.45 . . . . 0.0 111.735 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.46 97.22 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.224 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.74 -26.45 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.512 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 4.3 mt-10 -60.81 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.352 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.632 HG21 HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -105.25 -53.03 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.238 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.66 -34.58 2.46 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.679 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.88 HG22 ' HD3' ' A' ' 86' ' ' PRO . 39.4 t -54.64 139.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.684 0.278 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -143.11 167.65 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.43 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.818 HG12 HD13 ' A' ' 83' ' ' LEU . 42.6 mt -134.42 113.75 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.656 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.51 HG13 HG13 ' A' ' 16' ' ' VAL . 4.7 mp -90.71 122.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.574 HD12 ' CG ' ' A' ' 10' ' ' PHE . 7.1 mt -110.03 94.7 18.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 28' ' ' ILE . 34.8 Cg_endo -64.99 150.97 87.38 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.34 2.027 . . . . 0.0 112.05 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.79 108.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -2.79 4.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.141 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -82.43 -26.06 33.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.383 . . . . 0.0 111.24 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.795 HD13 ' HB2' ' A' ' 39' ' ' GLN . 48.6 mt -122.97 142.3 37.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.553 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.677 ' HD3' HD21 ' A' ' 78' ' ' LEU . 31.3 Cg_exo -59.15 155.48 39.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.398 2.065 . . . . 0.0 112.442 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -70.19 152.74 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 23.76 56.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.63 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 35' ' ' GLU . 42.0 t -131.22 160.9 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.179 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.554 ' N ' HG12 ' A' ' 37' ' ' VAL . 27.9 mt-10 -131.39 113.78 14.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.944 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.795 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -104.13 110.93 23.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.93 126.54 29.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.78 132.77 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.997 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.464 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 52.6 p90 -149.23 174.5 12.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.276 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.733 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.2 p90 -175.34 176.15 2.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.022 0.439 . . . . 0.0 111.783 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.28 148.58 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.995 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 22' ' ' THR . 59.4 t -142.37 139.31 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.685 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.411 ' O ' HD12 ' A' ' 67' ' ' LEU . 42.7 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.093 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -135.85 95.44 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.73 142.29 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.088 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.42 -57.58 1.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.929 0.395 . . . . 0.0 111.171 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -97.1 -174.28 0.37 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 71.5 Cg_exo -41.35 -45.4 5.8 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.263 1.975 . . . . 0.0 111.699 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.72 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.9 tm? -153.13 83.92 1.2 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 61.7 t -145.06 118.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.423 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.64 109.07 20.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.695 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -60.3 -173.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 42' ' ' TYR . . . -78.24 -126.84 0.42 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.595 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 37.3 Cg_endo -65.98 134.08 35.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.18 110.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.89 83.61 1.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 3.5 tp -131.4 84.43 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HD3' ' CE1' ' A' ' 117' ' ' HIS . 10.5 tptt -53.3 153.83 3.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.4 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 35.2 m-85 -136.35 144.27 44.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.677 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -94.68 17.59 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.285 0.564 . . . . 0.0 111.226 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -162.71 136.5 4.71 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.173 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.68 97.27 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.337 2.025 . . . . 0.0 112.488 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.8 m -72.91 154.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.53 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 pm0 -110.91 116.46 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.399 . . . . 0.0 111.275 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.818 HD13 HG12 ' A' ' 26' ' ' ILE . 9.3 tp -104.75 129.72 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.61 ' O ' HG13 ' A' ' 24' ' ' VAL . 1.8 mtt180 -112.88 126.2 55.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.944 0.402 . . . . 0.0 111.406 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -138.63 155.08 73.66 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.658 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.88 ' HD3' HG22 ' A' ' 24' ' ' VAL . 75.0 Cg_exo -48.25 144.21 13.36 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.687 2.258 . . . . 0.0 112.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -79.31 -26.28 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 m 68.3 -173.05 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.13 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -85.21 35.75 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.122 2.548 . . . . 0.0 112.866 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.24 -13.53 14.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.424 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t -122.65 15.78 10.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 111.786 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.63 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.5 p-90 -95.19 -36.12 11.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.941 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.63 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.0 mt-30 -104.67 114.38 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -161.02 -44.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 34.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.37 175.93 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 29.1 mt -87.65 128.6 53.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.26 -13.6 16.87 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.473 2.116 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.09 -21.21 8.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.857 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.419 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -74.46 137.17 74.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.617 0.246 . . . . 0.0 110.903 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.759 ' O ' HG22 ' A' ' 106' ' ' VAL . 56.4 Cg_endo -70.21 -26.63 25.24 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.162 . . . . 0.0 112.101 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -65.23 -15.68 62.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.752 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.34 -18.47 10.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.948 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.752 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 12.7 mt -156.93 -27.89 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.55 36.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 172.61 -33.41 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.604 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.83 44.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -88.58 96.59 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.65 143.13 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 113' ' ' VAL . 7.9 p -112.05 133.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.257 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.24 104.99 17.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 83' ' ' LEU . 10.6 m -119.57 123.78 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.029 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.0 137.16 33.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 81' ' ' VAL . 25.9 mm -129.82 123.28 56.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.256 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.86 25.66 5.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.941 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.546 ' CE1' ' HD3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 178.82 104.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.655 0.264 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.741 HG22 ' CB ' ' A' ' 44' ' ' LYS . 37.6 p -136.01 143.22 44.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -142.36 121.95 13.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.813 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.435 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 1.1 ttp180 -127.05 130.22 49.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.14 144.12 8.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.66 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 29.6 mt -79.6 152.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.65 0.262 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 28' ' ' ILE . 42.3 m-85 -129.6 154.04 47.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 0.0 111.303 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.51 172.62 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.592 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.1 m -44.18 -30.43 0.78 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.188 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.13 -42.02 99.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.454 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.06 142.32 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.096 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -120.23 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.787 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.671 HG13 HG13 ' A' ' 27' ' ' ILE . 2.0 t -151.29 145.98 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.238 0.542 . . . . 0.0 111.53 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 6' ' ' ALA . 26.5 tp -123.51 100.38 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.65 138.31 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 112.077 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.538 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 49.8 m -100.57 96.84 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.391 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.06 -26.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.014 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.757 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -69.27 -21.53 63.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.27 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.675 HG23 ' CB ' ' A' ' 4' ' ' ALA . 12.2 p -126.04 -52.99 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.659 0.266 . . . . 0.0 111.494 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.84 2.34 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.537 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.605 ' HB ' HG21 ' A' ' 45' ' ' VAL . 40.9 t -52.54 145.55 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.731 0.301 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.4 p -148.06 165.31 31.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.635 HG12 HD13 ' A' ' 83' ' ' LEU . 48.1 mt -138.12 113.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.671 HG13 HG13 ' A' ' 16' ' ' VAL . 2.8 mt -96.07 112.86 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 111.123 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 ' CD1' ' A' ' 10' ' ' PHE . 6.3 mt -98.31 99.85 8.0 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.773 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 156.66 63.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.268 1.979 . . . . 0.0 112.343 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -60.35 111.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.06 0.6 6.96 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.043 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.415 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -78.07 -30.05 49.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.929 0.365 . . . . 0.0 111.057 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.8 mt -115.37 142.52 28.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.448 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.39 155.52 46.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.284 1.989 . . . . 0.0 112.351 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.1 mt-10 -66.57 153.36 43.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.2 25.5 57.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 35' ' ' GLU . 34.3 t -132.85 160.24 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.303 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' N ' HG12 ' A' ' 37' ' ' VAL . 20.0 mt-10 -137.84 113.83 9.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.739 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.84 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.9 mm-40 -101.6 125.63 48.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.055 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 26.5 tt0 -82.45 121.64 27.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 mt -124.97 136.39 60.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.221 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CD2' ' HD2' ' A' ' 7' ' ' ARG . 26.6 p90 -155.51 159.92 40.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.487 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -165.65 165.45 18.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 111.654 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.741 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -137.57 119.32 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.055 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.916 HG22 HG13 ' A' ' 68' ' ' VAL . 38.7 t -105.33 137.24 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.61 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.41 97.27 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.446 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.59 139.22 37.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.338 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.412 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.45 -57.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.989 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.593 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -89.53 -175.77 0.58 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.217 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.04 -35.39 1.78 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.268 1.979 . . . . 0.0 111.785 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -168.09 78.24 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.955 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.916 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -137.46 117.87 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.48 105.99 17.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.717 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -165.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -71.47 -154.36 1.7 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.576 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 51.9 Cg_exo -53.9 130.1 37.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.5 2.134 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -56.68 110.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.742 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.05 83.95 1.77 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.551 HD13 ' CD ' ' A' ' 39' ' ' GLN . 3.4 tp -138.68 86.52 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.293 0.568 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -50.54 164.47 0.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -149.48 136.82 19.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.554 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.93 16.95 16.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.319 0.581 . . . . 0.0 111.06 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 3.3 tptm -159.8 136.45 6.57 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.258 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.3 Cg_exo -63.7 95.82 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.505 2.137 . . . . 0.0 112.51 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 m -70.72 142.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.607 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 7.0 mp0 -90.93 129.19 36.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 111.563 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.635 HD13 HG12 ' A' ' 26' ' ' ILE . 26.9 tp -124.32 114.99 20.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -112.32 131.18 55.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.876 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -143.85 141.43 18.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.521 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.03 127.66 10.83 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.492 2.128 . . . . 0.0 112.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -43.78 30.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t 62.09 59.75 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.92 122.74 1.13 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.714 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -86.62 39.87 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.643 2.229 . . . . 0.0 112.871 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 -4.29 16.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.612 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -122.67 16.16 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 6.8 p-90 -117.7 -43.49 2.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -91.74 133.04 35.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.291 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.31 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.66 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 32.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.734 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.36 -166.88 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 98' ' ' LEU . 13.4 mt -95.72 121.43 61.34 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 5.7 Cg_exo -77.84 4.03 6.44 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.753 2.302 . . . . 0.0 112.686 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.55 2.24 8.14 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.822 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.502 ' OD1' ' HB3' ' A' ' 104' ' ' TYR . 37.1 p-10 -81.31 133.23 53.94 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 117.62 0.71 . . . . 0.0 110.317 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.625 ' O ' HG21 ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.65 -9.43 24.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.504 2.136 . . . . 0.0 113.085 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 7.2 m120 -96.89 17.62 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 111.109 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.502 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -75.03 -110.02 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -55.89 -13.81 2.06 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.625 HG21 ' O ' ' A' ' 102' ' ' PRO . 11.2 m -69.14 36.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.84 -37.88 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.134 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -24.79 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.651 0.262 . . . . 0.0 111.243 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.37 65.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 173.21 127.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.721 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 111' ' ' VAL . 11.6 p -102.52 105.93 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.37 105.05 5.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.307 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 83' ' ' LEU . 5.9 m -126.51 120.74 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.87 132.31 37.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.639 ' O ' HG22 ' A' ' 81' ' ' VAL . 26.7 mm -113.74 124.79 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.58 26.52 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.637 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.466 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -178.32 98.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.89 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.738 0.304 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 44' ' ' LYS . 28.7 p -123.15 143.64 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.374 . . . . 0.0 111.195 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.646 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.36 124.77 20.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.831 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.8 mtt180 -130.42 129.84 43.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.42 145.89 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.039 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 10' ' ' PHE . 29.2 mt -90.45 159.67 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.514 0.197 . . . . 0.0 110.539 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.779 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.9 m-85 -137.57 152.29 49.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 111.411 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 38' ' ' GLU . 1.6 t-20 -123.76 172.11 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.764 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.02 -28.47 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -60.14 -37.28 79.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.62 -160.81 12.99 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.752 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.63 170.74 13.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.204 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -124.51 149.09 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.646 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' A' ' 6' ' ' ALA . 31.7 tp -123.35 100.38 6.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.58 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -129.47 153.95 47.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.142 0.496 . . . . 0.0 111.925 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -126.28 97.09 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.074 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -51.81 -26.68 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.639 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 4.0 mt-10 -62.21 -26.95 68.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.656 HG21 HG12 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -119.88 -52.91 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.137 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.55 -28.91 3.92 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.728 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 45' ' ' VAL . 55.7 t -57.09 145.87 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.671 0.272 . . . . 0.0 110.795 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 p -149.66 156.35 41.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.43 . . . . 0.0 111.381 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 HD13 ' A' ' 83' ' ' LEU . 23.9 mt -135.03 113.59 16.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.656 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.7 mp -93.26 126.79 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.894 0.378 . . . . 0.0 110.98 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.779 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.9 mt -110.77 99.36 41.72 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.39 153.45 76.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.586 2.191 . . . . 0.0 112.28 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -60.67 100.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.68 -6.3 3.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -73.28 -24.14 60.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.878 0.339 . . . . 0.0 111.202 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.436 HG23 ' HD2' ' A' ' 34' ' ' PRO . 18.5 mt -121.64 140.91 32.56 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.672 ' HD3' HD21 ' A' ' 78' ' ' LEU . 31.7 Cg_exo -58.18 152.9 49.43 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.316 2.011 . . . . 0.0 112.243 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.59 143.42 57.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.75 25.58 72.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 38' ' ' GLU . 48.0 t -127.99 161.14 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.555 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -139.96 113.67 8.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.847 179.123 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.417 ' HB2' HD13 ' A' ' 33' ' ' ILE . 27.9 mm100 -103.56 113.77 27.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.093 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.43 122.33 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.18 137.31 57.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.018 0.437 . . . . 0.0 111.213 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 13.2 p90 -154.41 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.28 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -166.95 153.88 8.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.058 0.456 . . . . 0.0 111.539 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -120.24 117.48 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.827 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 22' ' ' THR . 59.6 t -102.87 126.86 57.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.582 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 111.08 -179.587 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.763 ' OE1' ' HB1' ' A' ' 69' ' ' ALA . 2.5 tp10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.786 0.327 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.72 95.44 4.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.624 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -77.97 139.31 39.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.025 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.44 -57.71 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.646 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.03 -174.49 0.48 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.246 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 53.4 Cg_exo -38.68 -45.06 2.4 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.287 1.991 . . . . 0.0 112.125 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.781 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -161.66 65.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.558 HG22 HG13 ' A' ' 45' ' ' VAL . 90.0 t -121.63 118.61 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.573 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB1' ' OE1' ' A' ' 61' ' ' GLU . . . -101.58 106.71 17.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.871 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -63.74 -167.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -78.12 -150.75 4.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 52.0 Cg_exo -54.47 121.59 10.03 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 112.006 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -55.53 110.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.938 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.33 78.55 0.9 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.738 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.697 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 65.8 tp -136.65 84.68 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.184 0.516 . . . . 0.0 110.477 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.1 tttt -58.85 162.11 4.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.184 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.416 ' CE1' ' HG ' ' A' ' 75' ' ' LEU . 42.1 m-85 -144.42 150.01 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.672 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.75 12.61 31.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.302 0.573 . . . . 0.0 111.259 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mmpp? -157.24 136.73 8.37 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.965 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.87 93.49 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.293 1.995 . . . . 0.0 112.28 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.6 m -64.26 166.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 126.84 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.045 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.568 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.1 tp -124.22 107.04 10.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.22 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.441 ' HD3' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.34 129.69 53.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.362 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -136.34 154.18 76.89 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.652 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' HG22 ' A' ' 24' ' ' VAL . 34.9 Cg_endo -64.96 120.21 7.4 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.502 2.135 . . . . 0.0 112.069 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.55 -54.4 7.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.27 158.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' CB ' ' CD ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -57.92 177.84 0.2 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.693 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 89' ' ' ASP . 92.4 Cg_endo -84.78 35.62 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.558 2.172 . . . . 0.0 112.93 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -109.33 -0.19 19.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.361 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -122.54 15.86 10.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 112.038 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.674 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 5.1 p-90 -105.48 -35.67 7.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 93' ' ' TRP . 1.1 pt20 -94.18 29.83 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.369 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -101.7 -30.95 11.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -172.2 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.23 -165.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.788 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 11.4 mt -89.67 124.64 63.5 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 13.3 Cg_exo -68.78 -23.68 35.35 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.563 2.175 . . . . 0.0 112.25 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.88 4.43 39.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.136 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -60.96 138.97 94.1 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.916 0.358 . . . . 0.0 110.474 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.789 ' O ' HG21 ' A' ' 106' ' ' VAL . 3.0 Cg_exo -74.38 -3.08 13.27 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.483 2.122 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.437 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 10.3 p30 -109.22 17.41 21.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 0.0 111.053 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.617 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.15 -113.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.978 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.674 HD11 ' CZ3' ' A' ' 93' ' ' TRP . 0.5 OUTLIER -47.76 -19.55 0.23 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.789 HG21 ' O ' ' A' ' 102' ' ' PRO . 8.4 m -68.4 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -174.39 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.849 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.58 67.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.86 -66.56 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.45 142.74 51.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.66 ' O ' HG13 ' A' ' 111' ' ' VAL . 12.0 p -98.09 103.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.98 104.78 6.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 83' ' ' LEU . 10.6 m -116.11 126.82 73.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.837 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.6 mt -81.62 136.55 35.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.731 ' O ' HG22 ' A' ' 81' ' ' VAL . 34.9 mm -129.79 121.71 53.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.39 25.46 6.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.206 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 176.71 111.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.697 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.3 m-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.027 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.697 ' HB2' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.814 0.34 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 44' ' ' LYS . 17.1 p -140.6 144.37 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -150.98 113.7 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.418 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -125.83 129.88 50.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.16 145.26 9.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.625 HG21 ' HB3' ' A' ' 38' ' ' GLU . 4.1 mt -84.05 138.89 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.752 ' CG ' HD12 ' A' ' 28' ' ' ILE . 79.0 m-85 -117.41 161.24 19.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -134.55 172.07 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 t -49.91 -27.04 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -56.35 -33.11 65.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.64 173.2 22.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.647 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.63 158.35 8.74 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.067 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.628 HG22 HG23 ' A' ' 27' ' ' ILE . 4.7 t -113.9 152.05 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.359 0.6 . . . . 0.0 111.824 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD11 ' HB1' ' A' ' 6' ' ' ALA . 54.2 tp -123.66 100.21 6.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.38 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.12 142.02 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.076 0.465 . . . . 0.0 111.767 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.74 97.11 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.338 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.48 -26.4 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.617 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -54.66 -26.63 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.365 -179.555 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.697 HG23 ' HB2' ' A' ' 4' ' ' ALA . 23.0 p -132.32 -52.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.59 -36.65 1.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.755 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.841 ' HB ' HG21 ' A' ' 45' ' ' VAL . 22.5 t -48.56 142.1 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 51.0 p -149.73 172.05 15.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 111.525 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 83' ' ' LEU . 20.4 mt -145.02 113.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.606 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.628 HG23 HG22 ' A' ' 16' ' ' VAL . 4.1 mp -93.05 118.83 39.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.752 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.6 mt -106.48 90.96 5.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.43 159.52 43.74 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.517 2.145 . . . . 0.0 112.334 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.31 106.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.08 -8.88 3.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.056 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.01 -23.91 55.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.97 0.385 . . . . 0.0 111.451 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 39' ' ' GLN . 36.3 mt -131.0 141.09 40.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.771 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.34 155.48 46.26 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.392 2.061 . . . . 0.0 112.264 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -68.27 152.63 45.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.74 23.34 63.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 38' ' ' GLU . 41.6 t -128.51 160.75 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.146 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.625 ' HB3' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -135.8 113.84 11.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.008 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.821 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.2 tp60 -101.05 110.73 22.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.6 114.16 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.546 HD11 ' HE1' ' A' ' 77' ' ' PHE . 24.7 mt -124.99 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.418 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 40.4 p90 -155.56 152.92 29.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -157.1 162.92 39.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.401 . . . . 0.0 111.384 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.541 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -130.33 126.67 37.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.774 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.841 HG21 ' HB ' ' A' ' 24' ' ' VAL . 39.2 t -114.3 134.71 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.944 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' HB3' HD12 ' A' ' 67' ' ' LEU . 11.2 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.7 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.8 pm0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -100.76 98.47 8.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.588 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -76.45 133.92 39.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.44 -57.66 1.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.206 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -87.13 174.31 5.55 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.576 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 7.5 Cg_exo -34.5 -44.85 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 0.0 111.735 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.1 tm? -156.45 84.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.699 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 64' ' ' LEU . 51.6 t -146.89 118.07 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.289 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -108.85 106.19 16.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.786 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.25 -168.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.85 -148.07 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.53 127.56 21.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.505 2.137 . . . . 0.0 112.009 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.2 110.87 0.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.88 76.33 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.74 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 39' ' ' GLN . 18.9 tp -140.56 86.06 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 110.006 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 11.2 mtpp -75.99 123.89 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.173 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.546 ' HE1' HD11 ' A' ' 41' ' ' ILE . 40.8 m-85 -98.68 168.59 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.557 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.771 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -105.63 16.16 25.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.609 . . . . 0.0 111.032 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -161.42 136.51 5.54 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.46 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.6 Cg_exo -63.41 107.06 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.491 2.128 . . . . 0.0 112.499 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.9 m -79.41 144.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -88.4 116.04 26.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 111.05 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 84' ' ' ARG . 9.2 tp -113.39 129.83 56.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 83' ' ' LEU . 51.2 mtp180 -121.66 132.65 54.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.736 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -139.51 113.82 8.0 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.64 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.68 120.69 8.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.095 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.77 -21.32 55.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 68.66 -168.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 62.62 79.53 0.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.47 46.57 2.12 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.826 2.351 . . . . 0.0 112.776 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.06 4.94 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.468 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.53 16.0 10.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.881 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.402 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.8 p-90 -114.17 -36.86 4.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.402 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -108.67 43.63 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.934 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 -47.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.12 -38.19 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.36 174.51 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.47 139.27 21.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.27 -17.82 27.21 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.597 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.47 -29.47 19.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.705 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 140.29 83.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.792 0.33 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.743 ' O ' HG22 ' A' ' 106' ' ' VAL . 43.0 Cg_endo -67.2 -25.73 42.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.592 2.195 . . . . 0.0 112.259 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -16.85 62.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.607 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.777 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.31 -19.01 19.65 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.936 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.777 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 18.0 mt -155.96 -26.87 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.5 m -67.35 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 156.82 -27.92 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.411 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.03 -32.39 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -127.66 42.1 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.45 122.21 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.736 HG11 HD12 ' A' ' 85' ' ' LEU . 13.5 p -106.15 111.54 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.388 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.9 104.98 13.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 111' ' ' VAL . 6.3 m -122.78 126.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mt -99.12 121.0 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.902 ' O ' HG22 ' A' ' 81' ' ' VAL . 12.4 mm -111.88 119.53 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.356 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.457 ' C ' ' CG ' ' A' ' 117' ' ' HIS . 2.7 t0 -119.57 15.39 12.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.8 m-70 -162.35 125.42 2.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.723 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.17 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.8 p -132.55 143.8 49.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -133.58 120.97 21.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 1.4 mtt180 -122.0 132.12 54.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.39 157.29 28.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.954 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.1 mt -94.98 151.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.977 ' CD1' HD12 ' A' ' 28' ' ' ILE . 41.1 m-85 -128.26 144.86 51.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 111.402 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.73 ' HA ' HG21 ' A' ' 33' ' ' ILE . 2.9 m120 -128.58 171.91 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -47.38 -28.64 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.203 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -54.3 -38.48 65.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.04 173.73 40.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.717 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.28 -155.17 26.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.605 HG13 HG13 ' A' ' 27' ' ' ILE . 2.4 t -146.97 150.23 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 0.0 111.628 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 6' ' ' ALA . 56.4 tp -123.34 100.27 6.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.352 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.79 148.48 50.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 112.016 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 p -116.16 96.99 5.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.001 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -50.15 -26.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.741 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -64.45 -38.49 91.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.679 HG21 HG12 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -105.01 -52.87 2.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.193 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.73 -30.92 3.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.758 HG22 ' HD2' ' A' ' 86' ' ' PRO . 42.1 t -56.12 142.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.01 154.0 41.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 111.453 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.671 HG12 HD13 ' A' ' 83' ' ' LEU . 49.7 mt -132.13 113.62 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 16' ' ' VAL . 2.5 mt -93.59 136.11 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.992 0.425 . . . . 0.0 111.174 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.977 HD12 ' CD1' ' A' ' 10' ' ' PHE . 2.3 mt -128.69 87.02 56.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.744 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.42 162.19 37.61 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.494 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.72 107.4 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.992 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 139.89 -10.75 3.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.114 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.833 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -86.14 -33.69 20.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 11' ' ' ASN . 1.9 mm -101.51 132.74 21.42 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.526 ' HB2' HG21 ' A' ' 37' ' ' VAL . 16.7 Cg_exo -66.08 144.97 77.77 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.154 1.903 . . . . 0.0 111.949 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 37' ' ' VAL . 5.1 mt-10 -57.76 141.57 48.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.25 28.04 71.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 38' ' ' GLU . 26.0 t -131.98 159.87 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG12 ' A' ' 37' ' ' VAL . 31.1 mt-10 -129.96 113.95 15.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.755 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG2' HD11 ' A' ' 75' ' ' LEU . 5.4 tp60 -101.22 109.0 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.374 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -75.8 116.06 16.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 HD11 ' HE1' ' A' ' 77' ' ' PHE . 26.4 mt -124.63 134.29 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.151 0.501 . . . . 0.0 111.6 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.428 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 30.6 p90 -150.79 155.06 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.972 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.6 p90 -157.86 160.36 37.61 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.653 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -120.07 151.65 38.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.846 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.679 HG12 HG21 ' A' ' 22' ' ' THR . 48.4 t -156.81 143.38 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 111.348 -179.796 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.566 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 79.7 mt-10 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.886 0.374 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 m -102.05 111.77 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -77.2 142.04 39.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.198 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.488 HD21 ' HE1' ' A' ' 118' ' ' PHE . 0.1 OUTLIER -126.44 -57.56 1.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -103.2 -173.1 0.27 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.192 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 55.7 Cg_exo -39.87 -58.49 0.88 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.075 1.85 . . . . 0.0 111.747 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.712 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -138.13 85.24 2.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.1 t -147.17 118.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.731 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -112.14 106.11 14.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.9 -143.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.55 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 31.7 Cg_endo -64.07 131.53 30.96 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.494 2.129 . . . . 0.0 112.04 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -56.59 110.82 0.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.37 79.8 1.27 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.638 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 28.9 tp -142.3 85.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HD2' ' CE1' ' A' ' 117' ' ' HIS . 4.9 ptmt -85.23 122.01 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.078 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.549 ' HE1' HD11 ' A' ' 41' ' ' ILE . 33.2 m-85 -93.2 170.9 9.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -98.6 18.41 16.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.569 . . . . 0.0 111.077 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 136.6 3.02 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.512 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.52 104.08 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.504 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.6 m -76.73 139.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.887 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 2.0 tp10 -84.5 127.98 34.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.919 0.39 . . . . 0.0 111.347 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.671 HD13 HG12 ' A' ' 26' ' ' ILE . 25.3 tp -124.21 118.24 26.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.47 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 24' ' ' VAL . 10.1 mmm-85 -105.46 134.33 48.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.933 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.985 HD12 HG11 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -131.83 122.26 18.46 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.758 ' HD2' HG22 ' A' ' 24' ' ' VAL . 74.2 Cg_endo -75.27 120.24 5.9 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.429 2.086 . . . . 0.0 112.168 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -73.52 -27.12 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.2 m 63.41 55.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.011 0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -130.92 92.0 35.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.774 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.0 41.03 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.191 2.594 . . . . 0.0 112.783 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -1.46 19.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.525 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -122.75 16.14 10.21 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.447 ' CD1' ' HG2' ' A' ' 94' ' ' GLN . 4.9 p-90 -110.73 -38.77 5.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.447 ' HG2' ' CD1' ' A' ' 93' ' ' TRP . 5.0 pt20 -95.51 152.73 18.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.059 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 64.04 31.22 13.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.761 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.22 -47.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.6 m -129.3 -172.3 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.2 mt -85.75 141.01 35.66 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.57 -1.71 11.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.67 2.247 . . . . 0.0 112.847 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.41 -34.22 4.55 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.707 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.414 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 77.3 m-20 -61.08 123.12 74.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.538 0.209 . . . . 0.0 110.978 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.821 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.24 -30.84 63.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.345 2.03 . . . . 0.0 112.158 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -61.91 -17.22 55.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.38 -17.69 13.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.665 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 14.0 mt -157.94 -30.58 0.08 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.93 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 178.84 -47.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.688 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.75 67.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.388 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -97.63 53.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -162.6 135.9 5.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.985 HG11 HD12 ' A' ' 85' ' ' LEU . 13.2 p -99.86 116.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.28 105.03 13.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.916 0.389 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 83' ' ' LEU . 4.4 m -126.18 123.09 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mt -93.17 131.95 37.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 81' ' ' VAL . 39.8 mm -114.15 117.26 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.305 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.81 27.23 8.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.13 179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.562 ' CE1' ' HD2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.3 104.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.4 m-85 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.14 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.2 p -119.07 143.7 46.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.413 . . . . 0.0 110.782 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.584 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -139.53 112.29 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.437 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.4 mtp85 -110.53 137.61 48.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.05 153.93 22.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.928 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 38' ' ' GLU . 35.4 mt -95.97 154.43 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 28' ' ' ILE . 22.4 m-85 -122.79 172.18 8.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -155.1 171.87 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 p -58.62 -25.63 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.58 -57.4 12.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.48 133.11 4.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.45 -169.83 21.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.126 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.65 HG13 HG13 ' A' ' 27' ' ' ILE . 1.9 t -139.89 148.76 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.669 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.14 100.11 6.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.22 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.45 140.87 52.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.733 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 6' ' ' ALA . 0.5 OUTLIER -107.47 97.17 6.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.225 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.37 -26.53 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.671 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 1.4 mt-10 -63.02 -40.82 98.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.291 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.6 HG23 ' HB3' ' A' ' 4' ' ' ALA . 2.4 p -105.84 -52.95 2.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.73 -30.94 3.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.609 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.65 HG22 ' HD2' ' A' ' 86' ' ' PRO . 56.3 t -57.15 144.01 10.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.715 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 p -144.95 161.58 39.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.47 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 HD13 ' A' ' 83' ' ' LEU . 12.7 mt -137.88 114.07 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.843 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.65 HG13 HG13 ' A' ' 16' ' ' VAL . 3.0 mt -96.31 136.38 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.705 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -108.85 93.94 13.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.98 145.07 96.93 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.335 2.023 . . . . 0.0 112.236 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.75 104.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.276 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.09 5.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.203 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.699 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.34 -28.07 56.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.013 0.406 . . . . 0.0 111.258 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.575 HD13 ' HG3' ' A' ' 39' ' ' GLN . 27.4 mt -126.42 141.84 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.746 ' HD3' HD21 ' A' ' 78' ' ' LEU . 39.4 Cg_exo -60.34 155.37 46.9 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.395 2.063 . . . . 0.0 112.234 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.48 141.91 57.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.03 79.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.683 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 38' ' ' GLU . 46.9 t -121.84 160.69 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.311 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.556 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -140.11 113.8 8.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.868 179.211 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.575 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.21 120.03 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.23 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -81.31 108.85 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.651 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.491 ' HB ' ' CE2' ' A' ' 10' ' ' PHE . 2.5 mt -117.17 137.54 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.417 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.437 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 52.5 p90 -149.06 157.14 43.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.052 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -159.37 159.71 34.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.075 0.464 . . . . 0.0 111.64 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -126.45 124.08 39.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.809 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.538 HG21 ' HB ' ' A' ' 24' ' ' VAL . 60.6 t -112.75 130.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' HB3' HD12 ' A' ' 67' ' ' LEU . 53.2 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.707 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 91.7 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.903 0.383 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 m -106.02 106.36 16.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -75.69 135.11 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.38 -57.7 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.297 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 68' ' ' VAL . 1.1 p -86.78 -175.16 0.56 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.511 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 79.6 Cg_exo -42.06 -47.86 6.56 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.214 1.943 . . . . 0.0 111.705 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.748 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.7 tm? -154.86 81.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.805 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG23 ' OG ' ' A' ' 65' ' ' SER . 69.0 t -142.27 118.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.296 178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -105.72 106.16 16.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.507 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -166.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.211 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -79.35 -144.2 2.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 75.4 Cg_exo -49.77 121.69 7.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.144 . . . . 0.0 112.197 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -58.17 111.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.09 83.93 1.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.625 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 11.9 tp -137.64 85.1 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 77' ' ' PHE . 1.7 tptp -61.7 132.82 54.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 43.3 m-85 -112.7 144.11 42.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.746 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -88.8 17.22 5.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 111.369 179.427 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -164.68 136.33 3.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.21 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.28 102.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.522 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.4 m -74.06 161.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.504 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -104.81 129.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 111.317 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.572 ' HB3' HG23 ' A' ' 113' ' ' VAL . 27.8 tp -124.16 118.07 26.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.387 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.503 ' O ' HG13 ' A' ' 24' ' ' VAL . 10.9 mmt180 -105.94 130.93 53.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.961 HD12 HG11 ' A' ' 111' ' ' VAL . 1.3 mt -128.13 116.18 20.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 24' ' ' VAL . 51.6 Cg_exo -54.48 136.73 70.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.385 2.057 . . . . 0.0 112.251 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.29 -20.12 57.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 68.31 31.45 5.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -143.63 77.88 14.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.697 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.48 54.42 2.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.923 2.415 . . . . 0.0 112.628 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.31 -13.05 14.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.617 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 t -122.6 16.1 10.33 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.474 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.4 p-90 -106.78 -36.05 6.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.474 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -104.32 71.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -119.37 -39.51 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -43.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 35.4 m -54.56 179.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.13 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 98' ' ' LEU . 11.5 mt -99.0 135.87 20.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.93 -5.72 16.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 112.58 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.4 -41.04 7.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.648 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 61.2 m-20 -61.53 138.51 95.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.52 0.2 . . . . 0.0 110.745 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.762 ' O ' HG22 ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.05 -27.29 50.04 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.175 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -65.28 -15.06 62.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.986 0.422 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.805 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.97 -19.45 18.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.839 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.805 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 14.7 mt -155.58 -28.2 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.11 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -177.88 -36.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.649 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.98 -58.95 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.256 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -96.18 88.39 4.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.47 141.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.961 HG11 HD12 ' A' ' 85' ' ' LEU . 14.2 p -97.32 115.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.18 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.77 104.99 10.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.133 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 83' ' ' LEU . 12.3 m -128.07 120.97 54.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.994 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 12.2 mt -87.06 146.12 26.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 81' ' ' VAL . 30.8 mm -129.8 120.39 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.2 25.87 8.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.078 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.36 103.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.823 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.8 0.333 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.497 HG22 ' HB3' ' A' ' 44' ' ' LYS . 57.2 p -118.57 143.27 46.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.863 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -139.45 122.96 17.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.967 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.458 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -127.85 129.36 46.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.36 142.88 7.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -89.89 135.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.838 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.7 m-85 -115.89 151.6 35.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 111.374 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.0 172.31 11.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.654 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.42 -28.97 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -54.76 -29.7 54.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 167.43 32.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.679 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.97 158.48 9.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.347 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.615 HG22 HG23 ' A' ' 27' ' ' ILE . 2.9 t -114.58 151.03 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' A' ' 6' ' ' ALA . 44.0 tp -123.47 100.24 6.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.29 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.47 152.9 42.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.022 0.439 . . . . 0.0 111.89 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.463 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 51.2 m -120.75 97.25 5.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -52.73 -26.54 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' HB2' ' A' ' 4' ' ' ALA . 3.3 mm-40 -66.7 -36.3 82.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.304 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.444 HG21 ' HB ' ' A' ' 45' ' ' VAL . 4.3 p -109.22 -52.89 2.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.736 0.303 . . . . 0.0 111.356 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.92 -43.11 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.812 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.629 ' HB ' HG21 ' A' ' 45' ' ' VAL . 47.2 t -49.83 143.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.4 p -149.47 167.14 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.516 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 83' ' ' LEU . 14.0 mt -139.67 113.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.038 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.615 HG23 HG22 ' A' ' 16' ' ' VAL . 2.2 mp -92.81 122.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.838 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.2 mt -112.08 89.48 11.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.85 156.67 65.03 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.499 2.133 . . . . 0.0 112.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -57.29 104.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 145.17 -13.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.13 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -78.13 -36.01 48.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.382 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.465 HD13 ' CG ' ' A' ' 39' ' ' GLN . 16.3 mt -108.32 141.37 23.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.596 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 19.7 Cg_exo -65.37 155.17 70.12 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.336 2.024 . . . . 0.0 112.131 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 142.46 57.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.53 23.37 75.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 38' ' ' GLU . 48.2 t -126.88 161.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 111.251 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.56 ' N ' HG12 ' A' ' 37' ' ' VAL . 3.2 mt-10 -137.04 113.74 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.813 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.465 ' CG ' HD13 ' A' ' 33' ' ' ILE . 1.4 mm-40 -105.71 117.41 33.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -69.72 119.58 14.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.501 HD11 HD21 ' A' ' 75' ' ' LEU . 3.7 mm -120.66 109.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.458 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 12.3 p90 -138.18 161.27 37.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.309 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.5 OUTLIER -170.84 165.22 7.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 111.86 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 2.3 pttp -132.37 132.63 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.691 HG22 HG13 ' A' ' 68' ' ' VAL . 56.4 t -119.2 138.52 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.228 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.773 -179.924 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.22 111.31 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.472 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.87 144.04 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.296 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -126.34 -57.68 1.38 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.013 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.543 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -98.97 -173.37 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.297 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.2 Cg_exo -40.49 -42.4 3.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.223 1.949 . . . . 0.0 111.864 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.6 tm? -157.6 81.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.744 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.691 HG13 HG22 ' A' ' 45' ' ' VAL . 43.2 t -141.55 118.01 7.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.63 106.19 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.553 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.529 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -66.8 -169.6 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.041 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -61.3 -152.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.541 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 37.1 Cg_endo -65.94 134.37 36.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.544 2.163 . . . . 0.0 112.065 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -60.57 110.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.37 75.98 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.718 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 24.4 tp -142.27 86.41 1.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.144 0.497 . . . . 0.0 110.2 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -53.78 164.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.433 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -146.34 141.37 27.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.625 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.412 HD21 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.68 16.66 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.317 0.58 . . . . 0.0 110.827 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -166.51 136.78 2.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.021 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.77 100.65 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.525 2.15 . . . . 0.0 112.641 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 115' ' ' ILE . 13.5 m -68.13 139.48 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -82.86 123.39 29.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 0.0 111.409 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 26' ' ' ILE . 7.7 tp -124.2 121.05 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.182 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.517 ' N ' HD12 ' A' ' 83' ' ' LEU . 71.7 mtt-85 -115.78 132.88 56.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.709 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 119.49 6.37 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.527 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.63 130.75 38.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.274 1.983 . . . . 0.0 112.236 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.6 -54.8 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.27 168.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 56.04 85.25 0.19 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.187 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.14 38.21 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.855 2.37 . . . . 0.0 112.681 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -108.98 13.17 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.54 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 t -105.47 15.92 26.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 111.819 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.512 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 4.6 p-90 -121.16 -39.94 2.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 4.6 mm100 -99.51 59.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.97 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -127.12 89.2 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tptt 60.74 29.62 19.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -120.5 -171.13 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 98' ' ' LEU . 16.5 mt -85.81 128.75 57.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.27 -7.97 17.26 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.497 2.132 . . . . 0.0 112.539 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.92 10.95 8.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.053 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -71.48 126.62 91.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.937 0.369 . . . . 0.0 110.375 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.744 ' O ' HG21 ' A' ' 106' ' ' VAL . 58.2 Cg_endo -71.48 -7.03 20.41 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.165 1.91 . . . . 0.0 112.671 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.485 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -104.82 17.36 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -75.43 -113.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.034 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -48.04 -21.09 0.4 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.744 HG21 ' O ' ' A' ' 102' ' ' PRO . 15.6 m -68.71 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 155.2 34.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.645 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.72 -51.59 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.04 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.3 29.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.859 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 151.17 36.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.769 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.709 HG11 HD12 ' A' ' 85' ' ' LEU . 11.8 p -93.63 103.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.204 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.34 104.98 7.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 83' ' ' LEU . 5.4 m -120.85 123.22 69.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.45 135.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.7 mm -119.54 117.83 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.244 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.34 26.29 9.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.292 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.509 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.7 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.503 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 2' ' ' VAL . 10.7 p 44.36 30.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.677 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.89 HG11 ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -114.24 142.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.994 0.426 . . . . 0.0 111.153 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.759 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -119.65 117.76 29.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 44' ' ' LYS . 81.1 p -122.52 143.25 49.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -141.81 112.4 7.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 11.3 ttm-85 -121.54 129.43 52.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 156.89 27.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.685 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 38.1 mt -89.68 154.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.608 ' CE2' HD11 ' A' ' 28' ' ' ILE . 18.7 m-85 -127.5 175.25 8.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.135 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 37' ' ' VAL . 2.3 m120 -151.31 171.79 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -61.7 -23.13 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.942 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -56.4 -45.44 80.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.29 152.36 8.75 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.827 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.69 -173.32 45.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.087 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.498 HG13 HG13 ' A' ' 27' ' ' ILE . 2.8 t -145.64 150.61 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.392 0.615 . . . . 0.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.652 HD11 ' CB ' ' A' ' 6' ' ' ALA . 22.3 tp -123.34 100.18 6.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.233 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 143.82 50.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.99 0.424 . . . . 0.0 111.811 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.29 97.09 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.247 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -54.06 -26.82 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.419 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.759 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 1.4 mm-40 -62.47 -22.73 66.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.314 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' CB ' ' A' ' 4' ' ' ALA . 1.1 p -126.16 -52.97 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.79 -40.27 1.65 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.694 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 84' ' ' ARG . 33.9 t -53.55 137.98 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.741 0.305 . . . . 0.0 111.129 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.5 p -141.82 169.75 17.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.632 HG12 HD13 ' A' ' 83' ' ' LEU . 24.0 mt -141.59 113.65 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.209 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.0 mp -93.14 131.42 40.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.608 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -103.41 95.15 6.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.608 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.54 138.41 75.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.353 2.036 . . . . 0.0 112.084 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -51.09 101.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.009 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.3 -3.98 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.013 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.05 -30.28 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.892 0.346 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 39' ' ' GLN . 28.3 mt -119.93 143.48 35.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.53 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.5 Cg_exo -64.9 150.8 87.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.375 2.05 . . . . 0.0 112.114 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.6 mt-10 -66.57 151.68 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.46 65.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.57 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 38' ' ' GLU . 44.2 t -127.81 160.56 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG12 ' A' ' 37' ' ' VAL . 17.8 mt-10 -128.68 113.83 15.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.05 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.937 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.05 109.05 20.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.04 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.3 tt0 -74.45 114.69 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.808 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -124.91 139.02 52.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.138 0.494 . . . . 0.0 111.048 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 7' ' ' ARG . 21.3 p90 -153.45 171.51 18.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -175.5 156.81 2.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.181 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.659 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -129.41 122.12 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.077 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.753 HG22 HG13 ' A' ' 68' ' ' VAL . 39.6 t -110.32 136.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.537 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.594 ' HB3' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -168.3 149.02 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -30.77 62.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.2 133.77 33.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.584 ' O ' HD22 ' A' ' 52' ' ' LEU . 4.4 m120 -90.68 -31.31 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 p -84.49 -28.46 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.158 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.533 ' O ' HG22 ' A' ' 51' ' ' ILE . 30.3 mm -76.78 -2.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.517 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 49' ' ' ASN . 1.4 pt? -52.92 124.6 37.1 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.157 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.89 ' HD3' HG11 ' A' ' 3' ' ' VAL . 97.7 Cg_endo -79.37 138.32 13.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.414 2.076 . . . . 0.0 112.236 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 48.8 Cg_exo -55.42 122.36 11.58 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.413 2.075 . . . . 0.0 112.346 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.613 HD13 ' HG2' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -122.77 -62.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -175.4 76.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.703 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.02 18.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.005 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.32 -29.69 66.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -64.31 -31.06 72.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.69 113.19 2.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.401 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.45 129.77 53.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.27 96.43 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.554 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -69.14 143.16 54.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -126.25 -57.73 1.38 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.539 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -96.42 -173.89 0.36 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.258 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.37 -40.31 3.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.281 1.987 . . . . 0.0 111.877 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.74 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -161.19 78.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.753 HG13 HG22 ' A' ' 45' ' ' VAL . 48.6 t -137.61 117.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.566 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.42 106.17 16.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.707 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -60.28 -163.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.114 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -74.59 -144.54 0.97 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.442 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 45.2 Cg_endo -68.12 128.33 17.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.133 . . . . 0.0 112.148 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -57.58 110.83 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.8 77.48 0.86 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.743 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.729 HD11 ' HG2' ' A' ' 39' ' ' GLN . 22.6 tp -141.41 86.64 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 110.061 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.505 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -56.18 166.27 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.134 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 19.2 m-85 -148.72 143.54 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.683 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -96.53 17.9 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.3 ttmt -167.48 136.37 2.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.209 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 39.3 Cg_exo -60.54 96.88 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.408 2.072 . . . . 0.0 112.6 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 115' ' ' ILE . 3.5 m -68.1 140.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.536 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.03 125.12 32.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.798 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 26' ' ' ILE . 20.5 tp -124.19 128.1 48.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.944 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.763 ' O ' HG13 ' A' ' 24' ' ' VAL . 36.1 mtt-85 -119.76 130.71 55.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.862 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.543 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 154.96 60.06 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.531 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 131.57 23.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.352 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.13 -51.84 8.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.73 44.9 10.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.59 105.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.78 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.81 39.39 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.666 2.244 . . . . 0.0 112.828 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -108.71 13.26 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.132 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -120.99 16.19 11.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.493 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 8.8 p-90 -118.72 -45.01 2.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.781 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.493 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.9 OUTLIER -88.07 91.36 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -162.04 71.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tptp 60.29 34.93 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.64 -173.59 4.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 23.0 mt -83.87 126.03 71.55 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 9.4 Cg_exo -71.29 -24.44 23.02 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.584 2.189 . . . . 0.0 112.602 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.31 14.12 20.97 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 6.3 t70 -114.0 130.53 23.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.893 0.346 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.823 ' O ' HG22 ' A' ' 106' ' ' VAL . 29.3 Cg_endo -62.94 -30.83 77.27 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.57 2.18 . . . . 0.0 112.222 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -55.57 -20.17 12.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 110.888 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CE1' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.52 -12.21 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.06 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.849 HD22 ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -165.26 -13.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -177.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 102' ' ' PRO . 15.9 m -65.12 36.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -153.15 25.26 0.79 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.15 -33.91 14.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.133 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -58.63 -31.62 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -150.43 139.14 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 111' ' ' VAL . 13.8 p -91.31 112.0 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 105.04 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 83' ' ' LEU . 11.5 m -123.27 123.6 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.061 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -93.5 139.16 31.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.953 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.502 ' HB ' HG22 ' A' ' 81' ' ' VAL . 37.2 mm -121.33 122.22 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.41 25.94 6.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.092 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.505 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.63 102.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.078 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.41 140.7 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.886 HG21 HD22 ' A' ' 52' ' ' LEU . 20.5 t -147.54 139.28 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -97.15 117.57 31.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.712 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.556 HG22 ' CG ' ' A' ' 44' ' ' LYS . 55.7 p -137.41 143.39 41.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.995 0.426 . . . . 0.0 111.274 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.706 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -137.37 137.21 38.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.8 mpp_? -134.73 137.72 43.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 160.86 33.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.822 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.424 HD13 ' HG3' ' A' ' 40' ' ' GLU . 10.4 mm -94.43 154.88 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.598 0.237 . . . . 0.0 110.655 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.931 ' CD1' HD12 ' A' ' 28' ' ' ILE . 51.1 m-85 -135.17 146.01 48.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.28 171.87 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.631 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p -48.84 -26.92 2.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.172 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -56.8 -31.91 65.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.62 -174.57 32.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.546 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.26 -161.66 29.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.121 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 27' ' ' ILE . 2.8 t -143.75 151.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 111.731 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 25' ' ' SER . 39.2 tp -123.02 99.96 6.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.041 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.39 154.8 33.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 111.961 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 m -120.94 97.22 5.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.147 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.56 -26.53 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.697 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.2 mt-10 -66.41 -46.29 77.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.464 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.632 HG21 HG12 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -100.92 -52.94 3.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 111.371 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.02 -36.25 2.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG22 ' HD2' ' A' ' 86' ' ' PRO . 43.6 t -53.93 145.8 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.738 0.304 . . . . 0.0 110.853 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.69 167.34 26.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 0.0 111.513 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.818 HG12 HD13 ' A' ' 83' ' ' LEU . 27.8 mt -134.1 113.84 18.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.717 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.5 mp -91.69 119.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.797 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.931 HD12 ' CD1' ' A' ' 10' ' ' PHE . 5.3 mt -106.77 97.35 17.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.95 156.86 64.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.435 2.09 . . . . 0.0 112.139 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -57.75 112.97 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.71 5.93 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.198 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -86.68 -25.88 24.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.022 0.411 . . . . 0.0 111.21 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.868 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.4 mt -122.53 141.92 36.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.45 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -61.75 155.47 53.92 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.315 2.01 . . . . 0.0 112.11 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 37' ' ' VAL . 34.1 mt-10 -67.89 154.99 40.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.41 26.6 56.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 35' ' ' GLU . 38.6 t -133.3 159.93 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -133.64 113.81 12.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.852 179.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.868 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -104.74 112.05 25.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.14 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG3' HD13 ' A' ' 9' ' ' ILE . 44.2 tt0 -72.59 124.23 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.72 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.6 135.24 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.17 0.509 . . . . 0.0 111.423 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.485 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.9 p90 -148.36 169.33 20.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.9 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.706 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -165.63 157.7 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.443 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.714 ' CB ' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -124.66 115.95 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 22' ' ' THR . 25.0 t -109.44 135.44 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.523 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.873 ' HB2' HG13 ' A' ' 3' ' ' VAL . 24.9 t -175.36 149.59 1.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.388 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.25 5.12 18.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.774 ' CG ' HD13 ' A' ' 51' ' ' ILE . 6.0 m-20 -119.99 110.81 17.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.505 ' CG ' HD23 ' A' ' 67' ' ' LEU . 45.5 t-20 -90.86 -59.68 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.591 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.49 -28.01 46.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.774 HD13 ' CG ' ' A' ' 48' ' ' ASP . 3.2 mp -72.85 -6.26 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -151.65 136.38 10.29 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.248 . . . . 0.0 111.1 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -78.33 160.5 29.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.483 2.122 . . . . 0.0 112.382 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.5 172.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.674 2.249 . . . . 0.0 112.414 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.714 HD11 ' CB ' ' A' ' 44' ' ' LYS . 2.2 mp -64.25 -66.45 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -138.59 103.19 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -32.13 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -72.37 -37.21 68.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -73.36 -29.0 62.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.78 113.24 2.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.282 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.03 106.45 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.49 109.45 20.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.26 142.57 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.5 -57.75 1.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 111.254 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.519 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.58 -175.22 0.42 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.308 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.5 Cg_exo -40.53 -44.35 4.4 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.242 1.961 . . . . 0.0 111.684 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.688 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -153.18 86.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.495 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.3 t -147.63 117.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.429 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -108.52 105.86 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.83 -172.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.19 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 42' ' ' TYR . . . -62.87 -147.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.42 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 36.6 Cg_endo -65.51 126.68 16.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.137 . . . . 0.0 111.932 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -52.97 110.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.27 80.86 1.37 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.9 tp -143.05 86.81 1.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.17 0.51 . . . . 0.0 110.26 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 8.5 tmtt? -67.39 145.72 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.092 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 52.3 m-85 -122.77 151.41 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.715 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.552 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.16 14.62 21.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.28 0.562 . . . . 0.0 111.145 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -161.15 136.51 5.72 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.288 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.47 98.47 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.376 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.5 m -70.58 142.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.82 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.75 125.94 36.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.309 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.818 HD13 HG12 ' A' ' 26' ' ' ILE . 9.1 tp -124.08 129.01 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.593 ' N ' HD12 ' A' ' 83' ' ' LEU . 10.5 mtm105 -125.76 124.78 41.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.182 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.519 HD13 ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -137.0 134.36 19.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.631 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.646 ' HD2' HG22 ' A' ' 24' ' ' VAL . 52.0 Cg_exo -52.94 143.37 49.56 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.352 2.035 . . . . 0.0 112.152 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 25.6 p-80 -49.78 -47.32 51.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 9.2 m 49.22 76.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.213 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.32 92.83 0.28 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.71 41.13 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.94 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.08 -11.3 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.1 t -120.69 16.07 11.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.483 ' CZ2' ' HG3' ' A' ' 94' ' ' GLN . 2.4 p-90 -113.65 -35.75 5.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 0.7 OUTLIER -101.45 -23.25 14.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.254 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -98.81 -27.09 14.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -67.3 0.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.134 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.92 177.0 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 23.4 mt -91.53 129.45 42.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 36.7 Cg_exo -59.98 -22.31 68.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.662 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.48 -39.92 6.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.946 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 2.5 m-20 -55.3 124.96 56.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.899 ' O ' HG22 ' A' ' 106' ' ' VAL . 49.3 Cg_exo -55.24 -31.58 76.99 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.377 2.051 . . . . 0.0 112.2 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.8 -14.94 57.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.76 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -17.49 6.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.912 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.76 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 10.3 mt -158.08 -32.11 0.07 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.1 m -69.11 36.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -144.04 -42.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.746 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.42 -60.29 3.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 111.346 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 62.91 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 22.4 m -151.2 171.55 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 0.0 111.009 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 111' ' ' VAL . 11.1 p -109.24 120.11 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.34 105.1 7.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 83' ' ' LEU . 10.6 m -127.24 121.71 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.056 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 mt -89.46 140.33 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 81' ' ' VAL . 29.8 mm -127.22 121.93 58.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.73 24.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.251 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER 179.2 111.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.004 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.767 0.317 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 2' ' ' VAL . 14.4 p -149.66 36.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.047 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 46' ' ' CYS . 1.4 t -101.36 148.41 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 22' ' ' THR . . . -101.99 117.58 35.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.479 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.496 HG21 HD11 ' A' ' 55' ' ' LEU . 32.3 p -127.46 143.69 51.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 0.0 111.15 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -130.7 107.07 8.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.452 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 17.6 mtt180 -107.08 129.39 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.4 142.03 6.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.006 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 10' ' ' PHE . 25.9 mt -87.51 159.82 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.633 0.254 . . . . 0.0 110.433 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.5 m-85 -140.73 152.28 45.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -131.17 172.3 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.6 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -44.82 -28.89 0.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.49 -33.79 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -174.86 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.754 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.07 163.28 11.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.144 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 27' ' ' ILE . 2.9 t -119.92 150.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.369 0.604 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.535 HD11 ' HB1' ' A' ' 6' ' ' ALA . 22.3 tp -123.5 100.34 6.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.457 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.18 149.53 50.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 111.958 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.54 97.1 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.927 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.77 -26.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.742 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 9.5 tt0 -62.24 -41.42 98.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.599 HG23 ' CB ' ' A' ' 4' ' ' ALA . 2.8 p -106.34 -52.91 2.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.67 -35.18 2.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 45' ' ' VAL . 22.6 t -49.08 139.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.14 155.64 42.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 111.382 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.736 HG12 HD13 ' A' ' 83' ' ' LEU . 49.5 mt -136.98 113.54 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.568 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 16' ' ' VAL . 2.0 mp -92.64 136.01 26.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.002 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.736 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.7 mt -124.65 89.22 52.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.8 160.87 46.38 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.495 2.13 . . . . 0.0 112.218 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -57.12 113.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.65 -2.7 4.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.033 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -87.33 -29.43 21.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.997 0.399 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 39' ' ' GLN . 20.9 mt -122.78 137.16 27.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.609 ' HD3' HD21 ' A' ' 78' ' ' LEU . 34.3 Cg_exo -60.62 155.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.214 1.943 . . . . 0.0 112.149 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.59 140.43 58.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.39 21.71 78.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.429 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 38' ' ' GLU . 43.3 t -123.34 160.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 111.211 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.553 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.7 mt-10 -139.28 113.6 8.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.74 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' CG ' HD13 ' A' ' 33' ' ' ILE . 7.5 mm-40 -105.04 108.95 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.056 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -72.96 121.1 19.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 mt -128.18 130.16 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.452 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 31.8 p90 -144.75 142.2 29.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.904 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.488 ' CE1' HG23 ' A' ' 45' ' ' VAL . 2.3 p90 -145.08 164.36 31.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.088 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' CE ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -128.83 150.25 50.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.22 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 68' ' ' VAL . 78.6 t -144.07 140.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.487 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -168.01 148.89 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -36.49 82.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.621 ' OD2' HD12 ' A' ' 51' ' ' ILE . 0.5 OUTLIER -97.77 116.34 29.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.991 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' HA ' ' HG ' ' A' ' 67' ' ' LEU . 4.5 p30 -90.75 -50.61 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.472 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.6 t -74.18 -29.31 61.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.363 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.621 HD12 ' OD2' ' A' ' 48' ' ' ASP . 23.4 mt -78.51 -2.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.311 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.869 HD13 ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -144.93 121.82 6.24 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.848 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.869 ' HD2' HD13 ' A' ' 52' ' ' LEU . 38.4 Cg_endo -66.5 144.46 73.16 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.36 2.04 . . . . 0.0 112.216 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 52.8 Cg_exo -54.66 172.14 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.493 2.129 . . . . 0.0 112.457 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 5' ' ' THR . 1.8 tp -82.33 -41.8 19.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.813 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -149.56 82.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.725 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -56.05 5.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.034 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.02 -35.52 73.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -33.46 71.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.62 111.8 3.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.468 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.799 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.8 pp20? -123.79 138.59 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.309 . . . . 0.0 110.946 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 118.77 30.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -95.66 137.97 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.722 HD13 HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.39 -57.59 1.38 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.612 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -89.68 -177.56 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.679 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.3 -49.02 4.01 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.53 2.154 . . . . 0.0 111.771 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.711 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -151.15 84.82 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 45' ' ' VAL . 46.2 t -146.78 118.21 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.563 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.799 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -110.66 107.08 16.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.692 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -65.94 -168.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.151 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 42' ' ' TYR . . . -64.55 -155.98 0.17 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.615 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 51.1 Cg_exo -53.78 130.63 40.02 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.519 2.146 . . . . 0.0 112.201 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 111.05 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.816 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.21 84.04 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.719 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 33.0 tp -142.16 86.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 110.146 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.5 OUTLIER -57.53 164.51 1.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.117 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -148.13 146.98 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.609 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.67 15.32 22.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -160.07 136.53 6.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.52 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 26.5 Cg_exo -62.64 99.32 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.446 2.098 . . . . 0.0 112.457 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 115' ' ' ILE . 11.3 m -69.67 143.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.864 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.85 128.2 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.192 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 26' ' ' ILE . 7.1 tp -124.35 127.06 47.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.499 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.628 ' N ' HD12 ' A' ' 83' ' ' LEU . 25.1 mtt180 -114.93 133.78 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.956 HD12 HG11 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -129.7 107.6 17.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.894 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.08 131.23 43.62 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.388 2.059 . . . . 0.0 112.14 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -27.13 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.085 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 12.9 m 65.37 -166.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.25 94.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.38 49.57 3.25 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.668 2.245 . . . . 0.0 112.666 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 5.04 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.412 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.51 16.12 10.41 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.922 0.392 . . . . 0.0 111.845 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.664 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -115.0 -36.11 4.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.664 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 3.1 mt-30 -105.04 55.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.098 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -157.63 105.16 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.16 33.3 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.4 m -133.95 176.17 8.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.991 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.5 mt -91.31 131.67 35.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -77.23 -2.35 12.56 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.26 -18.44 6.72 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.806 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.409 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -66.26 116.57 34.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.59 0.233 . . . . 0.0 110.86 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.792 ' O ' HG22 ' A' ' 106' ' ' VAL . 71.6 Cg_exo -50.82 -30.61 30.33 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.472 2.115 . . . . 0.0 112.296 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.803 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 32.9 m-80 -60.59 -19.49 57.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.4 -18.71 19.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.735 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 20.2 mt -157.01 -29.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.85 36.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 118.62 47.41 0.41 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.566 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 103' ' ' ASN . . . -94.5 -34.49 12.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.46 82.47 2.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.04 139.24 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.706 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.956 HG11 HD12 ' A' ' 85' ' ' LEU . 14.9 p -99.57 108.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.466 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.09 104.91 11.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.1 m -122.68 131.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.241 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mt -103.35 134.81 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.899 ' O ' HG22 ' A' ' 81' ' ' VAL . 38.0 mm -122.13 122.9 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.559 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -124.01 26.47 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.956 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.453 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -173.11 101.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.16 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.718 ' CE1' HG21 ' A' ' 115' ' ' ILE . 2.3 m-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 2' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.573 0.225 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 1' ' ' THR . 7.0 p 50.93 162.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.988 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.942 HG13 HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.0 133.72 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -110.67 117.81 34.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.676 HG21 HD11 ' A' ' 55' ' ' LEU . 43.5 p -119.89 143.99 47.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -131.74 115.71 16.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.852 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -120.48 131.95 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.35 28.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.084 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -105.72 131.84 54.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.709 0.29 . . . . 0.0 110.453 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CG ' HD13 ' A' ' 28' ' ' ILE . 71.6 m-85 -112.48 153.26 27.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.047 0.451 . . . . 0.0 111.429 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.7 171.99 9.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -48.26 -27.48 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.33 -37.26 69.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.258 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 179.01 23.62 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.577 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.01 167.45 15.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.084 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG13 HG13 ' A' ' 27' ' ' ILE . 1.9 t -117.87 148.22 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.73 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.737 HD11 ' HB1' ' A' ' 6' ' ' ALA . 30.4 tp -123.3 100.2 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.203 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.91 145.51 50.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 111.854 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -110.84 97.19 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.249 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -50.48 -26.5 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.644 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -65.86 -30.5 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.36 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 4' ' ' ALA . 1.3 p -115.52 -53.0 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.726 0.298 . . . . 0.0 111.291 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.65 -38.04 1.97 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.788 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG22 ' HD2' ' A' ' 86' ' ' PRO . 60.6 t -48.56 144.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.0 p -149.73 152.06 34.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.465 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.664 HG12 HD13 ' A' ' 83' ' ' LEU . 41.6 mt -129.84 113.37 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.442 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.645 HG13 HG13 ' A' ' 16' ' ' VAL . 2.8 mt -97.3 123.24 49.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.058 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.68 ' CG2' ' HB3' ' A' ' 32' ' ' ALA . 1.5 mt -113.53 92.91 25.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.63 157.37 58.93 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.94 106.54 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 137.68 -7.23 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.106 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -81.72 -24.28 36.22 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.934 0.367 . . . . 0.0 111.234 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.642 HD13 ' CB ' ' A' ' 39' ' ' GLN . 35.4 mt -125.68 141.1 38.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.472 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' HD21 ' A' ' 78' ' ' LEU . 39.2 Cg_exo -59.92 155.45 44.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 37' ' ' VAL . 20.6 mt-10 -70.85 148.68 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.63 22.89 68.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.547 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 38' ' ' GLU . 38.5 t -130.31 160.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.027 0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' N ' HG12 ' A' ' 37' ' ' VAL . 20.1 mt-10 -131.55 113.96 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.996 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.693 ' HG2' HD11 ' A' ' 75' ' ' LEU . 23.6 tp60 -101.12 109.05 20.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.993 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.1 123.23 21.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.595 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.34 132.71 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.521 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.5 p90 -146.81 170.07 17.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.333 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.681 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.3 p90 -175.93 157.31 1.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.378 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' HD22 ' A' ' 55' ' ' LEU . 7.2 pttt -128.35 133.04 48.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.079 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.811 HG22 HG13 ' A' ' 68' ' ' VAL . 88.9 t -119.86 130.63 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.569 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.62 ' HB3' HG12 ' A' ' 3' ' ' VAL . 1.1 p -162.99 149.41 12.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.179 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -78.25 0.45 25.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.858 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.62 122.13 16.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.847 0.356 . . . . 0.0 111.128 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 57.5 t30 -90.71 -59.92 2.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.486 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -66.62 -26.06 66.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.499 ' O ' HG22 ' A' ' 51' ' ' ILE . 29.6 mm -74.68 -4.54 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.631 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.942 HD13 HG13 ' A' ' 3' ' ' VAL . 2.8 mt -143.37 147.42 40.02 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 60.2 Cg_endo -72.64 139.18 30.61 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.499 2.133 . . . . 0.0 112.297 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 50.7 Cg_exo -54.02 164.87 2.29 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.424 2.083 . . . . 0.0 112.33 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.676 HD11 HG21 ' A' ' 5' ' ' THR . 1.3 tp -92.88 -37.29 12.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.93 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -169.45 75.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.799 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -72.86 -31.84 65.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -69.31 -33.31 72.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -30.17 57.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.16 113.19 2.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.341 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 pm0 -101.06 141.39 34.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 3.0 m -123.01 99.15 6.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.236 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.34 138.32 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.444 HD13 HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.39 -57.62 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.996 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.544 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -91.49 -172.56 0.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.195 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 63.7 Cg_exo -40.19 -48.53 3.97 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.203 1.936 . . . . 0.0 111.815 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.68 ' O ' HD13 ' A' ' 67' ' ' LEU . 1.9 tm? -155.67 78.72 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.781 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.811 HG13 HG22 ' A' ' 45' ' ' VAL . 42.5 t -137.56 117.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.746 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.3 106.91 17.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.662 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -61.86 -171.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -63.87 -144.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.542 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 51.4 Cg_endo -68.97 130.59 20.61 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.475 2.116 . . . . 0.0 111.989 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -57.67 110.76 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.5 75.59 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.765 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.693 HD11 ' HG2' ' A' ' 39' ' ' GLN . 5.1 tp -138.76 84.62 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.578 ' HG3' ' CE1' ' A' ' 117' ' ' HIS . 1.5 tmtm? -63.23 151.88 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.236 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 31.4 m-85 -129.69 151.17 50.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.551 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.706 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -93.73 15.23 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 111.221 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -165.04 136.42 3.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.269 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.06 99.2 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 115' ' ' ILE . 6.6 m -69.76 152.8 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HB3' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -95.0 126.81 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 111.343 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.666 ' HG ' HD21 ' A' ' 85' ' ' LEU . 36.5 tp -124.21 116.94 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -106.92 131.01 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.159 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.94 HD12 HG11 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -130.54 123.29 20.26 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.765 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 24' ' ' VAL . 73.9 Cg_endo -75.08 120.1 5.9 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.34 2.027 . . . . 0.0 112.095 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.06 -30.19 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.1 m 60.54 65.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -114.32 110.83 47.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.815 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.98 39.04 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.653 2.235 . . . . 0.0 112.929 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 -9.13 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.597 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.6 t -122.7 16.07 10.25 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.456 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.8 p-90 -107.03 -38.4 6.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.071 0.462 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.456 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -95.61 56.4 1.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.811 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.16 -45.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.1 -46.58 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 62.3 m -54.9 176.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.122 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 11.8 mt -99.86 124.26 44.47 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.23 -26.97 72.22 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.469 2.112 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.55 -16.11 44.06 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.967 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 98' ' ' LEU . 5.8 t70 -80.62 137.95 51.13 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.808 0.304 . . . . 0.0 111.008 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.76 ' O ' HG22 ' A' ' 106' ' ' VAL . 53.2 Cg_endo -68.71 -24.39 35.0 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.751 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 96.9 m-20 -64.07 -17.01 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.79 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -20.21 15.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.85 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.79 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 16.6 mt -155.08 -26.82 0.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.9 m -66.78 36.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 123.06 36.4 0.66 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.531 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 103' ' ' ASN . . . -94.44 -33.32 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.113 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -134.03 51.48 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.87 141.05 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.94 HG11 HD12 ' A' ' 85' ' ' LEU . 13.8 p -85.38 107.61 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.391 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.71 104.92 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 111' ' ' VAL . 7.7 m -123.99 125.0 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.4 mt -90.07 145.13 25.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.3 mm -129.32 117.66 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.53 27.42 8.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.578 ' CE1' ' HG3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 177.98 106.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.815 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.796 0.332 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 2' ' ' VAL . 13.8 p -138.75 30.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.919 HG21 HD22 ' A' ' 52' ' ' LEU . 27.3 t -105.56 133.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.232 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.15 117.43 30.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.616 HG22 ' HG2' ' A' ' 44' ' ' LYS . 21.5 p -136.59 145.38 44.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.757 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -133.84 133.06 41.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 4.6 ttt180 -135.7 129.33 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.526 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.99 169.96 42.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.64 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 28.2 mt -104.49 137.88 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.719 ' CG ' HD12 ' A' ' 28' ' ' ILE . 87.9 m-85 -120.35 153.2 36.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -124.21 171.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 p -55.91 -22.38 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.266 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.61 -36.31 71.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 110.963 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.68 158.68 11.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.72 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.01 164.46 25.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.255 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 27' ' ' ILE . 3.1 t -122.26 152.38 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.757 HD11 ' CB ' ' A' ' 6' ' ' ALA . 28.5 tp -123.34 100.2 6.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.365 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.47 154.35 42.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 0.0 112.039 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.468 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 2.7 p -119.92 97.2 5.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.967 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.0 mm -49.4 -26.57 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.914 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.817 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -65.35 -55.69 16.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.343 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 4' ' ' ALA . 6.9 p -90.45 -52.88 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.296 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.43 -36.54 2.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.781 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 84' ' ' ARG . 21.5 t -48.66 143.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.655 0.264 . . . . 0.0 111.072 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -148.8 161.63 41.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.474 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.793 HG12 HD13 ' A' ' 83' ' ' LEU . 32.2 mt -137.38 113.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.774 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 16' ' ' VAL . 2.4 mp -92.39 128.24 44.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.851 0.358 . . . . 0.0 110.926 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.761 HG22 ' HB3' ' A' ' 32' ' ' ALA . 2.2 mt -112.75 94.49 28.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.435 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.21 157.68 48.46 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.661 2.241 . . . . 0.0 112.452 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -60.89 95.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.617 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 145.14 -11.3 1.82 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.877 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.761 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -72.94 -23.57 60.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.823 0.311 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.823 HD13 ' HB2' ' A' ' 39' ' ' GLN . 39.1 mt -124.5 141.85 38.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.449 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.728 ' HD3' HD21 ' A' ' 78' ' ' LEU . 32.0 Cg_exo -58.68 152.37 56.71 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.378 2.052 . . . . 0.0 112.371 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -67.93 152.55 45.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.96 23.34 56.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 35' ' ' GLU . 39.1 t -131.1 160.75 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 111.075 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.545 ' N ' HG12 ' A' ' 37' ' ' VAL . 14.9 mt-10 -132.62 113.94 13.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.121 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.823 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -99.01 113.37 25.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.037 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -74.4 115.66 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.577 HD11 ' HE1' ' A' ' 77' ' ' PHE . 29.4 mt -123.23 139.71 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.174 0.511 . . . . 0.0 111.255 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.432 ' CD1' HD22 ' A' ' 55' ' ' LEU . 21.0 p90 -153.06 162.61 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -166.36 158.89 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.923 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.664 ' HE2' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.92 149.33 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.509 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 68' ' ' VAL . 37.1 t -145.29 135.36 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.893 ' HB2' HG13 ' A' ' 3' ' ' VAL . 18.1 t -173.44 148.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.944 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -24.38 67.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.414 ' HB3' HG12 ' A' ' 51' ' ' ILE . 0.7 OUTLIER -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.978 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -90.7 -59.52 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.65 -25.28 6.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 51' ' ' ILE . 30.1 mm -71.07 -8.34 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.651 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.919 HD22 HG21 ' A' ' 3' ' ' VAL . 2.1 tp -173.68 106.4 0.3 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.221 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.84 172.02 3.23 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.597 2.198 . . . . 0.0 111.91 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.32 170.93 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.56 2.173 . . . . 0.0 112.226 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 42' ' ' TYR . 5.2 mp -59.89 -37.41 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.066 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -162.94 121.08 2.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -72.97 -37.13 67.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -73.14 -32.98 65.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -33.69 74.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 112.18 3.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.542 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.28 141.97 40.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.78 104.98 10.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.71 139.06 37.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.46 -57.6 1.37 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.284 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.704 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -94.37 -175.37 0.47 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.29 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.25 -46.97 5.49 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.169 1.912 . . . . 0.0 111.538 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.74 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.6 tm? -151.53 80.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.528 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.9 t -141.85 118.24 6.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.511 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -106.53 106.16 16.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.613 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB1' ' CE2' ' A' ' 118' ' ' PHE . . . -64.87 -178.67 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.08 -156.71 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.637 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 48.7 Cg_exo -55.4 129.26 34.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.534 2.156 . . . . 0.0 112.12 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -58.45 111.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.06 72.42 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.727 HD11 ' HG2' ' A' ' 39' ' ' GLN . 20.6 tp -137.96 83.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.262 0.553 . . . . 0.0 110.002 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 10.3 mttt -73.0 117.16 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.046 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' HE1' HD11 ' A' ' 41' ' ' ILE . 84.6 m-85 -90.76 154.24 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.728 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.36 17.17 16.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.43 136.68 4.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.69 94.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.537 2.158 . . . . 0.0 112.769 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.5 m -70.1 133.4 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.553 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 28.9 mt-10 -82.64 128.18 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 111.563 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.793 HD13 HG12 ' A' ' 26' ' ' ILE . 14.7 tp -124.19 128.72 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.164 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.609 ' O ' HG13 ' A' ' 24' ' ' VAL . 25.5 mtt180 -115.73 127.41 55.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 0.0 111.561 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.704 HD13 ' OG ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -143.64 162.25 42.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.18 120.07 6.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.391 2.061 . . . . 0.0 112.313 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.54 -54.52 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 65.0 m 56.14 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.85 74.87 0.72 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.265 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HA ' ' CD1' ' A' ' 93' ' ' TRP . 96.3 Cg_endo -86.46 35.48 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.753 2.302 . . . . 0.0 112.929 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -13.75 14.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.658 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -122.62 16.15 10.32 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.502 ' CD1' ' HA ' ' A' ' 90' ' ' PRO . 3.3 p-90 -106.83 -35.87 6.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.476 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 7.7 pt20 -102.02 35.02 2.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -156.81 28.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -177.2 -62.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.4 m -70.75 178.93 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 98' ' ' LEU . 11.1 mt -98.68 121.61 55.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.8 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.71 -35.54 97.75 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.457 2.105 . . . . 0.0 112.36 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.56 -17.42 66.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.889 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -81.56 138.57 47.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.976 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.753 ' O ' HG22 ' A' ' 106' ' ' VAL . 50.0 Cg_endo -68.4 -24.52 36.74 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.516 2.144 . . . . 0.0 112.327 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.411 ' HA ' HG22 ' A' ' 106' ' ' VAL . 66.6 m-20 -63.73 -16.77 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 110.568 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.773 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.68 -18.89 23.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.98 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.773 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 16.4 mt -156.75 -24.19 0.1 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 102' ' ' PRO . 8.0 m -67.99 36.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.5 -44.18 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.238 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.83 -68.28 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.402 . . . . 0.0 110.994 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.68 -67.91 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 66.1 m -121.34 167.85 12.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.095 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 85' ' ' LEU . 13.4 p -108.0 139.22 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.86 105.05 16.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.371 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 m -129.8 123.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.073 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mt -97.04 142.12 29.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.74 ' O ' HG22 ' A' ' 81' ' ' VAL . 39.5 mm -123.84 123.26 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.0 25.83 7.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.915 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.473 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -174.2 103.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.401 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.686 ' CE1' HG21 ' A' ' 115' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 2' ' ' VAL . 11.4 p -156.15 26.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.38 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -114.63 134.86 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.159 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.765 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -107.08 117.78 34.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.642 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 44' ' ' LYS . 71.2 p -118.35 143.25 46.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.0 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.69 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -135.56 109.35 8.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.664 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -117.68 129.85 55.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.07 154.26 22.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.709 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.28 144.14 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.935 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.971 ' CD2' HD12 ' A' ' 28' ' ' ILE . 29.4 m-85 -117.64 151.87 36.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.218 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -125.52 171.89 10.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.753 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -53.85 -23.65 13.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -42.48 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.186 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.04 130.47 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.771 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -151.93 -139.78 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.983 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 27' ' ' ILE . 2.1 t -151.52 148.3 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 111.684 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.69 HD11 ' HB1' ' A' ' 6' ' ' ALA . 15.3 tp -123.29 100.06 6.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.718 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.22 139.91 52.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.198 0.523 . . . . 0.0 112.391 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.745 ' OG ' ' HB1' ' A' ' 4' ' ' ALA . 32.1 t -111.54 96.54 6.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.905 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 20' ' ' ILE . 4.6 tp -58.85 -26.61 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.81 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.765 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -60.27 -28.8 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.313 . . . . 0.0 110.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.692 HG23 ' HB3' ' A' ' 4' ' ' ALA . 1.9 p -115.73 -52.81 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.777 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.56 -32.03 3.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.953 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 84' ' ' ARG . 21.7 t -59.6 147.07 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.826 0.346 . . . . 0.0 111.201 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.78 160.81 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.726 HG12 HD13 ' A' ' 83' ' ' LEU . 13.5 mt -135.58 113.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.75 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 16' ' ' VAL . 2.6 mt -96.38 114.72 33.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.971 HD12 ' CD2' ' A' ' 10' ' ' PHE . 4.3 mt -103.41 91.67 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.26 161.67 33.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.472 2.115 . . . . 0.0 112.506 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -59.49 111.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.36 -4.46 5.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.086 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.633 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -82.51 -22.51 35.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.782 0.291 . . . . 0.0 111.377 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.803 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.9 mt -131.58 139.17 34.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.768 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.79 ' HD3' HD21 ' A' ' 78' ' ' LEU . 35.1 Cg_exo -57.03 155.47 28.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.46 2.106 . . . . 0.0 112.221 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -68.82 148.96 49.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.81 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.51 24.86 69.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.3 t -130.02 160.69 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.7 mp0 -134.7 113.82 12.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.018 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.803 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.8 tp60 -100.64 109.59 21.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -69.71 118.43 12.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.65 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.4 mt -127.1 139.95 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB3' ' CG ' ' A' ' 7' ' ' ARG . 39.9 p90 -155.62 159.17 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.347 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -164.18 163.5 22.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.955 0.407 . . . . 0.0 111.592 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.553 ' HB3' HG22 ' A' ' 5' ' ' THR . 2.3 pttp -131.06 142.31 50.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.743 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 HG13 ' A' ' 68' ' ' VAL . 57.7 t -132.54 138.8 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.61 ' HB2' HG12 ' A' ' 3' ' ' VAL . 40.9 t -176.03 149.09 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -65.15 119.26 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.567 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 63.15 141.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -90.5 -30.19 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.32 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 p -54.78 -25.97 31.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.373 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 47' ' ' ARG . 33.1 mt -71.56 -9.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.385 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.17 128.75 0.22 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.576 0.227 . . . . 0.0 110.981 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 164.36 9.29 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.464 2.11 . . . . 0.0 112.279 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.7 172.26 14.78 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.623 2.215 . . . . 0.0 112.513 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 44' ' ' LYS . 1.2 mp -63.33 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.836 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.32 108.19 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -72.92 -42.58 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.19 -31.27 65.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -75.41 -28.89 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.03 113.02 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.291 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -100.68 105.04 16.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.351 . . . . 0.0 111.176 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.49 98.35 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.73 142.14 35.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.993 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.605 ' CB ' HD13 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -90.56 -173.19 0.37 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.187 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.3 Cg_exo -40.63 -43.71 4.39 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.209 1.94 . . . . 0.0 111.716 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -160.6 79.73 0.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.834 HG13 HG22 ' A' ' 45' ' ' VAL . 47.2 t -138.27 118.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.701 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' HB1' ' HG2' ' A' ' 61' ' ' GLU . . . -102.06 106.27 17.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.632 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -170.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -62.94 -154.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.431 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -62.56 123.4 12.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.462 2.108 . . . . 0.0 112.058 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -50.77 110.86 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.54 0.67 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 39' ' ' GLN . 11.9 tp -139.15 85.17 2.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.0 110.242 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 16.2 tttm -65.96 138.49 57.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.866 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 37.6 m-85 -115.89 151.94 34.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.572 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.79 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.27 14.04 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 111.032 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -160.77 136.42 5.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.131 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.86 98.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.391 2.061 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.1 m -66.92 156.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.884 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.35 106.62 17.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.354 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.726 HD13 HG12 ' A' ' 26' ' ' ILE . 22.9 tp -104.26 129.72 52.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.424 ' O ' HG13 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -121.82 134.04 54.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.605 HD13 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -143.67 136.46 13.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.3 135.16 18.18 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.488 2.125 . . . . 0.0 112.206 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -59.2 -26.41 64.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.56 31.2 18.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.783 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -153.32 100.6 2.63 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.07 50.65 3.56 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.651 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 -6.64 15.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.514 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -111.07 16.15 21.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.422 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.6 p-90 -113.26 -37.24 4.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.422 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.8 OUTLIER -107.79 162.68 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.993 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.88 -65.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -69.01 -61.35 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 m -84.04 -178.27 6.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.95 123.32 66.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.24 -46.35 25.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.533 2.155 . . . . 0.0 112.467 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.54 -21.12 79.21 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.992 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -69.15 121.74 82.92 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.584 0.231 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.796 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.8 Cg_exo -53.3 -29.87 49.45 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.414 2.076 . . . . 0.0 112.223 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.51 -19.72 57.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.761 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.35 -19.81 16.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.627 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.761 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 17.9 mt -155.79 -29.2 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.98 36.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 174.59 -32.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.71 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.05 18.46 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.587 0.232 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -70.46 -31.76 69.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 13.0 m -139.88 166.05 25.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 111' ' ' VAL . 14.8 p -101.34 120.22 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 105.15 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 113' ' ' VAL . 11.4 m -126.18 121.88 60.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.88 145.99 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.046 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.506 ' O ' HG22 ' A' ' 81' ' ' VAL . 33.9 mm -129.72 120.24 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -123.61 25.76 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.234 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.424 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.46 109.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 2' ' ' VAL . 12.6 p -154.12 51.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.024 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.836 HG12 ' SG ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -104.77 131.07 54.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.21 123.12 37.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.391 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 44' ' ' LYS . 30.9 p -133.52 143.57 48.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 0.0 111.199 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -143.13 124.05 14.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.899 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 15.0 mtm180 -127.09 129.52 48.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.574 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 148.03 11.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.042 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 10' ' ' PHE . 25.5 mt -87.68 155.39 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.519 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.801 ' CG ' HD12 ' A' ' 28' ' ' ILE . 56.5 m-85 -132.02 148.23 52.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.26 172.21 12.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.449 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -46.56 -27.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.438 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -50.23 -41.23 49.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.76 129.06 3.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.44 -158.86 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.016 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 27' ' ' ILE . 2.7 t -140.02 151.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.793 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.578 HD11 ' HB1' ' A' ' 6' ' ' ALA . 35.5 tp -123.22 100.18 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -122.47 154.03 38.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.469 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 p -126.09 97.15 4.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.101 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -53.33 -26.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.783 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -59.8 -24.86 64.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.44 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 4' ' ' ALA . 6.6 p -129.03 -52.79 1.21 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 111.306 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.96 -35.88 2.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.713 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.669 ' HB ' HG21 ' A' ' 45' ' ' VAL . 20.5 t -49.31 141.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.706 0.289 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.6 p -148.24 162.28 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.826 HG12 HD13 ' A' ' 83' ' ' LEU . 26.8 mt -135.52 113.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.889 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.1 mp -94.05 123.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.801 HD12 ' CG ' ' A' ' 10' ' ' PHE . 3.3 mt -112.62 91.37 17.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 157.54 57.55 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.136 . . . . 0.0 112.25 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 107.9 0.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 139.57 -9.39 3.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.051 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -77.85 -29.05 50.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.969 0.384 . . . . 0.0 111.202 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.49 HD13 ' CG ' ' A' ' 39' ' ' GLN . 20.4 mt -118.83 141.52 30.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.534 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.1 Cg_exo -64.79 155.32 68.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.454 2.102 . . . . 0.0 112.101 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.78 141.04 58.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.25 23.37 78.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.624 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 38' ' ' GLU . 43.4 t -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.274 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.552 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.8 mt-10 -137.46 113.73 10.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.706 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.49 ' CG ' HD13 ' A' ' 33' ' ' ILE . 4.6 mm-40 -105.74 108.95 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -70.54 122.57 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -130.74 129.9 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.544 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 39.4 p90 -145.72 158.41 43.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.935 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -163.09 160.81 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.733 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -131.7 123.67 28.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.96 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.669 HG21 ' HB ' ' A' ' 24' ' ' VAL . 38.7 t -107.15 129.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.836 ' SG ' HG12 ' A' ' 3' ' ' VAL . 1.9 m -143.12 149.0 37.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.942 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -29.4 58.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.795 ' HB2' HD23 ' A' ' 52' ' ' LEU . 43.6 m-20 -113.37 134.94 54.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' HA ' ' HG ' ' A' ' 67' ' ' LEU . 8.4 p-10 -90.98 -53.11 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.709 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -35.01 59.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.69 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.634 ' C ' HD22 ' A' ' 52' ' ' LEU . 3.3 mp -74.34 -2.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.352 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 48' ' ' ASP . 4.1 mm? -132.65 138.35 31.84 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.717 0.294 . . . . 0.0 110.998 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 84.4 Cg_endo -82.29 151.93 15.81 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.627 2.218 . . . . 0.0 112.616 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 31.7 Cg_exo -61.29 172.24 3.46 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.672 2.248 . . . . 0.0 112.342 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 5' ' ' THR . 3.8 tp -97.57 -67.04 0.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 0.0 110.869 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -145.71 65.91 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -37.04 85.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.23 -31.31 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -86.38 -23.76 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.94 113.34 1.55 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.271 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.474 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 5.8 tt0 -112.69 122.74 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 111.316 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.74 101.4 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.288 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.4 142.95 40.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -126.46 -57.61 1.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.116 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.616 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -96.93 -174.12 0.37 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 87.6 Cg_exo -43.28 -32.97 3.54 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.024 1.816 . . . . 0.0 111.52 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -165.49 84.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.851 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.65 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -145.91 117.64 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.099 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB1' ' CG ' ' A' ' 61' ' ' GLU . . . -104.31 106.15 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.532 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -66.93 -172.01 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.12 -158.25 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.5 Cg_endo -63.23 121.74 9.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.526 2.151 . . . . 0.0 111.994 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.69 110.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.72 72.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.471 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 31.4 tp -142.52 85.86 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 110.321 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 40.4 tttt -57.69 159.64 5.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.045 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.97 143.16 34.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.534 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.55 16.71 16.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.142 0.496 . . . . 0.0 111.228 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -161.53 136.45 5.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.333 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 27.3 Cg_exo -62.31 100.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.473 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 115' ' ' ILE . 16.3 m -72.94 139.42 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.759 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -85.57 124.57 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.269 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 26' ' ' ILE . 21.1 tp -124.21 128.26 48.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.439 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.666 ' O ' HG13 ' A' ' 24' ' ' VAL . 13.0 mtm-85 -119.06 127.17 53.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.821 ' O ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -141.99 131.47 12.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.31 143.94 73.88 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.398 2.066 . . . . 0.0 112.092 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -59.13 -46.35 88.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.3 m 57.76 176.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.6 t70 58.28 100.58 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.08 41.02 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.672 2.248 . . . . 0.0 112.87 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -108.94 -3.75 17.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.564 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -122.62 16.07 10.32 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.459 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.7 p-90 -110.26 -36.68 5.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 6.3 pt20 -106.85 51.43 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.974 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -21.97 13.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -171.58 -38.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 m -47.89 171.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 9.9 mt -87.66 123.5 69.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 23.2 Cg_exo -63.93 -33.81 62.11 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.542 2.162 . . . . 0.0 112.223 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.05 76.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.898 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -70.9 121.52 84.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.688 0.244 . . . . 0.0 110.776 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.766 ' O ' HG22 ' A' ' 106' ' ' VAL . 27.9 Cg_endo -62.35 -27.5 77.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.348 2.032 . . . . 0.0 112.107 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.35 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.774 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.38 -18.35 10.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.958 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.774 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 13.4 mt -156.7 -28.92 0.09 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.7 m -67.44 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.64 -38.42 0.04 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.61 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.0 18.46 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.702 0.287 . . . . 0.0 111.512 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.48 -63.11 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.5 p -93.49 149.32 21.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 85' ' ' LEU . 11.8 p -109.83 119.09 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.87 105.05 12.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.281 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 83' ' ' LEU . 4.6 m -121.02 129.22 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.042 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mt -96.8 132.06 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.066 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.86 ' O ' HG22 ' A' ' 81' ' ' VAL . 42.9 mm -118.77 118.79 59.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -119.93 25.65 9.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.39 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -178.79 115.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.26 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.616 ' CE1' HG21 ' A' ' 115' ' ' ILE . 1.2 m-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.684 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.628 0.252 . . . . 0.0 111.129 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 1' ' ' THR . 7.3 p 52.14 160.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.983 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.638 HG12 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -131.9 147.75 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.567 ' HB3' HG23 ' A' ' 22' ' ' THR . . . -107.37 117.82 35.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.802 HG21 HD11 ' A' ' 55' ' ' LEU . 65.4 p -123.59 143.76 50.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -131.93 131.02 42.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.1 mtt-85 -128.51 138.69 52.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.33 143.83 8.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.662 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -89.11 138.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.644 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.64 ' CG ' HD12 ' A' ' 28' ' ' ILE . 76.1 m-85 -129.35 148.97 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.334 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.01 172.08 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.748 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -45.18 -28.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -57.32 -31.14 65.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.89 168.84 16.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.823 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.62 148.09 5.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.085 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 27' ' ' ILE . 4.0 t -110.66 152.76 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.4 0.619 . . . . 0.0 111.85 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 32.4 tp -123.53 100.23 6.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.21 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 153.65 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.15 0.5 . . . . 0.0 111.889 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.08 96.92 4.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.971 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -55.42 -26.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.573 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 26.8 mt-10 -64.94 -26.11 68.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 4' ' ' ALA . 2.3 p -121.32 -52.95 2.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.685 0.279 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.09 -41.39 1.51 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.775 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 84' ' ' ARG . 42.0 t -50.16 144.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.676 0.274 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.5 t -149.89 167.74 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.423 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.7 HG12 HD13 ' A' ' 83' ' ' LEU . 44.2 mt -142.54 113.45 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 ' HE ' ' A' ' 84' ' ' ARG . 4.4 mp -93.23 120.49 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.827 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.64 HD12 ' CG ' ' A' ' 10' ' ' PHE . 5.2 mt -105.98 91.84 5.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.48 159.92 38.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.512 2.141 . . . . 0.0 112.475 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.38 104.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.07 -9.81 3.59 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.215 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -75.66 -28.31 58.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.942 0.371 . . . . 0.0 111.308 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.859 HD13 ' HB2' ' A' ' 39' ' ' GLN . 33.7 mt -119.69 142.75 33.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.373 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.2 Cg_exo -60.07 152.9 62.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.24 1.96 . . . . 0.0 112.178 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.0 mt-10 -68.63 150.1 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 24.97 68.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.462 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.1 t -130.58 160.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 111.242 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 37' ' ' VAL . 55.1 mt-10 -133.09 113.9 13.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.998 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.859 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -102.76 109.24 20.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -74.53 122.36 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.08 141.51 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.149 0.5 . . . . 0.0 111.584 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' A' ' 72' ' ' PRO . 14.0 p90 -153.5 146.87 24.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.781 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CE1' ' HG ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -147.98 159.0 44.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.063 0.458 . . . . 0.0 112.031 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' CB ' HG22 ' A' ' 5' ' ' THR . 2.1 tmmm? -116.0 147.83 40.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.468 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.522 HG22 HG13 ' A' ' 68' ' ' VAL . 25.1 t -145.23 140.81 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.045 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.638 ' HB2' HG12 ' A' ' 3' ' ' VAL . 26.7 t -176.64 149.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.46 2.4 25.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.723 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.55 115.78 7.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -90.62 -42.92 10.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -52.82 -24.4 8.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.605 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 51' ' ' ILE . 32.5 mm -65.99 -13.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.539 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.769 HD23 ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 178.21 142.43 0.28 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.026 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD2' HD23 ' A' ' 52' ' ' LEU . 34.5 Cg_endo -64.68 172.72 6.48 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.491 2.127 . . . . 0.0 112.274 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.99 172.14 3.24 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.57 2.18 . . . . 0.0 112.348 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.802 HD11 HG21 ' A' ' 5' ' ' THR . 1.5 tp -60.71 -74.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.029 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.67 107.56 8.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.026 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -72.95 -35.72 67.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -64.9 -36.81 85.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -72.74 -27.85 62.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.89 111.36 3.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 124.2 51.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -105.54 100.37 9.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.681 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.23 136.1 36.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.506 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.35 -57.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.455 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.746 ' CB ' HD13 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -85.16 -177.95 1.06 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 75.8 Cg_exo -41.32 -47.07 5.6 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -153.58 84.49 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.427 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.4 t -146.04 118.1 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.597 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.68 106.21 16.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.564 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.07 -168.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.17 -137.86 0.93 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 32.8 Cg_endo -64.17 125.95 16.18 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.441 2.094 . . . . 0.0 112.073 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -56.33 110.85 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.14 83.35 1.58 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.813 HD11 ' HG2' ' A' ' 39' ' ' GLN . 16.6 tp -142.2 86.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.189 0.519 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 17.3 tttp -57.98 159.9 5.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.124 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 24.4 m-85 -141.49 147.91 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.655 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -98.92 17.62 19.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.26 0.552 . . . . 0.0 111.19 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 2.5 tttm -164.81 136.55 3.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.577 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 27.4 Cg_exo -62.0 97.96 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 0.0 112.472 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.1 m -70.5 137.69 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE1' HD13 ' A' ' 27' ' ' ILE . 8.2 tm-20 -81.3 119.25 23.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.258 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.7 HD13 HG12 ' A' ' 26' ' ' ILE . 13.6 tp -124.32 119.18 28.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HE ' HD11 ' A' ' 27' ' ' ILE . 6.2 ptt85 -113.99 133.31 55.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.746 HD13 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -137.33 112.68 9.37 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.927 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.29 120.25 8.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.293 1.995 . . . . 0.0 111.918 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.68 -54.67 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.148 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.86 -177.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.99 167.56 12.75 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.94 41.73 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.843 2.362 . . . . 0.0 112.944 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.52 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.698 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -99.36 3.54 46.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.565 0.698 . . . . 0.0 111.081 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.627 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 1.8 p-90 -56.0 -31.79 63.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.845 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.627 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 4.5 mt-30 -95.44 138.35 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.612 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -177.71 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.484 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -163.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.3 m 71.17 -167.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 8.9 mt -99.91 117.99 62.47 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.673 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 3.6 Cg_exo -74.96 -6.63 18.32 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.64 2.227 . . . . 0.0 111.913 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.84 -43.17 35.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.981 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 m-20 -85.38 111.48 37.04 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.837 0.319 . . . . 0.0 110.807 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.4 Cg_exo -60.25 -27.21 84.42 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.276 1.984 . . . . 0.0 111.946 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.506 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 11.1 p30 -78.79 4.64 13.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -50.54 -100.42 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -80.15 -12.5 59.65 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 27.8 m -62.65 27.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.13 -3.86 2.42 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.164 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.55 17.66 12.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.593 0.235 . . . . 0.0 111.386 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.44 -75.43 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.724 0.297 . . . . 0.0 111.04 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.3 m -101.13 133.69 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 85' ' ' LEU . 14.3 p -105.39 106.95 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.469 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.64 104.87 11.46 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 111' ' ' VAL . 10.1 m -122.01 131.65 72.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.2 mt -95.84 146.85 24.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.661 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 81' ' ' VAL . 43.5 mm -128.49 121.64 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.23 25.44 7.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.081 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.22 109.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.845 0.355 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -129.26 132.08 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.897 HG13 ' HB2' ' A' ' 46' ' ' CYS . 25.7 t -142.65 141.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.71 117.64 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.176 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.789 HG22 ' CB ' ' A' ' 44' ' ' LYS . 30.3 p -136.12 143.91 44.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 111.107 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.36 132.72 24.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.984 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.5 mtt180 -128.23 135.25 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.32 156.95 27.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.9 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.502 HG21 ' HG2' ' A' ' 38' ' ' GLU . 29.7 mt -91.39 156.26 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD1' HG13 ' A' ' 28' ' ' ILE . 25.8 m-85 -131.46 170.59 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.36 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -152.14 171.94 17.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.915 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.7 p -58.69 -21.09 53.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -54.87 -51.25 66.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.46 128.64 3.76 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.733 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.16 -172.73 25.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.02 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 27' ' ' ILE . 2.5 t -141.78 150.29 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 111.745 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 43' ' ' PHE . 23.5 tp -123.24 100.1 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.324 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -125.24 154.52 41.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 111.786 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -127.11 97.14 4.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.1 mm -52.62 -26.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.647 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 14.9 mt-10 -63.39 -21.22 66.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.305 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -126.93 -52.93 1.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.788 0.327 . . . . 0.0 111.264 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.6 -33.82 2.9 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.696 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.751 ' HB ' HG21 ' A' ' 45' ' ' VAL . 58.1 t -55.67 145.4 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 10.8 t -148.7 164.41 34.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.604 HG12 HD13 ' A' ' 83' ' ' LEU . 21.0 mt -139.25 113.81 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.933 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.0 mp -94.72 135.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.638 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -107.67 97.08 18.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.712 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 81' ' ' VAL . 27.5 Cg_endo -62.49 145.19 95.52 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.288 1.992 . . . . 0.0 112.115 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.1 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.202 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.18 4.27 5.52 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.367 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.61 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -81.7 -26.41 34.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.108 0.454 . . . . 0.0 111.201 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.965 HD13 ' HB2' ' A' ' 39' ' ' GLN . 26.2 mt -121.81 141.49 34.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' HD21 ' A' ' 78' ' ' LEU . 42.1 Cg_exo -56.69 143.87 88.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.333 2.022 . . . . 0.0 112.218 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.1 mt-10 -61.79 151.35 34.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.08 25.54 62.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 34' ' ' PRO . 40.5 t -129.47 160.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.268 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -129.02 113.93 15.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.797 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.965 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.35 109.23 21.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 14.2 tt0 -72.29 118.96 15.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.6 mt -127.35 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.014 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 34.3 p90 -152.83 173.46 15.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.43 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -175.05 163.51 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.885 0.374 . . . . 0.0 111.535 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.789 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER -135.62 117.63 15.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.045 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.751 HG21 ' HB ' ' A' ' 24' ' ' VAL . 33.1 t -106.87 141.82 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.897 ' HB2' HG13 ' A' ' 3' ' ' VAL . 52.9 t -178.1 149.09 0.53 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 49.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.767 ' CG ' HD13 ' A' ' 51' ' ' ILE . 11.9 m-20 -167.85 107.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.673 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.666 ' ND2' HD23 ' A' ' 67' ' ' LEU . 40.9 t-20 -90.6 -55.06 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.637 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.7 p -64.31 -34.41 78.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.767 HD13 ' CG ' ' A' ' 48' ' ' ASP . 4.3 mp -75.39 -2.49 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.498 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.738 ' HG ' HG21 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -169.36 116.49 0.54 Allowed Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.617 0.246 . . . . 0.0 111.066 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.96 169.05 21.17 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.472 2.115 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.62 172.32 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.588 2.192 . . . . 0.0 112.265 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -62.68 -65.62 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.839 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.85 121.12 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -33.32 65.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -62.44 -31.39 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -81.39 -30.97 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 110.91 3.14 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.434 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.797 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -105.83 111.38 24.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 m -85.71 105.26 16.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.59 139.64 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.43 -57.69 1.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -95.18 -174.53 0.4 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.332 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.8 Cg_exo -40.46 -46.99 4.45 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.228 1.952 . . . . 0.0 111.843 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.719 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.7 tm? -153.89 82.23 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.748 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -143.15 118.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.476 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.797 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -105.87 106.25 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.614 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -165.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.028 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.53 -146.71 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 41.6 Cg_endo -67.38 134.15 32.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.451 2.101 . . . . 0.0 112.191 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.99 111.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.86 84.0 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.1 tp -144.44 87.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 77.4 tttt -62.7 159.78 15.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.956 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 29.0 m-85 -138.6 155.79 48.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.66 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.706 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -99.22 14.33 29.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.367 0.603 . . . . 0.0 110.96 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -166.62 136.51 2.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.263 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 32.7 Cg_exo -61.58 95.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.413 2.075 . . . . 0.0 112.414 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 115' ' ' ILE . 9.2 m -61.38 166.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.516 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 126.12 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 111.493 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 26' ' ' ILE . 34.4 tp -124.24 128.01 48.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.098 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 24' ' ' VAL . 50.4 mtp180 -120.45 126.1 49.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.788 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.647 ' O ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.58 163.31 37.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.477 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.52 120.07 7.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.447 2.098 . . . . 0.0 112.202 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -82.32 -48.55 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.19 48.09 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -112.89 81.91 4.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.45 47.24 2.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.73 2.287 . . . . 0.0 112.611 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -108.93 13.09 24.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 t -119.58 15.96 12.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.46 . . . . 0.0 111.812 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.579 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.1 p-90 -121.01 -37.87 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.579 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 49.2 mt-30 -103.53 68.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -156.22 -45.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -46.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.25 -178.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 28.8 mt -98.64 131.46 25.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 33.0 Cg_exo -59.35 -23.59 70.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.421 2.081 . . . . 0.0 112.316 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.87 -25.21 32.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.832 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 8.3 m-20 -61.3 113.56 8.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.562 0.181 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.795 ' O ' HG22 ' A' ' 106' ' ' VAL . 72.7 Cg_exo -50.09 -30.72 25.87 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.378 2.052 . . . . 0.0 112.273 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.11 -19.89 62.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.361 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.778 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.97 -20.45 16.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.824 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.778 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 19.0 mt -155.51 -26.57 0.11 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.5 m -68.18 36.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -155.17 -42.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.584 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.47 18.69 10.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.655 0.264 . . . . 0.0 111.455 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -65.84 -44.57 85.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.63 149.03 21.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.94 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 85' ' ' LEU . 14.3 p -106.32 109.83 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.68 105.03 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 83' ' ' LEU . 12.1 m -122.07 122.05 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.4 mt -87.5 137.67 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.1 mm -122.43 116.85 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.348 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 27.03 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.195 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.87 114.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.859 0.361 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 3' ' ' VAL . 13.2 p -105.45 159.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.806 HG12 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -126.71 142.41 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.144 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -106.76 117.73 34.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.613 HG22 ' CB ' ' A' ' 44' ' ' LYS . 65.3 p -122.34 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.685 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -127.57 121.77 31.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.6 mtt180 -120.97 131.52 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.22 147.82 11.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.797 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 10' ' ' PHE . 26.2 mt -90.53 159.64 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.685 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.721 ' CG ' HD12 ' A' ' 28' ' ' ILE . 79.9 m-85 -141.49 154.87 45.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.421 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -128.4 172.15 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -51.69 -24.5 5.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -55.19 -38.9 68.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.215 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 137.84 9.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.67 171.83 40.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.198 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -117.49 150.29 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.156 0.503 . . . . 0.0 111.548 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' SER . 32.9 tp -123.21 100.16 6.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.12 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.44 151.0 45.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.108 0.48 . . . . 0.0 111.835 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 12.6 p -121.23 97.05 5.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.023 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mm -52.53 -26.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.536 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.5 mm-40 -61.86 -29.6 70.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.083 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -119.66 -52.93 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.054 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.5 -38.02 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.694 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.603 ' CG2' HG11 ' A' ' 45' ' ' VAL . 24.2 t -49.48 144.47 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.73 0.3 . . . . 0.0 111.144 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.74 158.37 44.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.627 HG12 HD13 ' A' ' 83' ' ' LEU . 38.1 mt -132.39 113.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.446 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.508 HG13 HG13 ' A' ' 16' ' ' VAL . 3.6 mt -94.64 118.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 0.0 111.276 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.721 HD12 ' CG ' ' A' ' 10' ' ' PHE . 3.9 mt -105.97 92.98 7.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 148.39 92.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.393 2.062 . . . . 0.0 112.167 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -53.34 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.7 -19.54 0.78 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.946 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -66.29 -36.8 83.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.841 0.321 . . . . 0.0 111.363 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.917 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.1 mt -110.97 143.94 29.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.589 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -62.85 155.18 61.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.439 2.093 . . . . 0.0 112.295 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.5 mp0 -69.41 153.81 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.17 24.46 58.73 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 35' ' ' GLU . 44.8 t -130.08 160.87 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' N ' HG12 ' A' ' 37' ' ' VAL . 32.7 mt-10 -132.87 113.64 13.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.854 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.917 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -106.08 109.06 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.02 128.56 36.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -134.87 140.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.275 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 28.0 p90 -154.22 149.66 27.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -151.53 167.01 29.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.056 0.455 . . . . 0.0 111.662 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.613 ' CB ' HG22 ' A' ' 5' ' ' THR . 2.9 ptmt -127.52 146.12 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.542 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.603 HG11 ' CG2' ' A' ' 24' ' ' VAL . 45.3 t -138.78 136.91 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.806 ' HB2' HG12 ' A' ' 3' ' ' VAL . 47.1 t -162.02 148.75 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.845 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -34.54 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' CB ' HG12 ' A' ' 51' ' ' ILE . 10.2 m-20 -122.56 144.36 49.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.499 ' HB3' HD23 ' A' ' 67' ' ' LEU . 25.8 p30 -90.65 -26.41 19.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -70.52 -23.01 62.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.22 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.4 HG12 ' CB ' ' A' ' 48' ' ' ASP . 36.6 mm -60.93 -20.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 tp 176.81 135.47 0.2 Allowed Pre-proline 0 C--O 1.232 0.15 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.64 173.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.425 2.083 . . . . 0.0 112.297 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.86 172.29 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.573 HD12 ' H ' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -100.58 -29.25 12.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.921 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.573 ' H ' HD12 ' A' ' 55' ' ' LEU . 11.4 m-20 -74.85 85.21 2.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -37.61 66.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.32 -56.75 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 56' ' ' ASP . 3.2 mppt? -64.06 -76.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.074 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . 169.62 -97.7 0.13 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.133 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 165.4 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.864 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -99.93 97.5 8.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.515 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.76 140.24 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.43 -57.58 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.931 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.1 p -91.28 -173.85 0.4 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.249 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.8 Cg_exo -41.63 -51.27 4.41 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.19 1.926 . . . . 0.0 111.861 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.705 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -151.08 85.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 92.7 t -147.09 118.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.216 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -107.22 109.33 21.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.785 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -62.26 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 42' ' ' TYR . . . -78.26 -144.33 2.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.76 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 59.8 Cg_exo -51.84 123.14 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.596 2.197 . . . . 0.0 112.186 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -55.38 110.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.63 83.76 1.75 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 15.1 tp -138.43 85.01 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.199 0.524 . . . . 0.0 110.084 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 85.5 tttt -58.03 161.98 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.167 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 17.2 m-85 -143.38 148.43 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.576 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.485 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -97.06 18.26 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.263 0.554 . . . . 0.0 110.941 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -163.86 136.39 3.96 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.409 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 20.8 Cg_exo -65.61 101.09 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.496 2.131 . . . . 0.0 112.467 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 115' ' ' ILE . 7.7 m -68.53 153.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.698 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 108.66 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.627 HD13 HG12 ' A' ' 26' ' ' ILE . 5.0 tp -105.02 121.32 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.577 ' N ' HD12 ' A' ' 83' ' ' LEU . 23.8 mtm180 -123.87 139.83 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.19 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -129.42 144.77 54.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.613 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.15 134.74 17.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.478 2.119 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -49.49 -47.05 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.46 -81.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.878 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.48 162.51 46.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.74 32.84 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.966 2.444 . . . . 0.0 112.848 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.01 1.17 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.402 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -122.67 16.07 10.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.822 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 10.8 p-90 -117.69 -47.86 2.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.545 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 5.1 pt20 -77.28 64.79 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.33 -46.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -32.73 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.0 m -85.14 172.12 11.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 20.9 mt -99.9 125.17 41.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 21.6 Cg_exo -65.09 -15.48 50.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.541 2.161 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.77 -22.22 31.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.8 t0 -62.19 136.45 95.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.649 0.262 . . . . 0.0 110.723 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.462 ' O ' HG21 ' A' ' 106' ' ' VAL . 55.6 Cg_endo -69.84 -20.73 34.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.42 2.08 . . . . 0.0 112.274 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 87.9 m-20 -91.61 17.31 8.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.921 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.606 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.68 -113.44 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.993 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.606 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -48.98 -23.14 1.02 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 11.8 m -71.29 36.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 0.0 111.33 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 145.49 40.54 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.77 -74.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.796 0.332 . . . . 0.0 111.362 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -148.78 32.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.06 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.3 p -80.97 150.06 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.734 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 111' ' ' VAL . 14.0 p -84.81 114.45 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.265 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.68 105.08 12.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.195 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.4 m -123.91 124.85 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.57 143.26 26.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 81' ' ' VAL . 37.6 mm -129.71 120.1 49.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.24 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -123.27 25.74 8.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.21 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.418 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.43 108.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.936 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.573 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.063 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.27 143.16 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.052 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.869 HG11 HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -149.73 156.54 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -117.41 117.53 29.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.477 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 1.035 HG21 HD13 ' A' ' 55' ' ' LEU . 45.3 p -123.11 143.76 49.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 111.081 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.554 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -132.78 130.55 40.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.412 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.5 mtp85 -129.34 132.18 47.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.29 149.71 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.91 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.579 HG21 ' HB3' ' A' ' 38' ' ' GLU . 20.1 mt -88.26 158.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.599 0.237 . . . . 0.0 110.636 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.566 ' CG ' HD13 ' A' ' 28' ' ' ILE . 49.8 m-85 -138.64 164.03 30.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.971 0.415 . . . . 0.0 111.438 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.73 172.13 14.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -53.05 -22.7 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.122 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -51.28 -35.23 36.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 28' ' ' ILE . . . 100.29 112.8 3.47 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.698 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.852 ' O ' HD12 ' A' ' 28' ' ' ILE . . . -157.36 144.2 10.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.054 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 17' ' ' LEU . 2.2 p -102.89 157.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.0 111.814 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 43' ' ' PHE . 15.2 tp -119.98 99.9 6.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.462 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -115.51 145.6 42.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.7 m -121.82 96.68 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.258 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 20' ' ' ILE . 3.4 tp -60.3 -26.6 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.4 mt-10 -62.68 -26.38 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.674 HG21 ' HB ' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -115.71 -52.9 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.13 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.69 6.56 9.35 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.216 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 45' ' ' VAL . 38.4 t -106.02 141.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.856 0.328 . . . . 0.0 110.822 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 92.5 p -149.75 162.52 40.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.917 0.389 . . . . 0.0 111.529 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.758 HG12 HD13 ' A' ' 83' ' ' LEU . 26.2 mt -130.79 113.46 24.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.188 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.5 mp -91.6 116.29 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 15' ' ' GLY . 1.2 mt -102.94 87.0 1.11 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.682 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 158.73 40.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.546 2.164 . . . . 0.0 112.328 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.14 108.57 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.23 -9.94 3.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.904 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.639 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -84.09 -33.13 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.874 0.337 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 39' ' ' GLN . 36.7 mt -119.91 143.75 35.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.344 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD3' HD21 ' A' ' 78' ' ' LEU . 15.1 Cg_exo -68.09 154.3 72.85 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.364 2.043 . . . . 0.0 112.247 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.1 tt0 -66.17 154.22 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.78 62.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.567 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 38' ' ' GLU . 41.2 t -128.1 160.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.059 0.456 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 9' ' ' ILE . 43.1 mt-10 -134.35 113.9 12.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.967 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.816 ' HB2' HD13 ' A' ' 33' ' ' ILE . 6.4 tp60 -101.71 109.01 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.061 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.91 116.7 12.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.0 mt -127.21 139.39 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 111.263 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' GLY . 29.9 p90 -153.06 162.82 40.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.203 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -167.28 168.43 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.873 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.638 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -133.06 132.69 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.721 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.68 HG22 HG13 ' A' ' 68' ' ' VAL . 21.7 t -126.1 148.29 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.95 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 67' ' ' LEU . 17.2 p -143.71 148.96 36.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.014 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -76.75 -31.02 56.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.26 134.2 54.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.743 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -66.01 -9.29 29.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.766 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.7 m -50.44 -23.07 2.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.739 0.304 . . . . 0.0 111.392 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.869 HG21 HG11 ' A' ' 3' ' ' VAL . 18.7 mm -75.91 -1.41 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.696 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.553 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 12.84 -74.86 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 52' ' ' LEU . 1.2 Cg_endo -44.56 125.99 6.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.631 2.221 . . . . 0.0 112.573 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 9.8 Cg_exo -71.42 172.38 14.31 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.831 2.354 . . . . 0.0 112.475 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.035 HD13 HG21 ' A' ' 5' ' ' THR . 17.5 tp -73.89 -30.45 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.46 92.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -41.67 63.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.225 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -62.82 -24.41 67.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.48 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -93.96 19.92 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.519 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 107.97 0.43 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.46 105.07 13.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.934 0.397 . . . . 0.0 111.209 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.22 100.77 11.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.67 139.18 37.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.492 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.35 -57.63 1.38 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.639 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.57 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -91.58 -171.32 0.27 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.974 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 47.5 Cg_exo -38.4 -48.42 2.46 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.324 2.016 . . . . 0.0 112.116 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.717 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -158.66 66.72 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 111.054 178.246 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG13 HG22 ' A' ' 45' ' ' VAL . 99.0 t -121.58 118.35 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.575 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.5 106.24 17.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.575 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -167.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.998 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -68.38 -152.35 0.41 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.655 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 71.4 Cg_exo -50.71 160.57 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.563 2.175 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -84.51 111.0 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.66 78.98 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.899 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 8.3 tp -135.9 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.28 0.562 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.0 ttpt -73.0 149.69 43.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.909 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 73.5 m-85 -122.59 166.97 13.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.446 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.98 16.39 19.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.448 0.642 . . . . 0.0 110.824 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' A' ' 80' ' ' PRO . 1.8 tttm -168.75 136.54 1.66 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.185 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.426 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 31.5 Cg_exo -59.55 107.24 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.438 2.092 . . . . 0.0 112.579 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.427 HG22 ' HB ' ' A' ' 115' ' ' ILE . 10.8 m -70.71 140.64 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -87.51 108.35 19.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.564 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.758 HD13 HG12 ' A' ' 26' ' ' ILE . 7.1 tp -105.77 129.71 53.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.658 ' N ' HD12 ' A' ' 83' ' ' LEU . 4.9 mmt180 -123.32 132.23 53.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 111.613 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.819 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.63 156.07 59.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.481 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 24' ' ' VAL . 41.5 Cg_endo -67.44 123.9 11.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 49.9 p-80 -71.66 -46.92 57.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 85.8 m 57.61 178.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.993 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.38 87.94 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.53 46.86 2.18 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.814 2.342 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -109.06 5.09 23.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.665 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -122.56 16.17 10.37 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.922 0.391 . . . . 0.0 111.931 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.492 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 4.6 p-90 -110.6 -37.26 5.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 5.5 pt20 -101.13 61.0 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.097 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -106.48 -37.05 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -86.47 -179.05 6.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 9.6 mt -100.05 120.54 56.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 25.4 Cg_exo -62.76 -21.32 72.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.605 2.203 . . . . 0.0 112.669 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.46 -5.42 54.2 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.116 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.63 123.93 58.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.896 0.348 . . . . 0.0 111.004 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.818 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.58 -28.71 56.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.387 2.058 . . . . 0.0 112.335 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -61.72 -18.38 59.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.751 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.63 -19.3 15.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.62 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.751 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 15.6 mt -156.22 -30.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.0 m -68.05 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 177.41 -30.49 0.07 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.851 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 18.58 6.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -57.93 -30.27 65.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.95 170.74 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.74 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.819 HG11 HD12 ' A' ' 85' ' ' LEU . 11.7 p -103.7 105.88 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.287 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 105.09 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.2 m -122.82 121.53 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.255 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.99 143.8 26.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.427 ' HB ' HG22 ' A' ' 81' ' ' VAL . 28.5 mm -129.89 116.72 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.0 0.429 . . . . 0.0 111.544 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.84 27.48 8.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.974 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.79 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.784 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 2' ' ' VAL . 11.4 p -139.93 124.16 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.746 HG13 ' HB2' ' A' ' 46' ' ' CYS . 2.6 t -152.2 145.24 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.461 ' CB ' HG23 ' A' ' 22' ' ' THR . . . -94.13 117.54 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.047 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.661 HG21 HD11 ' A' ' 55' ' ' LEU . 38.9 p -125.28 143.01 51.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.945 0.402 . . . . 0.0 111.39 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -136.14 106.97 6.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.3 mtt180 -113.52 131.88 55.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 140.67 6.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.786 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 38' ' ' GLU . 13.4 mt -87.09 135.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.608 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.808 ' CG ' HD12 ' A' ' 28' ' ' ILE . 83.1 m-85 -116.71 160.98 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.286 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -146.48 172.31 13.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.592 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -44.44 -27.43 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -33.93 56.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 111.185 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 154.27 29.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.9 175.06 39.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.459 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -126.96 150.86 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.471 . . . . 0.0 111.415 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD11 ' HB1' ' A' ' 6' ' ' ALA . 49.4 tp -123.22 100.16 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.472 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -126.37 152.19 46.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.044 0.45 . . . . 0.0 111.745 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.76 97.05 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.1 -26.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.19 -26.69 67.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.235 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' CB ' ' A' ' 4' ' ' ALA . 4.5 p -123.91 -52.92 1.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.42 -36.63 2.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.896 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.622 HG13 HD23 ' A' ' 85' ' ' LEU . 38.6 t -48.56 144.4 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 111.26 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 p -149.83 150.75 32.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.515 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 83' ' ' LEU . 32.2 mt -128.75 113.69 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.492 HG13 HG13 ' A' ' 16' ' ' VAL . 3.8 mt -93.21 134.41 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.808 HD12 ' CG ' ' A' ' 10' ' ' PHE . 4.2 mt -123.93 94.26 45.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.161 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 155.82 66.97 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.423 2.082 . . . . 0.0 112.085 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.68 98.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.34 -21.75 0.74 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.945 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -68.21 -28.38 67.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 39' ' ' GLN . 38.9 mt -123.84 137.88 29.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.548 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.786 ' HD3' HD21 ' A' ' 78' ' ' LEU . 17.8 Cg_endo -60.35 155.5 46.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.385 2.056 . . . . 0.0 112.544 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.0 mt-10 -66.64 151.86 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.766 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.05 19.52 59.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.635 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.8 t -125.62 160.77 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.551 ' N ' HG12 ' A' ' 37' ' ' VAL . 5.3 mt-10 -137.06 113.71 10.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.053 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.821 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -102.16 110.75 22.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.814 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.65 119.4 13.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.136 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mt -126.92 139.82 50.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 110.867 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.425 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 29.7 p90 -155.55 162.96 40.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -166.98 159.49 13.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.945 0.402 . . . . 0.0 111.526 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 133.5 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.297 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 68' ' ' VAL . 40.3 t -124.87 135.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.586 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.746 ' HB2' HG13 ' A' ' 3' ' ' VAL . 52.2 t -173.18 149.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.033 0.444 . . . . 0.0 111.272 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -71.29 108.28 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.85 107.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' HB2' HD11 ' A' ' 67' ' ' LEU . 48.1 t30 -90.59 -21.52 21.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.301 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -50.7 -25.13 3.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.518 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 51' ' ' ILE . 30.9 mm -72.49 -7.45 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.726 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -153.24 164.37 20.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.861 0.362 . . . . 0.0 111.252 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.475 ' O ' HD12 ' A' ' 52' ' ' LEU . 9.8 Cg_exo -71.79 150.8 56.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.711 2.274 . . . . 0.0 112.14 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 39.5 Cg_exo -57.31 172.15 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 5' ' ' THR . 2.4 tp -83.67 -34.56 24.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.92 89.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -73.05 -44.23 60.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.84 -31.95 65.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -79.55 -27.82 41.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.048 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.99 111.37 3.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.357 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.821 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 19.8 mt-10 -111.5 113.9 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.252 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 m -89.67 110.8 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.5 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.87 138.18 34.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.303 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.51 -57.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -92.19 -175.59 0.51 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.379 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 69.5 Cg_exo -40.93 -46.79 4.97 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.326 2.017 . . . . 0.0 111.529 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.8 tm? -153.57 83.93 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.658 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 45' ' ' VAL . 47.6 t -145.15 117.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.405 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.821 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -106.13 106.2 16.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.07 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -64.06 -153.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 20.6 Cg_endo -60.97 129.73 29.97 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.457 2.104 . . . . 0.0 111.909 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -54.98 110.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.48 79.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.716 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.75 HD11 ' HG2' ' A' ' 39' ' ' GLN . 14.8 tp -138.94 85.28 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 110.2 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 59.7 tttp -63.71 151.09 42.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.873 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 75.0 m-85 -127.92 154.11 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.771 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.786 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -98.51 13.92 30.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.436 0.636 . . . . 0.0 110.765 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.02 136.39 4.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.188 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.15 99.01 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.359 2.039 . . . . 0.0 112.379 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.0 m -67.86 154.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 119.0 38.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.413 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.862 HD13 HG12 ' A' ' 26' ' ' ILE . 15.6 tp -115.81 114.96 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.286 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.0 136.46 52.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.43 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.795 HD12 HG11 ' A' ' 111' ' ' VAL . 1.2 mt -125.63 133.02 24.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 119.71 6.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.189 1.926 . . . . 0.0 112.383 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.64 -33.68 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.53 163.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.78 69.95 0.46 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.27 42.4 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.247 2.631 . . . . 0.0 112.558 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 13.17 25.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 t -114.02 15.98 18.3 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 0.0 111.914 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.597 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -117.53 -36.67 3.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.597 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 41.1 mt-30 -106.38 76.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.34 -49.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -138.89 29.82 2.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.4 m -138.48 -175.38 4.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.751 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.91 127.6 38.5 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.12 -5.01 15.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.495 2.13 . . . . 0.0 112.558 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.46 -7.42 26.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.945 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.449 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -68.75 134.28 90.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.812 0.306 . . . . 0.0 110.621 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 106' ' ' VAL . 58.3 Cg_endo -71.51 -8.17 22.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.341 2.027 . . . . 0.0 112.612 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 77.2 m-20 -99.8 17.29 21.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 110.843 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.559 ' CE1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.35 -113.9 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.282 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -47.87 -15.85 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 102' ' ' PRO . 5.1 m -67.62 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 111.782 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -175.91 -34.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.39 25.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 110.835 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.59 -57.16 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.079 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.9 p -141.84 159.77 41.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.795 HG11 HD12 ' A' ' 85' ' ' LEU . 13.4 p -95.67 113.41 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.219 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.49 105.1 10.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.143 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 111' ' ' VAL . 8.5 m -128.79 122.67 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 mt -91.87 148.53 22.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 81' ' ' VAL . 33.8 mm -129.82 123.49 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.317 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.15 24.5 6.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.181 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.49 104.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.872 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 2' ' ' VAL . 12.1 p -98.67 38.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.536 HG21 HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -110.66 137.54 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.238 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.824 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -95.49 127.29 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 44' ' ' LYS . 21.7 p -142.24 143.74 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.135 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.631 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -149.48 116.93 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.8 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.17 144.63 8.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.673 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.66 134.44 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.458 ' CG ' HD12 ' A' ' 28' ' ' ILE . 77.2 m-85 -119.73 157.79 27.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.35 172.16 13.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.754 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 t -48.19 -27.26 2.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.379 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -55.17 -32.46 62.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 111.341 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.96 173.05 21.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.589 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.33 155.26 7.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.22 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 27' ' ' ILE . 3.4 t -112.08 151.98 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.366 0.603 . . . . 0.0 111.734 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.631 HD11 ' HB1' ' A' ' 6' ' ' ALA . 40.9 tp -123.57 100.23 6.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.149 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -121.62 149.46 43.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 112.017 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.04 97.13 5.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.166 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.41 -26.53 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.725 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.824 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -50.54 -50.53 53.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.679 -179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.808 HG21 ' CG1' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -114.34 -52.8 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.529 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.64 -28.42 2.04 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.132 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.659 HG13 HD23 ' A' ' 85' ' ' LEU . 84.3 t -52.8 135.9 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 66.3 p -146.06 170.96 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.655 HG12 HD13 ' A' ' 83' ' ' LEU . 20.3 mt -141.27 113.86 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.4 mp -92.4 120.28 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.603 HG22 ' HB3' ' A' ' 32' ' ' ALA . 3.2 mt -108.46 90.4 7.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.34 151.86 82.81 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.088 . . . . 0.0 112.142 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -53.9 107.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 138.06 -6.7 3.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.092 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.603 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -78.92 -29.63 44.28 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.985 0.392 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.715 HD13 ' HB2' ' A' ' 39' ' ' GLN . 35.5 mt -119.4 141.76 31.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.601 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.0 Cg_exo -64.9 154.21 74.22 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.279 1.986 . . . . 0.0 112.054 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.1 mt-10 -65.93 154.45 39.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.43 60.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 35' ' ' GLU . 42.8 t -129.46 160.77 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.258 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.545 ' N ' HG12 ' A' ' 37' ' ' VAL . 4.9 mt-10 -134.31 113.8 12.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.957 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.715 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -103.32 109.13 20.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.075 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.97 110.43 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.673 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.71 136.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.413 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 54.3 p90 -154.96 151.29 28.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.7 OUTLIER -154.24 159.76 41.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 0.0 111.314 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG22 ' A' ' 5' ' ' THR . 1.7 pttp -128.15 124.76 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.029 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.808 ' CG1' HG21 ' A' ' 22' ' ' THR . 46.1 t -113.81 128.79 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.718 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 8.8 t -153.72 148.92 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 0.0 111.25 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -74.32 -23.64 59.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.55 102.69 3.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.614 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.73 -30.36 61.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -58.23 -22.89 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.247 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 51' ' ' ILE . 38.7 mt -70.53 -10.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.611 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.536 HD13 HG21 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -179.06 134.07 0.28 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.64 0.257 . . . . 0.0 110.871 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.78 158.17 48.1 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.521 2.148 . . . . 0.0 112.473 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.22 172.32 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.684 2.256 . . . . 0.0 112.415 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.43 HD11 ' CG2' ' A' ' 5' ' ' THR . 0.4 OUTLIER -82.32 -51.42 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 110.827 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -149.47 85.57 1.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.84 -33.48 66.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.022 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.51 -35.72 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -72.29 -28.2 62.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.09 112.7 2.27 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -110.18 108.66 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 108.41 19.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -87.67 138.84 31.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.266 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.515 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -88.86 -175.22 0.53 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.421 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 70.2 Cg_exo -41.01 -50.58 4.11 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.267 1.978 . . . . 0.0 111.676 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.8 tm? -151.94 83.35 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.703 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.722 HG13 HG22 ' A' ' 45' ' ' VAL . 44.4 t -144.46 118.23 3.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.529 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.53 106.11 16.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.658 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.15 -166.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.41 -148.25 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.73 127.77 20.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.431 2.087 . . . . 0.0 112.103 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -56.29 110.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.92 78.3 1.0 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.715 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.57 HD11 ' HG3' ' A' ' 39' ' ' GLN . 6.0 tp -142.45 87.52 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.255 0.55 . . . . 0.0 110.016 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 7.6 ttpp -64.13 149.24 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 42.2 m-85 -126.61 151.32 48.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.49 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -99.38 16.14 24.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.353 0.597 . . . . 0.0 111.007 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.38 136.5 4.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.394 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.4 Cg_exo -63.49 103.6 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.532 2.154 . . . . 0.0 112.695 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.5 m -76.44 143.78 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.736 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.95 117.36 29.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.655 HD13 HG12 ' A' ' 26' ' ' ILE . 31.8 tp -111.73 117.59 33.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -108.34 139.45 43.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.944 HD12 HG11 ' A' ' 111' ' ' VAL . 1.3 mt -134.47 140.76 36.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.527 ' HD2' HG22 ' A' ' 24' ' ' VAL . 72.0 Cg_endo -75.4 125.89 9.35 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.391 2.061 . . . . 0.0 112.388 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -77.69 -44.16 28.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.5 m 60.2 86.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -179.35 75.62 0.2 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.17 42.92 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.973 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -108.61 -47.52 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.025 0.44 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 t -111.57 3.99 18.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.598 0.713 . . . . 0.0 111.055 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.517 ' CE3' ' HB2' ' A' ' 105' ' ' LEU . 1.5 p-90 -55.36 -31.67 61.94 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.96 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.457 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 1.8 pt20 -92.68 144.73 25.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.47 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -170.56 -42.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.749 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 -164.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m 64.23 159.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.054 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.2 mt -59.89 137.13 90.52 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.059 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -17.79 16.56 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.674 2.249 . . . . 0.0 112.691 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.97 -43.93 7.94 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.794 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.48 113.23 17.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.538 0.209 . . . . 0.0 111.061 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.65 ' O ' HG13 ' A' ' 106' ' ' VAL . 39.3 Cg_exo -56.9 -26.61 68.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.439 2.093 . . . . 0.0 111.995 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.506 ' HA ' HG22 ' A' ' 106' ' ' VAL . 4.5 t-20 -70.69 -11.21 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.396 . . . . 0.0 110.806 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -52.58 -23.28 6.13 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.151 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.635 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -156.73 -20.17 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.337 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 102' ' ' PRO . 6.1 m -67.74 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -146.23 -42.61 0.04 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.375 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.45 62.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.583 0.23 . . . . 0.0 111.569 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.92 80.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 175.42 131.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.944 HG11 HD12 ' A' ' 85' ' ' LEU . 12.5 p -84.9 110.71 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.45 104.88 11.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.11 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.1 m -125.33 122.02 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.35 135.57 33.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.909 ' O ' HG22 ' A' ' 81' ' ' VAL . 15.3 mm -126.45 115.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.463 ' C ' ' CG ' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -116.7 14.07 15.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.463 ' CG ' ' C ' ' A' ' 116' ' ' ASP . 7.5 m-70 -162.8 127.95 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.903 0.382 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.18 133.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.1 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.58 148.15 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.997 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.607 ' CB ' HG23 ' A' ' 22' ' ' THR . . . -93.96 117.64 30.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.464 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.1 p -121.86 143.54 49.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.733 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.82 108.02 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.987 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.464 ' HG3' ' CB ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -111.36 136.09 50.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.054 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.26 149.28 12.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.231 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.2 mt -104.86 138.82 27.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.711 0.291 . . . . 0.0 110.52 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CG ' HD12 ' A' ' 28' ' ' ILE . 90.3 m-85 -127.64 174.04 9.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 111.422 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -147.87 172.17 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.636 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -45.19 -28.79 0.82 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -56.39 -31.41 63.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 177.98 22.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.645 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.52 162.78 10.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.17 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.51 HG13 HG13 ' A' ' 27' ' ' ILE . 3.9 t -118.46 153.74 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.269 0.557 . . . . 0.0 111.762 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' SER . 40.5 tp -123.14 100.09 6.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.107 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 149.32 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.45 . . . . 0.0 111.735 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.46 97.22 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.224 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.74 -26.45 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.512 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 4.3 mt-10 -60.81 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.352 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.632 HG21 HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -105.25 -53.03 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.238 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.66 -34.58 2.46 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.679 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.88 HG22 ' HD3' ' A' ' 86' ' ' PRO . 39.4 t -54.64 139.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.684 0.278 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -143.11 167.65 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.43 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.818 HG12 HD13 ' A' ' 83' ' ' LEU . 42.6 mt -134.42 113.75 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.656 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.51 HG13 HG13 ' A' ' 16' ' ' VAL . 4.7 mp -90.71 122.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.574 HD12 ' CG ' ' A' ' 10' ' ' PHE . 7.1 mt -110.03 94.7 18.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 28' ' ' ILE . 34.8 Cg_endo -64.99 150.97 87.38 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.34 2.027 . . . . 0.0 112.05 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.79 108.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -2.79 4.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.141 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -82.43 -26.06 33.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.383 . . . . 0.0 111.24 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.795 HD13 ' HB2' ' A' ' 39' ' ' GLN . 48.6 mt -122.97 142.3 37.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.553 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.677 ' HD3' HD21 ' A' ' 78' ' ' LEU . 31.3 Cg_exo -59.15 155.48 39.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.398 2.065 . . . . 0.0 112.442 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -70.19 152.74 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 23.76 56.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.63 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 35' ' ' GLU . 42.0 t -131.22 160.9 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.179 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' N ' HG12 ' A' ' 37' ' ' VAL . 27.9 mt-10 -131.39 113.78 14.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.944 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.795 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -104.13 110.93 23.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.93 126.54 29.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.78 132.77 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.997 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.464 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 52.6 p90 -149.23 174.5 12.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.276 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.733 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.2 p90 -175.34 176.15 2.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.022 0.439 . . . . 0.0 111.783 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.671 ' HB2' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -133.28 148.58 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.995 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 22' ' ' THR . 59.4 t -142.37 139.31 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.685 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.411 ' O ' HD12 ' A' ' 67' ' ' LEU . 42.7 t -173.16 148.93 1.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.093 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 145.38 54.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.836 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.767 ' CG ' HD12 ' A' ' 51' ' ' ILE . 3.8 m-20 64.16 125.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.017 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.64 -34.69 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.236 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 t -76.61 -27.82 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.767 HD12 ' CG ' ' A' ' 48' ' ' ASP . 48.6 mt -77.16 -2.93 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.482 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.69 HD23 ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -165.47 128.26 1.55 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.039 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HD2' HD23 ' A' ' 52' ' ' LEU . 58.9 Cg_endo -72.25 171.35 17.07 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.451 2.101 . . . . 0.0 112.272 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.15 171.79 3.68 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 44' ' ' LYS . 14.4 tp -67.25 -66.43 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.015 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -145.76 115.81 7.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.02 -54.08 9.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.209 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.7 -55.41 35.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -26.55 60.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.299 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 72' ' ' PRO . . . 148.43 110.76 0.58 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.674 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.44 104.93 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -135.85 95.44 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.73 142.29 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.088 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.42 -57.58 1.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.929 0.395 . . . . 0.0 111.171 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -97.1 -174.28 0.37 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 71.5 Cg_exo -41.35 -45.4 5.8 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.263 1.975 . . . . 0.0 111.699 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.72 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.9 tm? -153.13 83.92 1.2 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 61.7 t -145.06 118.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.423 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.64 109.07 20.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.695 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -60.3 -173.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 42' ' ' TYR . . . -78.24 -126.84 0.42 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.595 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 37.3 Cg_endo -65.98 134.08 35.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.18 110.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.89 83.61 1.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 3.5 tp -131.4 84.43 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HD3' ' CE1' ' A' ' 117' ' ' HIS . 10.5 tptt -53.3 153.83 3.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.4 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 35.2 m-85 -136.35 144.27 44.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.677 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -94.68 17.59 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.285 0.564 . . . . 0.0 111.226 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -162.71 136.5 4.71 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.173 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.68 97.27 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.337 2.025 . . . . 0.0 112.488 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.8 m -72.91 154.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.53 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 pm0 -110.91 116.46 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.399 . . . . 0.0 111.275 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.818 HD13 HG12 ' A' ' 26' ' ' ILE . 9.3 tp -104.75 129.72 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.61 ' O ' HG13 ' A' ' 24' ' ' VAL . 1.8 mtt180 -112.88 126.2 55.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.944 0.402 . . . . 0.0 111.406 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -138.63 155.08 73.66 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.658 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.88 ' HD3' HG22 ' A' ' 24' ' ' VAL . 75.0 Cg_exo -48.25 144.21 13.36 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.687 2.258 . . . . 0.0 112.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -79.31 -26.28 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 m 68.3 -173.05 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.13 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -85.21 35.75 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.122 2.548 . . . . 0.0 112.866 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.24 -13.53 14.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.424 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t -122.65 15.78 10.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 111.786 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.63 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.5 p-90 -95.19 -36.12 11.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.941 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.63 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.0 mt-30 -104.67 114.38 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -161.02 -44.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 34.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.37 175.93 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 29.1 mt -87.65 128.6 53.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.26 -13.6 16.87 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.473 2.116 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.09 -21.21 8.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.857 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.419 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -74.46 137.17 74.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.617 0.246 . . . . 0.0 110.903 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.759 ' O ' HG22 ' A' ' 106' ' ' VAL . 56.4 Cg_endo -70.21 -26.63 25.24 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.162 . . . . 0.0 112.101 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -65.23 -15.68 62.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.752 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.34 -18.47 10.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.948 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.752 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 12.7 mt -156.93 -27.89 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.55 36.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 172.61 -33.41 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.604 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.83 44.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -88.58 96.59 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.65 143.13 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 113' ' ' VAL . 7.9 p -112.05 133.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.257 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.24 104.99 17.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 83' ' ' LEU . 10.6 m -119.57 123.78 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.029 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.0 137.16 33.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 81' ' ' VAL . 25.9 mm -129.82 123.28 56.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.256 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.86 25.66 5.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.941 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.546 ' CE1' ' HD3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 178.82 104.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.815 0.341 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -150.55 151.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.662 HG11 ' HZ3' ' A' ' 44' ' ' LYS . 5.1 t -140.93 155.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.137 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -101.6 117.83 35.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.355 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.741 HG22 ' CB ' ' A' ' 44' ' ' LYS . 37.6 p -136.01 143.22 44.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -142.36 121.95 13.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.813 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.435 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 1.1 ttp180 -127.05 130.22 49.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.14 144.12 8.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.66 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 29.6 mt -79.6 152.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.65 0.262 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 28' ' ' ILE . 42.3 m-85 -129.6 154.04 47.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 0.0 111.303 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.51 172.62 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.592 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.1 m -44.18 -30.43 0.78 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.188 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.13 -42.02 99.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.454 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.06 142.32 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.096 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -120.23 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.787 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.671 HG13 HG13 ' A' ' 27' ' ' ILE . 2.0 t -151.29 145.98 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.238 0.542 . . . . 0.0 111.53 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 6' ' ' ALA . 26.5 tp -123.51 100.38 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.65 138.31 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 112.077 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.538 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 49.8 m -100.57 96.84 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.391 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.06 -26.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.014 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.757 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -69.27 -21.53 63.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.27 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.675 HG23 ' CB ' ' A' ' 4' ' ' ALA . 12.2 p -126.04 -52.99 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.659 0.266 . . . . 0.0 111.494 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.84 2.34 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.537 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.605 ' HB ' HG21 ' A' ' 45' ' ' VAL . 40.9 t -52.54 145.55 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.731 0.301 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.4 p -148.06 165.31 31.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.635 HG12 HD13 ' A' ' 83' ' ' LEU . 48.1 mt -138.12 113.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.671 HG13 HG13 ' A' ' 16' ' ' VAL . 2.8 mt -96.07 112.86 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 111.123 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 ' CD1' ' A' ' 10' ' ' PHE . 6.3 mt -98.31 99.85 8.0 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.773 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 156.66 63.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.268 1.979 . . . . 0.0 112.343 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -60.35 111.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.06 0.6 6.96 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.043 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.415 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -78.07 -30.05 49.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.929 0.365 . . . . 0.0 111.057 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.8 mt -115.37 142.52 28.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.448 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.39 155.52 46.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.284 1.989 . . . . 0.0 112.351 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.1 mt-10 -66.57 153.36 43.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.2 25.5 57.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 35' ' ' GLU . 34.3 t -132.85 160.24 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.303 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' N ' HG12 ' A' ' 37' ' ' VAL . 20.0 mt-10 -137.84 113.83 9.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.739 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.84 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.9 mm-40 -101.6 125.63 48.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.055 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 26.5 tt0 -82.45 121.64 27.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 mt -124.97 136.39 60.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.221 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.523 ' CD1' HD22 ' A' ' 55' ' ' LEU . 26.6 p90 -155.51 159.92 40.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.487 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -165.65 165.45 18.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 111.654 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.741 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -137.57 119.32 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.055 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.916 HG22 HG13 ' A' ' 68' ' ' VAL . 38.7 t -105.33 137.24 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.61 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.661 ' SG ' HG13 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -162.22 149.06 13.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.32 -31.62 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -135.12 156.06 49.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -90.64 -36.29 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.31 -25.67 62.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.29 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 52' ' ' LEU . 20.2 mt -61.73 -17.26 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.281 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER 179.66 140.23 0.3 Allowed Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 120.657 0.265 . . . . 0.0 111.045 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.72 171.52 17.28 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.541 2.16 . . . . 0.0 112.217 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.55 161.81 7.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.689 2.26 . . . . 0.0 112.252 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 44' ' ' LYS . 3.6 mp -59.07 -79.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.06 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.84 119.24 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.937 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -72.71 -19.25 61.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -51.06 -32.77 23.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.388 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -95.02 -76.46 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . 170.01 -99.53 0.15 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.241 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 160.57 124.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.55 0.34 . . . . 0.0 110.912 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.41 97.27 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.446 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.59 139.22 37.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.338 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.412 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.45 -57.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.989 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.593 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -89.53 -175.77 0.58 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.217 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.04 -35.39 1.78 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.268 1.979 . . . . 0.0 111.785 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -168.09 78.24 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.955 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.916 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -137.46 117.87 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.48 105.99 17.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.717 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -165.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -71.47 -154.36 1.7 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.576 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 51.9 Cg_exo -53.9 130.1 37.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.5 2.134 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -56.68 110.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.742 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.05 83.95 1.77 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.551 HD13 ' CD ' ' A' ' 39' ' ' GLN . 3.4 tp -138.68 86.52 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.293 0.568 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -50.54 164.47 0.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -149.48 136.82 19.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.554 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.93 16.95 16.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.319 0.581 . . . . 0.0 111.06 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 3.3 tptm -159.8 136.45 6.57 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.258 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.3 Cg_exo -63.7 95.82 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.505 2.137 . . . . 0.0 112.51 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 m -70.72 142.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.607 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 7.0 mp0 -90.93 129.19 36.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 111.563 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.635 HD13 HG12 ' A' ' 26' ' ' ILE . 26.9 tp -124.32 114.99 20.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -112.32 131.18 55.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.876 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -143.85 141.43 18.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.521 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.03 127.66 10.83 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.492 2.128 . . . . 0.0 112.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -43.78 30.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t 62.09 59.75 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.92 122.74 1.13 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.714 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -86.62 39.87 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.643 2.229 . . . . 0.0 112.871 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 -4.29 16.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.612 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -122.67 16.16 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 6.8 p-90 -117.7 -43.49 2.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -91.74 133.04 35.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.291 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.31 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.66 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 32.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.734 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.36 -166.88 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 98' ' ' LEU . 13.4 mt -95.72 121.43 61.34 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 5.7 Cg_exo -77.84 4.03 6.44 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.753 2.302 . . . . 0.0 112.686 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.55 2.24 8.14 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.822 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.502 ' OD1' ' HB3' ' A' ' 104' ' ' TYR . 37.1 p-10 -81.31 133.23 53.94 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 117.62 0.71 . . . . 0.0 110.317 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.625 ' O ' HG21 ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.65 -9.43 24.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.504 2.136 . . . . 0.0 113.085 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 7.2 m120 -96.89 17.62 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 111.109 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.502 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -75.03 -110.02 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -55.89 -13.81 2.06 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.625 HG21 ' O ' ' A' ' 102' ' ' PRO . 11.2 m -69.14 36.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.84 -37.88 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.134 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -24.79 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.651 0.262 . . . . 0.0 111.243 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.37 65.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 173.21 127.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.721 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 111' ' ' VAL . 11.6 p -102.52 105.93 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.37 105.05 5.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.307 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 83' ' ' LEU . 5.9 m -126.51 120.74 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.87 132.31 37.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.639 ' O ' HG22 ' A' ' 81' ' ' VAL . 26.7 mm -113.74 124.79 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.58 26.52 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.637 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.466 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -178.32 98.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.89 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.518 HG11 ' NH2' ' A' ' 47' ' ' ARG . 10.1 p -60.46 158.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.985 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.846 HG12 ' SG ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -142.21 134.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.227 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -106.66 117.71 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.3 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 44' ' ' LYS . 28.7 p -123.15 143.64 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.374 . . . . 0.0 111.195 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.646 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.36 124.77 20.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.831 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.529 HH21 HD21 ' A' ' 55' ' ' LEU . 10.8 mtt180 -130.42 129.84 43.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.42 145.89 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.039 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 10' ' ' PHE . 29.2 mt -90.45 159.67 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.514 0.197 . . . . 0.0 110.539 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.779 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.9 m-85 -137.57 152.29 49.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 111.411 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 38' ' ' GLU . 1.6 t-20 -123.76 172.11 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.764 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.02 -28.47 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -60.14 -37.28 79.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.62 -160.81 12.99 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.752 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.63 170.74 13.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.204 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -124.51 149.09 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.646 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' A' ' 6' ' ' ALA . 31.7 tp -123.35 100.38 6.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.58 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -129.47 153.95 47.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.142 0.496 . . . . 0.0 111.925 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -126.28 97.09 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.074 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -51.81 -26.68 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.639 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 4.0 mt-10 -62.21 -26.95 68.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.656 HG21 HG12 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -119.88 -52.91 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.137 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.55 -28.91 3.92 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.728 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 45' ' ' VAL . 55.7 t -57.09 145.87 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.671 0.272 . . . . 0.0 110.795 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 p -149.66 156.35 41.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.43 . . . . 0.0 111.381 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 HD13 ' A' ' 83' ' ' LEU . 23.9 mt -135.03 113.59 16.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.656 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.7 mp -93.26 126.79 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.894 0.378 . . . . 0.0 110.98 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.779 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.9 mt -110.77 99.36 41.72 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.39 153.45 76.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.586 2.191 . . . . 0.0 112.28 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -60.67 100.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.68 -6.3 3.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -73.28 -24.14 60.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.878 0.339 . . . . 0.0 111.202 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.436 HG23 ' HD2' ' A' ' 34' ' ' PRO . 18.5 mt -121.64 140.91 32.56 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.672 ' HD3' HD21 ' A' ' 78' ' ' LEU . 31.7 Cg_exo -58.18 152.9 49.43 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.316 2.011 . . . . 0.0 112.243 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.59 143.42 57.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.75 25.58 72.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 38' ' ' GLU . 48.0 t -127.99 161.14 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -139.96 113.67 8.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.847 179.123 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.417 ' HB2' HD13 ' A' ' 33' ' ' ILE . 27.9 mm100 -103.56 113.77 27.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.093 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.43 122.33 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.18 137.31 57.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.018 0.437 . . . . 0.0 111.213 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 13.2 p90 -154.41 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.28 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -166.95 153.88 8.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.058 0.456 . . . . 0.0 111.539 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -120.24 117.48 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.827 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 22' ' ' THR . 59.6 t -102.87 126.86 57.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.582 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.846 ' SG ' HG12 ' A' ' 3' ' ' VAL . 5.6 m -137.97 132.76 32.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 111.08 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' NH2' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -73.41 -28.41 61.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.34 134.87 51.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.021 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.07 -8.85 57.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.317 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -50.58 -22.65 2.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 51' ' ' ILE . 22.8 mm -69.51 -2.0 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.852 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.552 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 2.8 mt 7.06 -71.98 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 52' ' ' LEU . 80.0 Cg_exo -44.2 125.81 5.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.009 1.806 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.84 172.33 14.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.582 2.188 . . . . 0.0 112.686 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD21 HH21 ' A' ' 7' ' ' ARG . 1.2 tp -83.84 -30.71 26.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.548 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -171.35 83.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -62.98 -40.66 98.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -28.69 60.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.74 -29.3 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.55 112.76 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.372 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.763 ' OE1' ' HB1' ' A' ' 69' ' ' ALA . 2.5 tp10 -91.64 121.64 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 111.198 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.72 95.44 4.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.624 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -77.97 139.31 39.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.025 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.44 -57.71 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.646 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.03 -174.49 0.48 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.246 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 53.4 Cg_exo -38.68 -45.06 2.4 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.287 1.991 . . . . 0.0 112.125 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.781 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -161.66 65.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.558 HG22 HG13 ' A' ' 45' ' ' VAL . 90.0 t -121.63 118.61 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.573 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB1' ' OE1' ' A' ' 61' ' ' GLU . . . -101.58 106.71 17.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.871 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -63.74 -167.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -78.12 -150.75 4.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 52.0 Cg_exo -54.47 121.59 10.03 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 112.006 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -55.53 110.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.938 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.33 78.55 0.9 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.738 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.697 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 65.8 tp -136.65 84.68 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.184 0.516 . . . . 0.0 110.477 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.1 tttt -58.85 162.11 4.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.184 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.416 ' CE1' ' HG ' ' A' ' 75' ' ' LEU . 42.1 m-85 -144.42 150.01 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.672 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.75 12.61 31.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.302 0.573 . . . . 0.0 111.259 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mmpp? -157.24 136.73 8.37 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.965 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.87 93.49 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.293 1.995 . . . . 0.0 112.28 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.6 m -64.26 166.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 126.84 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.045 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.568 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.1 tp -124.22 107.04 10.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.22 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.441 ' HD3' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.34 129.69 53.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.362 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -136.34 154.18 76.89 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.652 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' HG22 ' A' ' 24' ' ' VAL . 34.9 Cg_endo -64.96 120.21 7.4 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.502 2.135 . . . . 0.0 112.069 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.55 -54.4 7.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.27 158.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' CB ' ' CD ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -57.92 177.84 0.2 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.693 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 89' ' ' ASP . 92.4 Cg_endo -84.78 35.62 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.558 2.172 . . . . 0.0 112.93 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -109.33 -0.19 19.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.361 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -122.54 15.86 10.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 112.038 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.674 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 5.1 p-90 -105.48 -35.67 7.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 93' ' ' TRP . 1.1 pt20 -94.18 29.83 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.369 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -101.7 -30.95 11.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -172.2 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.23 -165.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.788 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 11.4 mt -89.67 124.64 63.5 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 13.3 Cg_exo -68.78 -23.68 35.35 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.563 2.175 . . . . 0.0 112.25 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.88 4.43 39.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.136 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -60.96 138.97 94.1 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.916 0.358 . . . . 0.0 110.474 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.789 ' O ' HG21 ' A' ' 106' ' ' VAL . 3.0 Cg_exo -74.38 -3.08 13.27 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.483 2.122 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.437 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 10.3 p30 -109.22 17.41 21.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 0.0 111.053 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.617 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.15 -113.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.978 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD11 ' CZ3' ' A' ' 93' ' ' TRP . 0.5 OUTLIER -47.76 -19.55 0.23 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.789 HG21 ' O ' ' A' ' 102' ' ' PRO . 8.4 m -68.4 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -174.39 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.849 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.58 67.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.86 -66.56 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.45 142.74 51.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.66 ' O ' HG13 ' A' ' 111' ' ' VAL . 12.0 p -98.09 103.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.98 104.78 6.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 83' ' ' LEU . 10.6 m -116.11 126.82 73.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.837 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.6 mt -81.62 136.55 35.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.731 ' O ' HG22 ' A' ' 81' ' ' VAL . 34.9 mm -129.79 121.71 53.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.39 25.46 6.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.206 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 176.71 111.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.697 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.3 m-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.027 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -171.79 150.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.558 ' CG2' HD13 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -141.92 142.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.697 ' HB2' HG23 ' A' ' 22' ' ' THR . . . -94.33 125.03 38.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 44' ' ' LYS . 17.1 p -140.6 144.37 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -150.98 113.7 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -125.83 129.88 50.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.16 145.26 9.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.625 HG21 ' HB3' ' A' ' 38' ' ' GLU . 4.1 mt -84.05 138.89 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.752 ' CG ' HD12 ' A' ' 28' ' ' ILE . 79.0 m-85 -117.41 161.24 19.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -134.55 172.07 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 t -49.91 -27.04 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -56.35 -33.11 65.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.64 173.2 22.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.647 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.63 158.35 8.74 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.067 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.628 HG22 HG23 ' A' ' 27' ' ' ILE . 4.7 t -113.9 152.05 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.359 0.6 . . . . 0.0 111.824 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD11 ' HB1' ' A' ' 6' ' ' ALA . 54.2 tp -123.66 100.21 6.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.38 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.12 142.02 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.076 0.465 . . . . 0.0 111.767 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.74 97.11 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.338 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.48 -26.4 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.617 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -54.66 -26.63 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.365 -179.555 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.697 HG23 ' HB2' ' A' ' 4' ' ' ALA . 23.0 p -132.32 -52.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.59 -36.65 1.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.755 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.841 ' HB ' HG21 ' A' ' 45' ' ' VAL . 22.5 t -48.56 142.1 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 51.0 p -149.73 172.05 15.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 111.525 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 83' ' ' LEU . 20.4 mt -145.02 113.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.606 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.628 HG23 HG22 ' A' ' 16' ' ' VAL . 4.1 mp -93.05 118.83 39.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.752 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.6 mt -106.48 90.96 5.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.43 159.52 43.74 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.517 2.145 . . . . 0.0 112.334 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.31 106.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.08 -8.88 3.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.056 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.01 -23.91 55.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.97 0.385 . . . . 0.0 111.451 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 39' ' ' GLN . 36.3 mt -131.0 141.09 40.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.771 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.34 155.48 46.26 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.392 2.061 . . . . 0.0 112.264 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -68.27 152.63 45.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.74 23.34 63.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 38' ' ' GLU . 41.6 t -128.51 160.75 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.146 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.625 ' HB3' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -135.8 113.84 11.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.008 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.821 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.2 tp60 -101.05 110.73 22.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.6 114.16 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.546 HD11 ' HE1' ' A' ' 77' ' ' PHE . 24.7 mt -124.99 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.418 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 40.4 p90 -155.56 152.92 29.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -157.1 162.92 39.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.401 . . . . 0.0 111.384 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.643 ' HB3' HD11 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -130.33 126.67 37.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.774 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.841 HG21 ' HB ' ' A' ' 24' ' ' VAL . 39.2 t -114.3 134.71 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.944 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' HB3' HD12 ' A' ' 67' ' ' LEU . 11.2 t -159.66 148.81 17.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -70.95 -24.18 62.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.701 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' CB ' HG12 ' A' ' 51' ' ' ILE . 34.4 m-20 -132.74 139.96 47.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -90.59 -30.79 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.274 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 m -71.26 -26.49 62.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 51' ' ' ILE . 32.7 mm -65.56 -14.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.418 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.2 OUTLIER 177.57 116.89 0.17 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.035 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.36 173.22 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.483 2.122 . . . . 0.0 112.115 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 171.99 15.22 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.506 2.137 . . . . 0.0 112.354 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 44' ' ' LYS . 5.5 mp -62.21 -73.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -130.82 89.73 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.92 75.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.61 -35.82 77.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.945 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -66.87 -28.51 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.8 111.7 3.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.7 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.8 pm0 -113.36 136.88 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -100.76 98.47 8.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.588 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -76.45 133.92 39.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.44 -57.66 1.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.206 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -87.13 174.31 5.55 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.576 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 7.5 Cg_exo -34.5 -44.85 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 0.0 111.735 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.1 tm? -156.45 84.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.699 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 64' ' ' LEU . 51.6 t -146.89 118.07 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.289 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -108.85 106.19 16.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.786 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.25 -168.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.85 -148.07 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.53 127.56 21.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.505 2.137 . . . . 0.0 112.009 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.2 110.87 0.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.88 76.33 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.74 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 39' ' ' GLN . 18.9 tp -140.56 86.06 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 110.006 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 11.2 mtpp -75.99 123.89 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.173 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.546 ' HE1' HD11 ' A' ' 41' ' ' ILE . 40.8 m-85 -98.68 168.59 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.557 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.771 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -105.63 16.16 25.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.609 . . . . 0.0 111.032 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -161.42 136.51 5.54 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.46 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.6 Cg_exo -63.41 107.06 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.491 2.128 . . . . 0.0 112.499 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.9 m -79.41 144.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -88.4 116.04 26.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 111.05 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 84' ' ' ARG . 9.2 tp -113.39 129.83 56.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 83' ' ' LEU . 51.2 mtp180 -121.66 132.65 54.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.736 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -139.51 113.82 8.0 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.64 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.68 120.69 8.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.095 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.77 -21.32 55.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 68.66 -168.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 62.62 79.53 0.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.47 46.57 2.12 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.826 2.351 . . . . 0.0 112.776 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.06 4.94 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.468 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.53 16.0 10.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.881 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.402 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.8 p-90 -114.17 -36.86 4.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.402 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -108.67 43.63 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.934 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 -47.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.12 -38.19 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.36 174.51 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.47 139.27 21.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.27 -17.82 27.21 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.597 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.47 -29.47 19.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.705 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 140.29 83.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.792 0.33 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.743 ' O ' HG22 ' A' ' 106' ' ' VAL . 43.0 Cg_endo -67.2 -25.73 42.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.592 2.195 . . . . 0.0 112.259 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -16.85 62.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.607 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.777 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.31 -19.01 19.65 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.936 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.777 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 18.0 mt -155.96 -26.87 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.5 m -67.35 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 156.82 -27.92 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.411 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.03 -32.39 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -127.66 42.1 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.45 122.21 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.736 HG11 HD12 ' A' ' 85' ' ' LEU . 13.5 p -106.15 111.54 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.388 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.9 104.98 13.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 111' ' ' VAL . 6.3 m -122.78 126.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mt -99.12 121.0 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.902 ' O ' HG22 ' A' ' 81' ' ' VAL . 12.4 mm -111.88 119.53 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.356 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.457 ' C ' ' CG ' ' A' ' 117' ' ' HIS . 2.7 t0 -119.57 15.39 12.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.8 m-70 -162.35 125.42 2.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.723 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.17 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.706 ' O ' HG12 ' A' ' 2' ' ' VAL . 6.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.487 0.184 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 1' ' ' THR . 8.0 p 52.34 162.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.927 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.825 HG21 ' CD ' ' A' ' 53' ' ' PRO . 13.0 t -121.64 139.07 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.302 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.31 117.3 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.156 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.884 HG21 HD11 ' A' ' 55' ' ' LEU . 41.8 p -132.55 143.8 49.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -133.58 120.97 21.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 1.4 mtt180 -122.0 132.12 54.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.39 157.29 28.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.954 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.1 mt -94.98 151.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.977 ' CD1' HD12 ' A' ' 28' ' ' ILE . 41.1 m-85 -128.26 144.86 51.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 111.402 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.73 ' HA ' HG21 ' A' ' 33' ' ' ILE . 2.9 m120 -128.58 171.91 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -47.38 -28.64 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.203 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -54.3 -38.48 65.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.04 173.73 40.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.717 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.28 -155.17 26.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.605 HG13 HG13 ' A' ' 27' ' ' ILE . 2.4 t -146.97 150.23 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 0.0 111.628 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 6' ' ' ALA . 56.4 tp -123.34 100.27 6.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.352 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.79 148.48 50.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 112.016 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 p -116.16 96.99 5.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.001 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -50.15 -26.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.741 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -64.45 -38.49 91.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.679 HG21 HG12 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -105.01 -52.87 2.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.193 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.73 -30.92 3.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.758 HG22 ' HD2' ' A' ' 86' ' ' PRO . 42.1 t -56.12 142.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.01 154.0 41.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 111.453 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.671 HG12 HD13 ' A' ' 83' ' ' LEU . 49.7 mt -132.13 113.62 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 16' ' ' VAL . 2.5 mt -93.59 136.11 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.992 0.425 . . . . 0.0 111.174 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.977 HD12 ' CD1' ' A' ' 10' ' ' PHE . 2.3 mt -128.69 87.02 56.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.744 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.42 162.19 37.61 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.494 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.72 107.4 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.992 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 139.89 -10.75 3.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.114 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.833 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -86.14 -33.69 20.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 11' ' ' ASN . 1.9 mm -101.51 132.74 21.42 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.526 ' HB2' HG21 ' A' ' 37' ' ' VAL . 16.7 Cg_exo -66.08 144.97 77.77 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.154 1.903 . . . . 0.0 111.949 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 37' ' ' VAL . 5.1 mt-10 -57.76 141.57 48.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.25 28.04 71.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 38' ' ' GLU . 26.0 t -131.98 159.87 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG12 ' A' ' 37' ' ' VAL . 31.1 mt-10 -129.96 113.95 15.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.755 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG2' HD11 ' A' ' 75' ' ' LEU . 5.4 tp60 -101.22 109.0 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.374 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -75.8 116.06 16.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 HD11 ' HE1' ' A' ' 77' ' ' PHE . 26.4 mt -124.63 134.29 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.151 0.501 . . . . 0.0 111.6 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.428 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 30.6 p90 -150.79 155.06 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.972 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.6 p90 -157.86 160.36 37.61 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.653 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' HD3' HD13 ' A' ' 55' ' ' LEU . 16.2 ttpp -120.07 151.65 38.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.846 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.679 HG12 HG21 ' A' ' 22' ' ' THR . 48.4 t -156.81 143.38 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.772 ' HB3' HG13 ' A' ' 3' ' ' VAL . 26.5 p -173.76 149.1 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 111.348 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -38.28 76.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 111.0 23.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.91 -9.49 58.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.668 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -72.47 -43.92 63.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 51' ' ' ILE . 26.3 mt -77.45 0.12 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.449 ' CD1' HD11 ' A' ' 67' ' ' LEU . 11.5 tp -47.53 104.12 0.4 Allowed Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.825 ' CD ' HG21 ' A' ' 3' ' ' VAL . 97.2 Cg_endo -84.87 147.52 10.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.703 2.269 . . . . 0.0 112.203 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 49.6 Cg_exo -55.64 122.79 12.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.402 2.068 . . . . 0.0 112.259 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.884 HD11 HG21 ' A' ' 5' ' ' THR . 0.1 OUTLIER -110.88 -50.74 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -178.38 68.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.99 -49.89 26.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.064 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.13 -34.58 68.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.112 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -25.54 66.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 112.2 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.254 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.566 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 79.7 mt-10 -115.18 124.55 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 111.239 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 m -102.05 111.77 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -77.2 142.04 39.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.198 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.488 HD21 ' HE1' ' A' ' 118' ' ' PHE . 0.1 OUTLIER -126.44 -57.56 1.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -103.2 -173.1 0.27 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.192 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 55.7 Cg_exo -39.87 -58.49 0.88 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.075 1.85 . . . . 0.0 111.747 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.712 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -138.13 85.24 2.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.1 t -147.17 118.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.731 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -112.14 106.11 14.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.9 -143.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.55 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 31.7 Cg_endo -64.07 131.53 30.96 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.494 2.129 . . . . 0.0 112.04 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -56.59 110.82 0.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.37 79.8 1.27 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.638 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 28.9 tp -142.3 85.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HD2' ' CE1' ' A' ' 117' ' ' HIS . 4.9 ptmt -85.23 122.01 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.078 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.549 ' HE1' HD11 ' A' ' 41' ' ' ILE . 33.2 m-85 -93.2 170.9 9.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -98.6 18.41 16.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.569 . . . . 0.0 111.077 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 136.6 3.02 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.512 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.52 104.08 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.504 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.6 m -76.73 139.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.887 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 2.0 tp10 -84.5 127.98 34.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.919 0.39 . . . . 0.0 111.347 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.671 HD13 HG12 ' A' ' 26' ' ' ILE . 25.3 tp -124.21 118.24 26.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.47 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 24' ' ' VAL . 10.1 mmm-85 -105.46 134.33 48.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.933 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.985 HD12 HG11 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -131.83 122.26 18.46 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.758 ' HD2' HG22 ' A' ' 24' ' ' VAL . 74.2 Cg_endo -75.27 120.24 5.9 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.429 2.086 . . . . 0.0 112.168 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -73.52 -27.12 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.2 m 63.41 55.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.011 0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -130.92 92.0 35.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.774 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.0 41.03 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.191 2.594 . . . . 0.0 112.783 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -1.46 19.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.525 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -122.75 16.14 10.21 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.447 ' CD1' ' HG2' ' A' ' 94' ' ' GLN . 4.9 p-90 -110.73 -38.77 5.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.447 ' HG2' ' CD1' ' A' ' 93' ' ' TRP . 5.0 pt20 -95.51 152.73 18.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.059 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 64.04 31.22 13.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.761 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.22 -47.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.6 m -129.3 -172.3 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.2 mt -85.75 141.01 35.66 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.57 -1.71 11.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.67 2.247 . . . . 0.0 112.847 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.41 -34.22 4.55 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.707 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.414 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 77.3 m-20 -61.08 123.12 74.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.538 0.209 . . . . 0.0 110.978 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.821 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.24 -30.84 63.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.345 2.03 . . . . 0.0 112.158 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -61.91 -17.22 55.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.38 -17.69 13.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.665 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 14.0 mt -157.94 -30.58 0.08 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.93 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 178.84 -47.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.688 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.75 67.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.388 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -97.63 53.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -162.6 135.9 5.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.985 HG11 HD12 ' A' ' 85' ' ' LEU . 13.2 p -99.86 116.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.28 105.03 13.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.916 0.389 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 83' ' ' LEU . 4.4 m -126.18 123.09 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mt -93.17 131.95 37.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 81' ' ' VAL . 39.8 mm -114.15 117.26 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.305 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.81 27.23 8.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.13 179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.562 ' CE1' ' HD2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.3 104.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.4 m-85 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.14 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.737 0.303 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 3' ' ' VAL . 9.2 p -122.19 164.31 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.891 HG13 ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -107.47 125.13 63.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.15 117.63 30.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.554 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.705 HG21 HD11 ' A' ' 55' ' ' LEU . 72.2 p -119.07 143.7 46.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.413 . . . . 0.0 110.782 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.584 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -139.53 112.29 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.437 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.4 mtp85 -110.53 137.61 48.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.05 153.93 22.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.928 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 38' ' ' GLU . 35.4 mt -95.97 154.43 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 28' ' ' ILE . 22.4 m-85 -122.79 172.18 8.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -155.1 171.87 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 p -58.62 -25.63 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.58 -57.4 12.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.48 133.11 4.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.45 -169.83 21.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.126 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.65 HG13 HG13 ' A' ' 27' ' ' ILE . 1.9 t -139.89 148.76 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.669 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.14 100.11 6.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.22 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.45 140.87 52.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.733 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 6' ' ' ALA . 0.5 OUTLIER -107.47 97.17 6.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.225 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.37 -26.53 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.671 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 1.4 mt-10 -63.02 -40.82 98.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.291 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.6 HG23 ' HB3' ' A' ' 4' ' ' ALA . 2.4 p -105.84 -52.95 2.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.73 -30.94 3.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.609 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG22 ' HD2' ' A' ' 86' ' ' PRO . 56.3 t -57.15 144.01 10.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.715 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 p -144.95 161.58 39.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.47 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 HD13 ' A' ' 83' ' ' LEU . 12.7 mt -137.88 114.07 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.843 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.65 HG13 HG13 ' A' ' 16' ' ' VAL . 3.0 mt -96.31 136.38 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.705 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -108.85 93.94 13.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.98 145.07 96.93 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.335 2.023 . . . . 0.0 112.236 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.75 104.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.276 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.09 5.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.203 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.699 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.34 -28.07 56.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.013 0.406 . . . . 0.0 111.258 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.575 HD13 ' HG3' ' A' ' 39' ' ' GLN . 27.4 mt -126.42 141.84 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.746 ' HD3' HD21 ' A' ' 78' ' ' LEU . 39.4 Cg_exo -60.34 155.37 46.9 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.395 2.063 . . . . 0.0 112.234 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.48 141.91 57.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.03 79.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.683 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 38' ' ' GLU . 46.9 t -121.84 160.69 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.311 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.556 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -140.11 113.8 8.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.868 179.211 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.575 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.21 120.03 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.23 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -81.31 108.85 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.651 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' HB ' ' CE2' ' A' ' 10' ' ' PHE . 2.5 mt -117.17 137.54 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.417 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.437 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 52.5 p90 -149.06 157.14 43.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.052 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -159.37 159.71 34.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.075 0.464 . . . . 0.0 111.64 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -126.45 124.08 39.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.809 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.538 HG21 ' HB ' ' A' ' 24' ' ' VAL . 60.6 t -112.75 130.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.693 ' HB2' HG12 ' A' ' 3' ' ' VAL . 53.2 t -151.65 148.86 28.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -74.75 -41.78 59.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . 1.1 m-20 -100.96 131.03 47.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.738 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -90.65 -40.63 11.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.11 -31.49 27.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.911 ' O ' HD22 ' A' ' 52' ' ' LEU . 22.5 mm -75.89 -3.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.385 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -147.32 114.73 4.19 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.96 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.16 157.89 28.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.403 2.068 . . . . 0.0 112.261 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.49 172.2 14.72 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.634 2.223 . . . . 0.0 112.444 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.705 HD11 HG21 ' A' ' 5' ' ' THR . 2.9 tp -77.2 -53.57 7.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 107.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -73.0 -35.71 66.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.8 -35.6 73.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.018 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -71.49 -29.92 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.37 111.55 3.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.392 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.707 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 91.7 mt-10 -128.37 132.46 48.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 m -106.02 106.36 16.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -75.69 135.11 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.38 -57.7 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.297 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 68' ' ' VAL . 1.1 p -86.78 -175.16 0.56 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.511 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 79.6 Cg_exo -42.06 -47.86 6.56 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.214 1.943 . . . . 0.0 111.705 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.748 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.7 tm? -154.86 81.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.805 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG23 ' OG ' ' A' ' 65' ' ' SER . 69.0 t -142.27 118.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.296 178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -105.72 106.16 16.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.507 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -166.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.211 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -79.35 -144.2 2.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 75.4 Cg_exo -49.77 121.69 7.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.144 . . . . 0.0 112.197 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -58.17 111.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.09 83.93 1.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.625 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 11.9 tp -137.64 85.1 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 77' ' ' PHE . 1.7 tptp -61.7 132.82 54.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 43.3 m-85 -112.7 144.11 42.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.746 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -88.8 17.22 5.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 111.369 179.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -164.68 136.33 3.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.21 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.28 102.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.522 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.4 m -74.06 161.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.504 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -104.81 129.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 111.317 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.572 ' HB3' HG23 ' A' ' 113' ' ' VAL . 27.8 tp -124.16 118.07 26.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.387 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.503 ' O ' HG13 ' A' ' 24' ' ' VAL . 10.9 mmt180 -105.94 130.93 53.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.961 HD12 HG11 ' A' ' 111' ' ' VAL . 1.3 mt -128.13 116.18 20.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 24' ' ' VAL . 51.6 Cg_exo -54.48 136.73 70.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.385 2.057 . . . . 0.0 112.251 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.29 -20.12 57.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 68.31 31.45 5.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -143.63 77.88 14.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.697 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.48 54.42 2.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.923 2.415 . . . . 0.0 112.628 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.31 -13.05 14.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.617 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 t -122.6 16.1 10.33 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.474 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.4 p-90 -106.78 -36.05 6.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -104.32 71.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -119.37 -39.51 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -43.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 35.4 m -54.56 179.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.13 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 98' ' ' LEU . 11.5 mt -99.0 135.87 20.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.93 -5.72 16.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 112.58 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.4 -41.04 7.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.648 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 61.2 m-20 -61.53 138.51 95.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.52 0.2 . . . . 0.0 110.745 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.762 ' O ' HG22 ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.05 -27.29 50.04 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.175 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -65.28 -15.06 62.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.986 0.422 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.805 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.97 -19.45 18.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.839 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.805 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 14.7 mt -155.58 -28.2 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.11 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -177.88 -36.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.649 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.98 -58.95 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.256 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -96.18 88.39 4.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.47 141.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.961 HG11 HD12 ' A' ' 85' ' ' LEU . 14.2 p -97.32 115.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.18 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.77 104.99 10.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.133 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 83' ' ' LEU . 12.3 m -128.07 120.97 54.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.994 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 12.2 mt -87.06 146.12 26.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 81' ' ' VAL . 30.8 mm -129.8 120.39 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.2 25.87 8.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.078 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.36 103.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.823 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.2 -19.16 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.752 HG21 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -111.21 126.25 68.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.363 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' A' ' 21' ' ' GLU . . . -104.84 117.61 34.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.497 HG22 ' HB3' ' A' ' 44' ' ' LYS . 57.2 p -118.57 143.27 46.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.863 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -139.45 122.96 17.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.967 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.458 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -127.85 129.36 46.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.36 142.88 7.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -89.89 135.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.838 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.7 m-85 -115.89 151.6 35.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 111.374 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.0 172.31 11.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.654 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.42 -28.97 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -54.76 -29.7 54.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 167.43 32.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.679 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.97 158.48 9.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.347 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.615 HG22 HG23 ' A' ' 27' ' ' ILE . 2.9 t -114.58 151.03 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' A' ' 6' ' ' ALA . 44.0 tp -123.47 100.24 6.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.29 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.47 152.9 42.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.022 0.439 . . . . 0.0 111.89 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.463 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 51.2 m -120.75 97.25 5.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -52.73 -26.54 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' HB2' ' A' ' 4' ' ' ALA . 3.3 mm-40 -66.7 -36.3 82.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.304 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.444 HG21 ' HB ' ' A' ' 45' ' ' VAL . 4.3 p -109.22 -52.89 2.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.736 0.303 . . . . 0.0 111.356 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.92 -43.11 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.812 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.629 ' HB ' HG21 ' A' ' 45' ' ' VAL . 47.2 t -49.83 143.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.4 p -149.47 167.14 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.516 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 83' ' ' LEU . 14.0 mt -139.67 113.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.038 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.615 HG23 HG22 ' A' ' 16' ' ' VAL . 2.2 mp -92.81 122.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.838 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.2 mt -112.08 89.48 11.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.85 156.67 65.03 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.499 2.133 . . . . 0.0 112.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -57.29 104.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 145.17 -13.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.13 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -78.13 -36.01 48.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.382 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.465 HD13 ' CG ' ' A' ' 39' ' ' GLN . 16.3 mt -108.32 141.37 23.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.596 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 19.7 Cg_exo -65.37 155.17 70.12 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.336 2.024 . . . . 0.0 112.131 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 142.46 57.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.53 23.37 75.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 38' ' ' GLU . 48.2 t -126.88 161.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 111.251 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.56 ' N ' HG12 ' A' ' 37' ' ' VAL . 3.2 mt-10 -137.04 113.74 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.813 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.465 ' CG ' HD13 ' A' ' 33' ' ' ILE . 1.4 mm-40 -105.71 117.41 33.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -69.72 119.58 14.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.501 HD11 HD21 ' A' ' 75' ' ' LEU . 3.7 mm -120.66 109.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.458 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 12.3 p90 -138.18 161.27 37.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.309 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.5 OUTLIER -170.84 165.22 7.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 111.86 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 2.3 pttp -132.37 132.63 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.691 HG22 HG13 ' A' ' 68' ' ' VAL . 56.4 t -119.2 138.52 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.228 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.554 ' HB2' HG12 ' A' ' 3' ' ' VAL . 53.3 t -165.53 148.99 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.773 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.7 -38.97 70.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 110.829 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' HB3' HG12 ' A' ' 51' ' ' ILE . 13.0 t70 -132.73 157.99 43.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.595 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -90.43 -40.77 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.553 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -53.54 -23.64 11.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.642 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 51' ' ' ILE . 24.8 mm -66.76 -12.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.647 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.752 HD22 HG21 ' A' ' 3' ' ' VAL . 16.0 tp -169.35 137.07 1.53 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.663 0.268 . . . . 0.0 111.07 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' A' ' 52' ' ' LEU . 64.4 Cg_endo -73.56 163.69 36.84 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.449 2.1 . . . . 0.0 112.333 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.43 169.17 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.575 2.183 . . . . 0.0 112.231 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 mp -86.63 -35.47 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.81 96.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -33.87 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.023 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.73 -29.58 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -80.33 -32.9 37.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.05 111.85 3.6 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.33 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -96.3 115.11 26.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.22 111.31 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.472 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.87 144.04 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.296 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -126.34 -57.68 1.38 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.013 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.543 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -98.97 -173.37 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.297 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.2 Cg_exo -40.49 -42.4 3.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.223 1.949 . . . . 0.0 111.864 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.6 tm? -157.6 81.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.744 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.691 HG13 HG22 ' A' ' 45' ' ' VAL . 43.2 t -141.55 118.01 7.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.63 106.19 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.553 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.529 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -66.8 -169.6 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.041 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -61.3 -152.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.541 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 37.1 Cg_endo -65.94 134.37 36.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.544 2.163 . . . . 0.0 112.065 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -60.57 110.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.37 75.98 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.718 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 24.4 tp -142.27 86.41 1.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.144 0.497 . . . . 0.0 110.2 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -53.78 164.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.433 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -146.34 141.37 27.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.625 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.412 HD21 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.68 16.66 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.317 0.58 . . . . 0.0 110.827 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -166.51 136.78 2.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.021 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.77 100.65 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.525 2.15 . . . . 0.0 112.641 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 115' ' ' ILE . 13.5 m -68.13 139.48 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -82.86 123.39 29.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 0.0 111.409 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 26' ' ' ILE . 7.7 tp -124.2 121.05 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.182 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.517 ' N ' HD12 ' A' ' 83' ' ' LEU . 71.7 mtt-85 -115.78 132.88 56.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.709 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 119.49 6.37 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.527 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.63 130.75 38.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.274 1.983 . . . . 0.0 112.236 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.6 -54.8 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.27 168.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 56.04 85.25 0.19 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.187 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.14 38.21 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.855 2.37 . . . . 0.0 112.681 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -108.98 13.17 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.54 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 t -105.47 15.92 26.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 111.819 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.512 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 4.6 p-90 -121.16 -39.94 2.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 4.6 mm100 -99.51 59.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.97 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -127.12 89.2 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tptt 60.74 29.62 19.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -120.5 -171.13 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 98' ' ' LEU . 16.5 mt -85.81 128.75 57.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.27 -7.97 17.26 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.497 2.132 . . . . 0.0 112.539 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.92 10.95 8.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.053 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -71.48 126.62 91.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.937 0.369 . . . . 0.0 110.375 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.744 ' O ' HG21 ' A' ' 106' ' ' VAL . 58.2 Cg_endo -71.48 -7.03 20.41 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.165 1.91 . . . . 0.0 112.671 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.485 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -104.82 17.36 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -75.43 -113.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.034 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -48.04 -21.09 0.4 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.744 HG21 ' O ' ' A' ' 102' ' ' PRO . 15.6 m -68.71 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 155.2 34.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.645 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.72 -51.59 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.04 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.3 29.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.859 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 151.17 36.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.769 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.709 HG11 HD12 ' A' ' 85' ' ' LEU . 11.8 p -93.63 103.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.204 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.34 104.98 7.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 83' ' ' LEU . 5.4 m -120.85 123.22 69.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.45 135.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.7 mm -119.54 117.83 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.244 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.34 26.29 9.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.292 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.509 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.7 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.759 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 44' ' ' LYS . 81.1 p -122.52 143.25 49.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -141.81 112.4 7.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 11.3 ttm-85 -121.54 129.43 52.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 156.89 27.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.685 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 38.1 mt -89.68 154.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.608 ' CE2' HD11 ' A' ' 28' ' ' ILE . 18.7 m-85 -127.5 175.25 8.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.135 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -151.31 171.79 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -61.7 -23.13 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.942 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -56.4 -45.44 80.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.29 152.36 8.75 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.827 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.69 -173.32 45.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.087 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.498 HG13 HG13 ' A' ' 27' ' ' ILE . 2.8 t -145.64 150.61 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.392 0.615 . . . . 0.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.652 HD11 ' CB ' ' A' ' 6' ' ' ALA . 22.3 tp -123.34 100.18 6.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.233 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 143.82 50.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.99 0.424 . . . . 0.0 111.811 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.29 97.09 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.247 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -54.06 -26.82 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.419 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.759 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 1.4 mm-40 -62.47 -22.73 66.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.314 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' CB ' ' A' ' 4' ' ' ALA . 1.1 p -126.16 -52.97 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.79 -40.27 1.65 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.694 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 84' ' ' ARG . 33.9 t -53.55 137.98 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.741 0.305 . . . . 0.0 111.129 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.5 p -141.82 169.75 17.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.632 HG12 HD13 ' A' ' 83' ' ' LEU . 24.0 mt -141.59 113.65 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.209 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.0 mp -93.14 131.42 40.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.608 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -103.41 95.15 6.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.608 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.54 138.41 75.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.353 2.036 . . . . 0.0 112.084 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -51.09 101.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.009 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.3 -3.98 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.013 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.05 -30.28 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.892 0.346 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 39' ' ' GLN . 28.3 mt -119.93 143.48 35.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.53 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.5 Cg_exo -64.9 150.8 87.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.375 2.05 . . . . 0.0 112.114 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.6 mt-10 -66.57 151.68 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.46 65.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.57 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 38' ' ' GLU . 44.2 t -127.81 160.56 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG12 ' A' ' 37' ' ' VAL . 17.8 mt-10 -128.68 113.83 15.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.05 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.937 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.05 109.05 20.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.04 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.3 tt0 -74.45 114.69 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.808 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -124.91 139.02 52.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.138 0.494 . . . . 0.0 111.048 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 7' ' ' ARG . 21.3 p90 -153.45 171.51 18.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -175.5 156.81 2.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.181 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.659 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -129.41 122.12 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.077 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.753 HG22 HG13 ' A' ' 68' ' ' VAL . 39.6 t -110.32 136.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.537 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.27 96.43 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.554 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -69.14 143.16 54.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -126.25 -57.73 1.38 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.539 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -96.42 -173.89 0.36 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.258 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.37 -40.31 3.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.281 1.987 . . . . 0.0 111.877 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.74 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -161.19 78.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.753 HG13 HG22 ' A' ' 45' ' ' VAL . 48.6 t -137.61 117.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.566 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.42 106.17 16.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.707 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -60.28 -163.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.114 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -74.59 -144.54 0.97 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.442 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 45.2 Cg_endo -68.12 128.33 17.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.133 . . . . 0.0 112.148 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -57.58 110.83 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.8 77.48 0.86 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.743 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.729 HD11 ' HG2' ' A' ' 39' ' ' GLN . 22.6 tp -141.41 86.64 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 110.061 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.505 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -56.18 166.27 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.134 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 19.2 m-85 -148.72 143.54 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.683 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -96.53 17.9 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.3 ttmt -167.48 136.37 2.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.209 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 39.3 Cg_exo -60.54 96.88 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.408 2.072 . . . . 0.0 112.6 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 115' ' ' ILE . 3.5 m -68.1 140.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.536 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.03 125.12 32.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.798 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 26' ' ' ILE . 20.5 tp -124.19 128.1 48.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.944 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.763 ' O ' HG13 ' A' ' 24' ' ' VAL . 36.1 mtt-85 -119.76 130.71 55.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.862 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.543 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 154.96 60.06 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.531 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 131.57 23.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.352 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.41 ' CE1' HG21 ' A' ' 92' ' ' THR . 0.0 OUTLIER -79.13 -51.84 8.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.862 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.73 44.9 10.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.59 105.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.78 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.81 39.39 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.666 2.244 . . . . 0.0 112.828 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -108.71 13.26 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.132 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.41 HG21 ' CE1' ' A' ' 87' ' ' HIS . 3.7 t -120.99 16.19 11.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 111.547 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.493 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 8.8 p-90 -118.72 -45.01 2.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.781 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.493 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.9 OUTLIER -88.07 91.36 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -162.04 71.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tptp 60.29 34.93 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.64 -173.59 4.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 23.0 mt -83.87 126.03 71.55 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 9.4 Cg_exo -71.29 -24.44 23.02 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.584 2.189 . . . . 0.0 112.602 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.31 14.12 20.97 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 6.3 t70 -114.0 130.53 23.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.893 0.346 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.823 ' O ' HG22 ' A' ' 106' ' ' VAL . 29.3 Cg_endo -62.94 -30.83 77.27 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.57 2.18 . . . . 0.0 112.222 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -55.57 -20.17 12.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 110.888 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CE1' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.52 -12.21 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.06 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.849 HD22 ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -165.26 -13.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -177.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 102' ' ' PRO . 15.9 m -65.12 36.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -153.15 25.26 0.79 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.15 -33.91 14.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.133 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -58.63 -31.62 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -150.43 139.14 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 111' ' ' VAL . 13.8 p -91.31 112.0 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 105.04 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 83' ' ' LEU . 11.5 m -123.27 123.6 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.061 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -93.5 139.16 31.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.953 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.502 ' HB ' HG22 ' A' ' 81' ' ' VAL . 37.2 mm -121.33 122.22 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.41 25.94 6.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.092 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.505 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.63 102.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.078 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.556 HG22 ' CG ' ' A' ' 44' ' ' LYS . 55.7 p -137.41 143.39 41.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.995 0.426 . . . . 0.0 111.274 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.706 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -137.37 137.21 38.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.8 mpp_? -134.73 137.72 43.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 160.86 33.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.822 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.424 HD13 ' HG3' ' A' ' 40' ' ' GLU . 10.4 mm -94.43 154.88 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.598 0.237 . . . . 0.0 110.655 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.931 ' CD1' HD12 ' A' ' 28' ' ' ILE . 51.1 m-85 -135.17 146.01 48.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.28 171.87 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.631 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p -48.84 -26.92 2.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.172 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -56.8 -31.91 65.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.62 -174.57 32.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.546 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.26 -161.66 29.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.121 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 27' ' ' ILE . 2.8 t -143.75 151.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 111.731 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 25' ' ' SER . 39.2 tp -123.02 99.96 6.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.041 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.39 154.8 33.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 111.961 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 m -120.94 97.22 5.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.147 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.56 -26.53 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.697 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.2 mt-10 -66.41 -46.29 77.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.464 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.632 HG21 HG12 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -100.92 -52.94 3.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 111.371 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.02 -36.25 2.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.646 HG22 ' HD2' ' A' ' 86' ' ' PRO . 43.6 t -53.93 145.8 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.738 0.304 . . . . 0.0 110.853 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.69 167.34 26.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 0.0 111.513 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.818 HG12 HD13 ' A' ' 83' ' ' LEU . 27.8 mt -134.1 113.84 18.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.717 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.5 mp -91.69 119.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.797 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.931 HD12 ' CD1' ' A' ' 10' ' ' PHE . 5.3 mt -106.77 97.35 17.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.95 156.86 64.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.435 2.09 . . . . 0.0 112.139 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -57.75 112.97 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.71 5.93 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.198 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -86.68 -25.88 24.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.022 0.411 . . . . 0.0 111.21 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.868 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.4 mt -122.53 141.92 36.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.45 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -61.75 155.47 53.92 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.315 2.01 . . . . 0.0 112.11 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 37' ' ' VAL . 34.1 mt-10 -67.89 154.99 40.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.41 26.6 56.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 35' ' ' GLU . 38.6 t -133.3 159.93 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.532 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -133.64 113.81 12.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.852 179.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.868 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.74 112.05 25.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.14 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG3' HD13 ' A' ' 9' ' ' ILE . 44.2 tt0 -72.59 124.23 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.72 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.6 135.24 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.17 0.509 . . . . 0.0 111.423 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.485 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.9 p90 -148.36 169.33 20.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.9 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.706 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -165.63 157.7 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.443 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.556 ' CG ' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER -124.66 115.95 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 22' ' ' THR . 25.0 t -109.44 135.44 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.523 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.9 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.388 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.49 109.45 20.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.26 142.57 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.5 -57.75 1.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 111.254 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.519 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.58 -175.22 0.42 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.308 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.5 Cg_exo -40.53 -44.35 4.4 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.242 1.961 . . . . 0.0 111.684 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.688 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -153.18 86.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.495 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.3 t -147.63 117.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.429 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -108.52 105.86 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.83 -172.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.19 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 42' ' ' TYR . . . -62.87 -147.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.42 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 36.6 Cg_endo -65.51 126.68 16.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.137 . . . . 0.0 111.932 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -52.97 110.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.27 80.86 1.37 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.9 tp -143.05 86.81 1.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.17 0.51 . . . . 0.0 110.26 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 8.5 tmtt? -67.39 145.72 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.092 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 52.3 m-85 -122.77 151.41 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.715 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.552 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.16 14.62 21.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.28 0.562 . . . . 0.0 111.145 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -161.15 136.51 5.72 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.288 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.47 98.47 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.376 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.5 m -70.58 142.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.82 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.75 125.94 36.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.309 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.818 HD13 HG12 ' A' ' 26' ' ' ILE . 9.1 tp -124.08 129.01 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.593 ' N ' HD12 ' A' ' 83' ' ' LEU . 10.5 mtm105 -125.76 124.78 41.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.182 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.519 HD13 ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -137.0 134.36 19.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.631 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.646 ' HD2' HG22 ' A' ' 24' ' ' VAL . 52.0 Cg_exo -52.94 143.37 49.56 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.352 2.035 . . . . 0.0 112.152 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 25.6 p-80 -49.78 -47.32 51.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 9.2 m 49.22 76.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.213 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.32 92.83 0.28 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.71 41.13 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.94 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.08 -11.3 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.1 t -120.69 16.07 11.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.483 ' CZ2' ' HG3' ' A' ' 94' ' ' GLN . 2.4 p-90 -113.65 -35.75 5.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -101.45 -23.25 14.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.254 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -98.81 -27.09 14.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -67.3 0.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.134 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.92 177.0 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 23.4 mt -91.53 129.45 42.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 36.7 Cg_exo -59.98 -22.31 68.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.662 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.48 -39.92 6.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.946 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 2.5 m-20 -55.3 124.96 56.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.899 ' O ' HG22 ' A' ' 106' ' ' VAL . 49.3 Cg_exo -55.24 -31.58 76.99 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.377 2.051 . . . . 0.0 112.2 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.8 -14.94 57.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.76 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -17.49 6.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.912 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.76 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 10.3 mt -158.08 -32.11 0.07 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.1 m -69.11 36.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -144.04 -42.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.746 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.42 -60.29 3.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 111.346 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 62.91 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 22.4 m -151.2 171.55 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 0.0 111.009 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 111' ' ' VAL . 11.1 p -109.24 120.11 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.34 105.1 7.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 83' ' ' LEU . 10.6 m -127.24 121.71 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.056 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 mt -89.46 140.33 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 81' ' ' VAL . 29.8 mm -127.22 121.93 58.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.73 24.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.251 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.481 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 179.2 111.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.004 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.751 0.31 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -127.46 143.69 51.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 0.0 111.15 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -130.7 107.07 8.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.452 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 17.6 mtt180 -107.08 129.39 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.4 142.03 6.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.006 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 10' ' ' PHE . 25.9 mt -87.51 159.82 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.633 0.254 . . . . 0.0 110.433 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.5 m-85 -140.73 152.28 45.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -131.17 172.3 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.6 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -44.82 -28.89 0.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.49 -33.79 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -174.86 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.754 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.07 163.28 11.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.144 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 27' ' ' ILE . 2.9 t -119.92 150.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.369 0.604 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.535 HD11 ' HB1' ' A' ' 6' ' ' ALA . 22.3 tp -123.5 100.34 6.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.457 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.18 149.53 50.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 111.958 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.54 97.1 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.927 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.77 -26.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.742 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 9.5 tt0 -62.24 -41.42 98.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.599 HG23 ' CB ' ' A' ' 4' ' ' ALA . 2.8 p -106.34 -52.91 2.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.67 -35.18 2.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 45' ' ' VAL . 22.6 t -49.08 139.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.14 155.64 42.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 111.382 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.736 HG12 HD13 ' A' ' 83' ' ' LEU . 49.5 mt -136.98 113.54 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.568 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 16' ' ' VAL . 2.0 mp -92.64 136.01 26.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.002 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.736 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.7 mt -124.65 89.22 52.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.8 160.87 46.38 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.495 2.13 . . . . 0.0 112.218 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -57.12 113.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.65 -2.7 4.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.033 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -87.33 -29.43 21.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.997 0.399 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 39' ' ' GLN . 20.9 mt -122.78 137.16 27.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.609 ' HD3' HD21 ' A' ' 78' ' ' LEU . 34.3 Cg_exo -60.62 155.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.214 1.943 . . . . 0.0 112.149 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.59 140.43 58.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.39 21.71 78.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.429 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 38' ' ' GLU . 43.3 t -123.34 160.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 111.211 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.553 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.7 mt-10 -139.28 113.6 8.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.74 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' CG ' HD13 ' A' ' 33' ' ' ILE . 7.5 mm-40 -105.04 108.95 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.056 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -72.96 121.1 19.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 mt -128.18 130.16 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.452 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 31.8 p90 -144.75 142.2 29.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.904 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.488 ' CE1' HG23 ' A' ' 45' ' ' VAL . 2.3 p90 -145.08 164.36 31.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.088 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 150.25 50.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.22 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 68' ' ' VAL . 78.6 t -144.07 140.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.799 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.8 pp20? . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.748 0.309 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 118.77 30.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -95.66 137.97 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.722 HD13 HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.39 -57.59 1.38 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.612 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -89.68 -177.56 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.679 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.3 -49.02 4.01 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.53 2.154 . . . . 0.0 111.771 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.711 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -151.15 84.82 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 45' ' ' VAL . 46.2 t -146.78 118.21 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.563 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.799 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -110.66 107.08 16.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.692 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -65.94 -168.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.151 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 42' ' ' TYR . . . -64.55 -155.98 0.17 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.615 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 51.1 Cg_exo -53.78 130.63 40.02 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.519 2.146 . . . . 0.0 112.201 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 111.05 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.816 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.21 84.04 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.719 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 33.0 tp -142.16 86.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 110.146 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.5 OUTLIER -57.53 164.51 1.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.117 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -148.13 146.98 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.609 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.67 15.32 22.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -160.07 136.53 6.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.52 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 26.5 Cg_exo -62.64 99.32 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.446 2.098 . . . . 0.0 112.457 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 115' ' ' ILE . 11.3 m -69.67 143.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.864 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.85 128.2 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.192 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 26' ' ' ILE . 7.1 tp -124.35 127.06 47.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.499 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.628 ' N ' HD12 ' A' ' 83' ' ' LEU . 25.1 mtt180 -114.93 133.78 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.956 HD12 HG11 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -129.7 107.6 17.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.894 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.08 131.23 43.62 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.388 2.059 . . . . 0.0 112.14 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -27.13 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.085 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 12.9 m 65.37 -166.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.25 94.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.38 49.57 3.25 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.668 2.245 . . . . 0.0 112.666 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 5.04 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.412 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.51 16.12 10.41 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.922 0.392 . . . . 0.0 111.845 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.664 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -115.0 -36.11 4.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.664 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 3.1 mt-30 -105.04 55.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.098 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -157.63 105.16 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.16 33.3 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.4 m -133.95 176.17 8.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.991 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.5 mt -91.31 131.67 35.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -77.23 -2.35 12.56 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.26 -18.44 6.72 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.806 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.409 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -66.26 116.57 34.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.59 0.233 . . . . 0.0 110.86 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.792 ' O ' HG22 ' A' ' 106' ' ' VAL . 71.6 Cg_exo -50.82 -30.61 30.33 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.472 2.115 . . . . 0.0 112.296 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.803 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 32.9 m-80 -60.59 -19.49 57.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.4 -18.71 19.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.735 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 20.2 mt -157.01 -29.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.85 36.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 118.62 47.41 0.41 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.566 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 103' ' ' ASN . . . -94.5 -34.49 12.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.46 82.47 2.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.04 139.24 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.706 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.956 HG11 HD12 ' A' ' 85' ' ' LEU . 14.9 p -99.57 108.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.466 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.09 104.91 11.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.1 m -122.68 131.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.241 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mt -103.35 134.81 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.899 ' O ' HG22 ' A' ' 81' ' ' VAL . 38.0 mm -122.13 122.9 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.559 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -124.01 26.47 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.956 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.453 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -173.11 101.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.16 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.718 ' CE1' HG21 ' A' ' 115' ' ' ILE . 2.3 m-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.772 0.32 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.5 p -119.89 143.99 47.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -131.74 115.71 16.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.852 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -120.48 131.95 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.35 28.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.084 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -105.72 131.84 54.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.709 0.29 . . . . 0.0 110.453 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CG ' HD13 ' A' ' 28' ' ' ILE . 71.6 m-85 -112.48 153.26 27.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.047 0.451 . . . . 0.0 111.429 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.7 171.99 9.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -48.26 -27.48 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.33 -37.26 69.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.258 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 179.01 23.62 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.577 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.01 167.45 15.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.084 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG13 HG13 ' A' ' 27' ' ' ILE . 1.9 t -117.87 148.22 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.73 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.737 HD11 ' HB1' ' A' ' 6' ' ' ALA . 30.4 tp -123.3 100.2 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.203 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.91 145.51 50.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 111.854 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -110.84 97.19 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.249 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -50.48 -26.5 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.644 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -65.86 -30.5 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.36 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 4' ' ' ALA . 1.3 p -115.52 -53.0 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.726 0.298 . . . . 0.0 111.291 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.65 -38.04 1.97 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.788 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG22 ' HD2' ' A' ' 86' ' ' PRO . 60.6 t -48.56 144.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.0 p -149.73 152.06 34.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.465 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.664 HG12 HD13 ' A' ' 83' ' ' LEU . 41.6 mt -129.84 113.37 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.442 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.645 HG13 HG13 ' A' ' 16' ' ' VAL . 2.8 mt -97.3 123.24 49.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.058 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.68 ' CG2' ' HB3' ' A' ' 32' ' ' ALA . 1.5 mt -113.53 92.91 25.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.63 157.37 58.93 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.94 106.54 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 137.68 -7.23 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.106 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -81.72 -24.28 36.22 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.934 0.367 . . . . 0.0 111.234 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.642 HD13 ' CB ' ' A' ' 39' ' ' GLN . 35.4 mt -125.68 141.1 38.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.472 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' HD21 ' A' ' 78' ' ' LEU . 39.2 Cg_exo -59.92 155.45 44.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 37' ' ' VAL . 20.6 mt-10 -70.85 148.68 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.63 22.89 68.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.547 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 38' ' ' GLU . 38.5 t -130.31 160.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.027 0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' N ' HG12 ' A' ' 37' ' ' VAL . 20.1 mt-10 -131.55 113.96 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.996 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.693 ' HG2' HD11 ' A' ' 75' ' ' LEU . 23.6 tp60 -101.12 109.05 20.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.993 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.1 123.23 21.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.595 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.34 132.71 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.521 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.5 p90 -146.81 170.07 17.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.333 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.681 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.3 p90 -175.93 157.31 1.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.378 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -128.35 133.04 48.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.079 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.811 HG22 HG13 ' A' ' 68' ' ' VAL . 88.9 t -119.86 130.63 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.569 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.551 ' O ' HD12 ' A' ' 67' ' ' LEU . 1.1 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.179 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 pm0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 3.0 m -123.01 99.15 6.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.236 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.34 138.32 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.444 HD13 HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.39 -57.62 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.996 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.544 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -91.49 -172.56 0.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.195 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 63.7 Cg_exo -40.19 -48.53 3.97 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.203 1.936 . . . . 0.0 111.815 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.68 ' O ' HD13 ' A' ' 67' ' ' LEU . 1.9 tm? -155.67 78.72 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.781 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.811 HG13 HG22 ' A' ' 45' ' ' VAL . 42.5 t -137.56 117.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.746 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.3 106.91 17.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.662 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -61.86 -171.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -63.87 -144.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.542 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 51.4 Cg_endo -68.97 130.59 20.61 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.475 2.116 . . . . 0.0 111.989 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -57.67 110.76 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.5 75.59 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.765 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.693 HD11 ' HG2' ' A' ' 39' ' ' GLN . 5.1 tp -138.76 84.62 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 1.5 tmtm? -63.23 151.88 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.236 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 31.4 m-85 -129.69 151.17 50.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.551 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.706 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -93.73 15.23 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 111.221 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -165.04 136.42 3.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.269 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.06 99.2 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 115' ' ' ILE . 6.6 m -69.76 152.8 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HB3' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -95.0 126.81 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 111.343 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.666 ' HG ' HD21 ' A' ' 85' ' ' LEU . 36.5 tp -124.21 116.94 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -106.92 131.01 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.159 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.94 HD12 HG11 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -130.54 123.29 20.26 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.765 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 24' ' ' VAL . 73.9 Cg_endo -75.08 120.1 5.9 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.34 2.027 . . . . 0.0 112.095 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.06 -30.19 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.1 m 60.54 65.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -114.32 110.83 47.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.815 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.98 39.04 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.653 2.235 . . . . 0.0 112.929 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 -9.13 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.597 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.6 t -122.7 16.07 10.25 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.456 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.8 p-90 -107.03 -38.4 6.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.071 0.462 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.456 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -95.61 56.4 1.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.811 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.16 -45.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.1 -46.58 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 62.3 m -54.9 176.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.122 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 11.8 mt -99.86 124.26 44.47 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.23 -26.97 72.22 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.469 2.112 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.55 -16.11 44.06 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.967 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 98' ' ' LEU . 5.8 t70 -80.62 137.95 51.13 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.808 0.304 . . . . 0.0 111.008 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.76 ' O ' HG22 ' A' ' 106' ' ' VAL . 53.2 Cg_endo -68.71 -24.39 35.0 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.751 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 96.9 m-20 -64.07 -17.01 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.79 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -20.21 15.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.85 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.79 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 16.6 mt -155.08 -26.82 0.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.9 m -66.78 36.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 123.06 36.4 0.66 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.531 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 103' ' ' ASN . . . -94.44 -33.32 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.113 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -134.03 51.48 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.87 141.05 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.94 HG11 HD12 ' A' ' 85' ' ' LEU . 13.8 p -85.38 107.61 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.391 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.71 104.92 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 111' ' ' VAL . 7.7 m -123.99 125.0 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.4 mt -90.07 145.13 25.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.3 mm -129.32 117.66 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.53 27.42 8.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.492 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.98 106.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.815 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.616 HG22 ' HG2' ' A' ' 44' ' ' LYS . 21.5 p -136.59 145.38 44.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.757 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -133.84 133.06 41.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 4.6 ttt180 -135.7 129.33 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.526 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.99 169.96 42.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.64 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 28.2 mt -104.49 137.88 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.719 ' CG ' HD12 ' A' ' 28' ' ' ILE . 87.9 m-85 -120.35 153.2 36.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -124.21 171.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 p -55.91 -22.38 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.266 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.61 -36.31 71.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 110.963 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.68 158.68 11.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.72 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.01 164.46 25.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.255 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 27' ' ' ILE . 3.1 t -122.26 152.38 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.757 HD11 ' CB ' ' A' ' 6' ' ' ALA . 28.5 tp -123.34 100.2 6.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.365 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.47 154.35 42.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 0.0 112.039 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.468 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 2.7 p -119.92 97.2 5.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.967 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.0 mm -49.4 -26.57 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.914 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.817 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -65.35 -55.69 16.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.343 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 4' ' ' ALA . 6.9 p -90.45 -52.88 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.296 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.43 -36.54 2.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.781 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 84' ' ' ARG . 21.5 t -48.66 143.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.655 0.264 . . . . 0.0 111.072 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -148.8 161.63 41.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.474 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.793 HG12 HD13 ' A' ' 83' ' ' LEU . 32.2 mt -137.38 113.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.774 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 16' ' ' VAL . 2.4 mp -92.39 128.24 44.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.851 0.358 . . . . 0.0 110.926 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.761 HG22 ' HB3' ' A' ' 32' ' ' ALA . 2.2 mt -112.75 94.49 28.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.435 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.21 157.68 48.46 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.661 2.241 . . . . 0.0 112.452 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -60.89 95.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.617 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 145.14 -11.3 1.82 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.877 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.761 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -72.94 -23.57 60.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.823 0.311 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.823 HD13 ' HB2' ' A' ' 39' ' ' GLN . 39.1 mt -124.5 141.85 38.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.449 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.728 ' HD3' HD21 ' A' ' 78' ' ' LEU . 32.0 Cg_exo -58.68 152.37 56.71 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.378 2.052 . . . . 0.0 112.371 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -67.93 152.55 45.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.96 23.34 56.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 35' ' ' GLU . 39.1 t -131.1 160.75 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 111.075 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.545 ' N ' HG12 ' A' ' 37' ' ' VAL . 14.9 mt-10 -132.62 113.94 13.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.121 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.823 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -99.01 113.37 25.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.037 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -74.4 115.66 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.577 HD11 ' HE1' ' A' ' 77' ' ' PHE . 29.4 mt -123.23 139.71 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.174 0.511 . . . . 0.0 111.255 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.425 ' CB ' ' HA ' ' A' ' 7' ' ' ARG . 21.0 p90 -153.06 162.61 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -166.36 158.89 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.923 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.664 ' HE2' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.92 149.33 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.509 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 68' ' ' VAL . 37.1 t -145.29 135.36 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.42 ' O ' HD12 ' A' ' 67' ' ' LEU . 18.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.839 0.352 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.78 104.98 10.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.71 139.06 37.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.46 -57.6 1.37 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.284 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.704 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -94.37 -175.37 0.47 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.29 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.25 -46.97 5.49 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.169 1.912 . . . . 0.0 111.538 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.74 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.6 tm? -151.53 80.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.528 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.9 t -141.85 118.24 6.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.511 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -106.53 106.16 16.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.613 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB1' ' CE2' ' A' ' 118' ' ' PHE . . . -64.87 -178.67 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.08 -156.71 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.637 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 48.7 Cg_exo -55.4 129.26 34.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.534 2.156 . . . . 0.0 112.12 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -58.45 111.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.06 72.42 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.727 HD11 ' HG2' ' A' ' 39' ' ' GLN . 20.6 tp -137.96 83.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.262 0.553 . . . . 0.0 110.002 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 10.3 mttt -73.0 117.16 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.046 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' HE1' HD11 ' A' ' 41' ' ' ILE . 84.6 m-85 -90.76 154.24 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.728 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.36 17.17 16.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.43 136.68 4.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.69 94.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.537 2.158 . . . . 0.0 112.769 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.5 m -70.1 133.4 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.553 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 28.9 mt-10 -82.64 128.18 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 111.563 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.793 HD13 HG12 ' A' ' 26' ' ' ILE . 14.7 tp -124.19 128.72 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.164 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.609 ' O ' HG13 ' A' ' 24' ' ' VAL . 25.5 mtt180 -115.73 127.41 55.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 0.0 111.561 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.704 HD13 ' OG ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -143.64 162.25 42.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.18 120.07 6.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.391 2.061 . . . . 0.0 112.313 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.54 -54.52 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 65.0 m 56.14 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.85 74.87 0.72 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.265 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HA ' ' CD1' ' A' ' 93' ' ' TRP . 96.3 Cg_endo -86.46 35.48 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.753 2.302 . . . . 0.0 112.929 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -13.75 14.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.658 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -122.62 16.15 10.32 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.502 ' CD1' ' HA ' ' A' ' 90' ' ' PRO . 3.3 p-90 -106.83 -35.87 6.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.476 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 7.7 pt20 -102.02 35.02 2.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -156.81 28.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -177.2 -62.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.4 m -70.75 178.93 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 98' ' ' LEU . 11.1 mt -98.68 121.61 55.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.8 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.71 -35.54 97.75 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.457 2.105 . . . . 0.0 112.36 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.56 -17.42 66.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.889 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -81.56 138.57 47.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.976 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.753 ' O ' HG22 ' A' ' 106' ' ' VAL . 50.0 Cg_endo -68.4 -24.52 36.74 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.516 2.144 . . . . 0.0 112.327 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.411 ' HA ' HG22 ' A' ' 106' ' ' VAL . 66.6 m-20 -63.73 -16.77 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 110.568 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.773 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.68 -18.89 23.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.98 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.773 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 16.4 mt -156.75 -24.19 0.1 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 102' ' ' PRO . 8.0 m -67.99 36.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.5 -44.18 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.238 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.83 -68.28 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.402 . . . . 0.0 110.994 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.68 -67.91 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 66.1 m -121.34 167.85 12.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.095 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 85' ' ' LEU . 13.4 p -108.0 139.22 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.86 105.05 16.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.371 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 m -129.8 123.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.073 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mt -97.04 142.12 29.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.74 ' O ' HG22 ' A' ' 81' ' ' VAL . 39.5 mm -123.84 123.26 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.0 25.83 7.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.915 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.473 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -174.2 103.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.401 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.686 ' CE1' HG21 ' A' ' 115' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.765 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 44' ' ' LYS . 71.2 p -118.35 143.25 46.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.0 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.69 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -135.56 109.35 8.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.664 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.445 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -117.68 129.85 55.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.07 154.26 22.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.709 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.28 144.14 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.935 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.971 ' CD2' HD12 ' A' ' 28' ' ' ILE . 29.4 m-85 -117.64 151.87 36.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.218 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -125.52 171.89 10.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.753 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -53.85 -23.65 13.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -42.48 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.186 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.04 130.47 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.771 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -151.93 -139.78 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.983 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 27' ' ' ILE . 2.1 t -151.52 148.3 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 111.684 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.69 HD11 ' HB1' ' A' ' 6' ' ' ALA . 15.3 tp -123.29 100.06 6.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.718 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.22 139.91 52.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.198 0.523 . . . . 0.0 112.391 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.745 ' OG ' ' HB1' ' A' ' 4' ' ' ALA . 32.1 t -111.54 96.54 6.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.905 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 20' ' ' ILE . 4.6 tp -58.85 -26.61 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.81 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.765 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -60.27 -28.8 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.313 . . . . 0.0 110.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.692 HG23 ' HB3' ' A' ' 4' ' ' ALA . 1.9 p -115.73 -52.81 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.777 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.56 -32.03 3.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.953 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 84' ' ' ARG . 21.7 t -59.6 147.07 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.826 0.346 . . . . 0.0 111.201 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.78 160.81 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.726 HG12 HD13 ' A' ' 83' ' ' LEU . 13.5 mt -135.58 113.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.75 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 16' ' ' VAL . 2.6 mt -96.38 114.72 33.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.971 HD12 ' CD2' ' A' ' 10' ' ' PHE . 4.3 mt -103.41 91.67 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.26 161.67 33.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.472 2.115 . . . . 0.0 112.506 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -59.49 111.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.36 -4.46 5.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.086 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.633 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -82.51 -22.51 35.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.782 0.291 . . . . 0.0 111.377 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.803 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.9 mt -131.58 139.17 34.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.768 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.79 ' HD3' HD21 ' A' ' 78' ' ' LEU . 35.1 Cg_exo -57.03 155.47 28.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.46 2.106 . . . . 0.0 112.221 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -68.82 148.96 49.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.81 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.51 24.86 69.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.3 t -130.02 160.69 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.7 mp0 -134.7 113.82 12.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.018 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.803 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.8 tp60 -100.64 109.59 21.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -69.71 118.43 12.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.65 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.4 mt -127.1 139.95 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB3' ' CG ' ' A' ' 7' ' ' ARG . 39.9 p90 -155.62 159.17 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.347 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -164.18 163.5 22.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.955 0.407 . . . . 0.0 111.592 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.553 ' HB3' HG22 ' A' ' 5' ' ' THR . 2.3 pttp -131.06 142.31 50.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.743 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 HG13 ' A' ' 68' ' ' VAL . 57.7 t -132.54 138.8 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.445 ' O ' HD12 ' A' ' 67' ' ' LEU . 40.9 t . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 111.176 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.49 98.35 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.73 142.14 35.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.993 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.605 ' CB ' HD13 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -90.56 -173.19 0.37 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.187 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.3 Cg_exo -40.63 -43.71 4.39 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.209 1.94 . . . . 0.0 111.716 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -160.6 79.73 0.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.834 HG13 HG22 ' A' ' 45' ' ' VAL . 47.2 t -138.27 118.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.701 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' HB1' ' HG2' ' A' ' 61' ' ' GLU . . . -102.06 106.27 17.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.632 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -170.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -62.94 -154.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.431 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -62.56 123.4 12.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.462 2.108 . . . . 0.0 112.058 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -50.77 110.86 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.54 0.67 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 39' ' ' GLN . 11.9 tp -139.15 85.17 2.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.0 110.242 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 16.2 tttm -65.96 138.49 57.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.866 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 37.6 m-85 -115.89 151.94 34.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.572 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.79 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.27 14.04 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 111.032 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -160.77 136.42 5.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.131 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.86 98.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.391 2.061 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.1 m -66.92 156.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.884 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.35 106.62 17.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.354 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.726 HD13 HG12 ' A' ' 26' ' ' ILE . 22.9 tp -104.26 129.72 52.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.424 ' O ' HG13 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -121.82 134.04 54.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.605 HD13 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -143.67 136.46 13.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.3 135.16 18.18 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.488 2.125 . . . . 0.0 112.206 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -59.2 -26.41 64.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.56 31.2 18.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.783 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -153.32 100.6 2.63 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.07 50.65 3.56 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.651 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 -6.64 15.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.514 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -111.07 16.15 21.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.422 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.6 p-90 -113.26 -37.24 4.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.422 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.8 OUTLIER -107.79 162.68 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.993 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.88 -65.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -69.01 -61.35 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 m -84.04 -178.27 6.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.95 123.32 66.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.24 -46.35 25.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.533 2.155 . . . . 0.0 112.467 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.54 -21.12 79.21 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.992 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -69.15 121.74 82.92 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.584 0.231 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.796 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.8 Cg_exo -53.3 -29.87 49.45 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.414 2.076 . . . . 0.0 112.223 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.51 -19.72 57.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.761 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.35 -19.81 16.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.627 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.761 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 17.9 mt -155.79 -29.2 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.98 36.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 174.59 -32.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.71 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.05 18.46 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.587 0.232 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -70.46 -31.76 69.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 13.0 m -139.88 166.05 25.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 111' ' ' VAL . 14.8 p -101.34 120.22 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 105.15 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 113' ' ' VAL . 11.4 m -126.18 121.88 60.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.88 145.99 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.046 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.506 ' O ' HG22 ' A' ' 81' ' ' VAL . 33.9 mm -129.72 120.24 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -123.61 25.76 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.234 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.424 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.46 109.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.627 0.251 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 44' ' ' LYS . 30.9 p -133.52 143.57 48.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 0.0 111.199 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -143.13 124.05 14.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.899 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 15.0 mtm180 -127.09 129.52 48.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.574 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 148.03 11.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.042 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 10' ' ' PHE . 25.5 mt -87.68 155.39 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.519 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.801 ' CG ' HD12 ' A' ' 28' ' ' ILE . 56.5 m-85 -132.02 148.23 52.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.26 172.21 12.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.449 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -46.56 -27.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.438 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.23 -41.23 49.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.76 129.06 3.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.44 -158.86 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.016 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 27' ' ' ILE . 2.7 t -140.02 151.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.793 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.578 HD11 ' HB1' ' A' ' 6' ' ' ALA . 35.5 tp -123.22 100.18 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -122.47 154.03 38.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.469 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 p -126.09 97.15 4.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.101 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -53.33 -26.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.783 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -59.8 -24.86 64.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.44 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 4' ' ' ALA . 6.6 p -129.03 -52.79 1.21 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 111.306 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.96 -35.88 2.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.713 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.669 ' HB ' HG21 ' A' ' 45' ' ' VAL . 20.5 t -49.31 141.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.706 0.289 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.6 p -148.24 162.28 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.826 HG12 HD13 ' A' ' 83' ' ' LEU . 26.8 mt -135.52 113.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.889 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.1 mp -94.05 123.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.801 HD12 ' CG ' ' A' ' 10' ' ' PHE . 3.3 mt -112.62 91.37 17.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 157.54 57.55 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.136 . . . . 0.0 112.25 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 107.9 0.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 139.57 -9.39 3.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.051 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -77.85 -29.05 50.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.969 0.384 . . . . 0.0 111.202 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.49 HD13 ' CG ' ' A' ' 39' ' ' GLN . 20.4 mt -118.83 141.52 30.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.534 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.1 Cg_exo -64.79 155.32 68.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.454 2.102 . . . . 0.0 112.101 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.78 141.04 58.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.25 23.37 78.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.624 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 38' ' ' GLU . 43.4 t -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.274 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.552 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.8 mt-10 -137.46 113.73 10.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.706 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.49 ' CG ' HD13 ' A' ' 33' ' ' ILE . 4.6 mm-40 -105.74 108.95 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -70.54 122.57 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -130.74 129.9 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.544 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 39.4 p90 -145.72 158.41 43.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.935 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -163.09 160.81 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.733 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -131.7 123.67 28.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.96 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.669 HG21 ' HB ' ' A' ' 24' ' ' VAL . 38.7 t -107.15 129.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.667 ' HB2' HD12 ' A' ' 67' ' ' LEU . 1.9 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.942 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.474 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 5.8 tt0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.841 0.353 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.74 101.4 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.288 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.4 142.95 40.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -126.46 -57.61 1.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.116 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.616 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -96.93 -174.12 0.37 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 87.6 Cg_exo -43.28 -32.97 3.54 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.024 1.816 . . . . 0.0 111.52 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -165.49 84.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.851 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.65 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -145.91 117.64 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.099 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB1' ' CG ' ' A' ' 61' ' ' GLU . . . -104.31 106.15 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.532 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -66.93 -172.01 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.12 -158.25 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.5 Cg_endo -63.23 121.74 9.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.526 2.151 . . . . 0.0 111.994 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.69 110.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.72 72.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.471 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 31.4 tp -142.52 85.86 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 110.321 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 40.4 tttt -57.69 159.64 5.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.045 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.97 143.16 34.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.534 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.55 16.71 16.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.142 0.496 . . . . 0.0 111.228 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -161.53 136.45 5.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.333 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 27.3 Cg_exo -62.31 100.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.473 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 115' ' ' ILE . 16.3 m -72.94 139.42 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.759 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -85.57 124.57 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.269 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 26' ' ' ILE . 21.1 tp -124.21 128.26 48.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.439 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.666 ' O ' HG13 ' A' ' 24' ' ' VAL . 13.0 mtm-85 -119.06 127.17 53.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.821 ' O ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -141.99 131.47 12.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.31 143.94 73.88 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.398 2.066 . . . . 0.0 112.092 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -59.13 -46.35 88.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.3 m 57.76 176.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.6 t70 58.28 100.58 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.08 41.02 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.672 2.248 . . . . 0.0 112.87 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -108.94 -3.75 17.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.564 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -122.62 16.07 10.32 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.459 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.7 p-90 -110.26 -36.68 5.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 6.3 pt20 -106.85 51.43 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.974 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -21.97 13.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -171.58 -38.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 m -47.89 171.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 9.9 mt -87.66 123.5 69.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 23.2 Cg_exo -63.93 -33.81 62.11 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.542 2.162 . . . . 0.0 112.223 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.05 76.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.898 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -70.9 121.52 84.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.688 0.244 . . . . 0.0 110.776 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.766 ' O ' HG22 ' A' ' 106' ' ' VAL . 27.9 Cg_endo -62.35 -27.5 77.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.348 2.032 . . . . 0.0 112.107 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.35 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.774 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.38 -18.35 10.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.958 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.774 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 13.4 mt -156.7 -28.92 0.09 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.7 m -67.44 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.64 -38.42 0.04 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.61 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.0 18.46 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.702 0.287 . . . . 0.0 111.512 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -63.11 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.5 p -93.49 149.32 21.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 85' ' ' LEU . 11.8 p -109.83 119.09 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.87 105.05 12.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.281 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 83' ' ' LEU . 4.6 m -121.02 129.22 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.042 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mt -96.8 132.06 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.066 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.86 ' O ' HG22 ' A' ' 81' ' ' VAL . 42.9 mm -118.77 118.79 59.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -119.93 25.65 9.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.39 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -178.79 115.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.26 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.616 ' CE1' HG21 ' A' ' 115' ' ' ILE . 1.2 m-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.567 ' HB3' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.901 0.382 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.481 HG22 ' CB ' ' A' ' 44' ' ' LYS . 65.4 p -123.59 143.76 50.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -131.93 131.02 42.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.1 mtt-85 -128.51 138.69 52.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.33 143.83 8.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.662 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -89.11 138.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.644 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.64 ' CG ' HD12 ' A' ' 28' ' ' ILE . 76.1 m-85 -129.35 148.97 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.334 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 172.08 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.748 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -45.18 -28.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -57.32 -31.14 65.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.89 168.84 16.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.823 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.62 148.09 5.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.085 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 27' ' ' ILE . 4.0 t -110.66 152.76 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.4 0.619 . . . . 0.0 111.85 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 32.4 tp -123.53 100.23 6.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.21 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 153.65 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.15 0.5 . . . . 0.0 111.889 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.08 96.92 4.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.971 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -55.42 -26.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.573 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 26.8 mt-10 -64.94 -26.11 68.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 4' ' ' ALA . 2.3 p -121.32 -52.95 2.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.685 0.279 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.09 -41.39 1.51 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.775 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 84' ' ' ARG . 42.0 t -50.16 144.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.676 0.274 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.5 t -149.89 167.74 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.423 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.7 HG12 HD13 ' A' ' 83' ' ' LEU . 44.2 mt -142.54 113.45 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 ' HE ' ' A' ' 84' ' ' ARG . 4.4 mp -93.23 120.49 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.827 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.64 HD12 ' CG ' ' A' ' 10' ' ' PHE . 5.2 mt -105.98 91.84 5.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.48 159.92 38.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.512 2.141 . . . . 0.0 112.475 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.38 104.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.07 -9.81 3.59 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.215 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -75.66 -28.31 58.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.942 0.371 . . . . 0.0 111.308 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.859 HD13 ' HB2' ' A' ' 39' ' ' GLN . 33.7 mt -119.69 142.75 33.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.373 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.2 Cg_exo -60.07 152.9 62.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.24 1.96 . . . . 0.0 112.178 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.0 mt-10 -68.63 150.1 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 24.97 68.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.462 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.1 t -130.58 160.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 111.242 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 37' ' ' VAL . 55.1 mt-10 -133.09 113.9 13.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.998 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.859 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -102.76 109.24 20.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -74.53 122.36 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.08 141.51 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.149 0.5 . . . . 0.0 111.584 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' A' ' 72' ' ' PRO . 14.0 p90 -153.5 146.87 24.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.781 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CE1' ' HG ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -147.98 159.0 44.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.063 0.458 . . . . 0.0 112.031 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.481 ' CB ' HG22 ' A' ' 5' ' ' THR . 2.1 tmmm? -116.0 147.83 40.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.468 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.522 HG22 HG13 ' A' ' 68' ' ' VAL . 25.1 t -145.23 140.81 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.045 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.431 ' O ' HD12 ' A' ' 67' ' ' LEU . 26.7 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.798 0.333 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -105.54 100.37 9.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.681 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.23 136.1 36.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.506 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.35 -57.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.455 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.746 ' CB ' HD13 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -85.16 -177.95 1.06 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 75.8 Cg_exo -41.32 -47.07 5.6 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -153.58 84.49 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.427 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.4 t -146.04 118.1 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.597 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.68 106.21 16.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.564 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.07 -168.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.17 -137.86 0.93 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 32.8 Cg_endo -64.17 125.95 16.18 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.441 2.094 . . . . 0.0 112.073 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -56.33 110.85 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.14 83.35 1.58 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.813 HD11 ' HG2' ' A' ' 39' ' ' GLN . 16.6 tp -142.2 86.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.189 0.519 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 17.3 tttp -57.98 159.9 5.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.124 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 24.4 m-85 -141.49 147.91 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.655 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -98.92 17.62 19.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.26 0.552 . . . . 0.0 111.19 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 2.5 tttm -164.81 136.55 3.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.577 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 27.4 Cg_exo -62.0 97.96 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 0.0 112.472 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.1 m -70.5 137.69 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE1' HD13 ' A' ' 27' ' ' ILE . 8.2 tm-20 -81.3 119.25 23.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.258 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.7 HD13 HG12 ' A' ' 26' ' ' ILE . 13.6 tp -124.32 119.18 28.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HE ' HD11 ' A' ' 27' ' ' ILE . 6.2 ptt85 -113.99 133.31 55.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.746 HD13 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -137.33 112.68 9.37 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.927 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.29 120.25 8.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.293 1.995 . . . . 0.0 111.918 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.68 -54.67 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.148 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.86 -177.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.99 167.56 12.75 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.94 41.73 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.843 2.362 . . . . 0.0 112.944 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.52 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.698 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -99.36 3.54 46.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.565 0.698 . . . . 0.0 111.081 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.627 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 1.8 p-90 -56.0 -31.79 63.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.845 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.627 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 4.5 mt-30 -95.44 138.35 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.612 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.71 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.484 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -163.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.3 m 71.17 -167.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 8.9 mt -99.91 117.99 62.47 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.673 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 3.6 Cg_exo -74.96 -6.63 18.32 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.64 2.227 . . . . 0.0 111.913 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.84 -43.17 35.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.981 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 m-20 -85.38 111.48 37.04 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.837 0.319 . . . . 0.0 110.807 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.4 Cg_exo -60.25 -27.21 84.42 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.276 1.984 . . . . 0.0 111.946 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.506 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 11.1 p30 -78.79 4.64 13.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -50.54 -100.42 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -80.15 -12.5 59.65 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 27.8 m -62.65 27.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.13 -3.86 2.42 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.164 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.55 17.66 12.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.593 0.235 . . . . 0.0 111.386 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.44 -75.43 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.724 0.297 . . . . 0.0 111.04 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.3 m -101.13 133.69 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 85' ' ' LEU . 14.3 p -105.39 106.95 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.469 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.64 104.87 11.46 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 111' ' ' VAL . 10.1 m -122.01 131.65 72.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.2 mt -95.84 146.85 24.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.661 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 81' ' ' VAL . 43.5 mm -128.49 121.64 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.23 25.44 7.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.081 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.22 109.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.789 HG22 ' CB ' ' A' ' 44' ' ' LYS . 30.3 p -136.12 143.91 44.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 111.107 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.36 132.72 24.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.984 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.445 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.5 mtt180 -128.23 135.25 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.32 156.95 27.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.9 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.502 HG21 ' HG2' ' A' ' 38' ' ' GLU . 29.7 mt -91.39 156.26 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD1' HG13 ' A' ' 28' ' ' ILE . 25.8 m-85 -131.46 170.59 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.36 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -152.14 171.94 17.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.915 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.7 p -58.69 -21.09 53.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -54.87 -51.25 66.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.46 128.64 3.76 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.733 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.16 -172.73 25.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.02 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 27' ' ' ILE . 2.5 t -141.78 150.29 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 111.745 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 43' ' ' PHE . 23.5 tp -123.24 100.1 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.324 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -125.24 154.52 41.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 111.786 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -127.11 97.14 4.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.1 mm -52.62 -26.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.647 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 14.9 mt-10 -63.39 -21.22 66.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.305 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -126.93 -52.93 1.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.788 0.327 . . . . 0.0 111.264 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.6 -33.82 2.9 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.696 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.751 ' HB ' HG21 ' A' ' 45' ' ' VAL . 58.1 t -55.67 145.4 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 10.8 t -148.7 164.41 34.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.604 HG12 HD13 ' A' ' 83' ' ' LEU . 21.0 mt -139.25 113.81 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.933 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.0 mp -94.72 135.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.638 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -107.67 97.08 18.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.712 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 81' ' ' VAL . 27.5 Cg_endo -62.49 145.19 95.52 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.288 1.992 . . . . 0.0 112.115 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.1 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.202 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.18 4.27 5.52 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.367 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.61 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -81.7 -26.41 34.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.108 0.454 . . . . 0.0 111.201 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.965 HD13 ' HB2' ' A' ' 39' ' ' GLN . 26.2 mt -121.81 141.49 34.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' HD21 ' A' ' 78' ' ' LEU . 42.1 Cg_exo -56.69 143.87 88.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.333 2.022 . . . . 0.0 112.218 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.1 mt-10 -61.79 151.35 34.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.08 25.54 62.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 34' ' ' PRO . 40.5 t -129.47 160.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.268 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -129.02 113.93 15.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.797 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.965 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.35 109.23 21.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 14.2 tt0 -72.29 118.96 15.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.6 mt -127.35 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.014 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 34.3 p90 -152.83 173.46 15.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.43 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -175.05 163.51 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.885 0.374 . . . . 0.0 111.535 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.789 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER -135.62 117.63 15.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.045 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.751 HG21 ' HB ' ' A' ' 24' ' ' VAL . 33.1 t -106.87 141.82 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.841 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.797 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 m -85.71 105.26 16.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.59 139.64 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.43 -57.69 1.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -95.18 -174.53 0.4 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.332 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.8 Cg_exo -40.46 -46.99 4.45 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.228 1.952 . . . . 0.0 111.843 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.719 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.7 tm? -153.89 82.23 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.748 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -143.15 118.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.476 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.797 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -105.87 106.25 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.614 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -165.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.028 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.53 -146.71 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 41.6 Cg_endo -67.38 134.15 32.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.451 2.101 . . . . 0.0 112.191 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.99 111.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.86 84.0 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.1 tp -144.44 87.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 77.4 tttt -62.7 159.78 15.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.956 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 29.0 m-85 -138.6 155.79 48.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.66 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.706 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -99.22 14.33 29.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.367 0.603 . . . . 0.0 110.96 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -166.62 136.51 2.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.263 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 32.7 Cg_exo -61.58 95.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.413 2.075 . . . . 0.0 112.414 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 115' ' ' ILE . 9.2 m -61.38 166.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.516 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 126.12 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 111.493 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 26' ' ' ILE . 34.4 tp -124.24 128.01 48.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.098 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 24' ' ' VAL . 50.4 mtp180 -120.45 126.1 49.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.788 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.647 ' O ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.58 163.31 37.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.477 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.52 120.07 7.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.447 2.098 . . . . 0.0 112.202 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -82.32 -48.55 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.19 48.09 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -112.89 81.91 4.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.45 47.24 2.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.73 2.287 . . . . 0.0 112.611 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -108.93 13.09 24.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 t -119.58 15.96 12.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.46 . . . . 0.0 111.812 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.579 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.1 p-90 -121.01 -37.87 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.579 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.1 mt-30 -103.53 68.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -156.22 -45.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -46.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.25 -178.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 28.8 mt -98.64 131.46 25.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 33.0 Cg_exo -59.35 -23.59 70.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.421 2.081 . . . . 0.0 112.316 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.87 -25.21 32.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.832 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 8.3 m-20 -61.3 113.56 8.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.562 0.181 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.795 ' O ' HG22 ' A' ' 106' ' ' VAL . 72.7 Cg_exo -50.09 -30.72 25.87 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.378 2.052 . . . . 0.0 112.273 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.11 -19.89 62.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.361 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.778 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.97 -20.45 16.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.824 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.778 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 19.0 mt -155.51 -26.57 0.11 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.5 m -68.18 36.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -155.17 -42.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.584 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.47 18.69 10.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.655 0.264 . . . . 0.0 111.455 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -65.84 -44.57 85.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.63 149.03 21.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.94 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 85' ' ' LEU . 14.3 p -106.32 109.83 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.68 105.03 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 83' ' ' LEU . 12.1 m -122.07 122.05 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.4 mt -87.5 137.67 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.1 mm -122.43 116.85 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.348 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 27.03 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.195 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.87 114.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.613 HG22 ' CB ' ' A' ' 44' ' ' LYS . 65.3 p -122.34 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.685 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -127.57 121.77 31.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.6 mtt180 -120.97 131.52 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.22 147.82 11.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.797 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 10' ' ' PHE . 26.2 mt -90.53 159.64 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.685 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.721 ' CG ' HD12 ' A' ' 28' ' ' ILE . 79.9 m-85 -141.49 154.87 45.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.421 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -128.4 172.15 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -51.69 -24.5 5.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -55.19 -38.9 68.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.215 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 137.84 9.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.67 171.83 40.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.198 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -117.49 150.29 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.156 0.503 . . . . 0.0 111.548 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' SER . 32.9 tp -123.21 100.16 6.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.12 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.44 151.0 45.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.108 0.48 . . . . 0.0 111.835 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 12.6 p -121.23 97.05 5.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.023 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mm -52.53 -26.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.536 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.5 mm-40 -61.86 -29.6 70.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.083 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -119.66 -52.93 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.054 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.5 -38.02 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.694 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.603 ' CG2' HG11 ' A' ' 45' ' ' VAL . 24.2 t -49.48 144.47 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.73 0.3 . . . . 0.0 111.144 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.74 158.37 44.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.627 HG12 HD13 ' A' ' 83' ' ' LEU . 38.1 mt -132.39 113.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.446 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.508 HG13 HG13 ' A' ' 16' ' ' VAL . 3.6 mt -94.64 118.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 0.0 111.276 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.721 HD12 ' CG ' ' A' ' 10' ' ' PHE . 3.9 mt -105.97 92.98 7.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 148.39 92.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.393 2.062 . . . . 0.0 112.167 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -53.34 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.7 -19.54 0.78 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.946 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -66.29 -36.8 83.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.841 0.321 . . . . 0.0 111.363 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.917 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.1 mt -110.97 143.94 29.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.589 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -62.85 155.18 61.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.439 2.093 . . . . 0.0 112.295 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.5 mp0 -69.41 153.81 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.17 24.46 58.73 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 35' ' ' GLU . 44.8 t -130.08 160.87 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.544 ' N ' HG12 ' A' ' 37' ' ' VAL . 32.7 mt-10 -132.87 113.64 13.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.854 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.917 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -106.08 109.06 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.02 128.56 36.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -134.87 140.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.275 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 28.0 p90 -154.22 149.66 27.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -151.53 167.01 29.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.056 0.455 . . . . 0.0 111.662 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.613 ' CB ' HG22 ' A' ' 5' ' ' THR . 2.9 ptmt -127.52 146.12 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.542 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.603 HG11 ' CG2' ' A' ' 24' ' ' VAL . 45.3 t -138.78 136.91 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.845 -179.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -99.93 97.5 8.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.515 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.76 140.24 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.43 -57.58 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.931 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.1 p -91.28 -173.85 0.4 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.249 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.8 Cg_exo -41.63 -51.27 4.41 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.19 1.926 . . . . 0.0 111.861 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.705 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -151.08 85.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 92.7 t -147.09 118.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.216 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -107.22 109.33 21.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.785 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -62.26 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 42' ' ' TYR . . . -78.26 -144.33 2.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.76 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 59.8 Cg_exo -51.84 123.14 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.596 2.197 . . . . 0.0 112.186 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -55.38 110.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.63 83.76 1.75 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 15.1 tp -138.43 85.01 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.199 0.524 . . . . 0.0 110.084 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 85.5 tttt -58.03 161.98 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.167 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 17.2 m-85 -143.38 148.43 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.576 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.485 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -97.06 18.26 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.263 0.554 . . . . 0.0 110.941 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -163.86 136.39 3.96 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.409 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 20.8 Cg_exo -65.61 101.09 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.496 2.131 . . . . 0.0 112.467 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 115' ' ' ILE . 7.7 m -68.53 153.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.698 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 108.66 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.627 HD13 HG12 ' A' ' 26' ' ' ILE . 5.0 tp -105.02 121.32 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.577 ' N ' HD12 ' A' ' 83' ' ' LEU . 23.8 mtm180 -123.87 139.83 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.19 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -129.42 144.77 54.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.613 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.15 134.74 17.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.478 2.119 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.452 ' CD2' ' HB3' ' A' ' 109' ' ' ASN . 2.7 p80 -49.49 -47.05 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.46 -81.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.878 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.48 162.51 46.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.74 32.84 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.966 2.444 . . . . 0.0 112.848 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.01 1.17 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.402 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -122.67 16.07 10.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.822 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 10.8 p-90 -117.69 -47.86 2.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.545 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 5.1 pt20 -77.28 64.79 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.33 -46.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -32.73 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.0 m -85.14 172.12 11.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 20.9 mt -99.9 125.17 41.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 21.6 Cg_exo -65.09 -15.48 50.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.541 2.161 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.77 -22.22 31.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.8 t0 -62.19 136.45 95.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.649 0.262 . . . . 0.0 110.723 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.462 ' O ' HG21 ' A' ' 106' ' ' VAL . 55.6 Cg_endo -69.84 -20.73 34.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.42 2.08 . . . . 0.0 112.274 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 87.9 m-20 -91.61 17.31 8.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.921 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.606 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.68 -113.44 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.993 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.606 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -48.98 -23.14 1.02 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 11.8 m -71.29 36.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 0.0 111.33 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 145.49 40.54 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.77 -74.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.796 0.332 . . . . 0.0 111.362 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 2.9 t-20 -148.78 32.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.3 p -80.97 150.06 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.734 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 111' ' ' VAL . 14.0 p -84.81 114.45 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.265 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.68 105.08 12.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.195 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.4 m -123.91 124.85 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.57 143.26 26.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 81' ' ' VAL . 37.6 mm -129.71 120.1 49.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.24 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -123.27 25.74 8.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.21 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.418 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.43 108.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.936 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.573 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.063 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.707 0.289 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.638 HG22 ' CB ' ' A' ' 44' ' ' LYS . 45.3 p -123.11 143.76 49.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 111.081 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.554 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -132.78 130.55 40.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.412 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.5 mtp85 -129.34 132.18 47.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.29 149.71 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.91 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.579 HG21 ' HB3' ' A' ' 38' ' ' GLU . 20.1 mt -88.26 158.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.599 0.237 . . . . 0.0 110.636 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.566 ' CG ' HD13 ' A' ' 28' ' ' ILE . 49.8 m-85 -138.64 164.03 30.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.971 0.415 . . . . 0.0 111.438 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.73 172.13 14.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -53.05 -22.7 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.122 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -51.28 -35.23 36.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 28' ' ' ILE . . . 100.29 112.8 3.47 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.698 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.852 ' O ' HD12 ' A' ' 28' ' ' ILE . . . -157.36 144.2 10.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.054 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 17' ' ' LEU . 2.2 p -102.89 157.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.0 111.814 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 43' ' ' PHE . 15.2 tp -119.98 99.9 6.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.462 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -115.51 145.6 42.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.7 m -121.82 96.68 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.258 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 20' ' ' ILE . 3.4 tp -60.3 -26.6 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.4 mt-10 -62.68 -26.38 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.674 HG21 ' HB ' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -115.71 -52.9 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.13 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.69 6.56 9.35 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.216 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 45' ' ' VAL . 38.4 t -106.02 141.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.856 0.328 . . . . 0.0 110.822 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 92.5 p -149.75 162.52 40.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.917 0.389 . . . . 0.0 111.529 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.758 HG12 HD13 ' A' ' 83' ' ' LEU . 26.2 mt -130.79 113.46 24.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.188 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.5 mp -91.6 116.29 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 15' ' ' GLY . 1.2 mt -102.94 87.0 1.11 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.682 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 158.73 40.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.546 2.164 . . . . 0.0 112.328 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.14 108.57 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.23 -9.94 3.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.904 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.639 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -84.09 -33.13 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.874 0.337 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 39' ' ' GLN . 36.7 mt -119.91 143.75 35.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.344 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD3' HD21 ' A' ' 78' ' ' LEU . 15.1 Cg_exo -68.09 154.3 72.85 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.364 2.043 . . . . 0.0 112.247 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.1 tt0 -66.17 154.22 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.78 62.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.567 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 38' ' ' GLU . 41.2 t -128.1 160.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.059 0.456 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 9' ' ' ILE . 43.1 mt-10 -134.35 113.9 12.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.967 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.816 ' HB2' HD13 ' A' ' 33' ' ' ILE . 6.4 tp60 -101.71 109.01 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.061 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.91 116.7 12.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.0 mt -127.21 139.39 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 111.263 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' GLY . 29.9 p90 -153.06 162.82 40.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.203 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -167.28 168.43 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.873 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.638 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -133.06 132.69 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.721 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.68 HG22 HG13 ' A' ' 68' ' ' VAL . 21.7 t -126.1 148.29 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.95 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 67' ' ' LEU . 17.2 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.014 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.934 0.397 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.22 100.77 11.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.67 139.18 37.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.492 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.35 -57.63 1.38 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.639 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.57 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -91.58 -171.32 0.27 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.974 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 47.5 Cg_exo -38.4 -48.42 2.46 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.324 2.016 . . . . 0.0 112.116 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.717 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -158.66 66.72 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 111.054 178.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG13 HG22 ' A' ' 45' ' ' VAL . 99.0 t -121.58 118.35 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.575 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.5 106.24 17.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.575 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -167.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.998 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -68.38 -152.35 0.41 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.655 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 71.4 Cg_exo -50.71 160.57 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.563 2.175 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -84.51 111.0 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.66 78.98 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.899 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 8.3 tp -135.9 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.28 0.562 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.0 ttpt -73.0 149.69 43.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.909 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 73.5 m-85 -122.59 166.97 13.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.446 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.98 16.39 19.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.448 0.642 . . . . 0.0 110.824 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' A' ' 80' ' ' PRO . 1.8 tttm -168.75 136.54 1.66 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.185 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.426 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 31.5 Cg_exo -59.55 107.24 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.438 2.092 . . . . 0.0 112.579 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.427 HG22 ' HB ' ' A' ' 115' ' ' ILE . 10.8 m -70.71 140.64 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -87.51 108.35 19.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.564 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.758 HD13 HG12 ' A' ' 26' ' ' ILE . 7.1 tp -105.77 129.71 53.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.658 ' N ' HD12 ' A' ' 83' ' ' LEU . 4.9 mmt180 -123.32 132.23 53.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 111.613 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.819 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.63 156.07 59.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.481 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 24' ' ' VAL . 41.5 Cg_endo -67.44 123.9 11.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 49.9 p-80 -71.66 -46.92 57.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 85.8 m 57.61 178.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.993 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.38 87.94 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.53 46.86 2.18 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.814 2.342 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -109.06 5.09 23.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.665 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -122.56 16.17 10.37 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.922 0.391 . . . . 0.0 111.931 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.492 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 4.6 p-90 -110.6 -37.26 5.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 5.5 pt20 -101.13 61.0 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.097 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -106.48 -37.05 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -86.47 -179.05 6.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 9.6 mt -100.05 120.54 56.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 25.4 Cg_exo -62.76 -21.32 72.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.605 2.203 . . . . 0.0 112.669 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.46 -5.42 54.2 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.116 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.63 123.93 58.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.896 0.348 . . . . 0.0 111.004 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.818 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.58 -28.71 56.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.387 2.058 . . . . 0.0 112.335 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -61.72 -18.38 59.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.751 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.63 -19.3 15.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.62 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.751 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 15.6 mt -156.22 -30.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.0 m -68.05 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 177.41 -30.49 0.07 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.851 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 18.58 6.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -57.93 -30.27 65.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.95 170.74 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.74 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.819 HG11 HD12 ' A' ' 85' ' ' LEU . 11.7 p -103.7 105.88 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.287 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 105.09 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.2 m -122.82 121.53 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.255 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.99 143.8 26.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.427 ' HB ' HG22 ' A' ' 81' ' ' VAL . 28.5 mm -129.89 116.72 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.0 0.429 . . . . 0.0 111.544 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.84 27.48 8.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.974 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.79 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.784 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.461 ' CB ' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.9 p -125.28 143.01 51.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.945 0.402 . . . . 0.0 111.39 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -136.14 106.97 6.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.3 mtt180 -113.52 131.88 55.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 140.67 6.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.786 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 38' ' ' GLU . 13.4 mt -87.09 135.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.608 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.808 ' CG ' HD12 ' A' ' 28' ' ' ILE . 83.1 m-85 -116.71 160.98 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.286 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -146.48 172.31 13.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.592 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -44.44 -27.43 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -33.93 56.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 111.185 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 154.27 29.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.9 175.06 39.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.459 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -126.96 150.86 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.471 . . . . 0.0 111.415 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.572 HD11 ' HB1' ' A' ' 6' ' ' ALA . 49.4 tp -123.22 100.16 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.472 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -126.37 152.19 46.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.044 0.45 . . . . 0.0 111.745 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.76 97.05 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.1 -26.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.19 -26.69 67.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.235 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' CB ' ' A' ' 4' ' ' ALA . 4.5 p -123.91 -52.92 1.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.42 -36.63 2.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.896 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.622 HG13 HD23 ' A' ' 85' ' ' LEU . 38.6 t -48.56 144.4 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 111.26 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 p -149.83 150.75 32.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.515 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 83' ' ' LEU . 32.2 mt -128.75 113.69 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.492 HG13 HG13 ' A' ' 16' ' ' VAL . 3.8 mt -93.21 134.41 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.808 HD12 ' CG ' ' A' ' 10' ' ' PHE . 4.2 mt -123.93 94.26 45.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.161 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 155.82 66.97 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.423 2.082 . . . . 0.0 112.085 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.68 98.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.34 -21.75 0.74 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.945 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -68.21 -28.38 67.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 39' ' ' GLN . 38.9 mt -123.84 137.88 29.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.548 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.786 ' HD3' HD21 ' A' ' 78' ' ' LEU . 17.8 Cg_endo -60.35 155.5 46.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.385 2.056 . . . . 0.0 112.544 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.0 mt-10 -66.64 151.86 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.766 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.05 19.52 59.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.635 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.8 t -125.62 160.77 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.551 ' N ' HG12 ' A' ' 37' ' ' VAL . 5.3 mt-10 -137.06 113.71 10.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.053 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.821 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -102.16 110.75 22.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.814 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.65 119.4 13.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.136 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mt -126.92 139.82 50.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 110.867 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.425 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 29.7 p90 -155.55 162.96 40.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -166.98 159.49 13.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.945 0.402 . . . . 0.0 111.526 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 133.5 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.297 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 68' ' ' VAL . 40.3 t -124.87 135.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.586 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.637 ' O ' HD12 ' A' ' 67' ' ' LEU . 52.2 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.033 0.444 . . . . 0.0 111.272 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.821 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 19.8 mt-10 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.886 0.374 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 m -89.67 110.8 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.5 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.87 138.18 34.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.303 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.51 -57.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -92.19 -175.59 0.51 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.379 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 69.5 Cg_exo -40.93 -46.79 4.97 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.326 2.017 . . . . 0.0 111.529 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.8 tm? -153.57 83.93 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.658 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 45' ' ' VAL . 47.6 t -145.15 117.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.405 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.821 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -106.13 106.2 16.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.07 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -64.06 -153.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 20.6 Cg_endo -60.97 129.73 29.97 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.457 2.104 . . . . 0.0 111.909 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -54.98 110.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.48 79.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.716 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.75 HD11 ' HG2' ' A' ' 39' ' ' GLN . 14.8 tp -138.94 85.28 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 110.2 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 59.7 tttp -63.71 151.09 42.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.873 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 75.0 m-85 -127.92 154.11 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.771 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.786 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -98.51 13.92 30.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.436 0.636 . . . . 0.0 110.765 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.02 136.39 4.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.188 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.15 99.01 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.359 2.039 . . . . 0.0 112.379 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.0 m -67.86 154.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 119.0 38.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.413 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.862 HD13 HG12 ' A' ' 26' ' ' ILE . 15.6 tp -115.81 114.96 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.286 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.0 136.46 52.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.43 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.795 HD12 HG11 ' A' ' 111' ' ' VAL . 1.2 mt -125.63 133.02 24.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 119.71 6.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.189 1.926 . . . . 0.0 112.383 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.64 -33.68 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.53 163.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.78 69.95 0.46 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.27 42.4 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.247 2.631 . . . . 0.0 112.558 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 13.17 25.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 t -114.02 15.98 18.3 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 0.0 111.914 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.597 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -117.53 -36.67 3.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.597 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 10.4 mt-30 -106.38 76.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.34 -49.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -138.89 29.82 2.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.4 m -138.48 -175.38 4.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.751 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.91 127.6 38.5 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.12 -5.01 15.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.495 2.13 . . . . 0.0 112.558 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.46 -7.42 26.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.945 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.449 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -68.75 134.28 90.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.812 0.306 . . . . 0.0 110.621 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 106' ' ' VAL . 58.3 Cg_endo -71.51 -8.17 22.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.341 2.027 . . . . 0.0 112.612 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 77.2 m-20 -99.8 17.29 21.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 110.843 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.559 ' CE1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.35 -113.9 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.282 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -47.87 -15.85 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 102' ' ' PRO . 5.1 m -67.62 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 111.782 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -175.91 -34.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.39 25.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 110.835 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.59 -57.16 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.079 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.9 p -141.84 159.77 41.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.795 HG11 HD12 ' A' ' 85' ' ' LEU . 13.4 p -95.67 113.41 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.219 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.49 105.1 10.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.143 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 111' ' ' VAL . 8.5 m -128.79 122.67 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 mt -91.87 148.53 22.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 81' ' ' VAL . 33.8 mm -129.82 123.49 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.317 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.15 24.5 6.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.181 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.49 104.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.872 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.824 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 44' ' ' LYS . 21.7 p -142.24 143.74 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.135 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.631 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -149.48 116.93 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.8 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.17 144.63 8.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.673 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.66 134.44 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.458 ' CG ' HD12 ' A' ' 28' ' ' ILE . 77.2 m-85 -119.73 157.79 27.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.35 172.16 13.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.754 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 t -48.19 -27.26 2.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.379 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -32.46 62.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 111.341 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.96 173.05 21.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.589 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.33 155.26 7.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.22 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 27' ' ' ILE . 3.4 t -112.08 151.98 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.366 0.603 . . . . 0.0 111.734 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.631 HD11 ' HB1' ' A' ' 6' ' ' ALA . 40.9 tp -123.57 100.23 6.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.149 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -121.62 149.46 43.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 112.017 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.04 97.13 5.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.166 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.41 -26.53 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.725 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.824 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -50.54 -50.53 53.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.679 -179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.808 HG21 ' CG1' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -114.34 -52.8 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.529 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.64 -28.42 2.04 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.132 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.659 HG13 HD23 ' A' ' 85' ' ' LEU . 84.3 t -52.8 135.9 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 66.3 p -146.06 170.96 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.655 HG12 HD13 ' A' ' 83' ' ' LEU . 20.3 mt -141.27 113.86 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.4 mp -92.4 120.28 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.603 HG22 ' HB3' ' A' ' 32' ' ' ALA . 3.2 mt -108.46 90.4 7.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.34 151.86 82.81 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.088 . . . . 0.0 112.142 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -53.9 107.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 138.06 -6.7 3.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.092 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.603 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -78.92 -29.63 44.28 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.985 0.392 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.715 HD13 ' HB2' ' A' ' 39' ' ' GLN . 35.5 mt -119.4 141.76 31.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.601 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.0 Cg_exo -64.9 154.21 74.22 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.279 1.986 . . . . 0.0 112.054 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.1 mt-10 -65.93 154.45 39.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.43 60.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 35' ' ' GLU . 42.8 t -129.46 160.77 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.258 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.545 ' N ' HG12 ' A' ' 37' ' ' VAL . 4.9 mt-10 -134.31 113.8 12.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.957 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.715 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -103.32 109.13 20.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.075 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.97 110.43 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.673 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.71 136.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.413 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 54.3 p90 -154.96 151.29 28.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.7 OUTLIER -154.24 159.76 41.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 0.0 111.314 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG22 ' A' ' 5' ' ' THR . 1.7 pttp -128.15 124.76 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.029 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.808 ' CG1' HG21 ' A' ' 22' ' ' THR . 46.1 t -113.81 128.79 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.718 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 0.0 111.25 -179.612 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 108.41 19.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -87.67 138.84 31.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.266 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.515 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -88.86 -175.22 0.53 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.421 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 70.2 Cg_exo -41.01 -50.58 4.11 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.267 1.978 . . . . 0.0 111.676 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.8 tm? -151.94 83.35 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.703 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.722 HG13 HG22 ' A' ' 45' ' ' VAL . 44.4 t -144.46 118.23 3.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.529 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.53 106.11 16.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.658 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.15 -166.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.41 -148.25 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.73 127.77 20.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.431 2.087 . . . . 0.0 112.103 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -56.29 110.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.92 78.3 1.0 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.715 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.57 HD11 ' HG3' ' A' ' 39' ' ' GLN . 6.0 tp -142.45 87.52 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.255 0.55 . . . . 0.0 110.016 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 7.6 ttpp -64.13 149.24 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 42.2 m-85 -126.61 151.32 48.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.49 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -99.38 16.14 24.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.353 0.597 . . . . 0.0 111.007 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.38 136.5 4.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.394 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.4 Cg_exo -63.49 103.6 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.532 2.154 . . . . 0.0 112.695 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.5 m -76.44 143.78 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.736 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.95 117.36 29.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.655 HD13 HG12 ' A' ' 26' ' ' ILE . 31.8 tp -111.73 117.59 33.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -108.34 139.45 43.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.944 HD12 HG11 ' A' ' 111' ' ' VAL . 1.3 mt -134.47 140.76 36.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.527 ' HD2' HG22 ' A' ' 24' ' ' VAL . 72.0 Cg_endo -75.4 125.89 9.35 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.391 2.061 . . . . 0.0 112.388 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -77.69 -44.16 28.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.5 m 60.2 86.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -179.35 75.62 0.2 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.17 42.92 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.973 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -108.61 -47.52 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.025 0.44 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 t -111.57 3.99 18.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.598 0.713 . . . . 0.0 111.055 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.517 ' CE3' ' HB2' ' A' ' 105' ' ' LEU . 1.5 p-90 -55.36 -31.67 61.94 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.96 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.457 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 1.8 pt20 -92.68 144.73 25.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.47 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -170.56 -42.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.749 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 -164.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m 64.23 159.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.054 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.2 mt -59.89 137.13 90.52 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.059 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -17.79 16.56 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.674 2.249 . . . . 0.0 112.691 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.97 -43.93 7.94 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.794 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.48 113.23 17.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.538 0.209 . . . . 0.0 111.061 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.65 ' O ' HG13 ' A' ' 106' ' ' VAL . 39.3 Cg_exo -56.9 -26.61 68.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.439 2.093 . . . . 0.0 111.995 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.506 ' HA ' HG22 ' A' ' 106' ' ' VAL . 4.5 t-20 -70.69 -11.21 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.396 . . . . 0.0 110.806 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -52.58 -23.28 6.13 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.151 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.635 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -156.73 -20.17 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 102' ' ' PRO . 6.1 m -67.74 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -146.23 -42.61 0.04 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.375 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.45 62.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.583 0.23 . . . . 0.0 111.569 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.92 80.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 175.42 131.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.944 HG11 HD12 ' A' ' 85' ' ' LEU . 12.5 p -84.9 110.71 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.45 104.88 11.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.11 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.1 m -125.33 122.02 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.35 135.57 33.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.909 ' O ' HG22 ' A' ' 81' ' ' VAL . 15.3 mm -126.45 115.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -116.7 14.07 15.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 116' ' ' ASP . 4.3 m80 -162.8 127.95 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.607 ' CB ' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.1 p -121.86 143.54 49.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.733 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.82 108.02 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.987 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.464 ' HG3' ' CB ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -111.36 136.09 50.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.054 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.26 149.28 12.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.231 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.2 mt -104.86 138.82 27.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.711 0.291 . . . . 0.0 110.52 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CG ' HD12 ' A' ' 28' ' ' ILE . 90.3 m-85 -127.64 174.04 9.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 111.422 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -147.87 172.17 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.636 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -45.19 -28.79 0.82 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -56.39 -31.41 63.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 177.98 22.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.645 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.52 162.78 10.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.17 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG13 HG13 ' A' ' 27' ' ' ILE . 3.9 t -118.46 153.74 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.269 0.557 . . . . 0.0 111.762 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' SER . 40.5 tp -123.14 100.09 6.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.107 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 149.32 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.45 . . . . 0.0 111.735 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.46 97.22 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.224 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.74 -26.45 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.512 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 4.3 mt-10 -60.81 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.352 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.632 HG21 HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -105.25 -53.03 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.238 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.66 -34.58 2.46 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.679 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.88 HG22 ' HD3' ' A' ' 86' ' ' PRO . 39.4 t -54.64 139.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.684 0.278 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -143.11 167.65 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.43 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.818 HG12 HD13 ' A' ' 83' ' ' LEU . 42.6 mt -134.42 113.75 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.656 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.51 HG13 HG13 ' A' ' 16' ' ' VAL . 4.7 mp -90.71 122.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.574 HD12 ' CG ' ' A' ' 10' ' ' PHE . 7.1 mt -110.03 94.7 18.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 28' ' ' ILE . 34.8 Cg_endo -64.99 150.97 87.38 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.34 2.027 . . . . 0.0 112.05 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.79 108.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -2.79 4.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.141 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -82.43 -26.06 33.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.383 . . . . 0.0 111.24 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.795 HD13 ' HB2' ' A' ' 39' ' ' GLN . 48.6 mt -122.97 142.3 37.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.553 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.677 ' HD3' HD21 ' A' ' 78' ' ' LEU . 31.3 Cg_exo -59.15 155.48 39.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.398 2.065 . . . . 0.0 112.442 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -70.19 152.74 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 23.76 56.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.63 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 35' ' ' GLU . 42.0 t -131.22 160.9 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.179 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.554 ' N ' HG12 ' A' ' 37' ' ' VAL . 27.9 mt-10 -131.39 113.78 14.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.944 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.795 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -104.13 110.93 23.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.93 126.54 29.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.78 132.77 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.997 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.464 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 52.6 p90 -149.23 174.5 12.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.276 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.733 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.2 p90 -175.34 176.15 2.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.022 0.439 . . . . 0.0 111.783 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.28 148.58 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.995 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 22' ' ' THR . 59.4 t -142.37 139.31 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.685 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.411 ' O ' HD12 ' A' ' 67' ' ' LEU . 42.7 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.093 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -135.85 95.44 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.73 142.29 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.088 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.42 -57.58 1.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.929 0.395 . . . . 0.0 111.171 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -97.1 -174.28 0.37 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 71.5 Cg_exo -41.35 -45.4 5.8 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.263 1.975 . . . . 0.0 111.699 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.72 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.9 tm? -153.13 83.92 1.2 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 61.7 t -145.06 118.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.423 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.64 109.07 20.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.695 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -60.3 -173.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 42' ' ' TYR . . . -78.24 -126.84 0.42 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.595 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 37.3 Cg_endo -65.98 134.08 35.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.18 110.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.89 83.61 1.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 3.5 tp -131.4 84.43 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.478 ' CD ' ' CD2' ' A' ' 117' ' ' HIS . 10.5 tptt -53.3 153.83 3.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.4 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 35.2 m-85 -136.35 144.27 44.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.677 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -94.68 17.59 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.285 0.564 . . . . 0.0 111.226 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -162.71 136.5 4.71 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.173 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.68 97.27 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.337 2.025 . . . . 0.0 112.488 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.8 m -72.91 154.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.53 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 pm0 -110.91 116.46 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.399 . . . . 0.0 111.275 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.818 HD13 HG12 ' A' ' 26' ' ' ILE . 9.3 tp -104.75 129.72 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.61 ' O ' HG13 ' A' ' 24' ' ' VAL . 1.8 mtt180 -112.88 126.2 55.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.944 0.402 . . . . 0.0 111.406 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -138.63 155.08 73.66 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.658 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.88 ' HD3' HG22 ' A' ' 24' ' ' VAL . 75.0 Cg_exo -48.25 144.21 13.36 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.687 2.258 . . . . 0.0 112.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -79.31 -26.28 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 m 68.3 -173.05 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.13 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -85.21 35.75 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.122 2.548 . . . . 0.0 112.866 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.24 -13.53 14.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.424 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t -122.65 15.78 10.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 111.786 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.63 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.5 p-90 -95.19 -36.12 11.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.941 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.63 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.0 mt-30 -104.67 114.38 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -161.02 -44.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 34.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.37 175.93 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 29.1 mt -87.65 128.6 53.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.26 -13.6 16.87 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.473 2.116 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.09 -21.21 8.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.857 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.419 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -74.46 137.17 74.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.617 0.246 . . . . 0.0 110.903 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.759 ' O ' HG22 ' A' ' 106' ' ' VAL . 56.4 Cg_endo -70.21 -26.63 25.24 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.162 . . . . 0.0 112.101 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -65.23 -15.68 62.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.752 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.34 -18.47 10.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.948 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.752 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 12.7 mt -156.93 -27.89 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.55 36.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 172.61 -33.41 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.604 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.83 44.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -88.58 96.59 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.65 143.13 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 113' ' ' VAL . 7.9 p -112.05 133.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.257 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.24 104.99 17.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 83' ' ' LEU . 10.6 m -119.57 123.78 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.029 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.0 137.16 33.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 81' ' ' VAL . 25.9 mm -129.82 123.28 56.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.256 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.86 25.66 5.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.941 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.478 ' CD2' ' CD ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 178.82 104.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.655 0.264 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.741 HG22 ' CB ' ' A' ' 44' ' ' LYS . 37.6 p -136.01 143.22 44.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -142.36 121.95 13.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.813 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.435 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 1.1 ttp180 -127.05 130.22 49.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.14 144.12 8.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.66 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 29.6 mt -79.6 152.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.65 0.262 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 28' ' ' ILE . 42.3 m-85 -129.6 154.04 47.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 0.0 111.303 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.51 172.62 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.592 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.1 m -44.18 -30.43 0.78 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.188 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.13 -42.02 99.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.454 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.06 142.32 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.096 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -120.23 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.787 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.671 HG13 HG13 ' A' ' 27' ' ' ILE . 2.0 t -151.29 145.98 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.238 0.542 . . . . 0.0 111.53 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 6' ' ' ALA . 26.5 tp -123.51 100.38 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.65 138.31 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 112.077 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.538 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 49.8 m -100.57 96.84 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.391 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.06 -26.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.014 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.757 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -69.27 -21.53 63.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.675 HG23 ' CB ' ' A' ' 4' ' ' ALA . 12.2 p -126.04 -52.99 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.659 0.266 . . . . 0.0 111.494 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.84 2.34 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.537 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.605 ' HB ' HG21 ' A' ' 45' ' ' VAL . 40.9 t -52.54 145.55 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.731 0.301 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.4 p -148.06 165.31 31.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.635 HG12 HD13 ' A' ' 83' ' ' LEU . 48.1 mt -138.12 113.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.671 HG13 HG13 ' A' ' 16' ' ' VAL . 2.8 mt -96.07 112.86 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 111.123 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 ' CD1' ' A' ' 10' ' ' PHE . 6.3 mt -98.31 99.85 8.0 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.773 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 156.66 63.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.268 1.979 . . . . 0.0 112.343 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -60.35 111.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.06 0.6 6.96 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.043 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.415 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -78.07 -30.05 49.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.929 0.365 . . . . 0.0 111.057 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.8 mt -115.37 142.52 28.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.448 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.39 155.52 46.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.284 1.989 . . . . 0.0 112.351 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.1 mt-10 -66.57 153.36 43.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.2 25.5 57.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 35' ' ' GLU . 34.3 t -132.85 160.24 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.303 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' N ' HG12 ' A' ' 37' ' ' VAL . 20.0 mt-10 -137.84 113.83 9.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.739 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.84 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.9 mm-40 -101.6 125.63 48.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.055 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 26.5 tt0 -82.45 121.64 27.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 mt -124.97 136.39 60.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.221 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CD2' ' HD2' ' A' ' 7' ' ' ARG . 26.6 p90 -155.51 159.92 40.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.487 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -165.65 165.45 18.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 111.654 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.741 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -137.57 119.32 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.055 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.916 HG22 HG13 ' A' ' 68' ' ' VAL . 38.7 t -105.33 137.24 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.61 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.432 HG23 ' CD2' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -114.41 97.27 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.446 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.59 139.22 37.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.338 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.412 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.45 -57.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.989 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.593 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -89.53 -175.77 0.58 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.217 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.04 -35.39 1.78 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.268 1.979 . . . . 0.0 111.785 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -168.09 78.24 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.955 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.916 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -137.46 117.87 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.48 105.99 17.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.717 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -165.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -71.47 -154.36 1.7 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.576 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 51.9 Cg_exo -53.9 130.1 37.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.5 2.134 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.432 ' CD2' HG23 ' A' ' 62' ' ' THR . 1.8 t-80 -56.68 110.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.742 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.05 83.95 1.77 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.551 HD13 ' CD ' ' A' ' 39' ' ' GLN . 3.4 tp -138.68 86.52 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.293 0.568 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -50.54 164.47 0.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -149.48 136.82 19.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.554 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.93 16.95 16.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.319 0.581 . . . . 0.0 111.06 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 3.3 tptm -159.8 136.45 6.57 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.258 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.3 Cg_exo -63.7 95.82 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.505 2.137 . . . . 0.0 112.51 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 m -70.72 142.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.607 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 7.0 mp0 -90.93 129.19 36.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 111.563 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.635 HD13 HG12 ' A' ' 26' ' ' ILE . 26.9 tp -124.32 114.99 20.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -112.32 131.18 55.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.876 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -143.85 141.43 18.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.521 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.03 127.66 10.83 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.492 2.128 . . . . 0.0 112.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.55 -43.78 30.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t 62.09 59.75 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.92 122.74 1.13 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.714 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -86.62 39.87 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.643 2.229 . . . . 0.0 112.871 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 -4.29 16.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.612 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -122.67 16.16 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 6.8 p-90 -117.7 -43.49 2.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -91.74 133.04 35.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.291 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.31 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.66 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 32.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.734 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.36 -166.88 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 98' ' ' LEU . 13.4 mt -95.72 121.43 61.34 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 5.7 Cg_exo -77.84 4.03 6.44 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.753 2.302 . . . . 0.0 112.686 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.55 2.24 8.14 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.822 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.502 ' OD1' ' HB3' ' A' ' 104' ' ' TYR . 37.1 p-10 -81.31 133.23 53.94 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 117.62 0.71 . . . . 0.0 110.317 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.625 ' O ' HG21 ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.65 -9.43 24.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.504 2.136 . . . . 0.0 113.085 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 7.2 m120 -96.89 17.62 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 111.109 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.502 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -75.03 -110.02 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -55.89 -13.81 2.06 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.625 HG21 ' O ' ' A' ' 102' ' ' PRO . 11.2 m -69.14 36.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.84 -37.88 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.134 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -24.79 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.651 0.262 . . . . 0.0 111.243 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.37 65.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 173.21 127.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.721 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 111' ' ' VAL . 11.6 p -102.52 105.93 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.37 105.05 5.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.307 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 83' ' ' LEU . 5.9 m -126.51 120.74 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.87 132.31 37.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.639 ' O ' HG22 ' A' ' 81' ' ' VAL . 26.7 mm -113.74 124.79 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.58 26.52 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.637 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.466 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -178.32 98.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.89 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.738 0.304 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 44' ' ' LYS . 28.7 p -123.15 143.64 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.374 . . . . 0.0 111.195 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.646 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.36 124.77 20.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.831 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.468 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.8 mtt180 -130.42 129.84 43.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.42 145.89 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.039 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 10' ' ' PHE . 29.2 mt -90.45 159.67 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.514 0.197 . . . . 0.0 110.539 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.779 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.9 m-85 -137.57 152.29 49.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 111.411 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 38' ' ' GLU . 1.6 t-20 -123.76 172.11 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.764 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.02 -28.47 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -60.14 -37.28 79.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.62 -160.81 12.99 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.752 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.63 170.74 13.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.204 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -124.51 149.09 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.646 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' A' ' 6' ' ' ALA . 31.7 tp -123.35 100.38 6.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.58 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -129.47 153.95 47.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.142 0.496 . . . . 0.0 111.925 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -126.28 97.09 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.074 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -51.81 -26.68 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.639 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 4.0 mt-10 -62.21 -26.95 68.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.656 HG21 HG12 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -119.88 -52.91 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.137 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.55 -28.91 3.92 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.728 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 45' ' ' VAL . 55.7 t -57.09 145.87 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.671 0.272 . . . . 0.0 110.795 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 p -149.66 156.35 41.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.43 . . . . 0.0 111.381 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 HD13 ' A' ' 83' ' ' LEU . 23.9 mt -135.03 113.59 16.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.656 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.7 mp -93.26 126.79 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.894 0.378 . . . . 0.0 110.98 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.779 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.9 mt -110.77 99.36 41.72 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.39 153.45 76.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.586 2.191 . . . . 0.0 112.28 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -60.67 100.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.68 -6.3 3.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -73.28 -24.14 60.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.878 0.339 . . . . 0.0 111.202 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.436 HG23 ' HD2' ' A' ' 34' ' ' PRO . 18.5 mt -121.64 140.91 32.56 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.672 ' HD3' HD21 ' A' ' 78' ' ' LEU . 31.7 Cg_exo -58.18 152.9 49.43 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.316 2.011 . . . . 0.0 112.243 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.59 143.42 57.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.75 25.58 72.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 38' ' ' GLU . 48.0 t -127.99 161.14 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.555 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -139.96 113.67 8.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.847 179.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.417 ' HB2' HD13 ' A' ' 33' ' ' ILE . 27.9 mm100 -103.56 113.77 27.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.093 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.43 122.33 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.18 137.31 57.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.018 0.437 . . . . 0.0 111.213 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 13.2 p90 -154.41 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.28 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -166.95 153.88 8.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.058 0.456 . . . . 0.0 111.539 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -120.24 117.48 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.827 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 22' ' ' THR . 59.6 t -102.87 126.86 57.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.582 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 111.08 -179.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.763 ' OE1' ' HB1' ' A' ' 69' ' ' ALA . 2.5 tp10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.786 0.327 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.72 95.44 4.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.624 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -77.97 139.31 39.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.025 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.44 -57.71 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.646 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.03 -174.49 0.48 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.246 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 53.4 Cg_exo -38.68 -45.06 2.4 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.287 1.991 . . . . 0.0 112.125 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.781 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -161.66 65.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.558 HG22 HG13 ' A' ' 45' ' ' VAL . 90.0 t -121.63 118.61 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.573 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB1' ' OE1' ' A' ' 61' ' ' GLU . . . -101.58 106.71 17.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.871 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -63.74 -167.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -78.12 -150.75 4.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 52.0 Cg_exo -54.47 121.59 10.03 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 112.006 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -55.53 110.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.938 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.33 78.55 0.9 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.738 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.697 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 65.8 tp -136.65 84.68 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.184 0.516 . . . . 0.0 110.477 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.1 tttt -58.85 162.11 4.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.184 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.416 ' CE1' ' HG ' ' A' ' 75' ' ' LEU . 42.1 m-85 -144.42 150.01 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.672 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.75 12.61 31.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.302 0.573 . . . . 0.0 111.259 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mmpp? -157.24 136.73 8.37 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.965 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.87 93.49 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.293 1.995 . . . . 0.0 112.28 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.6 m -64.26 166.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 126.84 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.045 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.568 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.1 tp -124.22 107.04 10.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.22 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.441 ' HD3' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.34 129.69 53.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.362 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -136.34 154.18 76.89 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.652 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' HG22 ' A' ' 24' ' ' VAL . 34.9 Cg_endo -64.96 120.21 7.4 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.502 2.135 . . . . 0.0 112.069 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.55 -54.4 7.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.27 158.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' CB ' ' CD ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -57.92 177.84 0.2 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.693 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 89' ' ' ASP . 92.4 Cg_endo -84.78 35.62 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.558 2.172 . . . . 0.0 112.93 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -109.33 -0.19 19.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.361 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -122.54 15.86 10.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 112.038 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.674 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 5.1 p-90 -105.48 -35.67 7.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 93' ' ' TRP . 1.1 pt20 -94.18 29.83 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.369 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -101.7 -30.95 11.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -172.2 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.23 -165.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.788 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 11.4 mt -89.67 124.64 63.5 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 13.3 Cg_exo -68.78 -23.68 35.35 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.563 2.175 . . . . 0.0 112.25 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.88 4.43 39.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.136 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -60.96 138.97 94.1 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.916 0.358 . . . . 0.0 110.474 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.789 ' O ' HG21 ' A' ' 106' ' ' VAL . 3.0 Cg_exo -74.38 -3.08 13.27 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.483 2.122 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.437 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 10.3 p30 -109.22 17.41 21.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 0.0 111.053 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.617 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.15 -113.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.978 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.674 HD11 ' CZ3' ' A' ' 93' ' ' TRP . 0.5 OUTLIER -47.76 -19.55 0.23 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.789 HG21 ' O ' ' A' ' 102' ' ' PRO . 8.4 m -68.4 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -174.39 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.849 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.58 67.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.86 -66.56 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.45 142.74 51.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.66 ' O ' HG13 ' A' ' 111' ' ' VAL . 12.0 p -98.09 103.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.98 104.78 6.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 83' ' ' LEU . 10.6 m -116.11 126.82 73.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.837 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.6 mt -81.62 136.55 35.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.731 ' O ' HG22 ' A' ' 81' ' ' VAL . 34.9 mm -129.79 121.71 53.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.39 25.46 6.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.206 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 176.71 111.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.697 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.3 m-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.027 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.697 ' HB2' HG23 ' A' ' 22' ' ' THR . . . . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.814 0.34 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 44' ' ' LYS . 17.1 p -140.6 144.37 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -150.98 113.7 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.418 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -125.83 129.88 50.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.16 145.26 9.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.625 HG21 ' HB3' ' A' ' 38' ' ' GLU . 4.1 mt -84.05 138.89 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.752 ' CG ' HD12 ' A' ' 28' ' ' ILE . 79.0 m-85 -117.41 161.24 19.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -134.55 172.07 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 t -49.91 -27.04 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -56.35 -33.11 65.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.64 173.2 22.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.647 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.63 158.35 8.74 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.067 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.628 HG22 HG23 ' A' ' 27' ' ' ILE . 4.7 t -113.9 152.05 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.359 0.6 . . . . 0.0 111.824 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD11 ' HB1' ' A' ' 6' ' ' ALA . 54.2 tp -123.66 100.21 6.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.38 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.12 142.02 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.076 0.465 . . . . 0.0 111.767 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.74 97.11 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.338 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.48 -26.4 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.617 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -54.66 -26.63 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.365 -179.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.697 HG23 ' HB2' ' A' ' 4' ' ' ALA . 23.0 p -132.32 -52.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.59 -36.65 1.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.755 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.841 ' HB ' HG21 ' A' ' 45' ' ' VAL . 22.5 t -48.56 142.1 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 51.0 p -149.73 172.05 15.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 111.525 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 83' ' ' LEU . 20.4 mt -145.02 113.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.606 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.628 HG23 HG22 ' A' ' 16' ' ' VAL . 4.1 mp -93.05 118.83 39.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.752 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.6 mt -106.48 90.96 5.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.43 159.52 43.74 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.517 2.145 . . . . 0.0 112.334 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.31 106.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.08 -8.88 3.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.056 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.01 -23.91 55.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.97 0.385 . . . . 0.0 111.451 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 39' ' ' GLN . 36.3 mt -131.0 141.09 40.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.771 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.34 155.48 46.26 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.392 2.061 . . . . 0.0 112.264 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -68.27 152.63 45.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.74 23.34 63.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 38' ' ' GLU . 41.6 t -128.51 160.75 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.146 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.625 ' HB3' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -135.8 113.84 11.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.008 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.821 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.2 tp60 -101.05 110.73 22.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.6 114.16 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.546 HD11 ' HE1' ' A' ' 77' ' ' PHE . 24.7 mt -124.99 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.418 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 40.4 p90 -155.56 152.92 29.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -157.1 162.92 39.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.401 . . . . 0.0 111.384 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.541 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -130.33 126.67 37.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.774 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.841 HG21 ' HB ' ' A' ' 24' ' ' VAL . 39.2 t -114.3 134.71 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.944 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' HB3' HD12 ' A' ' 67' ' ' LEU . 11.2 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.7 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.8 pm0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -100.76 98.47 8.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.588 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -76.45 133.92 39.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.44 -57.66 1.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.206 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -87.13 174.31 5.55 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.576 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 7.5 Cg_exo -34.5 -44.85 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 0.0 111.735 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.1 tm? -156.45 84.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.699 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 64' ' ' LEU . 51.6 t -146.89 118.07 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.289 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -108.85 106.19 16.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.786 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.25 -168.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.85 -148.07 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.53 127.56 21.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.505 2.137 . . . . 0.0 112.009 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -57.2 110.87 0.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.88 76.33 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.74 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 39' ' ' GLN . 18.9 tp -140.56 86.06 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 110.006 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 11.2 mtpp -75.99 123.89 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.173 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.546 ' HE1' HD11 ' A' ' 41' ' ' ILE . 40.8 m-85 -98.68 168.59 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.557 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.771 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -105.63 16.16 25.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.609 . . . . 0.0 111.032 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -161.42 136.51 5.54 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.46 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.6 Cg_exo -63.41 107.06 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.491 2.128 . . . . 0.0 112.499 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.9 m -79.41 144.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -88.4 116.04 26.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 111.05 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 84' ' ' ARG . 9.2 tp -113.39 129.83 56.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 83' ' ' LEU . 51.2 mtp180 -121.66 132.65 54.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.736 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -139.51 113.82 8.0 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.64 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.68 120.69 8.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.095 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.77 -21.32 55.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 68.66 -168.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 62.62 79.53 0.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.47 46.57 2.12 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.826 2.351 . . . . 0.0 112.776 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.06 4.94 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.468 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.53 16.0 10.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.881 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.402 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.8 p-90 -114.17 -36.86 4.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.402 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -108.67 43.63 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.934 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 -47.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.12 -38.19 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.36 174.51 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.47 139.27 21.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.27 -17.82 27.21 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.597 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.47 -29.47 19.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.705 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 140.29 83.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.792 0.33 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.743 ' O ' HG22 ' A' ' 106' ' ' VAL . 43.0 Cg_endo -67.2 -25.73 42.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.592 2.195 . . . . 0.0 112.259 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -16.85 62.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.607 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.777 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.31 -19.01 19.65 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.936 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.777 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 18.0 mt -155.96 -26.87 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.5 m -67.35 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 156.82 -27.92 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.411 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.03 -32.39 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -127.66 42.1 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.45 122.21 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.736 HG11 HD12 ' A' ' 85' ' ' LEU . 13.5 p -106.15 111.54 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.388 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.9 104.98 13.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 111' ' ' VAL . 6.3 m -122.78 126.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mt -99.12 121.0 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.902 ' O ' HG22 ' A' ' 81' ' ' VAL . 12.4 mm -111.88 119.53 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.356 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.504 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 2.7 t0 -119.57 15.39 12.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 4.3 m80 -162.35 125.42 2.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.723 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.17 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.8 p -132.55 143.8 49.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -133.58 120.97 21.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 1.4 mtt180 -122.0 132.12 54.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.39 157.29 28.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.954 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.1 mt -94.98 151.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.977 ' CD1' HD12 ' A' ' 28' ' ' ILE . 41.1 m-85 -128.26 144.86 51.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 111.402 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.73 ' HA ' HG21 ' A' ' 33' ' ' ILE . 2.9 m120 -128.58 171.91 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -47.38 -28.64 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.203 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -54.3 -38.48 65.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.04 173.73 40.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.717 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.28 -155.17 26.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.605 HG13 HG13 ' A' ' 27' ' ' ILE . 2.4 t -146.97 150.23 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 0.0 111.628 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 6' ' ' ALA . 56.4 tp -123.34 100.27 6.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.352 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.79 148.48 50.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 112.016 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 p -116.16 96.99 5.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.001 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -50.15 -26.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.741 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -64.45 -38.49 91.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.679 HG21 HG12 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -105.01 -52.87 2.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.193 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.73 -30.92 3.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.758 HG22 ' HD2' ' A' ' 86' ' ' PRO . 42.1 t -56.12 142.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.01 154.0 41.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 111.453 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.671 HG12 HD13 ' A' ' 83' ' ' LEU . 49.7 mt -132.13 113.62 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 16' ' ' VAL . 2.5 mt -93.59 136.11 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.992 0.425 . . . . 0.0 111.174 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.977 HD12 ' CD1' ' A' ' 10' ' ' PHE . 2.3 mt -128.69 87.02 56.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.744 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.42 162.19 37.61 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.494 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.72 107.4 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.992 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 139.89 -10.75 3.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.114 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.833 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -86.14 -33.69 20.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 11' ' ' ASN . 1.9 mm -101.51 132.74 21.42 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.526 ' HB2' HG21 ' A' ' 37' ' ' VAL . 16.7 Cg_exo -66.08 144.97 77.77 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.154 1.903 . . . . 0.0 111.949 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 37' ' ' VAL . 5.1 mt-10 -57.76 141.57 48.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.25 28.04 71.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 38' ' ' GLU . 26.0 t -131.98 159.87 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG12 ' A' ' 37' ' ' VAL . 31.1 mt-10 -129.96 113.95 15.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.755 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG2' HD11 ' A' ' 75' ' ' LEU . 5.4 tp60 -101.22 109.0 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.374 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -75.8 116.06 16.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 HD11 ' HE1' ' A' ' 77' ' ' PHE . 26.4 mt -124.63 134.29 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.151 0.501 . . . . 0.0 111.6 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.428 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 30.6 p90 -150.79 155.06 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.972 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.6 p90 -157.86 160.36 37.61 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.653 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -120.07 151.65 38.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.846 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.679 HG12 HG21 ' A' ' 22' ' ' THR . 48.4 t -156.81 143.38 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 111.348 -179.796 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.566 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 79.7 mt-10 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.886 0.374 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 m -102.05 111.77 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -77.2 142.04 39.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.198 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.488 HD21 ' HE1' ' A' ' 118' ' ' PHE . 0.1 OUTLIER -126.44 -57.56 1.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -103.2 -173.1 0.27 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.192 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 55.7 Cg_exo -39.87 -58.49 0.88 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.075 1.85 . . . . 0.0 111.747 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.712 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -138.13 85.24 2.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.1 t -147.17 118.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.731 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -112.14 106.11 14.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.9 -143.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.55 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 31.7 Cg_endo -64.07 131.53 30.96 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.494 2.129 . . . . 0.0 112.04 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -56.59 110.82 0.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.37 79.8 1.27 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.638 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 28.9 tp -142.3 85.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.467 ' CB ' ' CD2' ' A' ' 117' ' ' HIS . 4.9 ptmt -85.23 122.01 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.078 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.549 ' HE1' HD11 ' A' ' 41' ' ' ILE . 33.2 m-85 -93.2 170.9 9.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -98.6 18.41 16.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.569 . . . . 0.0 111.077 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 136.6 3.02 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.512 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.52 104.08 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.504 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.6 m -76.73 139.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.887 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 2.0 tp10 -84.5 127.98 34.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.919 0.39 . . . . 0.0 111.347 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.671 HD13 HG12 ' A' ' 26' ' ' ILE . 25.3 tp -124.21 118.24 26.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.47 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 24' ' ' VAL . 10.1 mmm-85 -105.46 134.33 48.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.933 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.985 HD12 HG11 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -131.83 122.26 18.46 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.758 ' HD2' HG22 ' A' ' 24' ' ' VAL . 74.2 Cg_endo -75.27 120.24 5.9 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.429 2.086 . . . . 0.0 112.168 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -73.52 -27.12 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.2 m 63.41 55.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.011 0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -130.92 92.0 35.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.774 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.0 41.03 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.191 2.594 . . . . 0.0 112.783 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -1.46 19.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.525 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -122.75 16.14 10.21 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.447 ' CD1' ' HG2' ' A' ' 94' ' ' GLN . 4.9 p-90 -110.73 -38.77 5.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.447 ' HG2' ' CD1' ' A' ' 93' ' ' TRP . 5.0 pt20 -95.51 152.73 18.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.059 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 64.04 31.22 13.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.761 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.22 -47.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.6 m -129.3 -172.3 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.2 mt -85.75 141.01 35.66 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.57 -1.71 11.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.67 2.247 . . . . 0.0 112.847 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.41 -34.22 4.55 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.707 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.414 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 77.3 m-20 -61.08 123.12 74.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.538 0.209 . . . . 0.0 110.978 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.821 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.24 -30.84 63.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.345 2.03 . . . . 0.0 112.158 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -61.91 -17.22 55.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.38 -17.69 13.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.665 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 14.0 mt -157.94 -30.58 0.08 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.93 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 178.84 -47.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.688 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.75 67.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.388 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -97.63 53.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -162.6 135.9 5.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.985 HG11 HD12 ' A' ' 85' ' ' LEU . 13.2 p -99.86 116.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.28 105.03 13.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.916 0.389 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 83' ' ' LEU . 4.4 m -126.18 123.09 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mt -93.17 131.95 37.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 81' ' ' VAL . 39.8 mm -114.15 117.26 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.305 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.81 27.23 8.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.13 179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.467 ' CD2' ' CB ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 177.3 104.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.4 m-85 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.14 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.2 p -119.07 143.7 46.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.413 . . . . 0.0 110.782 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.584 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -139.53 112.29 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.437 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.4 mtp85 -110.53 137.61 48.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.05 153.93 22.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.928 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 38' ' ' GLU . 35.4 mt -95.97 154.43 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 28' ' ' ILE . 22.4 m-85 -122.79 172.18 8.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -155.1 171.87 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 p -58.62 -25.63 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.58 -57.4 12.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.48 133.11 4.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.45 -169.83 21.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.126 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.65 HG13 HG13 ' A' ' 27' ' ' ILE . 1.9 t -139.89 148.76 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.669 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.14 100.11 6.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.22 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.45 140.87 52.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.733 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 6' ' ' ALA . 0.5 OUTLIER -107.47 97.17 6.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.225 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.37 -26.53 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.671 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 1.4 mt-10 -63.02 -40.82 98.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.291 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.6 HG23 ' HB3' ' A' ' 4' ' ' ALA . 2.4 p -105.84 -52.95 2.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.73 -30.94 3.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.609 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.65 HG22 ' HD2' ' A' ' 86' ' ' PRO . 56.3 t -57.15 144.01 10.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.715 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 p -144.95 161.58 39.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.47 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 HD13 ' A' ' 83' ' ' LEU . 12.7 mt -137.88 114.07 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.843 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.65 HG13 HG13 ' A' ' 16' ' ' VAL . 3.0 mt -96.31 136.38 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.705 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -108.85 93.94 13.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.98 145.07 96.93 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.335 2.023 . . . . 0.0 112.236 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.75 104.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.276 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.09 5.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.203 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.699 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.34 -28.07 56.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.013 0.406 . . . . 0.0 111.258 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.575 HD13 ' HG3' ' A' ' 39' ' ' GLN . 27.4 mt -126.42 141.84 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.746 ' HD3' HD21 ' A' ' 78' ' ' LEU . 39.4 Cg_exo -60.34 155.37 46.9 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.395 2.063 . . . . 0.0 112.234 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.48 141.91 57.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.03 79.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.683 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 38' ' ' GLU . 46.9 t -121.84 160.69 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.311 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.556 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -140.11 113.8 8.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.868 179.211 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.575 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.21 120.03 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.23 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -81.31 108.85 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.651 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.491 ' HB ' ' CE2' ' A' ' 10' ' ' PHE . 2.5 mt -117.17 137.54 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.417 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.437 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 52.5 p90 -149.06 157.14 43.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.052 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -159.37 159.71 34.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.075 0.464 . . . . 0.0 111.64 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -126.45 124.08 39.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.809 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.538 HG21 ' HB ' ' A' ' 24' ' ' VAL . 60.6 t -112.75 130.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.501 ' HB3' HD12 ' A' ' 67' ' ' LEU . 53.2 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.707 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 91.7 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.903 0.383 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 m -106.02 106.36 16.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -75.69 135.11 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.38 -57.7 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.297 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 68' ' ' VAL . 1.1 p -86.78 -175.16 0.56 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.511 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 79.6 Cg_exo -42.06 -47.86 6.56 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.214 1.943 . . . . 0.0 111.705 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.748 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.7 tm? -154.86 81.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.805 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG23 ' OG ' ' A' ' 65' ' ' SER . 69.0 t -142.27 118.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.296 178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -105.72 106.16 16.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.507 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -166.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.211 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -79.35 -144.2 2.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 75.4 Cg_exo -49.77 121.69 7.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.144 . . . . 0.0 112.197 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -58.17 111.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.09 83.93 1.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.625 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 11.9 tp -137.64 85.1 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 77' ' ' PHE . 1.7 tptp -61.7 132.82 54.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 43.3 m-85 -112.7 144.11 42.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.746 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -88.8 17.22 5.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 111.369 179.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -164.68 136.33 3.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.21 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.28 102.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.522 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.4 m -74.06 161.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.504 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -104.81 129.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 111.317 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.572 ' HB3' HG23 ' A' ' 113' ' ' VAL . 27.8 tp -124.16 118.07 26.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.387 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.503 ' O ' HG13 ' A' ' 24' ' ' VAL . 10.9 mmt180 -105.94 130.93 53.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.961 HD12 HG11 ' A' ' 111' ' ' VAL . 1.3 mt -128.13 116.18 20.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 24' ' ' VAL . 51.6 Cg_exo -54.48 136.73 70.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.385 2.057 . . . . 0.0 112.251 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.29 -20.12 57.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 68.31 31.45 5.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -143.63 77.88 14.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.697 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.48 54.42 2.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.923 2.415 . . . . 0.0 112.628 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.31 -13.05 14.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.617 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 t -122.6 16.1 10.33 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.474 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.4 p-90 -106.78 -36.05 6.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.474 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -104.32 71.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -119.37 -39.51 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -43.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 35.4 m -54.56 179.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.13 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 98' ' ' LEU . 11.5 mt -99.0 135.87 20.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.93 -5.72 16.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 112.58 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.4 -41.04 7.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.648 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 61.2 m-20 -61.53 138.51 95.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.52 0.2 . . . . 0.0 110.745 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.762 ' O ' HG22 ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.05 -27.29 50.04 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.175 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -65.28 -15.06 62.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.986 0.422 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.805 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.97 -19.45 18.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.839 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.805 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 14.7 mt -155.58 -28.2 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.11 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -177.88 -36.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.649 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.98 -58.95 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.256 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -96.18 88.39 4.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.47 141.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.961 HG11 HD12 ' A' ' 85' ' ' LEU . 14.2 p -97.32 115.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.18 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.77 104.99 10.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.133 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 83' ' ' LEU . 12.3 m -128.07 120.97 54.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.994 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 12.2 mt -87.06 146.12 26.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 81' ' ' VAL . 30.8 mm -129.8 120.39 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.2 25.87 8.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.078 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.451 ' CD2' ' HD3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 179.36 103.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.823 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.8 0.333 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.497 HG22 ' HB3' ' A' ' 44' ' ' LYS . 57.2 p -118.57 143.27 46.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.863 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -139.45 122.96 17.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.967 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.458 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -127.85 129.36 46.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.36 142.88 7.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -89.89 135.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.838 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.7 m-85 -115.89 151.6 35.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 111.374 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.0 172.31 11.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.654 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.42 -28.97 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -54.76 -29.7 54.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 167.43 32.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.679 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.97 158.48 9.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.347 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.615 HG22 HG23 ' A' ' 27' ' ' ILE . 2.9 t -114.58 151.03 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' A' ' 6' ' ' ALA . 44.0 tp -123.47 100.24 6.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.29 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.47 152.9 42.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.022 0.439 . . . . 0.0 111.89 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.463 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 51.2 m -120.75 97.25 5.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -52.73 -26.54 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' HB2' ' A' ' 4' ' ' ALA . 3.3 mm-40 -66.7 -36.3 82.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.304 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.444 HG21 ' HB ' ' A' ' 45' ' ' VAL . 4.3 p -109.22 -52.89 2.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.736 0.303 . . . . 0.0 111.356 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.92 -43.11 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.812 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.629 ' HB ' HG21 ' A' ' 45' ' ' VAL . 47.2 t -49.83 143.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.4 p -149.47 167.14 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.516 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 83' ' ' LEU . 14.0 mt -139.67 113.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.038 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.615 HG23 HG22 ' A' ' 16' ' ' VAL . 2.2 mp -92.81 122.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.838 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.2 mt -112.08 89.48 11.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.85 156.67 65.03 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.499 2.133 . . . . 0.0 112.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -57.29 104.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 145.17 -13.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.13 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -78.13 -36.01 48.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.382 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.465 HD13 ' CG ' ' A' ' 39' ' ' GLN . 16.3 mt -108.32 141.37 23.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.596 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 19.7 Cg_exo -65.37 155.17 70.12 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.336 2.024 . . . . 0.0 112.131 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 142.46 57.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.53 23.37 75.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 38' ' ' GLU . 48.2 t -126.88 161.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 111.251 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.56 ' N ' HG12 ' A' ' 37' ' ' VAL . 3.2 mt-10 -137.04 113.74 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.813 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.465 ' CG ' HD13 ' A' ' 33' ' ' ILE . 1.4 mm-40 -105.71 117.41 33.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -69.72 119.58 14.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.501 HD11 HD21 ' A' ' 75' ' ' LEU . 3.7 mm -120.66 109.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.458 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 12.3 p90 -138.18 161.27 37.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.309 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.5 OUTLIER -170.84 165.22 7.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 111.86 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 2.3 pttp -132.37 132.63 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.691 HG22 HG13 ' A' ' 68' ' ' VAL . 56.4 t -119.2 138.52 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.228 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.773 -179.924 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.22 111.31 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.472 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.87 144.04 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.296 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -126.34 -57.68 1.38 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.013 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.543 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -98.97 -173.37 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.297 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.2 Cg_exo -40.49 -42.4 3.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.223 1.949 . . . . 0.0 111.864 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.6 tm? -157.6 81.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.744 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.691 HG13 HG22 ' A' ' 45' ' ' VAL . 43.2 t -141.55 118.01 7.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.63 106.19 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.553 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.529 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -66.8 -169.6 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.041 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -61.3 -152.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.541 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 37.1 Cg_endo -65.94 134.37 36.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.544 2.163 . . . . 0.0 112.065 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -60.57 110.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.37 75.98 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.718 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 24.4 tp -142.27 86.41 1.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.144 0.497 . . . . 0.0 110.2 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -53.78 164.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.433 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -146.34 141.37 27.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.625 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.412 HD21 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.68 16.66 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.317 0.58 . . . . 0.0 110.827 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -166.51 136.78 2.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.021 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.77 100.65 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.525 2.15 . . . . 0.0 112.641 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 115' ' ' ILE . 13.5 m -68.13 139.48 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -82.86 123.39 29.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 0.0 111.409 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 26' ' ' ILE . 7.7 tp -124.2 121.05 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.182 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.517 ' N ' HD12 ' A' ' 83' ' ' LEU . 71.7 mtt-85 -115.78 132.88 56.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.709 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 119.49 6.37 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.527 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.63 130.75 38.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.274 1.983 . . . . 0.0 112.236 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.6 -54.8 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.27 168.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 56.04 85.25 0.19 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.187 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.14 38.21 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.855 2.37 . . . . 0.0 112.681 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -108.98 13.17 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.54 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 t -105.47 15.92 26.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 111.819 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.512 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 4.6 p-90 -121.16 -39.94 2.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 4.6 mm100 -99.51 59.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.97 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -127.12 89.2 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tptt 60.74 29.62 19.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -120.5 -171.13 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 98' ' ' LEU . 16.5 mt -85.81 128.75 57.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.27 -7.97 17.26 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.497 2.132 . . . . 0.0 112.539 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.92 10.95 8.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.053 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -71.48 126.62 91.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.937 0.369 . . . . 0.0 110.375 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.744 ' O ' HG21 ' A' ' 106' ' ' VAL . 58.2 Cg_endo -71.48 -7.03 20.41 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.165 1.91 . . . . 0.0 112.671 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.485 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -104.82 17.36 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -75.43 -113.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.034 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -48.04 -21.09 0.4 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.744 HG21 ' O ' ' A' ' 102' ' ' PRO . 15.6 m -68.71 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 155.2 34.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.645 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.72 -51.59 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.04 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.3 29.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.859 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 151.17 36.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.769 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.709 HG11 HD12 ' A' ' 85' ' ' LEU . 11.8 p -93.63 103.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.204 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.34 104.98 7.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 83' ' ' LEU . 5.4 m -120.85 123.22 69.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.45 135.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.7 mm -119.54 117.83 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.244 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.34 26.29 9.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.292 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.509 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.7 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.503 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 2' ' ' VAL . 10.7 p 44.36 30.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.677 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.89 HG11 ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -114.24 142.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.994 0.426 . . . . 0.0 111.153 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.759 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -119.65 117.76 29.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 44' ' ' LYS . 81.1 p -122.52 143.25 49.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 111.078 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.652 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -141.81 112.4 7.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 11.3 ttm-85 -121.54 129.43 52.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.1 156.89 27.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.685 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 38.1 mt -89.68 154.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.813 0.339 . . . . 0.0 110.989 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.608 ' CE2' HD11 ' A' ' 28' ' ' ILE . 18.7 m-85 -127.5 175.25 8.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.135 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -151.31 171.79 16.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -61.7 -23.13 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.942 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -56.4 -45.44 80.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.056 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.29 152.36 8.75 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.827 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.69 -173.32 45.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.087 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.498 HG13 HG13 ' A' ' 27' ' ' ILE . 2.8 t -145.64 150.61 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.392 0.615 . . . . 0.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.652 HD11 ' CB ' ' A' ' 6' ' ' ALA . 22.3 tp -123.34 100.18 6.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.233 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 143.82 50.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.99 0.424 . . . . 0.0 111.811 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.29 97.09 5.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.247 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -54.06 -26.82 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.419 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.759 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 1.4 mm-40 -62.47 -22.73 66.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.314 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' CB ' ' A' ' 4' ' ' ALA . 1.1 p -126.16 -52.97 1.51 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.79 -40.27 1.65 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.694 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 84' ' ' ARG . 33.9 t -53.55 137.98 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.741 0.305 . . . . 0.0 111.129 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.5 p -141.82 169.75 17.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.632 HG12 HD13 ' A' ' 83' ' ' LEU . 24.0 mt -141.59 113.65 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.209 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.0 mp -93.14 131.42 40.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.608 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -103.41 95.15 6.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.608 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.54 138.41 75.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.353 2.036 . . . . 0.0 112.084 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -51.09 101.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.009 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.3 -3.98 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.013 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.05 -30.28 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.892 0.346 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 39' ' ' GLN . 28.3 mt -119.93 143.48 35.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.53 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.5 Cg_exo -64.9 150.8 87.6 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.375 2.05 . . . . 0.0 112.114 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.6 mt-10 -66.57 151.68 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.53 24.46 65.99 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.57 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 38' ' ' GLU . 44.2 t -127.81 160.56 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.068 0.461 . . . . 0.0 111.134 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG12 ' A' ' 37' ' ' VAL . 17.8 mt-10 -128.68 113.83 15.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.05 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.937 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.05 109.05 20.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.04 -179.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 1.3 tt0 -74.45 114.69 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.808 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.6 mt -124.91 139.02 52.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.138 0.494 . . . . 0.0 111.048 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 7' ' ' ARG . 21.3 p90 -153.45 171.51 18.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -175.5 156.81 2.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.886 0.374 . . . . 0.0 111.181 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.659 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -129.41 122.12 28.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.077 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.753 HG22 HG13 ' A' ' 68' ' ' VAL . 39.6 t -110.32 136.67 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.537 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.594 ' HB3' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -168.3 149.02 4.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -30.77 62.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.2 133.77 33.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.822 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.584 ' O ' HD22 ' A' ' 52' ' ' LEU . 4.4 m120 -90.68 -31.31 16.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 p -84.49 -28.46 26.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.158 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.533 ' O ' HG22 ' A' ' 51' ' ' ILE . 30.3 mm -76.78 -2.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.517 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 49' ' ' ASN . 1.4 pt? -52.92 124.6 37.1 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.157 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.89 ' HD3' HG11 ' A' ' 3' ' ' VAL . 97.7 Cg_endo -79.37 138.32 13.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.414 2.076 . . . . 0.0 112.236 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 48.8 Cg_exo -55.42 122.36 11.58 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.413 2.075 . . . . 0.0 112.346 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.613 HD13 ' HG2' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -122.77 -62.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -175.4 76.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.703 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.02 18.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.005 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.32 -29.69 66.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -64.31 -31.06 72.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.69 113.19 2.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.401 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -105.45 129.77 53.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.27 96.43 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.554 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -69.14 143.16 54.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -126.25 -57.73 1.38 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.539 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -96.42 -173.89 0.36 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.258 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.37 -40.31 3.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.281 1.987 . . . . 0.0 111.877 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.74 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -161.19 78.38 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.747 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.753 HG13 HG22 ' A' ' 45' ' ' VAL . 48.6 t -137.61 117.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.566 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.42 106.17 16.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.707 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -60.28 -163.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.114 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -74.59 -144.54 0.97 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.442 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 45.2 Cg_endo -68.12 128.33 17.41 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.5 2.133 . . . . 0.0 112.148 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -57.58 110.83 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.8 77.48 0.86 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.743 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.729 HD11 ' HG2' ' A' ' 39' ' ' GLN . 22.6 tp -141.41 86.64 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.519 . . . . 0.0 110.061 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.505 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -56.18 166.27 0.85 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.134 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 19.2 m-85 -148.72 143.54 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.683 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -96.53 17.9 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.3 ttmt -167.48 136.37 2.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.209 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 39.3 Cg_exo -60.54 96.88 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.408 2.072 . . . . 0.0 112.6 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 115' ' ' ILE . 3.5 m -68.1 140.73 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.536 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.03 125.12 32.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.798 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.632 HD13 HG12 ' A' ' 26' ' ' ILE . 20.5 tp -124.19 128.1 48.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.944 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.763 ' O ' HG13 ' A' ' 24' ' ' VAL . 36.1 mtt-85 -119.76 130.71 55.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.862 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.543 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 154.96 60.06 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.531 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.48 131.57 23.45 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.534 2.156 . . . . 0.0 112.352 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.41 ' CE1' HG21 ' A' ' 92' ' ' THR . 0.0 OUTLIER -79.13 -51.84 8.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.862 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.73 44.9 10.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.971 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.59 105.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.78 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.81 39.39 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.666 2.244 . . . . 0.0 112.828 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -108.71 13.26 25.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.132 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.41 HG21 ' CE1' ' A' ' 87' ' ' HIS . 3.7 t -120.99 16.19 11.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 111.547 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.493 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 8.8 p-90 -118.72 -45.01 2.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.781 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.493 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.9 OUTLIER -88.07 91.36 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -162.04 71.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tptp 60.29 34.93 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.64 -173.59 4.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 23.0 mt -83.87 126.03 71.55 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 9.4 Cg_exo -71.29 -24.44 23.02 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.584 2.189 . . . . 0.0 112.602 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.31 14.12 20.97 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 6.3 t70 -114.0 130.53 23.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.893 0.346 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.823 ' O ' HG22 ' A' ' 106' ' ' VAL . 29.3 Cg_endo -62.94 -30.83 77.27 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.57 2.18 . . . . 0.0 112.222 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -55.57 -20.17 12.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 110.888 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.849 ' CE1' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.52 -12.21 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.06 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.849 HD22 ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -165.26 -13.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -177.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 102' ' ' PRO . 15.9 m -65.12 36.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -153.15 25.26 0.79 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.15 -33.91 14.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.133 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -58.63 -31.62 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.986 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -150.43 139.14 20.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 111' ' ' VAL . 13.8 p -91.31 112.0 24.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.43 105.04 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 83' ' ' LEU . 11.5 m -123.27 123.6 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.061 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -93.5 139.16 31.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.953 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.502 ' HB ' HG22 ' A' ' 81' ' ' VAL . 37.2 mm -121.33 122.22 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.41 25.94 6.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.092 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.505 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.63 102.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.078 -179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.04 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.41 140.7 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.886 HG21 HD22 ' A' ' 52' ' ' LEU . 20.5 t -147.54 139.28 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -97.15 117.57 31.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.712 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.556 HG22 ' CG ' ' A' ' 44' ' ' LYS . 55.7 p -137.41 143.39 41.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.995 0.426 . . . . 0.0 111.274 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.706 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -137.37 137.21 38.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.8 mpp_? -134.73 137.72 43.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 160.86 33.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.822 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.424 HD13 ' HG3' ' A' ' 40' ' ' GLU . 10.4 mm -94.43 154.88 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.598 0.237 . . . . 0.0 110.655 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.931 ' CD1' HD12 ' A' ' 28' ' ' ILE . 51.1 m-85 -135.17 146.01 48.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.28 171.87 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.631 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p -48.84 -26.92 2.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.172 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -56.8 -31.91 65.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.62 -174.57 32.07 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.546 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.26 -161.66 29.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.121 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 27' ' ' ILE . 2.8 t -143.75 151.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 111.731 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 25' ' ' SER . 39.2 tp -123.02 99.96 6.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.041 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.39 154.8 33.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.11 0.481 . . . . 0.0 111.961 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 m -120.94 97.22 5.43 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.147 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.56 -26.53 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.697 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.2 mt-10 -66.41 -46.29 77.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.464 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.632 HG21 HG12 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -100.92 -52.94 3.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 111.371 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.02 -36.25 2.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG22 ' HD2' ' A' ' 86' ' ' PRO . 43.6 t -53.93 145.8 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.738 0.304 . . . . 0.0 110.853 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.69 167.34 26.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.898 0.38 . . . . 0.0 111.513 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.818 HG12 HD13 ' A' ' 83' ' ' LEU . 27.8 mt -134.1 113.84 18.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.717 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.5 mp -91.69 119.05 38.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.797 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.931 HD12 ' CD1' ' A' ' 10' ' ' PHE . 5.3 mt -106.77 97.35 17.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.95 156.86 64.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.435 2.09 . . . . 0.0 112.139 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -57.75 112.97 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.017 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.71 5.93 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.198 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -86.68 -25.88 24.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.022 0.411 . . . . 0.0 111.21 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.868 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.4 mt -122.53 141.92 36.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.45 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -61.75 155.47 53.92 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.315 2.01 . . . . 0.0 112.11 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 37' ' ' VAL . 34.1 mt-10 -67.89 154.99 40.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.41 26.6 56.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 35' ' ' GLU . 38.6 t -133.3 159.93 42.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.118 0.485 . . . . 0.0 111.328 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.532 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -133.64 113.81 12.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.852 179.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.868 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.74 112.05 25.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.14 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG3' HD13 ' A' ' 9' ' ' ILE . 44.2 tt0 -72.59 124.23 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.72 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.6 135.24 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.17 0.509 . . . . 0.0 111.423 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.485 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.9 p90 -148.36 169.33 20.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.9 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.706 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -165.63 157.7 14.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.443 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.714 ' CB ' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -124.66 115.95 21.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 22' ' ' THR . 25.0 t -109.44 135.44 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.523 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.873 ' HB2' HG13 ' A' ' 3' ' ' VAL . 24.9 t -175.36 149.59 1.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.867 0.365 . . . . 0.0 111.388 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.25 5.12 18.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.774 ' CG ' HD13 ' A' ' 51' ' ' ILE . 6.0 m-20 -119.99 110.81 17.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.505 ' CG ' HD23 ' A' ' 67' ' ' LEU . 45.5 t-20 -90.86 -59.68 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.591 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.49 -28.01 46.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.317 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.774 HD13 ' CG ' ' A' ' 48' ' ' ASP . 3.2 mp -72.85 -6.26 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -151.65 136.38 10.29 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.622 0.248 . . . . 0.0 111.1 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -78.33 160.5 29.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.483 2.122 . . . . 0.0 112.382 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.5 172.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.674 2.249 . . . . 0.0 112.414 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.714 HD11 ' CB ' ' A' ' 44' ' ' LYS . 2.2 mp -64.25 -66.45 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -138.59 103.19 4.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -32.13 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -72.37 -37.21 68.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -73.36 -29.0 62.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.922 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.78 113.24 2.84 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.282 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -111.03 106.45 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.49 109.45 20.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.26 142.57 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.5 -57.75 1.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.362 . . . . 0.0 111.254 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.519 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.58 -175.22 0.42 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.308 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.5 Cg_exo -40.53 -44.35 4.4 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.242 1.961 . . . . 0.0 111.684 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.688 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -153.18 86.27 1.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.495 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.3 t -147.63 117.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.429 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -108.52 105.86 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.83 -172.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.19 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 42' ' ' TYR . . . -62.87 -147.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.42 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 36.6 Cg_endo -65.51 126.68 16.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.137 . . . . 0.0 111.932 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -52.97 110.85 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.883 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.27 80.86 1.37 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.9 tp -143.05 86.81 1.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.17 0.51 . . . . 0.0 110.26 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 8.5 tmtt? -67.39 145.72 54.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.092 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 52.3 m-85 -122.77 151.41 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.715 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.552 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.16 14.62 21.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.28 0.562 . . . . 0.0 111.145 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -161.15 136.51 5.72 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.288 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.47 98.47 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.376 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.5 m -70.58 142.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.82 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.75 125.94 36.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.309 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.818 HD13 HG12 ' A' ' 26' ' ' ILE . 9.1 tp -124.08 129.01 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.593 ' N ' HD12 ' A' ' 83' ' ' LEU . 10.5 mtm105 -125.76 124.78 41.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.182 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.519 HD13 ' OG ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -137.0 134.36 19.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.631 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.646 ' HD2' HG22 ' A' ' 24' ' ' VAL . 52.0 Cg_exo -52.94 143.37 49.56 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.352 2.035 . . . . 0.0 112.152 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 25.6 p-80 -49.78 -47.32 51.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 9.2 m 49.22 76.59 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.213 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -175.32 92.83 0.28 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.71 41.13 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.94 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.08 -11.3 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.498 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.1 t -120.69 16.07 11.91 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.483 ' CZ2' ' HG3' ' A' ' 94' ' ' GLN . 2.4 p-90 -113.65 -35.75 5.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -101.45 -23.25 14.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.254 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -98.81 -27.09 14.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.205 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.21 -67.3 0.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.134 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.92 177.0 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 23.4 mt -91.53 129.45 42.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 36.7 Cg_exo -59.98 -22.31 68.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.479 2.12 . . . . 0.0 112.662 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.48 -39.92 6.58 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.946 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 2.5 m-20 -55.3 124.96 56.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.899 ' O ' HG22 ' A' ' 106' ' ' VAL . 49.3 Cg_exo -55.24 -31.58 76.99 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.377 2.051 . . . . 0.0 112.2 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.8 -14.94 57.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.76 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -17.49 6.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.912 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.76 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 10.3 mt -158.08 -32.11 0.07 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.1 m -69.11 36.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -144.04 -42.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.746 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.42 -60.29 3.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 111.346 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 62.91 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 22.4 m -151.2 171.55 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 0.0 111.009 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 111' ' ' VAL . 11.1 p -109.24 120.11 59.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.34 105.1 7.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.852 0.358 . . . . 0.0 110.323 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 83' ' ' LEU . 10.6 m -127.24 121.71 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.056 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 mt -89.46 140.33 29.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.94 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 81' ' ' VAL . 29.8 mm -127.22 121.93 58.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.73 24.8 7.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.251 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.481 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 179.2 111.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.004 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.767 0.317 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 2' ' ' VAL . 14.4 p -149.66 36.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.047 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 46' ' ' CYS . 1.4 t -101.36 148.41 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 22' ' ' THR . . . -101.99 117.58 35.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.479 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.496 HG21 HD11 ' A' ' 55' ' ' LEU . 32.3 p -127.46 143.69 51.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 0.0 111.15 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -130.7 107.07 8.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.452 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 17.6 mtt180 -107.08 129.39 54.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.4 142.03 6.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.006 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 10' ' ' PHE . 25.9 mt -87.51 159.82 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.633 0.254 . . . . 0.0 110.433 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.736 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.5 m-85 -140.73 152.28 45.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -131.17 172.3 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.6 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -44.82 -28.89 0.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.49 -33.79 71.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.42 -174.86 19.21 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.754 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.07 163.28 11.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.144 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 27' ' ' ILE . 2.9 t -119.92 150.61 22.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.369 0.604 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.535 HD11 ' HB1' ' A' ' 6' ' ' ALA . 22.3 tp -123.5 100.34 6.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.457 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.18 149.53 50.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.143 0.496 . . . . 0.0 111.958 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.54 97.1 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.927 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.77 -26.45 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.742 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 9.5 tt0 -62.24 -41.42 98.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.288 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.599 HG23 ' CB ' ' A' ' 4' ' ' ALA . 2.8 p -106.34 -52.91 2.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.67 -35.18 2.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 45' ' ' VAL . 22.6 t -49.08 139.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.761 0.315 . . . . 0.0 111.223 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.14 155.64 42.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 111.382 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.736 HG12 HD13 ' A' ' 83' ' ' LEU . 49.5 mt -136.98 113.54 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.568 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 16' ' ' VAL . 2.0 mp -92.64 136.01 26.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.002 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.736 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.7 mt -124.65 89.22 52.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.8 160.87 46.38 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.495 2.13 . . . . 0.0 112.218 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -57.12 113.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.65 -2.7 4.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.033 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -87.33 -29.43 21.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.997 0.399 . . . . 0.0 111.043 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 39' ' ' GLN . 20.9 mt -122.78 137.16 27.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.609 ' HD3' HD21 ' A' ' 78' ' ' LEU . 34.3 Cg_exo -60.62 155.47 47.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.214 1.943 . . . . 0.0 112.149 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -65.59 140.43 58.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.39 21.71 78.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.429 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 38' ' ' GLU . 43.3 t -123.34 160.38 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.139 0.495 . . . . 0.0 111.211 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.553 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.7 mt-10 -139.28 113.6 8.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.74 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' CG ' HD13 ' A' ' 33' ' ' ILE . 7.5 mm-40 -105.04 108.95 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.056 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -72.96 121.1 19.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.464 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 mt -128.18 130.16 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.1 0.476 . . . . 0.0 111.635 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.452 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 31.8 p90 -144.75 142.2 29.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.904 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.488 ' CE1' HG23 ' A' ' 45' ' ' VAL . 2.3 p90 -145.08 164.36 31.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.088 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' CE ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -128.83 150.25 50.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.22 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 68' ' ' VAL . 78.6 t -144.07 140.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.487 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -168.01 148.89 5.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.795 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -36.49 82.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.621 ' OD2' HD12 ' A' ' 51' ' ' ILE . 0.5 OUTLIER -97.77 116.34 29.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.991 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' HA ' ' HG ' ' A' ' 67' ' ' LEU . 4.5 p30 -90.75 -50.61 5.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.472 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.6 t -74.18 -29.31 61.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.363 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.621 HD12 ' OD2' ' A' ' 48' ' ' ASP . 23.4 mt -78.51 -2.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.311 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.869 HD13 ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -144.93 121.82 6.24 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.848 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.869 ' HD2' HD13 ' A' ' 52' ' ' LEU . 38.4 Cg_endo -66.5 144.46 73.16 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.36 2.04 . . . . 0.0 112.216 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 52.8 Cg_exo -54.66 172.14 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.493 2.129 . . . . 0.0 112.457 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 5' ' ' THR . 1.8 tp -82.33 -41.8 19.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.813 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -149.56 82.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.725 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -56.05 5.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.034 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.02 -35.52 73.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -33.46 71.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.62 111.8 3.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.468 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.799 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.8 pp20? -123.79 138.59 54.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.748 0.309 . . . . 0.0 110.946 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.47 118.77 30.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -95.66 137.97 33.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.722 HD13 HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.39 -57.59 1.38 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.612 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -89.68 -177.56 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.679 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 68.5 Cg_exo -40.3 -49.02 4.01 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.53 2.154 . . . . 0.0 111.771 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.711 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -151.15 84.82 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.751 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 45' ' ' VAL . 46.2 t -146.78 118.21 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.563 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.799 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -110.66 107.08 16.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.692 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -65.94 -168.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.151 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 42' ' ' TYR . . . -64.55 -155.98 0.17 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.615 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 51.1 Cg_exo -53.78 130.63 40.02 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.519 2.146 . . . . 0.0 112.201 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 111.05 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.816 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.21 84.04 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.719 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 33.0 tp -142.16 86.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 110.146 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.5 OUTLIER -57.53 164.51 1.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.117 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -148.13 146.98 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.609 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.67 15.32 22.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -160.07 136.53 6.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.52 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 26.5 Cg_exo -62.64 99.32 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.446 2.098 . . . . 0.0 112.457 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 115' ' ' ILE . 11.3 m -69.67 143.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.864 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -88.85 128.2 35.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 111.192 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 26' ' ' ILE . 7.1 tp -124.35 127.06 47.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.499 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.628 ' N ' HD12 ' A' ' 83' ' ' LEU . 25.1 mtt180 -114.93 133.78 55.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.956 HD12 HG11 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -129.7 107.6 17.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.894 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.08 131.23 43.62 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.388 2.059 . . . . 0.0 112.14 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -27.13 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.085 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 12.9 m 65.37 -166.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.25 94.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.38 49.57 3.25 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.668 2.245 . . . . 0.0 112.666 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 5.04 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.412 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.51 16.12 10.41 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.922 0.392 . . . . 0.0 111.845 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.664 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -115.0 -36.11 4.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.664 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 3.1 mt-30 -105.04 55.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.098 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -157.63 105.16 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.16 33.3 22.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.4 m -133.95 176.17 8.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.991 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.5 mt -91.31 131.67 35.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -77.23 -2.35 12.56 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.26 -18.44 6.72 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.806 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.409 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -66.26 116.57 34.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.59 0.233 . . . . 0.0 110.86 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.792 ' O ' HG22 ' A' ' 106' ' ' VAL . 71.6 Cg_exo -50.82 -30.61 30.33 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.472 2.115 . . . . 0.0 112.296 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.803 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 32.9 m-80 -60.59 -19.49 57.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.4 -18.71 19.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.735 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 20.2 mt -157.01 -29.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.85 36.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 118.62 47.41 0.41 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.566 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 103' ' ' ASN . . . -94.5 -34.49 12.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.743 0.306 . . . . 0.0 111.189 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.46 82.47 2.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.977 0.418 . . . . 0.0 111.007 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.04 139.24 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.706 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.956 HG11 HD12 ' A' ' 85' ' ' LEU . 14.9 p -99.57 108.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.466 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.09 104.91 11.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.1 m -122.68 131.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.241 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 mt -103.35 134.81 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.899 ' O ' HG22 ' A' ' 81' ' ' VAL . 38.0 mm -122.13 122.9 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.559 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -124.01 26.47 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.956 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.453 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -173.11 101.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.16 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.718 ' CE1' HG21 ' A' ' 115' ' ' ILE . 2.3 m-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.664 ' O ' HG12 ' A' ' 2' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.573 0.225 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 1' ' ' THR . 7.0 p 50.93 162.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.988 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.942 HG13 HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.0 133.72 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -110.67 117.81 34.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.676 HG21 HD11 ' A' ' 55' ' ' LEU . 43.5 p -119.89 143.99 47.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -131.74 115.71 16.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.852 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -120.48 131.95 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.44 157.35 28.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.084 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -105.72 131.84 54.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.709 0.29 . . . . 0.0 110.453 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CG ' HD13 ' A' ' 28' ' ' ILE . 71.6 m-85 -112.48 153.26 27.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.047 0.451 . . . . 0.0 111.429 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.7 171.99 9.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.497 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -48.26 -27.48 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.33 -37.26 69.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.258 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.9 179.01 23.62 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.577 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.01 167.45 15.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.084 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG13 HG13 ' A' ' 27' ' ' ILE . 1.9 t -117.87 148.22 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.73 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.737 HD11 ' HB1' ' A' ' 6' ' ' ALA . 30.4 tp -123.3 100.2 6.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.203 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.91 145.51 50.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.0 111.854 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -110.84 97.19 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.249 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -50.48 -26.5 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.644 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -65.86 -30.5 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.36 -179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 4' ' ' ALA . 1.3 p -115.52 -53.0 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.726 0.298 . . . . 0.0 111.291 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.65 -38.04 1.97 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.788 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG22 ' HD2' ' A' ' 86' ' ' PRO . 60.6 t -48.56 144.93 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.0 p -149.73 152.06 34.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.465 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.664 HG12 HD13 ' A' ' 83' ' ' LEU . 41.6 mt -129.84 113.37 26.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.442 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.645 HG13 HG13 ' A' ' 16' ' ' VAL . 2.8 mt -97.3 123.24 49.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.058 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.68 ' CG2' ' HB3' ' A' ' 32' ' ' ALA . 1.5 mt -113.53 92.91 25.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.63 157.37 58.93 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.94 106.54 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 137.68 -7.23 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.106 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -81.72 -24.28 36.22 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.934 0.367 . . . . 0.0 111.234 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.642 HD13 ' CB ' ' A' ' 39' ' ' GLN . 35.4 mt -125.68 141.1 38.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.472 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' HD21 ' A' ' 78' ' ' LEU . 39.2 Cg_exo -59.92 155.45 44.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 37' ' ' VAL . 20.6 mt-10 -70.85 148.68 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.63 22.89 68.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.547 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 38' ' ' GLU . 38.5 t -130.31 160.16 41.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.027 0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' N ' HG12 ' A' ' 37' ' ' VAL . 20.1 mt-10 -131.55 113.96 14.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.996 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.693 ' HG2' HD11 ' A' ' 75' ' ' LEU . 23.6 tp60 -101.12 109.05 20.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.993 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.1 123.23 21.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.595 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.34 132.71 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 111.3 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.521 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 21.5 p90 -146.81 170.07 17.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.333 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.681 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.3 p90 -175.93 157.31 1.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.378 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' HD22 ' A' ' 55' ' ' LEU . 7.2 pttt -128.35 133.04 48.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.079 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.811 HG22 HG13 ' A' ' 68' ' ' VAL . 88.9 t -119.86 130.63 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.569 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.62 ' HB3' HG12 ' A' ' 3' ' ' VAL . 1.1 p -162.99 149.41 12.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.179 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -78.25 0.45 25.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.858 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.62 122.13 16.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.847 0.356 . . . . 0.0 111.128 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 11.2 t-20 -90.71 -59.92 2.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.486 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -66.62 -26.06 66.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.499 ' O ' HG22 ' A' ' 51' ' ' ILE . 29.6 mm -74.68 -4.54 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.631 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.942 HD13 HG13 ' A' ' 3' ' ' VAL . 2.8 mt -143.37 147.42 40.02 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 60.2 Cg_endo -72.64 139.18 30.61 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.499 2.133 . . . . 0.0 112.297 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 50.7 Cg_exo -54.02 164.87 2.29 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.424 2.083 . . . . 0.0 112.33 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.676 HD11 HG21 ' A' ' 5' ' ' THR . 1.3 tp -92.88 -37.29 12.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.93 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -169.45 75.25 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.799 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -72.86 -31.84 65.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -69.31 -33.31 72.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -30.17 57.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.976 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.16 113.19 2.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.341 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.9 pm0 -101.06 141.39 34.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 3.0 m -123.01 99.15 6.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.236 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.34 138.32 41.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.444 HD13 HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.39 -57.62 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.996 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.544 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -91.49 -172.56 0.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.195 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 63.7 Cg_exo -40.19 -48.53 3.97 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.203 1.936 . . . . 0.0 111.815 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.68 ' O ' HD13 ' A' ' 67' ' ' LEU . 1.9 tm? -155.67 78.72 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.781 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.811 HG13 HG22 ' A' ' 45' ' ' VAL . 42.5 t -137.56 117.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.746 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.3 106.91 17.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.662 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -61.86 -171.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.065 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -63.87 -144.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.542 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 51.4 Cg_endo -68.97 130.59 20.61 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.475 2.116 . . . . 0.0 111.989 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -57.67 110.76 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.5 75.59 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.765 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.693 HD11 ' HG2' ' A' ' 39' ' ' GLN . 5.1 tp -138.76 84.62 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.166 0.508 . . . . 0.0 110.03 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' CG ' ' CD2' ' A' ' 117' ' ' HIS . 1.5 tmtm? -63.23 151.88 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.236 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 31.4 m-85 -129.69 151.17 50.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.551 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.706 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -93.73 15.23 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 111.221 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -165.04 136.42 3.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.269 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.06 99.2 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 115' ' ' ILE . 6.6 m -69.76 152.8 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HB3' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -95.0 126.81 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 111.343 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.666 ' HG ' HD21 ' A' ' 85' ' ' LEU . 36.5 tp -124.21 116.94 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -106.92 131.01 54.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.159 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.94 HD12 HG11 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -130.54 123.29 20.26 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.765 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 24' ' ' VAL . 73.9 Cg_endo -75.08 120.1 5.9 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.34 2.027 . . . . 0.0 112.095 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.06 -30.19 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 56.1 m 60.54 65.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -114.32 110.83 47.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.815 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.98 39.04 0.7 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.653 2.235 . . . . 0.0 112.929 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.14 -9.13 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.597 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.6 t -122.7 16.07 10.25 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.456 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 4.8 p-90 -107.03 -38.4 6.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.071 0.462 . . . . 0.0 110.955 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.456 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -95.61 56.4 1.78 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.811 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.16 -45.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.1 -46.58 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 62.3 m -54.9 176.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.122 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 11.8 mt -99.86 124.26 44.47 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.23 -26.97 72.22 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.469 2.112 . . . . 0.0 112.347 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.55 -16.11 44.06 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.967 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 98' ' ' LEU . 5.8 t70 -80.62 137.95 51.13 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.808 0.304 . . . . 0.0 111.008 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.76 ' O ' HG22 ' A' ' 106' ' ' VAL . 53.2 Cg_endo -68.71 -24.39 35.0 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.751 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 96.9 m-20 -64.07 -17.01 62.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.79 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.99 -20.21 15.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.85 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.79 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 16.6 mt -155.08 -26.82 0.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.9 m -66.78 36.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 123.06 36.4 0.66 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.531 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 103' ' ' ASN . . . -94.44 -33.32 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.113 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -134.03 51.48 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.87 141.05 33.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.94 HG11 HD12 ' A' ' 85' ' ' LEU . 13.8 p -85.38 107.61 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.391 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.71 104.92 10.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 111' ' ' VAL . 7.7 m -123.99 125.0 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.4 mt -90.07 145.13 25.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.3 mm -129.32 117.66 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.991 0.424 . . . . 0.0 111.589 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.53 27.42 8.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.883 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.492 ' CD2' ' CG ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.98 106.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.815 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.796 0.332 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 2' ' ' VAL . 13.8 p -138.75 30.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.919 HG21 HD22 ' A' ' 52' ' ' LEU . 27.3 t -105.56 133.3 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.232 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.15 117.43 30.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.616 HG22 ' HG2' ' A' ' 44' ' ' LYS . 21.5 p -136.59 145.38 44.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.757 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -133.84 133.06 41.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' HA ' ' CB ' ' A' ' 42' ' ' TYR . 4.6 ttt180 -135.7 129.33 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.526 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.99 169.96 42.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.64 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 28.2 mt -104.49 137.88 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.719 ' CG ' HD12 ' A' ' 28' ' ' ILE . 87.9 m-85 -120.35 153.2 36.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -124.21 171.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 p -55.91 -22.38 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.266 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.61 -36.31 71.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 110.963 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.68 158.68 11.75 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.72 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.01 164.46 25.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.255 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.59 HG13 HG13 ' A' ' 27' ' ' ILE . 3.1 t -122.26 152.38 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.168 0.509 . . . . 0.0 111.475 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.757 HD11 ' CB ' ' A' ' 6' ' ' ALA . 28.5 tp -123.34 100.2 6.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.365 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.47 154.35 42.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 0.0 112.039 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.468 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 2.7 p -119.92 97.2 5.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.967 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.0 mm -49.4 -26.57 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.914 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.817 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -65.35 -55.69 16.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.343 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.728 HG23 ' HB3' ' A' ' 4' ' ' ALA . 6.9 p -90.45 -52.88 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.296 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.43 -36.54 2.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.781 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 84' ' ' ARG . 21.5 t -48.66 143.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.655 0.264 . . . . 0.0 111.072 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -148.8 161.63 41.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.474 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.793 HG12 HD13 ' A' ' 83' ' ' LEU . 32.2 mt -137.38 113.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.774 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 16' ' ' VAL . 2.4 mp -92.39 128.24 44.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.851 0.358 . . . . 0.0 110.926 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.761 HG22 ' HB3' ' A' ' 32' ' ' ALA . 2.2 mt -112.75 94.49 28.96 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.435 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.21 157.68 48.46 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.661 2.241 . . . . 0.0 112.452 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -60.89 95.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.617 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . 145.14 -11.3 1.82 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.877 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.761 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -72.94 -23.57 60.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.823 0.311 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.823 HD13 ' HB2' ' A' ' 39' ' ' GLN . 39.1 mt -124.5 141.85 38.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.449 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.728 ' HD3' HD21 ' A' ' 78' ' ' LEU . 32.0 Cg_exo -58.68 152.37 56.71 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.378 2.052 . . . . 0.0 112.371 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -67.93 152.55 45.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.96 23.34 56.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.482 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 35' ' ' GLU . 39.1 t -131.1 160.75 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 111.075 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.545 ' N ' HG12 ' A' ' 37' ' ' VAL . 14.9 mt-10 -132.62 113.94 13.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.121 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.823 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -99.01 113.37 25.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.037 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -74.4 115.66 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.577 HD11 ' HE1' ' A' ' 77' ' ' PHE . 29.4 mt -123.23 139.71 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.174 0.511 . . . . 0.0 111.255 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.432 ' CD1' HD22 ' A' ' 55' ' ' LEU . 21.0 p90 -153.06 162.61 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -166.36 158.89 14.25 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.923 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.664 ' HE2' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.92 149.33 41.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.509 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 68' ' ' VAL . 37.1 t -145.29 135.36 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.893 ' HB2' HG13 ' A' ' 3' ' ' VAL . 18.1 t -173.44 148.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.944 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -24.38 67.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.186 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.414 ' HB3' HG12 ' A' ' 51' ' ' ILE . 0.7 OUTLIER -116.49 128.31 55.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.852 0.358 . . . . 0.0 110.978 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -90.7 -59.52 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.65 -25.28 6.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.499 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 51' ' ' ILE . 30.1 mm -71.07 -8.34 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.651 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.919 HD22 HG21 ' A' ' 3' ' ' VAL . 2.1 tp -173.68 106.4 0.3 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.221 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.84 172.02 3.23 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.597 2.198 . . . . 0.0 111.91 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -56.32 170.93 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.56 2.173 . . . . 0.0 112.226 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 42' ' ' TYR . 5.2 mp -59.89 -37.41 79.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.066 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -162.94 121.08 2.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -72.97 -37.13 67.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -73.14 -32.98 65.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.89 -33.69 74.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 112.18 3.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.542 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.28 141.97 40.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 111.09 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.78 104.98 10.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -79.71 139.06 37.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.929 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.46 -57.6 1.37 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.284 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.704 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -94.37 -175.37 0.47 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.29 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.25 -46.97 5.49 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.169 1.912 . . . . 0.0 111.538 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.74 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.6 tm? -151.53 80.8 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.528 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.9 t -141.85 118.24 6.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.511 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . -106.53 106.16 16.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.613 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB1' ' CE2' ' A' ' 118' ' ' PHE . . . -64.87 -178.67 0.45 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.08 -156.71 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.637 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 48.7 Cg_exo -55.4 129.26 34.22 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.534 2.156 . . . . 0.0 112.12 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -58.45 111.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.725 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.06 72.42 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.478 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.727 HD11 ' HG2' ' A' ' 39' ' ' GLN . 20.6 tp -137.96 83.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.262 0.553 . . . . 0.0 110.002 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 10.3 mttt -73.0 117.16 14.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.046 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' HE1' HD11 ' A' ' 41' ' ' ILE . 84.6 m-85 -90.76 154.24 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.728 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.36 17.17 16.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.296 0.57 . . . . 0.0 111.065 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.43 136.68 4.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.69 94.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.537 2.158 . . . . 0.0 112.769 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.5 m -70.1 133.4 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.553 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 28.9 mt-10 -82.64 128.18 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.006 0.432 . . . . 0.0 111.563 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.793 HD13 HG12 ' A' ' 26' ' ' ILE . 14.7 tp -124.19 128.72 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.164 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.609 ' O ' HG13 ' A' ' 24' ' ' VAL . 25.5 mtt180 -115.73 127.41 55.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 0.0 111.561 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.704 HD13 ' OG ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -143.64 162.25 42.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.559 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.18 120.07 6.27 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.391 2.061 . . . . 0.0 112.313 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -77.54 -54.52 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.944 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 65.0 m 56.14 -89.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.965 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.85 74.87 0.72 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.265 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.502 ' HA ' ' CD1' ' A' ' 93' ' ' TRP . 96.3 Cg_endo -86.46 35.48 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.753 2.302 . . . . 0.0 112.929 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -13.75 14.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.658 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -122.62 16.15 10.32 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.502 ' CD1' ' HA ' ' A' ' 90' ' ' PRO . 3.3 p-90 -106.83 -35.87 6.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.142 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.476 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 7.7 pt20 -102.02 35.02 2.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -156.81 28.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -177.2 -62.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.4 m -70.75 178.93 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 98' ' ' LEU . 11.1 mt -98.68 121.61 55.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.8 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.71 -35.54 97.75 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.457 2.105 . . . . 0.0 112.36 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.56 -17.42 66.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.889 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -81.56 138.57 47.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.976 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.753 ' O ' HG22 ' A' ' 106' ' ' VAL . 50.0 Cg_endo -68.4 -24.52 36.74 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.516 2.144 . . . . 0.0 112.327 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.411 ' HA ' HG22 ' A' ' 106' ' ' VAL . 66.6 m-20 -63.73 -16.77 61.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 110.568 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.773 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.68 -18.89 23.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.98 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.773 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 16.4 mt -156.75 -24.19 0.1 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 102' ' ' PRO . 8.0 m -67.99 36.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.5 -44.18 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.238 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.83 -68.28 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.943 0.402 . . . . 0.0 110.994 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.68 -67.91 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 66.1 m -121.34 167.85 12.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.095 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 85' ' ' LEU . 13.4 p -108.0 139.22 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.86 105.05 16.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.371 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 m -129.8 123.84 57.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.073 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mt -97.04 142.12 29.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.74 ' O ' HG22 ' A' ' 81' ' ' VAL . 39.5 mm -123.84 123.26 66.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.0 25.83 7.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.915 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.473 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -174.2 103.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.401 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.686 ' CE1' HG21 ' A' ' 115' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.922 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 2' ' ' VAL . 11.4 p -156.15 26.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.38 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -114.63 134.86 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.159 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.765 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -107.08 117.78 34.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.642 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 44' ' ' LYS . 71.2 p -118.35 143.25 46.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.0 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.69 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -135.56 109.35 8.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.664 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -117.68 129.85 55.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.07 154.26 22.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.709 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.28 144.14 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.935 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.971 ' CD2' HD12 ' A' ' 28' ' ' ILE . 29.4 m-85 -117.64 151.87 36.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.218 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -125.52 171.89 10.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.753 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 p -53.85 -23.65 13.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.209 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.24 -42.48 73.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.186 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.04 130.47 2.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.771 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -151.93 -139.78 3.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.983 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HG23 ' A' ' 27' ' ' ILE . 2.1 t -151.52 148.3 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 111.684 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.69 HD11 ' HB1' ' A' ' 6' ' ' ALA . 15.3 tp -123.29 100.06 6.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.718 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.22 139.91 52.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.198 0.523 . . . . 0.0 112.391 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.745 ' OG ' ' HB1' ' A' ' 4' ' ' ALA . 32.1 t -111.54 96.54 6.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.905 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 20' ' ' ILE . 4.6 tp -58.85 -26.61 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.81 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.765 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -60.27 -28.8 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.313 . . . . 0.0 110.722 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.692 HG23 ' HB3' ' A' ' 4' ' ' ALA . 1.9 p -115.73 -52.81 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.777 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.56 -32.03 3.0 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.953 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 84' ' ' ARG . 21.7 t -59.6 147.07 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.826 0.346 . . . . 0.0 111.201 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.78 160.81 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.726 HG12 HD13 ' A' ' 83' ' ' LEU . 13.5 mt -135.58 113.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.75 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 HG22 ' A' ' 16' ' ' VAL . 2.6 mt -96.38 114.72 33.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.971 HD12 ' CD2' ' A' ' 10' ' ' PHE . 4.3 mt -103.41 91.67 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.26 161.67 33.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.472 2.115 . . . . 0.0 112.506 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -59.49 111.54 1.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.36 -4.46 5.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.086 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.633 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -82.51 -22.51 35.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.782 0.291 . . . . 0.0 111.377 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.803 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.9 mt -131.58 139.17 34.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.768 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.79 ' HD3' HD21 ' A' ' 78' ' ' LEU . 35.1 Cg_exo -57.03 155.47 28.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.46 2.106 . . . . 0.0 112.221 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -68.82 148.96 49.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.81 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.51 24.86 69.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.3 t -130.02 160.69 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 37' ' ' VAL . 2.7 mp0 -134.7 113.82 12.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.018 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.803 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.8 tp60 -100.64 109.59 21.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.035 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -69.71 118.43 12.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.65 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.4 mt -127.1 139.95 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 111.197 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB3' ' CG ' ' A' ' 7' ' ' ARG . 39.9 p90 -155.62 159.17 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.347 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -164.18 163.5 22.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.955 0.407 . . . . 0.0 111.592 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.553 ' HB3' HG22 ' A' ' 5' ' ' THR . 2.3 pttp -131.06 142.31 50.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.743 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 HG13 ' A' ' 68' ' ' VAL . 57.7 t -132.54 138.8 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.61 ' HB2' HG12 ' A' ' 3' ' ' VAL . 40.9 t -176.03 149.09 0.87 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -65.15 119.26 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.567 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 63.15 141.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.511 HD22 HD11 ' A' ' 67' ' ' LEU . 7.2 t-20 -90.5 -30.19 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.32 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 p -54.78 -25.97 31.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.373 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 47' ' ' ARG . 33.1 mt -71.56 -9.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.385 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.17 128.75 0.22 Allowed Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.576 0.227 . . . . 0.0 110.981 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 164.36 9.29 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.464 2.11 . . . . 0.0 112.279 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.7 172.26 14.78 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.623 2.215 . . . . 0.0 112.513 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 44' ' ' LYS . 1.2 mp -63.33 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.836 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.32 108.19 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -72.92 -42.58 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -57.19 -31.27 65.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -75.41 -28.89 59.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.03 113.02 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.291 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HG2' ' HB1' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -100.68 105.04 16.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.351 . . . . 0.0 111.176 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.49 98.35 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.65 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.73 142.14 35.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.993 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.605 ' CB ' HD13 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -90.56 -173.19 0.37 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.187 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.3 Cg_exo -40.63 -43.71 4.39 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.209 1.94 . . . . 0.0 111.716 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -160.6 79.73 0.65 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.834 HG13 HG22 ' A' ' 45' ' ' VAL . 47.2 t -138.27 118.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.701 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' HB1' ' HG2' ' A' ' 61' ' ' GLU . . . -102.06 106.27 17.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.632 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.44 -170.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -62.94 -154.67 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.431 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -62.56 123.4 12.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.462 2.108 . . . . 0.0 112.058 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -50.77 110.86 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.157 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.54 0.67 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 39' ' ' GLN . 11.9 tp -139.15 85.17 2.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.167 0.508 . . . . 0.0 110.242 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 16.2 tttm -65.96 138.49 57.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.866 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 37.6 m-85 -115.89 151.94 34.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.572 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.79 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.27 14.04 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.314 0.578 . . . . 0.0 111.032 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -160.77 136.42 5.92 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.131 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.86 98.66 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.391 2.061 . . . . 0.0 112.395 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.1 m -66.92 156.02 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.884 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.35 106.62 17.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.354 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.726 HD13 HG12 ' A' ' 26' ' ' ILE . 22.9 tp -104.26 129.72 52.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.301 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.424 ' O ' HG13 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -121.82 134.04 54.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.393 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.605 HD13 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -143.67 136.46 13.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.731 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.3 135.16 18.18 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.488 2.125 . . . . 0.0 112.206 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -59.2 -26.41 64.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.56 31.2 18.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.783 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -153.32 100.6 2.63 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.738 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.07 50.65 3.56 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.651 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 -6.64 15.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.514 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -111.07 16.15 21.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.422 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.6 p-90 -113.26 -37.24 4.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.422 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.8 OUTLIER -107.79 162.68 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.993 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.88 -65.78 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -69.01 -61.35 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 m -84.04 -178.27 6.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.95 123.32 66.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.24 -46.35 25.61 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.533 2.155 . . . . 0.0 112.467 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.54 -21.12 79.21 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.992 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -69.15 121.74 82.92 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.584 0.231 . . . . 0.0 111.044 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.796 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.8 Cg_exo -53.3 -29.87 49.45 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.414 2.076 . . . . 0.0 112.223 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.51 -19.72 57.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.761 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.35 -19.81 16.33 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.627 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.761 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 17.9 mt -155.79 -29.2 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.98 36.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 174.59 -32.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.71 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.05 18.46 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.587 0.232 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -70.46 -31.76 69.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 13.0 m -139.88 166.05 25.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 111' ' ' VAL . 14.8 p -101.34 120.22 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.252 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 105.15 8.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.364 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 113' ' ' VAL . 11.4 m -126.18 121.88 60.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.88 145.99 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.046 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.506 ' O ' HG22 ' A' ' 81' ' ' VAL . 33.9 mm -129.72 120.24 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -123.61 25.76 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.234 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.424 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.46 109.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.031 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 2' ' ' VAL . 12.6 p -154.12 51.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.024 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.836 HG12 ' SG ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -104.77 131.07 54.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.21 123.12 37.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.391 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.693 HG22 ' HB3' ' A' ' 44' ' ' LYS . 30.9 p -133.52 143.57 48.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 0.0 111.199 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -143.13 124.05 14.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.899 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 15.0 mtm180 -127.09 129.52 48.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.574 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 148.03 11.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.042 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 10' ' ' PHE . 25.5 mt -87.68 155.39 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.519 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.801 ' CG ' HD12 ' A' ' 28' ' ' ILE . 56.5 m-85 -132.02 148.23 52.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.066 0.46 . . . . 0.0 111.427 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.26 172.21 12.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.449 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -46.56 -27.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.438 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.23 -41.23 49.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.395 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.76 129.06 3.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.44 -158.86 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.016 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 27' ' ' ILE . 2.7 t -140.02 151.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 0.0 111.793 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.578 HD11 ' HB1' ' A' ' 6' ' ' ALA . 35.5 tp -123.22 100.18 6.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m -122.47 154.03 38.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.469 . . . . 0.0 112.001 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 p -126.09 97.15 4.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.101 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -53.33 -26.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.783 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -59.8 -24.86 64.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.44 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 4' ' ' ALA . 6.6 p -129.03 -52.79 1.21 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 111.306 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.96 -35.88 2.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.713 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.669 ' HB ' HG21 ' A' ' 45' ' ' VAL . 20.5 t -49.31 141.81 2.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.706 0.289 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.6 p -148.24 162.28 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.826 HG12 HD13 ' A' ' 83' ' ' LEU . 26.8 mt -135.52 113.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.889 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.1 mp -94.05 123.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.801 HD12 ' CG ' ' A' ' 10' ' ' PHE . 3.3 mt -112.62 91.37 17.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 157.54 57.55 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.505 2.136 . . . . 0.0 112.25 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 107.9 0.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 139.57 -9.39 3.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.051 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -77.85 -29.05 50.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.969 0.384 . . . . 0.0 111.202 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.49 HD13 ' CG ' ' A' ' 39' ' ' GLN . 20.4 mt -118.83 141.52 30.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.723 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.534 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.1 Cg_exo -64.79 155.32 68.07 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.454 2.102 . . . . 0.0 112.101 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.78 141.04 58.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.25 23.37 78.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.624 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 38' ' ' GLU . 43.4 t -125.27 160.31 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.274 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.552 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.8 mt-10 -137.46 113.73 10.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.706 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.49 ' CG ' HD13 ' A' ' 33' ' ' ILE . 4.6 mm-40 -105.74 108.95 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -70.54 122.57 19.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -130.74 129.9 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.544 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 39.4 p90 -145.72 158.41 43.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.935 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -163.09 160.81 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.733 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -131.7 123.67 28.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.96 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.669 HG21 ' HB ' ' A' ' 24' ' ' VAL . 38.7 t -107.15 129.45 60.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.836 ' SG ' HG12 ' A' ' 3' ' ' VAL . 1.9 m -143.12 149.0 37.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.942 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -29.4 58.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.795 ' HB2' HD23 ' A' ' 52' ' ' LEU . 43.6 m-20 -113.37 134.94 54.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' HA ' ' HG ' ' A' ' 67' ' ' LEU . 8.4 p-10 -90.98 -53.11 4.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.709 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.01 -35.01 59.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.69 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.634 ' C ' HD22 ' A' ' 52' ' ' LEU . 3.3 mp -74.34 -2.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.352 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 48' ' ' ASP . 4.1 mm? -132.65 138.35 31.84 Favored Pre-proline 0 C--O 1.232 0.133 0 CA-C-O 120.717 0.294 . . . . 0.0 110.998 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 84.4 Cg_endo -82.29 151.93 15.81 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.627 2.218 . . . . 0.0 112.616 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 31.7 Cg_exo -61.29 172.24 3.46 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.672 2.248 . . . . 0.0 112.342 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 5' ' ' THR . 3.8 tp -97.57 -67.04 0.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 0.0 110.869 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -145.71 65.91 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -37.04 85.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -56.23 -31.31 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.037 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -86.38 -23.76 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.94 113.34 1.55 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.271 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.474 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 5.8 tt0 -112.69 122.74 48.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 111.316 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.74 101.4 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.288 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.4 142.95 40.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 -179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -126.46 -57.61 1.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.116 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.616 ' OG ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -96.93 -174.12 0.37 Allowed Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 87.6 Cg_exo -43.28 -32.97 3.54 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.024 1.816 . . . . 0.0 111.52 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.732 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -165.49 84.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.851 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.65 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -145.91 117.64 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.099 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB1' ' CG ' ' A' ' 61' ' ' GLU . . . -104.31 106.15 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.532 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -66.93 -172.01 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.12 -158.25 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.5 Cg_endo -63.23 121.74 9.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.526 2.151 . . . . 0.0 111.994 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.69 110.95 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.72 72.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.471 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 31.4 tp -142.52 85.86 1.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.183 0.516 . . . . 0.0 110.321 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 40.4 tttt -57.69 159.64 5.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.045 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.97 143.16 34.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.574 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.534 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.55 16.71 16.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.142 0.496 . . . . 0.0 111.228 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -161.53 136.45 5.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.333 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 27.3 Cg_exo -62.31 100.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.439 2.093 . . . . 0.0 112.473 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 115' ' ' ILE . 16.3 m -72.94 139.42 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.759 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -85.57 124.57 32.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.269 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 26' ' ' ILE . 21.1 tp -124.21 128.26 48.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.439 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.666 ' O ' HG13 ' A' ' 24' ' ' VAL . 13.0 mtm-85 -119.06 127.17 53.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.821 ' O ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -141.99 131.47 12.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.31 143.94 73.88 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.398 2.066 . . . . 0.0 112.092 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -59.13 -46.35 88.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.3 m 57.76 176.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.972 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.6 t70 58.28 100.58 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.08 41.02 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.672 2.248 . . . . 0.0 112.87 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -108.94 -3.75 17.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.564 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -122.62 16.07 10.32 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.459 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.7 p-90 -110.26 -36.68 5.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 6.3 pt20 -106.85 51.43 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.974 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -21.97 13.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -171.58 -38.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 m -47.89 171.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.252 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 9.9 mt -87.66 123.5 69.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 23.2 Cg_exo -63.93 -33.81 62.11 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.542 2.162 . . . . 0.0 112.223 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.05 76.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.898 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -70.9 121.52 84.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.688 0.244 . . . . 0.0 110.776 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.766 ' O ' HG22 ' A' ' 106' ' ' VAL . 27.9 Cg_endo -62.35 -27.5 77.72 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.348 2.032 . . . . 0.0 112.107 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.35 -15.64 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.774 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.38 -18.35 10.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.958 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.774 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 13.4 mt -156.7 -28.92 0.09 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.7 m -67.44 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.64 -38.42 0.04 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.61 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.0 18.46 10.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.702 0.287 . . . . 0.0 111.512 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -63.11 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.5 p -93.49 149.32 21.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 85' ' ' LEU . 11.8 p -109.83 119.09 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.87 105.05 12.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.281 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 83' ' ' LEU . 4.6 m -121.02 129.22 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.042 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.0 mt -96.8 132.06 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.066 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.86 ' O ' HG22 ' A' ' 81' ' ' VAL . 42.9 mm -118.77 118.79 59.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -119.93 25.65 9.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.39 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -178.79 115.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.26 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.616 ' CE1' HG21 ' A' ' 115' ' ' ILE . 1.2 m-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.684 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.628 0.252 . . . . 0.0 111.129 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.684 HG12 ' O ' ' A' ' 1' ' ' THR . 7.3 p 52.14 160.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.983 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.638 HG12 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -131.9 147.75 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.943 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.567 ' HB3' HG23 ' A' ' 22' ' ' THR . . . -107.37 117.82 35.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.802 HG21 HD11 ' A' ' 55' ' ' LEU . 65.4 p -123.59 143.76 50.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -131.93 131.02 42.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HG3' ' HB2' ' A' ' 42' ' ' TYR . 1.1 mtt-85 -128.51 138.69 52.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.33 143.83 8.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.662 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -89.11 138.1 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.644 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.64 ' CG ' HD12 ' A' ' 28' ' ' ILE . 76.1 m-85 -129.35 148.97 51.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 111.334 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 172.08 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.748 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -45.18 -28.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.602 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -57.32 -31.14 65.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.89 168.84 16.62 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.823 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.62 148.09 5.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.085 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.454 HG13 ' HA ' ' A' ' 27' ' ' ILE . 4.0 t -110.66 152.76 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.4 0.619 . . . . 0.0 111.85 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 32.4 tp -123.53 100.23 6.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.21 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 153.65 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.15 0.5 . . . . 0.0 111.889 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.08 96.92 4.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.971 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -55.42 -26.52 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.573 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 26.8 mt-10 -64.94 -26.11 68.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.436 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 4' ' ' ALA . 2.3 p -121.32 -52.95 2.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.685 0.279 . . . . 0.0 111.413 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.09 -41.39 1.51 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.775 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 84' ' ' ARG . 42.0 t -50.16 144.3 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.676 0.274 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.5 t -149.89 167.74 25.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.423 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.7 HG12 HD13 ' A' ' 83' ' ' LEU . 44.2 mt -142.54 113.45 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 ' HE ' ' A' ' 84' ' ' ARG . 4.4 mp -93.23 120.49 42.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.827 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.64 HD12 ' CG ' ' A' ' 10' ' ' PHE . 5.2 mt -105.98 91.84 5.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.48 159.92 38.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.512 2.141 . . . . 0.0 112.475 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.38 104.18 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.98 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.07 -9.81 3.59 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.215 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -75.66 -28.31 58.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.942 0.371 . . . . 0.0 111.308 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.859 HD13 ' HB2' ' A' ' 39' ' ' GLN . 33.7 mt -119.69 142.75 33.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.373 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.2 Cg_exo -60.07 152.9 62.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.24 1.96 . . . . 0.0 112.178 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.0 mt-10 -68.63 150.1 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.935 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 24.97 68.01 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.462 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.1 t -130.58 160.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 0.0 111.242 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 37' ' ' VAL . 55.1 mt-10 -133.09 113.9 13.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.998 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.859 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -102.76 109.24 20.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -74.53 122.36 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.08 141.51 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.149 0.5 . . . . 0.0 111.584 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' A' ' 72' ' ' PRO . 14.0 p90 -153.5 146.87 24.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.781 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CE1' ' HG ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -147.98 159.0 44.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.063 0.458 . . . . 0.0 112.031 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' CB ' HG22 ' A' ' 5' ' ' THR . 2.1 tmmm? -116.0 147.83 40.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.468 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.522 HG22 HG13 ' A' ' 68' ' ' VAL . 25.1 t -145.23 140.81 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.045 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.638 ' HB2' HG12 ' A' ' 3' ' ' VAL . 26.7 t -176.64 149.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.46 2.4 25.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.723 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.55 115.78 7.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -90.62 -42.92 10.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -52.82 -24.4 8.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.605 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 51' ' ' ILE . 32.5 mm -65.99 -13.91 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.539 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.769 HD23 ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 178.21 142.43 0.28 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.026 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD2' HD23 ' A' ' 52' ' ' LEU . 34.5 Cg_endo -64.68 172.72 6.48 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.491 2.127 . . . . 0.0 112.274 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.99 172.14 3.24 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.57 2.18 . . . . 0.0 112.348 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.802 HD11 HG21 ' A' ' 5' ' ' THR . 1.5 tp -60.71 -74.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.029 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.67 107.56 8.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.026 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -72.95 -35.72 67.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -64.9 -36.81 85.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -72.74 -27.85 62.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.89 111.36 3.6 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.373 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 124.2 51.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.333 . . . . 0.0 111.05 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -105.54 100.37 9.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.681 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.23 136.1 36.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.506 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.35 -57.61 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.455 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.746 ' CB ' HD13 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -85.16 -177.95 1.06 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 75.8 Cg_exo -41.32 -47.07 5.6 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 111.625 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -153.58 84.49 1.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.427 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 47.4 t -146.04 118.1 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.597 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.68 106.21 16.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.564 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.07 -168.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.17 -137.86 0.93 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 32.8 Cg_endo -64.17 125.95 16.18 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.441 2.094 . . . . 0.0 112.073 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -56.33 110.85 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.14 83.35 1.58 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.813 HD11 ' HG2' ' A' ' 39' ' ' GLN . 16.6 tp -142.2 86.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.189 0.519 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 17.3 tttp -57.98 159.9 5.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.124 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 24.4 m-85 -141.49 147.91 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.655 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -98.92 17.62 19.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.26 0.552 . . . . 0.0 111.19 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 2.5 tttm -164.81 136.55 3.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.577 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 27.4 Cg_exo -62.0 97.96 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.451 2.101 . . . . 0.0 112.472 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.1 m -70.5 137.69 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE1' HD13 ' A' ' 27' ' ' ILE . 8.2 tm-20 -81.3 119.25 23.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 111.258 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.7 HD13 HG12 ' A' ' 26' ' ' ILE . 13.6 tp -124.32 119.18 28.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.555 ' HE ' HD11 ' A' ' 27' ' ' ILE . 6.2 ptt85 -113.99 133.31 55.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.96 0.41 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.746 HD13 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -137.33 112.68 9.37 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.927 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.29 120.25 8.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.293 1.995 . . . . 0.0 111.918 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.68 -54.67 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.148 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.86 -177.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.109 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.99 167.56 12.75 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.94 41.73 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.843 2.362 . . . . 0.0 112.944 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.52 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.698 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 t -99.36 3.54 46.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.565 0.698 . . . . 0.0 111.081 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.627 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 1.8 p-90 -56.0 -31.79 63.37 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.845 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.627 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 4.5 mt-30 -95.44 138.35 33.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.612 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.71 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.484 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -163.82 1.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.3 m 71.17 -167.94 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.925 0.393 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 8.9 mt -99.91 117.99 62.47 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.673 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 3.6 Cg_exo -74.96 -6.63 18.32 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.64 2.227 . . . . 0.0 111.913 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.84 -43.17 35.86 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.981 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.471 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 m-20 -85.38 111.48 37.04 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.837 0.319 . . . . 0.0 110.807 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 38.4 Cg_exo -60.25 -27.21 84.42 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.276 1.984 . . . . 0.0 111.946 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.506 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 11.1 p30 -78.79 4.64 13.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -50.54 -100.42 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -80.15 -12.5 59.65 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 27.8 m -62.65 27.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -136.13 -3.86 2.42 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.436 -0.411 . . . . 0.0 112.164 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.55 17.66 12.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.593 0.235 . . . . 0.0 111.386 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.44 -75.43 0.12 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.724 0.297 . . . . 0.0 111.04 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.3 m -101.13 133.69 45.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.727 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 85' ' ' LEU . 14.3 p -105.39 106.95 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.469 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.64 104.87 11.46 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 111' ' ' VAL . 10.1 m -122.01 131.65 72.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.21 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.2 mt -95.84 146.85 24.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.661 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 81' ' ' VAL . 43.5 mm -128.49 121.64 55.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.23 25.44 7.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.081 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.22 109.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.998 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.845 0.355 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -129.26 132.08 67.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.897 HG13 ' HB2' ' A' ' 46' ' ' CYS . 25.7 t -142.65 141.05 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.142 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.71 117.64 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.176 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.789 HG22 ' CB ' ' A' ' 44' ' ' LYS . 30.3 p -136.12 143.91 44.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.908 0.385 . . . . 0.0 111.107 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.36 132.72 24.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.984 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.5 mtt180 -128.23 135.25 49.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.32 156.95 27.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.9 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.502 HG21 ' HG2' ' A' ' 38' ' ' GLU . 29.7 mt -91.39 156.26 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD1' HG13 ' A' ' 28' ' ' ILE . 25.8 m-85 -131.46 170.59 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.36 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -152.14 171.94 17.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.915 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.7 p -58.69 -21.09 53.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -54.87 -51.25 66.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 111.173 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.46 128.64 3.76 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.733 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.16 -172.73 25.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.02 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 27' ' ' ILE . 2.5 t -141.78 150.29 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 111.745 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 43' ' ' PHE . 23.5 tp -123.24 100.1 6.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.324 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -125.24 154.52 41.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.151 0.5 . . . . 0.0 111.786 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 t -127.11 97.14 4.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.066 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.1 mm -52.62 -26.66 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.647 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 14.9 mt-10 -63.39 -21.22 66.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.305 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -126.93 -52.93 1.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.788 0.327 . . . . 0.0 111.264 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.6 -33.82 2.9 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.696 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.751 ' HB ' HG21 ' A' ' 45' ' ' VAL . 58.1 t -55.67 145.4 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 10.8 t -148.7 164.41 34.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.357 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.604 HG12 HD13 ' A' ' 83' ' ' LEU . 21.0 mt -139.25 113.81 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.933 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.0 mp -94.72 135.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.638 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -107.67 97.08 18.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.712 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 81' ' ' VAL . 27.5 Cg_endo -62.49 145.19 95.52 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.288 1.992 . . . . 0.0 112.115 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.1 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.202 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.18 4.27 5.52 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.367 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.61 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -81.7 -26.41 34.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.108 0.454 . . . . 0.0 111.201 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.965 HD13 ' HB2' ' A' ' 39' ' ' GLN . 26.2 mt -121.81 141.49 34.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.357 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' HD21 ' A' ' 78' ' ' LEU . 42.1 Cg_exo -56.69 143.87 88.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.333 2.022 . . . . 0.0 112.218 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.1 mt-10 -61.79 151.35 34.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.08 25.54 62.23 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 34' ' ' PRO . 40.5 t -129.47 160.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 111.268 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -129.02 113.93 15.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.797 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.965 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -105.35 109.23 21.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 14.2 tt0 -72.29 118.96 15.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.6 mt -127.35 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.014 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.445 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 34.3 p90 -152.83 173.46 15.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.43 ' CD1' HD21 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -175.05 163.51 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.885 0.374 . . . . 0.0 111.535 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.789 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER -135.62 117.63 15.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.045 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.751 HG21 ' HB ' ' A' ' 24' ' ' VAL . 33.1 t -106.87 141.82 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.897 ' HB2' HG13 ' A' ' 3' ' ' VAL . 52.9 t -178.1 149.09 0.53 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 49.55 1.71 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.698 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.767 ' CG ' HD13 ' A' ' 51' ' ' ILE . 11.9 m-20 -167.85 107.26 0.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.673 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.666 ' ND2' HD23 ' A' ' 67' ' ' LEU . 40.9 t-20 -90.6 -55.06 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.637 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.7 p -64.31 -34.41 78.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.767 HD13 ' CG ' ' A' ' 48' ' ' ASP . 4.3 mp -75.39 -2.49 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.498 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.738 ' HG ' HG21 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -169.36 116.49 0.54 Allowed Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.617 0.246 . . . . 0.0 111.066 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.96 169.05 21.17 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.472 2.115 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.62 172.32 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.588 2.192 . . . . 0.0 112.265 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -62.68 -65.62 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.068 0.461 . . . . 0.0 110.839 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.85 121.12 11.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.861 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -33.32 65.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -62.44 -31.39 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -81.39 -30.97 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 110.91 3.14 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.434 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.797 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -105.83 111.38 24.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 m -85.71 105.26 16.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.665 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -75.59 139.64 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.43 -57.69 1.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.169 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -95.18 -174.53 0.4 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.332 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 66.8 Cg_exo -40.46 -46.99 4.45 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.228 1.952 . . . . 0.0 111.843 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.719 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.7 tm? -153.89 82.23 1.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.748 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -143.15 118.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.476 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.797 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -105.87 106.25 16.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.614 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.55 -165.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.028 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.53 -146.71 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.456 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 41.6 Cg_endo -67.38 134.15 32.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.451 2.101 . . . . 0.0 112.191 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.99 111.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.86 84.0 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.479 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 6.1 tp -144.44 87.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.174 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 77.4 tttt -62.7 159.78 15.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.956 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 29.0 m-85 -138.6 155.79 48.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.66 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.706 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -99.22 14.33 29.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.367 0.603 . . . . 0.0 110.96 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -166.62 136.51 2.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.263 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 32.7 Cg_exo -61.58 95.11 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.413 2.075 . . . . 0.0 112.414 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 115' ' ' ILE . 9.2 m -61.38 166.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.516 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 126.12 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 111.493 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 26' ' ' ILE . 34.4 tp -124.24 128.01 48.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.098 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 24' ' ' VAL . 50.4 mtp180 -120.45 126.1 49.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.971 0.415 . . . . 0.0 111.788 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.647 ' O ' HG12 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.58 163.31 37.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.477 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.52 120.07 7.27 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.447 2.098 . . . . 0.0 112.202 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -82.32 -48.55 11.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.19 48.09 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -112.89 81.91 4.82 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.45 47.24 2.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.73 2.287 . . . . 0.0 112.611 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -108.93 13.09 24.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 t -119.58 15.96 12.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.067 0.46 . . . . 0.0 111.812 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.579 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.1 p-90 -121.01 -37.87 2.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.579 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.1 mt-30 -103.53 68.33 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -156.22 -45.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.91 -46.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.25 -178.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 28.8 mt -98.64 131.46 25.8 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 33.0 Cg_exo -59.35 -23.59 70.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.421 2.081 . . . . 0.0 112.316 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.87 -25.21 32.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.832 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 8.3 m-20 -61.3 113.56 8.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.562 0.181 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.795 ' O ' HG22 ' A' ' 106' ' ' VAL . 72.7 Cg_exo -50.09 -30.72 25.87 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.378 2.052 . . . . 0.0 112.273 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.11 -19.89 62.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.361 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.778 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.97 -20.45 16.41 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.824 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.778 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 19.0 mt -155.51 -26.57 0.11 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.5 m -68.18 36.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -155.17 -42.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.584 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.47 18.69 10.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.655 0.264 . . . . 0.0 111.455 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -65.84 -44.57 85.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.0 110.982 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.5 m -94.63 149.03 21.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.94 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 85' ' ' LEU . 14.3 p -106.32 109.83 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.68 105.03 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 83' ' ' LEU . 12.1 m -122.07 122.05 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.4 mt -87.5 137.67 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.948 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.1 mm -122.43 116.85 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.348 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.32 27.03 8.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.195 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.423 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 177.87 114.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.902 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.859 0.361 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 3' ' ' VAL . 13.2 p -105.45 159.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.806 HG12 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -126.71 142.41 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.144 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -106.76 117.73 34.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.613 HG22 ' CB ' ' A' ' 44' ' ' LYS . 65.3 p -122.34 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.91 0.386 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.685 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -127.57 121.77 31.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.124 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 10.6 mtt180 -120.97 131.52 54.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.22 147.82 11.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.797 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 10' ' ' PHE . 26.2 mt -90.53 159.64 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.685 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.721 ' CG ' HD12 ' A' ' 28' ' ' ILE . 79.9 m-85 -141.49 154.87 45.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.421 . . . . 0.0 111.43 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -128.4 172.15 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -51.69 -24.5 5.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.21 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -55.19 -38.9 68.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.215 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 137.84 9.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.67 171.83 40.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.198 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -117.49 150.29 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.156 0.503 . . . . 0.0 111.548 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 25' ' ' SER . 32.9 tp -123.21 100.16 6.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.12 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.44 151.0 45.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.108 0.48 . . . . 0.0 111.835 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 12.6 p -121.23 97.05 5.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.023 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mm -52.53 -26.58 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.536 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.5 mm-40 -61.86 -29.6 70.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.083 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -119.66 -52.93 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.054 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.5 -38.02 1.98 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.694 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.603 ' CG2' HG11 ' A' ' 45' ' ' VAL . 24.2 t -49.48 144.47 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.73 0.3 . . . . 0.0 111.144 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -149.74 158.37 44.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.627 HG12 HD13 ' A' ' 83' ' ' LEU . 38.1 mt -132.39 113.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.446 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.508 HG13 HG13 ' A' ' 16' ' ' VAL . 3.6 mt -94.64 118.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 0.0 111.276 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.721 HD12 ' CG ' ' A' ' 10' ' ' PHE . 3.9 mt -105.97 92.98 7.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 148.39 92.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.393 2.062 . . . . 0.0 112.167 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -53.34 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.7 -19.54 0.78 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.946 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -66.29 -36.8 83.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.841 0.321 . . . . 0.0 111.363 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.917 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.1 mt -110.97 143.94 29.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.589 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD3' HD21 ' A' ' 78' ' ' LEU . 26.0 Cg_exo -62.85 155.18 61.49 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.439 2.093 . . . . 0.0 112.295 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.5 mp0 -69.41 153.81 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.17 24.46 58.73 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.602 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 35' ' ' GLU . 44.8 t -130.08 160.87 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 111.181 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.544 ' N ' HG12 ' A' ' 37' ' ' VAL . 32.7 mt-10 -132.87 113.64 13.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.854 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.917 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -106.08 109.06 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.799 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.02 128.56 36.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mt -134.87 140.14 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.275 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CE2' ' HD3' ' A' ' 72' ' ' PRO . 28.0 p90 -154.22 149.66 27.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.139 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.685 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -151.53 167.01 29.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.056 0.455 . . . . 0.0 111.662 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.613 ' CB ' HG22 ' A' ' 5' ' ' THR . 2.9 ptmt -127.52 146.12 50.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.542 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.603 HG11 ' CG2' ' A' ' 24' ' ' VAL . 45.3 t -138.78 136.91 43.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.806 ' HB2' HG12 ' A' ' 3' ' ' VAL . 47.1 t -162.02 148.75 13.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.845 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.78 -34.54 74.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' CB ' HG12 ' A' ' 51' ' ' ILE . 10.2 m-20 -122.56 144.36 49.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.499 ' HB3' HD23 ' A' ' 67' ' ' LEU . 25.8 p30 -90.65 -26.41 19.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -70.52 -23.01 62.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.22 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.4 HG12 ' CB ' ' A' ' 48' ' ' ASP . 36.6 mm -60.93 -20.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.5 tp 176.81 135.47 0.2 Allowed Pre-proline 0 C--O 1.232 0.15 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.64 173.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.425 2.083 . . . . 0.0 112.297 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.86 172.29 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.575 2.183 . . . . 0.0 112.373 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.573 HD12 ' H ' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -100.58 -29.25 12.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.921 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.573 ' H ' HD12 ' A' ' 55' ' ' LEU . 11.4 m-20 -74.85 85.21 2.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -37.61 66.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -78.32 -56.75 4.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.412 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 56' ' ' ASP . 3.2 mppt? -64.06 -76.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.074 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . 169.62 -97.7 0.13 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.133 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 165.4 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.864 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -99.93 97.5 8.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.515 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.76 140.24 29.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.019 -179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.43 -57.58 1.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.931 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 1.1 p -91.28 -173.85 0.4 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.249 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.8 Cg_exo -41.63 -51.27 4.41 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.19 1.926 . . . . 0.0 111.861 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.705 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -151.08 85.09 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 92.7 t -147.09 118.04 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.216 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -107.22 109.33 21.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.785 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -62.26 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 42' ' ' TYR . . . -78.26 -144.33 2.39 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.76 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 59.8 Cg_exo -51.84 123.14 11.72 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.596 2.197 . . . . 0.0 112.186 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -55.38 110.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.63 83.76 1.75 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 15.1 tp -138.43 85.01 2.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.199 0.524 . . . . 0.0 110.084 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 117' ' ' HIS . 85.5 tttt -58.03 161.98 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.167 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 17.2 m-85 -143.38 148.43 36.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.576 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.485 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -97.06 18.26 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.263 0.554 . . . . 0.0 110.941 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -163.86 136.39 3.96 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.409 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 20.8 Cg_exo -65.61 101.09 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.496 2.131 . . . . 0.0 112.467 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 115' ' ' ILE . 7.7 m -68.53 153.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.698 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.77 108.66 20.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 0.0 111.338 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.627 HD13 HG12 ' A' ' 26' ' ' ILE . 5.0 tp -105.02 121.32 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.577 ' N ' HD12 ' A' ' 83' ' ' LEU . 23.8 mtm180 -123.87 139.83 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.19 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -129.42 144.77 54.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.613 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.15 134.74 17.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.478 2.119 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.452 ' CD2' ' HB3' ' A' ' 109' ' ' ASN . 2.7 p80 -49.49 -47.05 48.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.097 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.46 -81.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.878 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.48 162.51 46.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.74 32.84 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.966 2.444 . . . . 0.0 112.848 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.01 1.17 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.402 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -122.67 16.07 10.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.822 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 10.8 p-90 -117.69 -47.86 2.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.545 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 5.1 pt20 -77.28 64.79 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.114 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -143.33 -46.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 -32.73 9.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.0 m -85.14 172.12 11.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.041 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 20.9 mt -99.9 125.17 41.15 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 21.6 Cg_exo -65.09 -15.48 50.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.541 2.161 . . . . 0.0 112.297 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.77 -22.22 31.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.8 t0 -62.19 136.45 95.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.649 0.262 . . . . 0.0 110.723 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.462 ' O ' HG21 ' A' ' 106' ' ' VAL . 55.6 Cg_endo -69.84 -20.73 34.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.42 2.08 . . . . 0.0 112.274 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 87.9 m-20 -91.61 17.31 8.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.921 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.606 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -64.68 -113.44 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.993 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.606 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -48.98 -23.14 1.02 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 103' ' ' ASN . 11.8 m -71.29 36.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 0.0 111.33 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 145.49 40.54 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.77 -74.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.796 0.332 . . . . 0.0 111.362 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 2.9 t-20 -148.78 32.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.06 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 20.3 p -80.97 150.06 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.734 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 111' ' ' VAL . 14.0 p -84.81 114.45 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.265 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.68 105.08 12.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.195 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.4 m -123.91 124.85 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.57 143.26 26.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 81' ' ' VAL . 37.6 mm -129.71 120.1 49.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.24 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -123.27 25.74 8.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.21 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.418 ' CD2' ' HG3' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.43 108.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.936 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.573 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.063 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.862 0.363 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.27 143.16 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.052 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.869 HG11 HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -149.73 156.54 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -117.41 117.53 29.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.477 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.035 HG21 HD13 ' A' ' 55' ' ' LEU . 45.3 p -123.11 143.76 49.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.92 0.391 . . . . 0.0 111.081 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.554 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -132.78 130.55 40.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.412 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.5 mtp85 -129.34 132.18 47.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.29 149.71 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.91 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.579 HG21 ' HB3' ' A' ' 38' ' ' GLU . 20.1 mt -88.26 158.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.599 0.237 . . . . 0.0 110.636 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.566 ' CG ' HD13 ' A' ' 28' ' ' ILE . 49.8 m-85 -138.64 164.03 30.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.971 0.415 . . . . 0.0 111.438 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.73 172.13 14.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.575 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -53.05 -22.7 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.122 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -51.28 -35.23 36.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 28' ' ' ILE . . . 100.29 112.8 3.47 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.698 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.852 ' O ' HD12 ' A' ' 28' ' ' ILE . . . -157.36 144.2 10.37 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.054 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 17' ' ' LEU . 2.2 p -102.89 157.22 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.0 111.814 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 43' ' ' PHE . 15.2 tp -119.98 99.9 6.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.462 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -115.51 145.6 42.47 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.7 m -121.82 96.68 5.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.258 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 20' ' ' ILE . 3.4 tp -60.3 -26.6 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 2.4 mt-10 -62.68 -26.38 68.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.674 HG21 ' HB ' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -115.71 -52.9 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.13 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.69 6.56 9.35 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.216 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 45' ' ' VAL . 38.4 t -106.02 141.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.856 0.328 . . . . 0.0 110.822 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 92.5 p -149.75 162.52 40.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.917 0.389 . . . . 0.0 111.529 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.758 HG12 HD13 ' A' ' 83' ' ' LEU . 26.2 mt -130.79 113.46 24.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.188 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 27' ' ' ILE . 2.5 mp -91.6 116.29 32.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 15' ' ' GLY . 1.2 mt -102.94 87.0 1.11 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.682 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 158.73 40.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.546 2.164 . . . . 0.0 112.328 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.14 108.57 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.23 -9.94 3.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.904 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.639 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -84.09 -33.13 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.874 0.337 . . . . 0.0 110.939 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 39' ' ' GLN . 36.7 mt -119.91 143.75 35.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.344 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD3' HD21 ' A' ' 78' ' ' LEU . 15.1 Cg_exo -68.09 154.3 72.85 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.364 2.043 . . . . 0.0 112.247 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.1 tt0 -66.17 154.22 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.78 62.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.567 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 38' ' ' GLU . 41.2 t -128.1 160.77 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.059 0.456 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HB3' HG21 ' A' ' 9' ' ' ILE . 43.1 mt-10 -134.35 113.9 12.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.967 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.816 ' HB2' HD13 ' A' ' 33' ' ' ILE . 6.4 tp60 -101.71 109.01 20.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.061 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.91 116.7 12.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.0 mt -127.21 139.39 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 111.263 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' GLY . 29.9 p90 -153.06 162.82 40.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.203 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -167.28 168.43 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.873 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.638 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -133.06 132.69 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.721 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.68 HG22 HG13 ' A' ' 68' ' ' VAL . 21.7 t -126.1 148.29 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.95 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 67' ' ' LEU . 17.2 p -143.71 148.96 36.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.014 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -76.75 -31.02 56.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.823 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.26 134.2 54.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.743 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -66.01 -9.29 29.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.766 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.7 m -50.44 -23.07 2.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.739 0.304 . . . . 0.0 111.392 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.869 HG21 HG11 ' A' ' 3' ' ' VAL . 18.7 mm -75.91 -1.41 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.696 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.553 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 12.84 -74.86 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.697 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 52' ' ' LEU . 1.2 Cg_endo -44.56 125.99 6.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.631 2.221 . . . . 0.0 112.573 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 9.8 Cg_exo -71.42 172.38 14.31 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.831 2.354 . . . . 0.0 112.475 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.035 HD13 HG21 ' A' ' 5' ' ' THR . 17.5 tp -73.89 -30.45 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -168.46 92.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -41.67 63.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.225 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -62.82 -24.41 67.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.48 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -93.96 19.92 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.519 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 107.97 0.43 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.46 105.07 13.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.934 0.397 . . . . 0.0 111.209 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.22 100.77 11.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.67 139.18 37.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.492 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.35 -57.63 1.38 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.639 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.57 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -91.58 -171.32 0.27 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.974 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 47.5 Cg_exo -38.4 -48.42 2.46 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.324 2.016 . . . . 0.0 112.116 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.717 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -158.66 66.72 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 111.054 178.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG13 HG22 ' A' ' 45' ' ' VAL . 99.0 t -121.58 118.35 55.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.575 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.5 106.24 17.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.575 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -167.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.998 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -68.38 -152.35 0.41 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.655 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 71.4 Cg_exo -50.71 160.57 1.7 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.563 2.175 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -84.51 111.0 19.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.66 78.98 1.43 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.899 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 8.3 tp -135.9 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.28 0.562 . . . . 0.0 109.99 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.0 ttpt -73.0 149.69 43.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.909 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 73.5 m-85 -122.59 166.97 13.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.518 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.446 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.98 16.39 19.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.448 0.642 . . . . 0.0 110.824 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' A' ' 80' ' ' PRO . 1.8 tttm -168.75 136.54 1.66 Allowed Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.185 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.426 ' HD2' ' HG3' ' A' ' 79' ' ' LYS . 31.5 Cg_exo -59.55 107.24 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.438 2.092 . . . . 0.0 112.579 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.427 HG22 ' HB ' ' A' ' 115' ' ' ILE . 10.8 m -70.71 140.64 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -87.51 108.35 19.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.564 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.758 HD13 HG12 ' A' ' 26' ' ' ILE . 7.1 tp -105.77 129.71 53.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.658 ' N ' HD12 ' A' ' 83' ' ' LEU . 4.9 mmt180 -123.32 132.23 53.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 0.0 111.613 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.819 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.63 156.07 59.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.481 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 24' ' ' VAL . 41.5 Cg_endo -67.44 123.9 11.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.472 2.115 . . . . 0.0 112.319 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 88' ' ' CYS . 49.9 p-80 -71.66 -46.92 57.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 87' ' ' HIS . 85.8 m 57.61 178.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.993 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.38 87.94 0.13 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.969 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.53 46.86 2.18 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.814 2.342 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -109.06 5.09 23.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.665 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t -122.56 16.17 10.37 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.922 0.391 . . . . 0.0 111.931 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.492 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 4.6 p-90 -110.6 -37.26 5.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.459 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 5.5 pt20 -101.13 61.0 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.097 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -106.48 -37.05 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -86.47 -179.05 6.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 9.6 mt -100.05 120.54 56.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 25.4 Cg_exo -62.76 -21.32 72.92 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.605 2.203 . . . . 0.0 112.669 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.46 -5.42 54.2 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.116 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.63 123.93 58.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.896 0.348 . . . . 0.0 111.004 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.818 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.58 -28.71 56.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.387 2.058 . . . . 0.0 112.335 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -61.72 -18.38 59.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.751 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.63 -19.3 15.53 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.62 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.751 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 15.6 mt -156.22 -30.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.0 m -68.05 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 177.41 -30.49 0.07 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.851 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 18.58 6.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -57.93 -30.27 65.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.95 170.74 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.74 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.819 HG11 HD12 ' A' ' 85' ' ' LEU . 11.7 p -103.7 105.88 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.287 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 105.09 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.2 m -122.82 121.53 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.255 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.3 mt -91.99 143.8 26.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.427 ' HB ' HG22 ' A' ' 81' ' ' VAL . 28.5 mm -129.89 116.72 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.0 0.429 . . . . 0.0 111.544 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.84 27.48 8.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.974 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.79 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.784 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 2' ' ' VAL . 11.4 p -139.93 124.16 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.746 HG13 ' HB2' ' A' ' 46' ' ' CYS . 2.6 t -152.2 145.24 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.461 ' CB ' HG23 ' A' ' 22' ' ' THR . . . -94.13 117.54 30.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.047 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.661 HG21 HD11 ' A' ' 55' ' ' LEU . 38.9 p -125.28 143.01 51.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.945 0.402 . . . . 0.0 111.39 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -136.14 106.97 6.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.762 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 9.3 mtt180 -113.52 131.88 55.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.34 140.67 6.13 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.786 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 38' ' ' GLU . 13.4 mt -87.09 135.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 110.608 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.808 ' CG ' HD12 ' A' ' 28' ' ' ILE . 83.1 m-85 -116.71 160.98 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.286 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -146.48 172.31 13.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.592 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -44.44 -27.43 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.487 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -33.93 56.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 111.185 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.15 154.27 29.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.9 175.06 39.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.459 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -126.96 150.86 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.088 0.471 . . . . 0.0 111.415 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.572 HD11 ' HB1' ' A' ' 6' ' ' ALA . 49.4 tp -123.22 100.16 6.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.472 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.5 m -126.37 152.19 46.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.044 0.45 . . . . 0.0 111.745 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.76 97.05 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.1 -26.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -61.19 -26.69 67.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.235 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.461 HG23 ' CB ' ' A' ' 4' ' ' ALA . 4.5 p -123.91 -52.92 1.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.174 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.42 -36.63 2.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.896 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.622 HG13 HD23 ' A' ' 85' ' ' LEU . 38.6 t -48.56 144.4 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 111.26 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 p -149.83 150.75 32.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.515 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 83' ' ' LEU . 32.2 mt -128.75 113.69 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.492 HG13 HG13 ' A' ' 16' ' ' VAL . 3.8 mt -93.21 134.41 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.808 HD12 ' CG ' ' A' ' 10' ' ' PHE . 4.2 mt -123.93 94.26 45.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.161 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 155.82 66.97 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.423 2.082 . . . . 0.0 112.085 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -57.68 98.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.34 -21.75 0.74 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.945 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -68.21 -28.38 67.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 111.419 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 39' ' ' GLN . 38.9 mt -123.84 137.88 29.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.548 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.786 ' HD3' HD21 ' A' ' 78' ' ' LEU . 17.8 Cg_endo -60.35 155.5 46.22 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.385 2.056 . . . . 0.0 112.544 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.0 mt-10 -66.64 151.86 46.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.766 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.05 19.52 59.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.635 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 38' ' ' GLU . 40.8 t -125.62 160.77 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.551 ' N ' HG12 ' A' ' 37' ' ' VAL . 5.3 mt-10 -137.06 113.71 10.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.053 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.821 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -102.16 110.75 22.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.814 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -69.65 119.4 13.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.136 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mt -126.92 139.82 50.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.011 0.434 . . . . 0.0 110.867 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.425 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 29.7 p90 -155.55 162.96 40.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -166.98 159.49 13.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.945 0.402 . . . . 0.0 111.526 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.66 133.5 46.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.297 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 68' ' ' VAL . 40.3 t -124.87 135.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.586 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.746 ' HB2' HG13 ' A' ' 3' ' ' VAL . 52.2 t -173.18 149.1 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.033 0.444 . . . . 0.0 111.272 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -71.29 108.28 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.85 107.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' HB2' HD11 ' A' ' 67' ' ' LEU . 48.1 t30 -90.59 -21.52 21.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.301 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -50.7 -25.13 3.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.518 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 51' ' ' ILE . 30.9 mm -72.49 -7.45 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.726 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -153.24 164.37 20.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.861 0.362 . . . . 0.0 111.252 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.475 ' O ' HD12 ' A' ' 52' ' ' LEU . 9.8 Cg_exo -71.79 150.8 56.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.711 2.274 . . . . 0.0 112.14 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 39.5 Cg_exo -57.31 172.15 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 5' ' ' THR . 2.4 tp -83.67 -34.56 24.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.92 89.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -73.05 -44.23 60.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.84 -31.95 65.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -79.55 -27.82 41.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.048 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.99 111.37 3.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.357 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.821 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 19.8 mt-10 -111.5 113.9 26.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 0.0 111.252 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 m -89.67 110.8 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.5 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -82.87 138.18 34.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.303 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.51 -57.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -92.19 -175.59 0.51 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.379 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 69.5 Cg_exo -40.93 -46.79 4.97 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.326 2.017 . . . . 0.0 111.529 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.8 tm? -153.57 83.93 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.658 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 45' ' ' VAL . 47.6 t -145.15 117.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.405 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.821 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -106.13 106.2 16.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.52 -170.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.07 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -64.06 -153.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 20.6 Cg_endo -60.97 129.73 29.97 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.457 2.104 . . . . 0.0 111.909 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -54.98 110.87 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.48 79.51 1.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.716 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.75 HD11 ' HG2' ' A' ' 39' ' ' GLN . 14.8 tp -138.94 85.28 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.171 0.51 . . . . 0.0 110.2 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 59.7 tttp -63.71 151.09 42.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.873 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 75.0 m-85 -127.92 154.11 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.771 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.786 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -98.51 13.92 30.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.436 0.636 . . . . 0.0 110.765 179.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -163.02 136.39 4.47 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.188 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.15 99.01 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.359 2.039 . . . . 0.0 112.379 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.0 m -67.86 154.05 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.17 119.0 38.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.413 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.862 HD13 HG12 ' A' ' 26' ' ' ILE . 15.6 tp -115.81 114.96 25.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.286 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.0 136.46 52.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.43 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.795 HD12 HG11 ' A' ' 111' ' ' VAL . 1.2 mt -125.63 133.02 24.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.274 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.07 119.71 6.67 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.189 1.926 . . . . 0.0 112.383 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -82.64 -33.68 27.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.53 163.39 0.24 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.78 69.95 0.46 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.27 42.4 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.247 2.631 . . . . 0.0 112.558 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 13.17 25.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 t -114.02 15.98 18.3 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 0.0 111.914 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.597 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 2.9 p-90 -117.53 -36.67 3.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.008 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.597 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 10.4 mt-30 -106.38 76.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.34 -49.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -138.89 29.82 2.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.4 m -138.48 -175.38 4.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.751 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -96.91 127.6 38.5 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.12 -5.01 15.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.495 2.13 . . . . 0.0 112.558 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -110.46 -7.42 26.22 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.945 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.449 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -68.75 134.28 90.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.812 0.306 . . . . 0.0 110.621 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 106' ' ' VAL . 58.3 Cg_endo -71.51 -8.17 22.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.341 2.027 . . . . 0.0 112.612 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 77.2 m-20 -99.8 17.29 21.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.339 . . . . 0.0 110.843 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.559 ' CE1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.35 -113.9 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.282 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -47.87 -15.85 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 102' ' ' PRO . 5.1 m -67.62 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 111.782 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -175.91 -34.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.39 25.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 110.835 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.59 -57.16 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.079 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 29.9 p -141.84 159.77 41.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.795 HG11 HD12 ' A' ' 85' ' ' LEU . 13.4 p -95.67 113.41 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.219 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.49 105.1 10.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.143 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 111' ' ' VAL . 8.5 m -128.79 122.67 57.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.144 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 mt -91.87 148.53 22.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 81' ' ' VAL . 33.8 mm -129.82 123.49 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.317 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.15 24.5 6.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.181 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 179.49 104.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.872 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 2' ' ' VAL . 12.1 p -98.67 38.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.536 HG21 HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -110.66 137.54 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.238 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.824 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -95.49 127.29 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 44' ' ' LYS . 21.7 p -142.24 143.74 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.135 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.631 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -149.48 116.93 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.802 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.413 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.8 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.17 144.63 8.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.673 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.66 134.44 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.458 ' CG ' HD12 ' A' ' 28' ' ' ILE . 77.2 m-85 -119.73 157.79 27.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.127 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -134.35 172.16 13.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.754 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 t -48.19 -27.26 2.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.379 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -32.46 62.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.801 0.334 . . . . 0.0 111.341 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.96 173.05 21.91 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.589 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.33 155.26 7.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.22 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 27' ' ' ILE . 3.4 t -112.08 151.98 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.366 0.603 . . . . 0.0 111.734 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.631 HD11 ' HB1' ' A' ' 6' ' ' ALA . 40.9 tp -123.57 100.23 6.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.149 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -121.62 149.46 43.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 112.017 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.04 97.13 5.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.166 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -50.41 -26.53 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.725 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.824 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -50.54 -50.53 53.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.679 -179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.808 HG21 ' CG1' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -114.34 -52.8 2.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.529 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.64 -28.42 2.04 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.132 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.659 HG13 HD23 ' A' ' 85' ' ' LEU . 84.3 t -52.8 135.9 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 66.3 p -146.06 170.96 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.655 HG12 HD13 ' A' ' 83' ' ' LEU . 20.3 mt -141.27 113.86 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.4 mp -92.4 120.28 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.603 HG22 ' HB3' ' A' ' 32' ' ' ALA . 3.2 mt -108.46 90.4 7.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.34 151.86 82.81 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.088 . . . . 0.0 112.142 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -53.9 107.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.959 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 138.06 -6.7 3.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.092 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.603 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -78.92 -29.63 44.28 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.985 0.392 . . . . 0.0 111.129 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.715 HD13 ' HB2' ' A' ' 39' ' ' GLN . 35.5 mt -119.4 141.76 31.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.601 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD3' HD21 ' A' ' 78' ' ' LEU . 21.0 Cg_exo -64.9 154.21 74.22 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.279 1.986 . . . . 0.0 112.054 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 37' ' ' VAL . 2.1 mt-10 -65.93 154.45 39.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.43 60.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 35' ' ' GLU . 42.8 t -129.46 160.77 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.258 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.545 ' N ' HG12 ' A' ' 37' ' ' VAL . 4.9 mt-10 -134.31 113.8 12.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.957 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.715 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -103.32 109.13 20.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.075 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -73.97 110.43 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.673 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.71 136.27 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.413 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 54.3 p90 -154.96 151.29 28.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.7 OUTLIER -154.24 159.76 41.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.008 0.432 . . . . 0.0 111.314 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG22 ' A' ' 5' ' ' THR . 1.7 pttp -128.15 124.76 37.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.029 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.808 ' CG1' HG21 ' A' ' 22' ' ' THR . 46.1 t -113.81 128.79 70.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.718 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 8.8 t -153.72 148.92 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 0.0 111.25 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -74.32 -23.64 59.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.55 102.69 3.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.614 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -55.73 -30.36 61.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -58.23 -22.89 53.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.247 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 51' ' ' ILE . 38.7 mt -70.53 -10.29 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.611 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.536 HD13 HG21 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -179.06 134.07 0.28 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.64 0.257 . . . . 0.0 110.871 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.78 158.17 48.1 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.521 2.148 . . . . 0.0 112.473 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.22 172.32 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.684 2.256 . . . . 0.0 112.415 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.43 HD11 ' CG2' ' A' ' 5' ' ' THR . 0.4 OUTLIER -82.32 -51.42 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 110.827 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -149.47 85.57 1.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.809 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.84 -33.48 66.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.022 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.51 -35.72 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -72.29 -28.2 62.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.0 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.09 112.7 2.27 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -110.18 108.66 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.72 108.41 19.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -87.67 138.84 31.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.48 -57.61 1.37 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.266 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.515 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -88.86 -175.22 0.53 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.421 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 70.2 Cg_exo -41.01 -50.58 4.11 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.267 1.978 . . . . 0.0 111.676 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.8 tm? -151.94 83.35 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.703 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.722 HG13 HG22 ' A' ' 45' ' ' VAL . 44.4 t -144.46 118.23 3.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.529 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.53 106.11 16.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.658 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.15 -166.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.41 -148.25 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.73 127.77 20.5 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.431 2.087 . . . . 0.0 112.103 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -56.29 110.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.989 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.92 78.3 1.0 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.715 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.57 HD11 ' HG3' ' A' ' 39' ' ' GLN . 6.0 tp -142.45 87.52 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.255 0.55 . . . . 0.0 110.016 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 7.6 ttpp -64.13 149.24 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 42.2 m-85 -126.61 151.32 48.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.49 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -99.38 16.14 24.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.353 0.597 . . . . 0.0 111.007 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.38 136.5 4.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.394 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.4 Cg_exo -63.49 103.6 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.532 2.154 . . . . 0.0 112.695 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.5 m -76.44 143.78 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.736 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.95 117.36 29.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.655 HD13 HG12 ' A' ' 26' ' ' ILE . 31.8 tp -111.73 117.59 33.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.303 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -108.34 139.45 43.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.549 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.944 HD12 HG11 ' A' ' 111' ' ' VAL . 1.3 mt -134.47 140.76 36.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.527 ' HD2' HG22 ' A' ' 24' ' ' VAL . 72.0 Cg_endo -75.4 125.89 9.35 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.391 2.061 . . . . 0.0 112.388 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -77.69 -44.16 28.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.814 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.5 m 60.2 86.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.979 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -179.35 75.62 0.2 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.17 42.92 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.973 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -108.61 -47.52 3.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.025 0.44 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 t -111.57 3.99 18.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.598 0.713 . . . . 0.0 111.055 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.517 ' CE3' ' HB2' ' A' ' 105' ' ' LEU . 1.5 p-90 -55.36 -31.67 61.94 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.96 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.457 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 1.8 pt20 -92.68 144.73 25.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.47 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -170.56 -42.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.749 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 -164.4 1.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.5 m 64.23 159.14 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.905 0.383 . . . . 0.0 111.054 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.2 mt -59.89 137.13 90.52 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.059 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -17.79 16.56 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.674 2.249 . . . . 0.0 112.691 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.97 -43.93 7.94 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.794 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.48 113.23 17.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.538 0.209 . . . . 0.0 111.061 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.65 ' O ' HG13 ' A' ' 106' ' ' VAL . 39.3 Cg_exo -56.9 -26.61 68.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.439 2.093 . . . . 0.0 111.995 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.506 ' HA ' HG22 ' A' ' 106' ' ' VAL . 4.5 t-20 -70.69 -11.21 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.396 . . . . 0.0 110.806 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -52.58 -23.28 6.13 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.151 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.635 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -156.73 -20.17 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 102' ' ' PRO . 6.1 m -67.74 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -146.23 -42.61 0.04 OUTLIER Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.375 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.79 -19.45 62.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.583 0.23 . . . . 0.0 111.569 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -62.92 80.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.16 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 175.42 131.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.944 HG11 HD12 ' A' ' 85' ' ' LEU . 12.5 p -84.9 110.71 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.45 104.88 11.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.11 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 83' ' ' LEU . 6.1 m -125.33 122.02 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.35 135.57 33.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.024 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.909 ' O ' HG22 ' A' ' 81' ' ' VAL . 15.3 mm -126.45 115.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 0.4 OUTLIER -116.7 14.07 15.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 178.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 116' ' ' ASP . 4.3 m80 -162.8 127.95 3.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.57 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.046 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.903 0.382 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.18 133.99 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.1 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.58 148.15 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.997 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.607 ' CB ' HG23 ' A' ' 22' ' ' THR . . . -93.96 117.64 30.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.464 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.1 p -121.86 143.54 49.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 110.972 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.733 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.82 108.02 6.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.987 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.464 ' HG3' ' CB ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -111.36 136.09 50.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.054 179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.26 149.28 12.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.231 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.2 mt -104.86 138.82 27.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.711 0.291 . . . . 0.0 110.52 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.574 ' CG ' HD12 ' A' ' 28' ' ' ILE . 90.3 m-85 -127.64 174.04 9.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 111.422 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -147.87 172.17 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.636 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -45.19 -28.79 0.82 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -56.39 -31.41 63.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 177.98 22.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.645 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.52 162.78 10.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.17 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.51 HG13 HG13 ' A' ' 27' ' ' ILE . 3.9 t -118.46 153.74 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.269 0.557 . . . . 0.0 111.762 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' SER . 40.5 tp -123.14 100.09 6.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.107 178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.24 149.32 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.046 0.45 . . . . 0.0 111.735 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.46 97.22 5.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.224 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.599 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -51.74 -26.45 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.512 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 4.3 mt-10 -60.81 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.352 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.632 HG21 HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -105.25 -53.03 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.238 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.66 -34.58 2.46 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.679 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.88 HG22 ' HD3' ' A' ' 86' ' ' PRO . 39.4 t -54.64 139.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.684 0.278 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -143.11 167.65 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.43 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.818 HG12 HD13 ' A' ' 83' ' ' LEU . 42.6 mt -134.42 113.75 17.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.656 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.51 HG13 HG13 ' A' ' 16' ' ' VAL . 4.7 mp -90.71 122.85 42.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 110.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.574 HD12 ' CG ' ' A' ' 10' ' ' PHE . 7.1 mt -110.03 94.7 18.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 28' ' ' ILE . 34.8 Cg_endo -64.99 150.97 87.38 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.34 2.027 . . . . 0.0 112.05 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.79 108.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.99 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -2.79 4.43 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.141 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -82.43 -26.06 33.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.383 . . . . 0.0 111.24 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.795 HD13 ' HB2' ' A' ' 39' ' ' GLN . 48.6 mt -122.97 142.3 37.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.553 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.677 ' HD3' HD21 ' A' ' 78' ' ' LEU . 31.3 Cg_exo -59.15 155.48 39.65 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.398 2.065 . . . . 0.0 112.442 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -70.19 152.74 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.77 23.76 56.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.63 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 35' ' ' GLU . 42.0 t -131.22 160.9 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.179 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' N ' HG12 ' A' ' 37' ' ' VAL . 27.9 mt-10 -131.39 113.78 14.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.944 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.795 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -104.13 110.93 23.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.93 126.54 29.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.78 132.77 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.997 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.464 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 52.6 p90 -149.23 174.5 12.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.276 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.733 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.2 p90 -175.34 176.15 2.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.022 0.439 . . . . 0.0 111.783 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.671 ' HB2' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -133.28 148.58 51.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.995 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 HG21 ' A' ' 22' ' ' THR . 59.4 t -142.37 139.31 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.685 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.411 ' O ' HD12 ' A' ' 67' ' ' LEU . 42.7 t -173.16 148.93 1.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.093 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 145.38 54.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.836 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.767 ' CG ' HD12 ' A' ' 51' ' ' ILE . 3.8 m-20 64.16 125.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.017 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.64 -34.69 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.236 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 t -76.61 -27.82 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.191 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.767 HD12 ' CG ' ' A' ' 48' ' ' ASP . 48.6 mt -77.16 -2.93 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.482 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.69 HD23 ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -165.47 128.26 1.55 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.039 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HD2' HD23 ' A' ' 52' ' ' LEU . 58.9 Cg_endo -72.25 171.35 17.07 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.451 2.101 . . . . 0.0 112.272 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.15 171.79 3.68 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.587 2.191 . . . . 0.0 112.259 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 44' ' ' LYS . 14.4 tp -67.25 -66.43 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.015 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -145.76 115.81 7.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.02 -54.08 9.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.209 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -58.7 -55.41 35.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -26.55 60.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.299 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 72' ' ' PRO . . . 148.43 110.76 0.58 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.674 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.44 104.93 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -135.85 95.44 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.352 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.73 142.29 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.088 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.42 -57.58 1.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.929 0.395 . . . . 0.0 111.171 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -97.1 -174.28 0.37 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 71.5 Cg_exo -41.35 -45.4 5.8 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.263 1.975 . . . . 0.0 111.699 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.72 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.9 tm? -153.13 83.92 1.2 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 61.7 t -145.06 118.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.423 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.64 109.07 20.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.695 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 62' ' ' THR . . . -60.3 -173.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.121 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 42' ' ' TYR . . . -78.24 -126.84 0.42 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.595 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 37.3 Cg_endo -65.98 134.08 35.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.291 1.994 . . . . 0.0 112.123 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -64.18 110.95 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.89 83.61 1.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 3.5 tp -131.4 84.43 2.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.494 0.664 . . . . 0.0 109.876 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.478 ' CD ' ' CD2' ' A' ' 117' ' ' HIS . 10.5 tptt -53.3 153.83 3.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.4 ' CZ ' ' HG ' ' A' ' 75' ' ' LEU . 35.2 m-85 -136.35 144.27 44.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.617 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.677 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -94.68 17.59 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.285 0.564 . . . . 0.0 111.226 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -162.71 136.5 4.71 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.173 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.68 97.27 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.337 2.025 . . . . 0.0 112.488 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.8 m -72.91 154.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.53 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 27' ' ' ILE . 1.9 pm0 -110.91 116.46 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.937 0.399 . . . . 0.0 111.275 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.818 HD13 HG12 ' A' ' 26' ' ' ILE . 9.3 tp -104.75 129.72 52.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.61 ' O ' HG13 ' A' ' 24' ' ' VAL . 1.8 mtt180 -112.88 126.2 55.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.944 0.402 . . . . 0.0 111.406 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.545 HD23 ' HG ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -138.63 155.08 73.66 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.658 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.88 ' HD3' HG22 ' A' ' 24' ' ' VAL . 75.0 Cg_exo -48.25 144.21 13.36 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.687 2.258 . . . . 0.0 112.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -79.31 -26.28 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 16.3 m 68.3 -173.05 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.13 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -85.21 35.75 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.122 2.548 . . . . 0.0 112.866 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.24 -13.53 14.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.424 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 t -122.65 15.78 10.27 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 111.786 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.63 ' CE2' ' HG3' ' A' ' 94' ' ' GLN . 3.5 p-90 -95.19 -36.12 11.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.941 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.63 ' HG3' ' CE2' ' A' ' 93' ' ' TRP . 13.0 mt-30 -104.67 114.38 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -161.02 -44.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 34.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.37 175.93 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 29.1 mt -87.65 128.6 53.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.26 -13.6 16.87 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.473 2.116 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.09 -21.21 8.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.857 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.419 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.7 OUTLIER -74.46 137.17 74.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.617 0.246 . . . . 0.0 110.903 -179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.759 ' O ' HG22 ' A' ' 106' ' ' VAL . 56.4 Cg_endo -70.21 -26.63 25.24 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.542 2.162 . . . . 0.0 112.101 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -65.23 -15.68 62.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.752 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.34 -18.47 10.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.948 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.752 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 12.7 mt -156.93 -27.89 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.55 36.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 172.61 -33.41 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.604 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.83 44.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -88.58 96.59 10.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -165.65 143.13 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 113' ' ' VAL . 7.9 p -112.05 133.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.257 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.24 104.99 17.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 83' ' ' LEU . 10.6 m -119.57 123.78 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.029 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.0 137.16 33.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' HG22 ' A' ' 81' ' ' VAL . 25.9 mm -129.82 123.28 56.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.256 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.86 25.66 5.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.941 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.478 ' CD2' ' CD ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 178.82 104.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.826 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.017 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.815 0.341 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -150.55 151.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.662 HG11 ' HZ3' ' A' ' 44' ' ' LYS . 5.1 t -140.93 155.28 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.137 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -101.6 117.83 35.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.355 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.741 HG22 ' CB ' ' A' ' 44' ' ' LYS . 37.6 p -136.01 143.22 44.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 111.12 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -142.36 121.95 13.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.813 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.435 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 1.1 ttp180 -127.05 130.22 49.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.14 144.12 8.27 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.66 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 29.6 mt -79.6 152.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.65 0.262 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.471 ' CD1' HD12 ' A' ' 28' ' ' ILE . 42.3 m-85 -129.6 154.04 47.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 0.0 111.303 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.51 172.62 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.592 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.1 m -44.18 -30.43 0.78 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.188 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.13 -42.02 99.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.454 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.06 142.32 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.096 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -120.23 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.787 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.671 HG13 HG13 ' A' ' 27' ' ' ILE . 2.0 t -151.29 145.98 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.238 0.542 . . . . 0.0 111.53 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 6' ' ' ALA . 26.5 tp -123.51 100.38 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.903 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.65 138.31 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.437 . . . . 0.0 112.077 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.538 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 49.8 m -100.57 96.84 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.391 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.06 -26.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.014 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.757 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -69.27 -21.53 63.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.675 HG23 ' CB ' ' A' ' 4' ' ' ALA . 12.2 p -126.04 -52.99 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.659 0.266 . . . . 0.0 111.494 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.84 2.34 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.537 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.605 ' HB ' HG21 ' A' ' 45' ' ' VAL . 40.9 t -52.54 145.55 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.731 0.301 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.4 p -148.06 165.31 31.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.899 0.381 . . . . 0.0 111.286 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.635 HG12 HD13 ' A' ' 83' ' ' LEU . 48.1 mt -138.12 113.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.671 HG13 HG13 ' A' ' 16' ' ' VAL . 2.8 mt -96.07 112.86 29.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 111.123 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 ' CD1' ' A' ' 10' ' ' PHE . 6.3 mt -98.31 99.85 8.0 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.773 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.29 156.66 63.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.268 1.979 . . . . 0.0 112.343 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -60.35 111.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.06 0.6 6.96 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.043 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.415 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . . . -78.07 -30.05 49.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.929 0.365 . . . . 0.0 111.057 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 39' ' ' GLN . 32.8 mt -115.37 142.52 28.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.448 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.39 155.52 46.29 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.284 1.989 . . . . 0.0 112.351 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.1 mt-10 -66.57 153.36 43.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.055 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.2 25.5 57.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.45 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 35' ' ' GLU . 34.3 t -132.85 160.24 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.303 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' N ' HG12 ' A' ' 37' ' ' VAL . 20.0 mt-10 -137.84 113.83 9.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.739 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.84 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.9 mm-40 -101.6 125.63 48.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.055 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 26.5 tt0 -82.45 121.64 27.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 mt -124.97 136.39 60.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.022 0.439 . . . . 0.0 111.221 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.523 ' CD1' HD22 ' A' ' 55' ' ' LEU . 26.6 p90 -155.51 159.92 40.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.253 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.487 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -165.65 165.45 18.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 111.654 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.741 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -137.57 119.32 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.055 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.916 HG22 HG13 ' A' ' 68' ' ' VAL . 38.7 t -105.33 137.24 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.61 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.661 ' SG ' HG13 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -162.22 149.06 13.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.095 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.32 -31.62 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -135.12 156.06 49.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -90.64 -36.29 14.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.31 -25.67 62.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.29 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 52' ' ' LEU . 20.2 mt -61.73 -17.26 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.281 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER 179.66 140.23 0.3 Allowed Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 120.657 0.265 . . . . 0.0 111.045 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.72 171.52 17.28 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.541 2.16 . . . . 0.0 112.217 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.55 161.81 7.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.689 2.26 . . . . 0.0 112.252 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 44' ' ' LYS . 3.6 mp -59.07 -79.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.06 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.84 119.24 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.937 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -72.71 -19.25 61.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -51.06 -32.77 23.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.388 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -95.02 -76.46 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . 170.01 -99.53 0.15 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.241 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 160.57 124.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.55 0.34 . . . . 0.0 110.912 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.432 HG23 ' CD2' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -114.41 97.27 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.446 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -79.59 139.22 37.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.338 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.412 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.45 -57.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.989 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.593 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -89.53 -175.77 0.58 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.217 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 72.2 Cg_exo -41.04 -35.39 1.78 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.268 1.979 . . . . 0.0 111.785 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -168.09 78.24 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.955 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.916 HG13 HG22 ' A' ' 45' ' ' VAL . 48.8 t -137.46 117.87 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.368 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.48 105.99 17.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.717 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.23 -165.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -71.47 -154.36 1.7 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.576 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 51.9 Cg_exo -53.9 130.1 37.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.5 2.134 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.432 ' CD2' HG23 ' A' ' 62' ' ' THR . 1.8 t-80 -56.68 110.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.742 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.05 83.95 1.77 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.434 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.551 HD13 ' CD ' ' A' ' 39' ' ' GLN . 3.4 tp -138.68 86.52 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.293 0.568 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' CE ' ' CE1' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -50.54 164.47 0.13 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.247 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -149.48 136.82 19.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.554 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.93 16.95 16.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.319 0.581 . . . . 0.0 111.06 179.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 3.3 tptm -159.8 136.45 6.57 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.258 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.3 Cg_exo -63.7 95.82 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.505 2.137 . . . . 0.0 112.51 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 m -70.72 142.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.607 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 7.0 mp0 -90.93 129.19 36.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 111.563 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.635 HD13 HG12 ' A' ' 26' ' ' ILE . 26.9 tp -124.32 114.99 20.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.962 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -112.32 131.18 55.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.024 0.44 . . . . 0.0 111.876 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -143.85 141.43 18.62 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.521 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.03 127.66 10.83 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.492 2.128 . . . . 0.0 112.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.55 -43.78 30.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t 62.09 59.75 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.92 122.74 1.13 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.714 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -86.62 39.87 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.643 2.229 . . . . 0.0 112.871 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 -4.29 16.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.612 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 t -122.67 16.16 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.081 0.401 . . . . 0.0 112.081 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' ' N ' ' A' ' 94' ' ' GLN . 6.8 p-90 -117.7 -43.49 2.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.453 ' N ' ' CG ' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -91.74 133.04 35.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.291 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.31 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.66 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 32.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.734 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.36 -166.88 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 98' ' ' LEU . 13.4 mt -95.72 121.43 61.34 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.349 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 5.7 Cg_exo -77.84 4.03 6.44 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.753 2.302 . . . . 0.0 112.686 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.55 2.24 8.14 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.822 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.502 ' OD1' ' HB3' ' A' ' 104' ' ' TYR . 37.1 p-10 -81.31 133.23 53.94 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 117.62 0.71 . . . . 0.0 110.317 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.625 ' O ' HG21 ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.65 -9.43 24.37 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.504 2.136 . . . . 0.0 113.085 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 7.2 m120 -96.89 17.62 16.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 111.109 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.502 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -75.03 -110.02 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.483 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -55.89 -13.81 2.06 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.625 HG21 ' O ' ' A' ' 102' ' ' PRO . 11.2 m -69.14 36.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -172.84 -37.88 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.134 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.76 -24.79 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.651 0.262 . . . . 0.0 111.243 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -70.37 65.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.947 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 173.21 127.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.721 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 111' ' ' VAL . 11.6 p -102.52 105.93 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.37 105.05 5.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.307 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 83' ' ' LEU . 5.9 m -126.51 120.74 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.87 132.31 37.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.639 ' O ' HG22 ' A' ' 81' ' ' VAL . 26.7 mm -113.74 124.79 70.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.426 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.58 26.52 5.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.637 178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.466 ' CE1' ' CE ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -178.32 98.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.89 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.069 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.802 0.334 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.518 HG11 ' NH2' ' A' ' 47' ' ' ARG . 10.1 p -60.46 158.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.985 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.846 HG12 ' SG ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -142.21 134.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.227 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.675 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -106.66 117.71 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.3 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 44' ' ' LYS . 28.7 p -123.15 143.64 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.374 . . . . 0.0 111.195 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.646 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . . . -138.36 124.77 20.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.831 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.529 HH21 HD21 ' A' ' 55' ' ' LEU . 10.8 mtt180 -130.42 129.84 43.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.42 145.89 9.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.039 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 10' ' ' PHE . 29.2 mt -90.45 159.67 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.514 0.197 . . . . 0.0 110.539 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.779 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.9 m-85 -137.57 152.29 49.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 111.411 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' ND2' ' HG3' ' A' ' 38' ' ' GLU . 1.6 t-20 -123.76 172.11 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.764 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.02 -28.47 1.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -60.14 -37.28 79.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.972 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.62 -160.81 12.99 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.752 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.63 170.74 13.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.204 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 27' ' ' ILE . 2.2 t -124.51 149.09 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.249 0.547 . . . . 0.0 111.646 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' A' ' 6' ' ' ALA . 31.7 tp -123.35 100.38 6.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.58 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -129.47 153.95 47.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.142 0.496 . . . . 0.0 111.925 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -126.28 97.09 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.074 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -51.81 -26.68 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.639 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 4.0 mt-10 -62.21 -26.95 68.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.656 HG21 HG12 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -119.88 -52.91 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.137 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.55 -28.91 3.92 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.728 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 45' ' ' VAL . 55.7 t -57.09 145.87 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.671 0.272 . . . . 0.0 110.795 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 p -149.66 156.35 41.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.43 . . . . 0.0 111.381 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 HD13 ' A' ' 83' ' ' LEU . 23.9 mt -135.03 113.59 16.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.656 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 27' ' ' ILE . 3.7 mp -93.26 126.79 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.894 0.378 . . . . 0.0 110.98 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.779 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.9 mt -110.77 99.36 41.72 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.581 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.39 153.45 76.83 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.586 2.191 . . . . 0.0 112.28 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -60.67 100.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.68 -6.3 3.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -73.28 -24.14 60.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.878 0.339 . . . . 0.0 111.202 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.436 HG23 ' HD2' ' A' ' 34' ' ' PRO . 18.5 mt -121.64 140.91 32.56 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.672 ' HD3' HD21 ' A' ' 78' ' ' LEU . 31.7 Cg_exo -58.18 152.9 49.43 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.316 2.011 . . . . 0.0 112.243 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -64.59 143.42 57.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 66.75 25.58 72.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 38' ' ' GLU . 48.0 t -127.99 161.14 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' N ' HG12 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -139.96 113.67 8.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.847 179.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.417 ' HB2' HD13 ' A' ' 33' ' ' ILE . 27.9 mm100 -103.56 113.77 27.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.093 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.43 122.33 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.18 137.31 57.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.018 0.437 . . . . 0.0 111.213 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 13.2 p90 -154.41 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.28 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -166.95 153.88 8.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.058 0.456 . . . . 0.0 111.539 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB3' HG22 ' A' ' 5' ' ' THR . 0.0 OUTLIER -120.24 117.48 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.827 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 22' ' ' THR . 59.6 t -102.87 126.86 57.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.582 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.846 ' SG ' HG12 ' A' ' 3' ' ' VAL . 5.6 m -137.97 132.76 32.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 111.08 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' NH2' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -73.41 -28.41 61.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.34 134.87 51.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.021 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.07 -8.85 57.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.317 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.7 t -50.58 -22.65 2.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 51' ' ' ILE . 22.8 mm -69.51 -2.0 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.852 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.552 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 2.8 mt 7.06 -71.98 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 52' ' ' LEU . 80.0 Cg_exo -44.2 125.81 5.95 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.009 1.806 . . . . 0.0 112.549 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.84 172.33 14.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.582 2.188 . . . . 0.0 112.686 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD21 HH21 ' A' ' 7' ' ' ARG . 1.2 tp -83.84 -30.71 26.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.548 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -171.35 83.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -62.98 -40.66 98.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.44 -28.69 60.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.74 -29.3 27.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.55 112.76 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.372 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.763 ' OE1' ' HB1' ' A' ' 69' ' ' ALA . 2.5 tp10 -91.64 121.64 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 111.198 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.72 95.44 4.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.582 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.624 HD21 ' HA ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -77.97 139.31 39.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.025 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.44 -57.71 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 -179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.646 ' HB3' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.03 -174.49 0.48 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.246 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 53.4 Cg_exo -38.68 -45.06 2.4 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.287 1.991 . . . . 0.0 112.125 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.781 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -161.66 65.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.558 HG22 HG13 ' A' ' 45' ' ' VAL . 90.0 t -121.63 118.61 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.573 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB1' ' OE1' ' A' ' 61' ' ' GLU . . . -101.58 106.71 17.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.871 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HA ' ' CB ' ' A' ' 43' ' ' PHE . . . -63.74 -167.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -78.12 -150.75 4.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 52.0 Cg_exo -54.47 121.59 10.03 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 112.006 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -55.53 110.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.938 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.33 78.55 0.9 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.738 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.697 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 65.8 tp -136.65 84.68 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.184 0.516 . . . . 0.0 110.477 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 29.1 tttt -58.85 162.11 4.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.184 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.416 ' CE1' ' HG ' ' A' ' 75' ' ' LEU . 42.1 m-85 -144.42 150.01 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.54 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.672 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -96.75 12.61 31.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.302 0.573 . . . . 0.0 111.259 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mmpp? -157.24 136.73 8.37 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.965 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.87 93.49 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.293 1.995 . . . . 0.0 112.28 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.6 m -64.26 166.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 126.84 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.045 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.568 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.1 tp -124.22 107.04 10.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.22 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.441 ' HD3' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -105.34 129.69 53.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.362 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -136.34 154.18 76.89 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.652 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' HG22 ' A' ' 24' ' ' VAL . 34.9 Cg_endo -64.96 120.21 7.4 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.502 2.135 . . . . 0.0 112.069 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.55 -54.4 7.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.27 158.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' CB ' ' CD ' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -57.92 177.84 0.2 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.693 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 89' ' ' ASP . 92.4 Cg_endo -84.78 35.62 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.558 2.172 . . . . 0.0 112.93 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -109.33 -0.19 19.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.361 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -122.54 15.86 10.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 112.038 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.674 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 5.1 p-90 -105.48 -35.67 7.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.802 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 93' ' ' TRP . 1.1 pt20 -94.18 29.83 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.369 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -101.7 -30.95 11.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -172.2 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.23 -165.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.788 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 11.4 mt -89.67 124.64 63.5 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 98' ' ' LEU . 13.3 Cg_exo -68.78 -23.68 35.35 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.563 2.175 . . . . 0.0 112.25 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.88 4.43 39.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.136 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -60.96 138.97 94.1 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.916 0.358 . . . . 0.0 110.474 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.789 ' O ' HG21 ' A' ' 106' ' ' VAL . 3.0 Cg_exo -74.38 -3.08 13.27 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.483 2.122 . . . . 0.0 112.658 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.437 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 10.3 p30 -109.22 17.41 21.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 0.0 111.053 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.617 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -80.15 -113.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.978 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD11 ' CZ3' ' A' ' 93' ' ' TRP . 0.5 OUTLIER -47.76 -19.55 0.23 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.789 HG21 ' O ' ' A' ' 102' ' ' PRO . 8.4 m -68.4 36.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -174.39 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.849 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.58 67.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 111.091 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.86 -66.56 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.022 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.45 142.74 51.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.66 ' O ' HG13 ' A' ' 111' ' ' VAL . 12.0 p -98.09 103.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.159 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.98 104.78 6.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 83' ' ' LEU . 10.6 m -116.11 126.82 73.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.837 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.6 mt -81.62 136.55 35.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.731 ' O ' HG22 ' A' ' 81' ' ' VAL . 34.9 mm -129.79 121.71 53.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.39 25.46 6.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.206 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 176.71 111.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.19 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.697 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.3 m-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.027 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -171.79 150.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.558 ' CG2' HD13 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -141.92 142.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.697 ' HB2' HG23 ' A' ' 22' ' ' THR . . . -94.33 125.03 38.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 44' ' ' LYS . 17.1 p -140.6 144.37 35.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -150.98 113.7 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.843 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -125.83 129.88 50.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.16 145.26 9.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.625 HG21 ' HB3' ' A' ' 38' ' ' GLU . 4.1 mt -84.05 138.89 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.752 ' CG ' HD12 ' A' ' 28' ' ' ILE . 79.0 m-85 -117.41 161.24 19.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.028 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -134.55 172.07 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 t -49.91 -27.04 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.184 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -56.35 -33.11 65.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.133 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.64 173.2 22.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.647 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.63 158.35 8.74 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.067 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.628 HG22 HG23 ' A' ' 27' ' ' ILE . 4.7 t -113.9 152.05 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.359 0.6 . . . . 0.0 111.824 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD11 ' HB1' ' A' ' 6' ' ' ALA . 54.2 tp -123.66 100.21 6.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.38 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.12 142.02 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.076 0.465 . . . . 0.0 111.767 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.74 97.11 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.338 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mm -52.48 -26.4 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.617 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -54.66 -26.63 34.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.365 -179.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.697 HG23 ' HB2' ' A' ' 4' ' ' ALA . 23.0 p -132.32 -52.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 111.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.59 -36.65 1.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.755 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.841 ' HB ' HG21 ' A' ' 45' ' ' VAL . 22.5 t -48.56 142.1 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 51.0 p -149.73 172.05 15.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.856 0.36 . . . . 0.0 111.525 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.542 HG12 HD13 ' A' ' 83' ' ' LEU . 20.4 mt -145.02 113.72 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.606 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.628 HG23 HG22 ' A' ' 16' ' ' VAL . 4.1 mp -93.05 118.83 39.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.791 0.329 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.752 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.6 mt -106.48 90.96 5.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.43 159.52 43.74 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.517 2.145 . . . . 0.0 112.334 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.31 106.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.908 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.08 -8.88 3.85 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.056 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.01 -23.91 55.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.97 0.385 . . . . 0.0 111.451 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.821 HD13 ' HB2' ' A' ' 39' ' ' GLN . 36.3 mt -131.0 141.09 40.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.798 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.771 ' HD3' HD21 ' A' ' 78' ' ' LEU . 38.3 Cg_exo -60.34 155.48 46.26 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.392 2.061 . . . . 0.0 112.264 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -68.27 152.63 45.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.74 23.34 63.05 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.529 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 38' ' ' GLU . 41.6 t -128.51 160.75 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.146 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.625 ' HB3' HG21 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -135.8 113.84 11.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.008 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.821 ' HB2' HD13 ' A' ' 33' ' ' ILE . 1.2 tp60 -101.05 110.73 22.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.026 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -70.6 114.16 8.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.546 HD11 ' HE1' ' A' ' 77' ' ' PHE . 24.7 mt -124.99 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.418 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 40.4 p90 -155.56 152.92 29.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -157.1 162.92 39.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.943 0.401 . . . . 0.0 111.384 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.643 ' HB3' HD11 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -130.33 126.67 37.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.774 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.841 HG21 ' HB ' ' A' ' 24' ' ' VAL . 39.2 t -114.3 134.71 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.944 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' HB3' HD12 ' A' ' 67' ' ' LEU . 11.2 t -159.66 148.81 17.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -70.95 -24.18 62.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.701 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' CB ' HG12 ' A' ' 51' ' ' ILE . 34.4 m-20 -132.74 139.96 47.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.612 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -90.59 -30.79 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.274 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 m -71.26 -26.49 62.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 51' ' ' ILE . 32.7 mm -65.56 -14.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.418 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.2 OUTLIER 177.57 116.89 0.17 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.035 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.36 173.22 1.52 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.483 2.122 . . . . 0.0 112.115 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.58 171.99 15.22 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.506 2.137 . . . . 0.0 112.354 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD11 ' HB3' ' A' ' 44' ' ' LYS . 5.5 mp -62.21 -73.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -130.82 89.73 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.92 75.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.61 -35.82 77.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.945 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -66.87 -28.51 68.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.8 111.7 3.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.7 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.8 pm0 -113.36 136.88 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 111.011 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 m -100.76 98.47 8.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.588 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -76.45 133.92 39.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -126.44 -57.66 1.37 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.206 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -87.13 174.31 5.55 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.576 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 7.5 Cg_exo -34.5 -44.85 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 0.0 111.735 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.1 tm? -156.45 84.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.699 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 64' ' ' LEU . 51.6 t -146.89 118.07 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.289 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB1' ' HB2' ' A' ' 61' ' ' GLU . . . -108.85 106.19 16.07 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.786 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.25 -168.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.85 -148.07 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.688 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.53 127.56 21.14 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.505 2.137 . . . . 0.0 112.009 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -57.2 110.87 0.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.961 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.88 76.33 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.74 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 39' ' ' GLN . 18.9 tp -140.56 86.06 2.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 110.006 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 117' ' ' HIS . 11.2 mtpp -75.99 123.89 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.173 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.546 ' HE1' HD11 ' A' ' 41' ' ' ILE . 40.8 m-85 -98.68 168.59 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.557 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.771 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -105.63 16.16 25.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.378 0.609 . . . . 0.0 111.032 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -161.42 136.51 5.54 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.46 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 79' ' ' LYS . 24.6 Cg_exo -63.41 107.06 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.491 2.128 . . . . 0.0 112.499 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.9 m -79.41 144.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -88.4 116.04 26.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 111.05 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 84' ' ' ARG . 9.2 tp -113.39 129.83 56.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 83' ' ' LEU . 51.2 mtp180 -121.66 132.65 54.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.736 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -139.51 113.82 8.0 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.64 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.68 120.69 8.77 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.095 . . . . 0.0 112.185 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.77 -21.32 55.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER 68.66 -168.6 0.18 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 62.62 79.53 0.26 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.47 46.57 2.12 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.826 2.351 . . . . 0.0 112.776 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.06 4.94 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.468 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 t -122.53 16.0 10.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.881 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.402 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.8 p-90 -114.17 -36.86 4.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.402 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.4 OUTLIER -108.67 43.63 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.934 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.05 -47.15 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.12 -38.19 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 4.5 m -85.36 174.51 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.47 139.27 21.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.27 -17.82 27.21 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.597 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.47 -29.47 19.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.705 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.71 140.29 83.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.792 0.33 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.743 ' O ' HG22 ' A' ' 106' ' ' VAL . 43.0 Cg_endo -67.2 -25.73 42.9 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.592 2.195 . . . . 0.0 112.259 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -16.85 62.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 110.607 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.777 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.31 -19.01 19.65 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.936 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.777 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 18.0 mt -155.96 -26.87 0.1 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.5 m -67.35 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 156.82 -27.92 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.411 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.03 -32.39 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -127.66 42.1 3.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.45 122.21 18.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.715 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.736 HG11 HD12 ' A' ' 85' ' ' LEU . 13.5 p -106.15 111.54 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.388 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.9 104.98 13.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 111' ' ' VAL . 6.3 m -122.78 126.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mt -99.12 121.0 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.902 ' O ' HG22 ' A' ' 81' ' ' VAL . 12.4 mm -111.88 119.53 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.356 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.504 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 2.7 t0 -119.57 15.39 12.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 4.3 m80 -162.35 125.42 2.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.723 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.17 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.706 ' O ' HG12 ' A' ' 2' ' ' VAL . 6.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.487 0.184 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 1' ' ' THR . 8.0 p 52.34 162.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.927 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.825 HG21 ' CD ' ' A' ' 53' ' ' PRO . 13.0 t -121.64 139.07 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.302 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.31 117.3 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.156 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.884 HG21 HD11 ' A' ' 55' ' ' LEU . 41.8 p -132.55 143.8 49.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -133.58 120.97 21.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 1.4 mtt180 -122.0 132.12 54.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.63 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.39 157.29 28.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.954 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.1 mt -94.98 151.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.741 0.305 . . . . 0.0 110.607 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.977 ' CD1' HD12 ' A' ' 28' ' ' ILE . 41.1 m-85 -128.26 144.86 51.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.978 0.418 . . . . 0.0 111.402 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.73 ' HA ' HG21 ' A' ' 33' ' ' ILE . 2.9 m120 -128.58 171.91 11.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -47.38 -28.64 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.203 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -54.3 -38.48 65.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.04 173.73 40.76 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.717 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.28 -155.17 26.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.07 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.605 HG13 HG13 ' A' ' 27' ' ' ILE . 2.4 t -146.97 150.23 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.266 0.555 . . . . 0.0 111.628 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 6' ' ' ALA . 56.4 tp -123.34 100.27 6.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.352 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.79 148.48 50.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 112.016 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 p -116.16 96.99 5.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.001 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -50.15 -26.62 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.741 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -64.45 -38.49 91.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.193 -179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.679 HG21 HG12 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -105.01 -52.87 2.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.193 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.73 -30.92 3.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.758 HG22 ' HD2' ' A' ' 86' ' ' PRO . 42.1 t -56.12 142.58 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.687 0.279 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.01 154.0 41.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 111.453 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.671 HG12 HD13 ' A' ' 83' ' ' LEU . 49.7 mt -132.13 113.62 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.527 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 16' ' ' VAL . 2.5 mt -93.59 136.11 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.992 0.425 . . . . 0.0 111.174 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.977 HD12 ' CD1' ' A' ' 10' ' ' PHE . 2.3 mt -128.69 87.02 56.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.744 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.42 162.19 37.61 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.494 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -54.72 107.4 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.992 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 139.89 -10.75 3.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.114 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.833 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -86.14 -33.69 20.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 11' ' ' ASN . 1.9 mm -101.51 132.74 21.42 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.526 ' HB2' HG21 ' A' ' 37' ' ' VAL . 16.7 Cg_exo -66.08 144.97 77.77 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.154 1.903 . . . . 0.0 111.949 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 37' ' ' VAL . 5.1 mt-10 -57.76 141.57 48.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.25 28.04 71.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.682 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 38' ' ' GLU . 26.0 t -131.98 159.87 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 111.613 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.533 ' N ' HG12 ' A' ' 37' ' ' VAL . 31.1 mt-10 -129.96 113.95 15.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.755 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG2' HD11 ' A' ' 75' ' ' LEU . 5.4 tp60 -101.22 109.0 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.374 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -75.8 116.06 16.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 HD11 ' HE1' ' A' ' 77' ' ' PHE . 26.4 mt -124.63 134.29 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.151 0.501 . . . . 0.0 111.6 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.428 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 30.6 p90 -150.79 155.06 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.972 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 1.6 p90 -157.86 160.36 37.61 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.653 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' HD3' HD13 ' A' ' 55' ' ' LEU . 16.2 ttpp -120.07 151.65 38.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.846 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.679 HG12 HG21 ' A' ' 22' ' ' THR . 48.4 t -156.81 143.38 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.772 ' HB3' HG13 ' A' ' 3' ' ' VAL . 26.5 p -173.76 149.1 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 111.348 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -38.28 76.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.11 111.0 23.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.91 -9.49 58.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.668 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -72.47 -43.92 63.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 51' ' ' ILE . 26.3 mt -77.45 0.12 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.449 ' CD1' HD11 ' A' ' 67' ' ' LEU . 11.5 tp -47.53 104.12 0.4 Allowed Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.838 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.825 ' CD ' HG21 ' A' ' 3' ' ' VAL . 97.2 Cg_endo -84.87 147.52 10.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.703 2.269 . . . . 0.0 112.203 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 49.6 Cg_exo -55.64 122.79 12.37 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.402 2.068 . . . . 0.0 112.259 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.884 HD11 HG21 ' A' ' 5' ' ' THR . 0.1 OUTLIER -110.88 -50.74 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -178.38 68.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.99 -49.89 26.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.064 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.13 -34.58 68.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.112 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -25.54 66.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.018 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 112.2 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.254 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.566 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 79.7 mt-10 -115.18 124.55 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 111.239 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.4 m -102.05 111.77 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.483 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -77.2 142.04 39.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.198 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.488 HD21 ' HE1' ' A' ' 118' ' ' PHE . 0.1 OUTLIER -126.44 -57.56 1.37 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.081 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -103.2 -173.1 0.27 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.192 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 55.7 Cg_exo -39.87 -58.49 0.88 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.075 1.85 . . . . 0.0 111.747 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.712 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.0 tm? -138.13 85.24 2.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 0.0 110.432 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 48.1 t -147.17 118.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.731 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -112.14 106.11 14.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.9 -143.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.55 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 31.7 Cg_endo -64.07 131.53 30.96 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.494 2.129 . . . . 0.0 112.04 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -56.59 110.82 0.85 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.37 79.8 1.27 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.638 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 28.9 tp -142.3 85.29 1.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.467 ' CB ' ' CD2' ' A' ' 117' ' ' HIS . 4.9 ptmt -85.23 122.01 28.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.078 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.549 ' HE1' HD11 ' A' ' 41' ' ' ILE . 33.2 m-85 -93.2 170.9 9.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.752 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -98.6 18.41 16.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.296 0.569 . . . . 0.0 111.077 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.62 136.6 3.02 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.512 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.52 104.08 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.504 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 115' ' ' ILE . 5.6 m -76.73 139.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.887 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 2.0 tp10 -84.5 127.98 34.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.919 0.39 . . . . 0.0 111.347 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.671 HD13 HG12 ' A' ' 26' ' ' ILE . 25.3 tp -124.21 118.24 26.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.47 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 24' ' ' VAL . 10.1 mmm-85 -105.46 134.33 48.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.933 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.985 HD12 HG11 ' A' ' 111' ' ' VAL . 0.4 OUTLIER -131.83 122.26 18.46 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.758 ' HD2' HG22 ' A' ' 24' ' ' VAL . 74.2 Cg_endo -75.27 120.24 5.9 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.429 2.086 . . . . 0.0 112.168 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -73.52 -27.12 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.067 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.2 m 63.41 55.43 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.011 0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -130.92 92.0 35.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.774 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.0 41.03 1.03 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.191 2.594 . . . . 0.0 112.783 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -1.46 19.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.525 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -122.75 16.14 10.21 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.447 ' CD1' ' HG2' ' A' ' 94' ' ' GLN . 4.9 p-90 -110.73 -38.77 5.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.447 ' HG2' ' CD1' ' A' ' 93' ' ' TRP . 5.0 pt20 -95.51 152.73 18.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.059 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 64.04 31.22 13.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.761 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.22 -47.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.6 m -129.3 -172.3 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.2 mt -85.75 141.01 35.66 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.57 -1.71 11.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.67 2.247 . . . . 0.0 112.847 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.41 -34.22 4.55 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.707 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.414 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 77.3 m-20 -61.08 123.12 74.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.538 0.209 . . . . 0.0 110.978 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.821 ' O ' HG22 ' A' ' 106' ' ' VAL . 51.6 Cg_exo -54.24 -30.84 63.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.345 2.03 . . . . 0.0 112.158 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -61.91 -17.22 55.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.767 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -57.38 -17.69 13.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.665 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.767 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 14.0 mt -157.94 -30.58 0.08 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 102' ' ' PRO . 3.3 m -67.93 36.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 178.84 -47.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.688 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.75 67.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.764 0.316 . . . . 0.0 111.388 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -97.63 53.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.937 0.398 . . . . 0.0 111.022 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.7 m -162.6 135.9 5.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.985 HG11 HD12 ' A' ' 85' ' ' LEU . 13.2 p -99.86 116.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.182 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.28 105.03 13.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.916 0.389 . . . . 0.0 110.367 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 83' ' ' LEU . 4.4 m -126.18 123.09 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mt -93.17 131.95 37.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 81' ' ' VAL . 39.8 mm -114.15 117.26 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.305 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.81 27.23 8.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.13 179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.467 ' CD2' ' CB ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 177.3 104.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.4 m-85 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.14 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.737 0.303 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 3' ' ' VAL . 9.2 p -122.19 164.31 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.891 HG13 ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -107.47 125.13 63.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.663 ' HB2' ' HB3' ' A' ' 21' ' ' GLU . . . -94.15 117.63 30.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.554 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.705 HG21 HD11 ' A' ' 55' ' ' LEU . 72.2 p -119.07 143.7 46.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.413 . . . . 0.0 110.782 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.584 ' HB3' ' HE1' ' A' ' 43' ' ' PHE . . . -139.53 112.29 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.437 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 3.4 mtp85 -110.53 137.61 48.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.05 153.93 22.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.928 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 38' ' ' GLU . 35.4 mt -95.97 154.43 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 28' ' ' ILE . 22.4 m-85 -122.79 172.18 8.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -155.1 171.87 19.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 p -58.62 -25.63 62.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.58 -57.4 12.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.93 0.395 . . . . 0.0 110.963 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.48 133.11 4.41 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.45 -169.83 21.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.126 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.65 HG13 HG13 ' A' ' 27' ' ' ILE . 1.9 t -139.89 148.76 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.175 0.512 . . . . 0.0 111.669 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.14 100.11 6.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.22 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.45 140.87 52.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.733 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 6' ' ' ALA . 0.5 OUTLIER -107.47 97.17 6.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.225 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.0 mm -51.37 -26.53 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.671 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 1.4 mt-10 -63.02 -40.82 98.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.291 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.6 HG23 ' HB3' ' A' ' 4' ' ' ALA . 2.4 p -105.84 -52.95 2.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.73 -30.94 3.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.609 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG22 ' HD2' ' A' ' 86' ' ' PRO . 56.3 t -57.15 144.01 10.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.715 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 p -144.95 161.58 39.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.015 0.436 . . . . 0.0 111.47 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 HD13 ' A' ' 83' ' ' LEU . 12.7 mt -137.88 114.07 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.843 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.65 HG13 HG13 ' A' ' 16' ' ' VAL . 3.0 mt -96.31 136.38 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.19 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.705 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -108.85 93.94 13.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.531 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.98 145.07 96.93 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.335 2.023 . . . . 0.0 112.236 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.75 104.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.276 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.64 -4.09 5.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.203 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.699 ' HB3' HG22 ' A' ' 28' ' ' ILE . . . -76.34 -28.07 56.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.013 0.406 . . . . 0.0 111.258 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.575 HD13 ' HG3' ' A' ' 39' ' ' GLN . 27.4 mt -126.42 141.84 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.746 ' HD3' HD21 ' A' ' 78' ' ' LEU . 39.4 Cg_exo -60.34 155.37 46.9 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.395 2.063 . . . . 0.0 112.234 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.48 141.91 57.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.64 22.03 79.24 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.683 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 38' ' ' GLU . 46.9 t -121.84 160.69 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.047 0.451 . . . . 0.0 111.311 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.556 ' N ' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -140.11 113.8 8.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.868 179.211 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.575 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.21 120.03 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.23 -179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -81.31 108.85 15.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.651 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' HB ' ' CE2' ' A' ' 10' ' ' PHE . 2.5 mt -117.17 137.54 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.955 0.407 . . . . 0.0 111.417 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.437 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 52.5 p90 -149.06 157.14 43.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.052 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -159.37 159.71 34.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.075 0.464 . . . . 0.0 111.64 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -126.45 124.08 39.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.809 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.538 HG21 ' HB ' ' A' ' 24' ' ' VAL . 60.6 t -112.75 130.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.693 ' HB2' HG12 ' A' ' 3' ' ' VAL . 53.2 t -151.65 148.86 28.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -74.75 -41.78 59.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . 1.1 m-20 -100.96 131.03 47.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.738 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -90.65 -40.63 11.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.11 -31.49 27.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.367 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.911 ' O ' HD22 ' A' ' 52' ' ' LEU . 22.5 mm -75.89 -3.62 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.385 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -147.32 114.73 4.19 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.96 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.16 157.89 28.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.403 2.068 . . . . 0.0 112.261 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.49 172.2 14.72 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.634 2.223 . . . . 0.0 112.444 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.705 HD11 HG21 ' A' ' 5' ' ' THR . 2.9 tp -77.2 -53.57 7.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.842 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.28 107.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.894 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -73.0 -35.71 66.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.8 -35.6 73.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.018 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -71.49 -29.92 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.37 111.55 3.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.392 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.707 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 91.7 mt-10 -128.37 132.46 48.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 m -106.02 106.36 16.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -75.69 135.11 40.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -126.38 -57.7 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.297 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 68' ' ' VAL . 1.1 p -86.78 -175.16 0.56 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.511 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 79.6 Cg_exo -42.06 -47.86 6.56 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.214 1.943 . . . . 0.0 111.705 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.748 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.7 tm? -154.86 81.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.805 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG23 ' OG ' ' A' ' 65' ' ' SER . 69.0 t -142.27 118.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.296 178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 61' ' ' GLU . . . -105.72 106.16 16.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.507 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -166.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.211 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -79.35 -144.2 2.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' CE1' ' A' ' 42' ' ' TYR . 75.4 Cg_exo -49.77 121.69 7.74 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.515 2.144 . . . . 0.0 112.197 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -58.17 111.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.09 83.93 1.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.625 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 11.9 tp -137.64 85.1 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 110.481 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 77' ' ' PHE . 1.7 tptp -61.7 132.82 54.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.789 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 43.3 m-85 -112.7 144.11 42.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.817 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.746 HD21 ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -88.8 17.22 5.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 111.369 179.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -164.68 136.33 3.45 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.21 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.28 102.54 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.522 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 115' ' ' ILE . 4.4 m -74.06 161.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.504 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -104.81 129.28 53.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 111.317 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.572 ' HB3' HG23 ' A' ' 113' ' ' VAL . 27.8 tp -124.16 118.07 26.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.387 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.503 ' O ' HG13 ' A' ' 24' ' ' VAL . 10.9 mmt180 -105.94 130.93 53.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.092 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.961 HD12 HG11 ' A' ' 111' ' ' VAL . 1.3 mt -128.13 116.18 20.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 24' ' ' VAL . 51.6 Cg_exo -54.48 136.73 70.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.385 2.057 . . . . 0.0 112.251 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.29 -20.12 57.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 68.31 31.45 5.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.833 0.349 . . . . 0.0 110.964 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -143.63 77.88 14.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.697 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.48 54.42 2.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.923 2.415 . . . . 0.0 112.628 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -109.31 -13.05 14.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.617 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 t -122.6 16.1 10.33 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.474 ' NE1' ' HG2' ' A' ' 94' ' ' GLN . 3.4 p-90 -106.78 -36.05 6.8 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.474 ' HG2' ' NE1' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -104.32 71.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -119.37 -39.51 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 -43.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 35.4 m -54.56 179.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.13 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 98' ' ' LEU . 11.5 mt -99.0 135.87 20.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.895 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.93 -5.72 16.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 112.58 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.4 -41.04 7.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.648 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 61.2 m-20 -61.53 138.51 95.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.52 0.2 . . . . 0.0 110.745 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.762 ' O ' HG22 ' A' ' 106' ' ' VAL . 38.1 Cg_endo -66.05 -27.29 50.04 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.614 2.209 . . . . 0.0 112.175 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -65.28 -15.06 62.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.986 0.422 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.805 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -56.97 -19.45 18.25 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.839 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.805 HD12 ' CZ ' ' A' ' 104' ' ' TYR . 14.7 mt -155.58 -28.2 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 102' ' ' PRO . 4.0 m -67.11 36.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . -177.88 -36.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.649 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.98 -58.95 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.256 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -96.18 88.39 4.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.9 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.47 141.74 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.961 HG11 HD12 ' A' ' 85' ' ' LEU . 14.2 p -97.32 115.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.18 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.77 104.99 10.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.133 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 83' ' ' LEU . 12.3 m -128.07 120.97 54.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.994 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 12.2 mt -87.06 146.12 26.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 81' ' ' VAL . 30.8 mm -129.8 120.39 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.2 25.87 8.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.078 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.451 ' CD2' ' HD3' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 179.36 103.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.823 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.2 -19.16 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.439 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.752 HG21 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -111.21 126.25 68.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.363 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' A' ' 21' ' ' GLU . . . -104.84 117.61 34.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.497 HG22 ' HB3' ' A' ' 44' ' ' LYS . 57.2 p -118.57 143.27 46.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.963 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.863 ' HB1' HD11 ' A' ' 17' ' ' LEU . . . -139.45 122.96 17.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.967 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.458 ' CG ' ' HB2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -127.85 129.36 46.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.36 142.88 7.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.932 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -89.89 135.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.627 0.251 . . . . 0.0 110.586 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.838 ' CG ' HD12 ' A' ' 28' ' ' ILE . 92.7 m-85 -115.89 151.6 35.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.101 0.477 . . . . 0.0 111.374 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -129.0 172.31 11.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.654 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.42 -28.97 0.62 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -54.76 -29.7 54.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.136 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.57 167.43 32.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.679 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.97 158.48 9.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.347 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.615 HG22 HG23 ' A' ' 27' ' ' ILE . 2.9 t -114.58 151.03 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' A' ' 6' ' ' ALA . 44.0 tp -123.47 100.24 6.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.29 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.47 152.9 42.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.022 0.439 . . . . 0.0 111.89 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.463 ' HB3' ' HB1' ' A' ' 4' ' ' ALA . 51.2 m -120.75 97.25 5.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.199 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -52.73 -26.54 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' CB ' ' HB2' ' A' ' 4' ' ' ALA . 3.3 mm-40 -66.7 -36.3 82.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.304 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.444 HG21 ' HB ' ' A' ' 45' ' ' VAL . 4.3 p -109.22 -52.89 2.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.736 0.303 . . . . 0.0 111.356 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.92 -43.11 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.812 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.629 ' HB ' HG21 ' A' ' 45' ' ' VAL . 47.2 t -49.83 143.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 111.181 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 9.4 p -149.47 167.14 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.516 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 83' ' ' LEU . 14.0 mt -139.67 113.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.038 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.615 HG23 HG22 ' A' ' 16' ' ' VAL . 2.2 mp -92.81 122.92 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.838 HD12 ' CG ' ' A' ' 10' ' ' PHE . 2.2 mt -112.08 89.48 11.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.85 156.67 65.03 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.499 2.133 . . . . 0.0 112.163 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -57.29 104.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 145.17 -13.51 1.87 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.13 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 79' ' ' LYS . . . -78.13 -36.01 48.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.965 0.382 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.465 HD13 ' CG ' ' A' ' 39' ' ' GLN . 16.3 mt -108.32 141.37 23.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.596 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 33' ' ' ILE . 19.7 Cg_exo -65.37 155.17 70.12 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.336 2.024 . . . . 0.0 112.131 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 142.46 57.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.53 23.37 75.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 38' ' ' GLU . 48.2 t -126.88 161.03 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 111.251 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.56 ' N ' HG12 ' A' ' 37' ' ' VAL . 3.2 mt-10 -137.04 113.74 10.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.813 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.465 ' CG ' HD13 ' A' ' 33' ' ' ILE . 1.4 mm-40 -105.71 117.41 33.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.909 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -69.72 119.58 14.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.596 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.501 HD11 HD21 ' A' ' 75' ' ' LEU . 3.7 mm -120.66 109.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.458 ' HB2' ' CG ' ' A' ' 7' ' ' ARG . 12.3 p90 -138.18 161.27 37.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.309 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 6' ' ' ALA . 0.5 OUTLIER -170.84 165.22 7.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.027 0.441 . . . . 0.0 111.86 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' NZ ' HD11 ' A' ' 67' ' ' LEU . 2.3 pttp -132.37 132.63 43.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.691 HG22 HG13 ' A' ' 68' ' ' VAL . 56.4 t -119.2 138.52 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.228 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.554 ' HB2' HG12 ' A' ' 3' ' ' VAL . 53.3 t -165.53 148.99 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.773 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.7 -38.97 70.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.049 0.452 . . . . 0.0 110.829 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' HB3' HG12 ' A' ' 51' ' ' ILE . 13.0 t70 -132.73 157.99 43.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.595 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -90.43 -40.77 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.553 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 m -53.54 -23.64 11.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.642 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 51' ' ' ILE . 24.8 mm -66.76 -12.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.647 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.752 HD22 HG21 ' A' ' 3' ' ' VAL . 16.0 tp -169.35 137.07 1.53 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.663 0.268 . . . . 0.0 111.07 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' A' ' 52' ' ' LEU . 64.4 Cg_endo -73.56 163.69 36.84 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.449 2.1 . . . . 0.0 112.333 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.43 169.17 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.575 2.183 . . . . 0.0 112.231 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.1 mp -86.63 -35.47 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.81 96.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -33.87 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.023 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.73 -29.58 68.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -80.33 -32.9 37.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.05 111.85 3.6 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.33 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -96.3 115.11 26.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.824 0.345 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.22 111.31 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.472 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -80.87 144.04 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.296 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -126.34 -57.68 1.38 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.013 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.543 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -98.97 -173.37 0.31 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.297 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 65' ' ' SER . 65.2 Cg_exo -40.49 -42.4 3.88 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.223 1.949 . . . . 0.0 111.864 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 67' ' ' LEU . 2.6 tm? -157.6 81.2 0.88 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.744 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.691 HG13 HG22 ' A' ' 45' ' ' VAL . 43.2 t -141.55 118.01 7.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.609 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.63 106.19 16.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.553 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.529 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -66.8 -169.6 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.041 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 42' ' ' TYR . . . -61.3 -152.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.541 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 37.1 Cg_endo -65.94 134.37 36.99 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.544 2.163 . . . . 0.0 112.065 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -60.57 110.95 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.37 75.98 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.718 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 118' ' ' PHE . 24.4 tp -142.27 86.41 1.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.144 0.497 . . . . 0.0 110.2 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HG2' ' CD2' ' A' ' 117' ' ' HIS . 0.1 OUTLIER -53.78 164.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.433 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -146.34 141.37 27.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.625 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.412 HD21 ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -95.68 16.66 16.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.317 0.58 . . . . 0.0 110.827 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -166.51 136.78 2.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.021 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.77 100.65 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.525 2.15 . . . . 0.0 112.641 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 115' ' ' ILE . 13.5 m -68.13 139.48 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -82.86 123.39 29.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 0.0 111.409 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 26' ' ' ILE . 7.7 tp -124.2 121.05 34.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.182 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.517 ' N ' HD12 ' A' ' 83' ' ' LEU . 71.7 mtt-85 -115.78 132.88 56.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.727 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.709 HD12 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.68 119.49 6.37 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.527 179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.63 130.75 38.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.274 1.983 . . . . 0.0 112.236 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.6 -54.8 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.029 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.27 168.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 56.04 85.25 0.19 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.187 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -87.14 38.21 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.855 2.37 . . . . 0.0 112.681 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -108.98 13.17 24.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.54 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.9 t -105.47 15.92 26.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 111.819 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.512 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 4.6 p-90 -121.16 -39.94 2.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 93' ' ' TRP . 4.6 mm100 -99.51 59.38 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.97 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -127.12 89.2 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.821 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tptt 60.74 29.62 19.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 m -120.5 -171.13 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 98' ' ' LEU . 16.5 mt -85.81 128.75 57.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.27 -7.97 17.26 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.497 2.132 . . . . 0.0 112.539 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.92 10.95 8.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.053 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -71.48 126.62 91.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.937 0.369 . . . . 0.0 110.375 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.744 ' O ' HG21 ' A' ' 106' ' ' VAL . 58.2 Cg_endo -71.48 -7.03 20.41 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.165 1.91 . . . . 0.0 112.671 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.485 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -104.82 17.36 24.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.542 ' CD1' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -75.43 -113.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.034 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -48.04 -21.09 0.4 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.744 HG21 ' O ' ' A' ' 102' ' ' PRO . 15.6 m -68.71 36.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 105' ' ' LEU . . . 155.2 34.83 0.02 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.645 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.72 -51.59 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 111.04 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.3 29.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.859 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 151.17 36.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.769 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.709 HG11 HD12 ' A' ' 85' ' ' LEU . 11.8 p -93.63 103.87 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.204 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.34 104.98 7.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 83' ' ' LEU . 5.4 m -120.85 123.22 69.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.45 135.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.53 ' O ' HG22 ' A' ' 81' ' ' VAL . 35.7 mm -119.54 117.83 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.244 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.34 26.29 9.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.292 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.509 ' CD2' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER 178.7 111.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 m-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.052 179.893 . . . . . . . . 1 1 . 1 stop_ save_